id	sid	tid	token	lemma	pos
inlawrev-25507	1	1	indiana	indiana	PROPN
inlawrev-25507	1	2	law	law	PROPN
inlawrev-25507	1	3	review	review	NOUN
inlawrev-25507	1	4	volume	volume	NOUN
inlawrev-25507	1	5	54	54	NUM
inlawrev-25507	1	6	2021	2021	NUM
inlawrev-25507	1	7	number	number	NOUN
inlawrev-25507	1	8	1	1	NUM
inlawrev-25507	1	9	notes	note	NOUN
inlawrev-25507	1	10	leaving	leave	VERB
inlawrev-25507	1	11	the	the	DET
inlawrev-25507	1	12	evergreening	evergreene	VERB
inlawrev-25507	1	13	problem	problem	NOUN
inlawrev-25507	1	14	to	to	ADP
inlawrev-25507	1	15	the	the	DET
inlawrev-25507	1	16	patent	patent	NOUN
inlawrev-25507	1	17	experts	expert	NOUN
inlawrev-25507	1	18	–	–	PUNCT
inlawrev-25507	1	19	the	the	DET
inlawrev-25507	1	20	uspto	uspto	NOUN
inlawrev-25507	1	21	,	,	PUNCT
inlawrev-25507	1	22	the	the	DET
inlawrev-25507	1	23	ptab	ptab	NOUN
inlawrev-25507	1	24	,	,	PUNCT
inlawrev-25507	1	25	and	and	CCONJ
inlawrev-25507	1	26	the	the	DET
inlawrev-25507	1	27	federal	federal	ADJ
inlawrev-25507	1	28	circuit	circuit	PROPN
inlawrev-25507	1	29	malissa	malissa	PROPN
inlawrev-25507	1	30	s.	s.	PROPN
inlawrev-25507	1	31	magiera	magiera	PROPN
inlawrev-25507	1	32	*	*	PROPN
inlawrev-25507	2	1	introduction	introduction	NOUN
inlawrev-25507	2	2	one	one	NUM
inlawrev-25507	2	3	of	of	ADP
inlawrev-25507	2	4	the	the	DET
inlawrev-25507	2	5	top	top	ADJ
inlawrev-25507	2	6	ten	ten	NUM
inlawrev-25507	2	7	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	2	8	companies	company	NOUN
inlawrev-25507	2	9	in	in	ADP
inlawrev-25507	2	10	the	the	DET
inlawrev-25507	2	11	world	world	NOUN
inlawrev-25507	2	12	,	,	PUNCT
inlawrev-25507	2	13	abbvie	abbvie	PROPN
inlawrev-25507	2	14	,	,	PUNCT
inlawrev-25507	2	15	inc	inc	PROPN
inlawrev-25507	2	16	.	.	PROPN
inlawrev-25507	2	17	,	,	PUNCT
inlawrev-25507	2	18	lost	lose	VERB
inlawrev-25507	2	19	its	its	PRON
inlawrev-25507	2	20	compound	compound	NOUN
inlawrev-25507	2	21	patent	patent	NOUN
inlawrev-25507	2	22	on	on	ADP
inlawrev-25507	2	23	the	the	DET
inlawrev-25507	2	24	world	world	NOUN
inlawrev-25507	2	25	’s	’s	PART
inlawrev-25507	2	26	best	well	ADV
inlawrev-25507	2	27	-	-	PUNCT
inlawrev-25507	2	28	selling	sell	VERB
inlawrev-25507	2	29	drug	drug	NOUN
inlawrev-25507	2	30	in	in	ADP
inlawrev-25507	2	31	2016.1	2016.1	NUM
inlawrev-25507	2	32	adalimumab	adalimumab	NOUN
inlawrev-25507	2	33	,	,	PUNCT
inlawrev-25507	2	34	also	also	ADV
inlawrev-25507	2	35	known	know	VERB
inlawrev-25507	2	36	as	as	ADP
inlawrev-25507	2	37	humira	humira	PROPN
inlawrev-25507	2	38	®	®	PROPN
inlawrev-25507	2	39	,	,	PUNCT
inlawrev-25507	2	40	generates	generate	VERB
inlawrev-25507	2	41	approximately	approximately	ADV
inlawrev-25507	2	42	$	$	SYM
inlawrev-25507	2	43	583	583	NUM
inlawrev-25507	2	44	per	per	ADP
inlawrev-25507	2	45	second	second	NOUN
inlawrev-25507	2	46	for	for	ADP
inlawrev-25507	2	47	abbvie.2	abbvie.2	ADP
inlawrev-25507	2	48	the	the	DET
inlawrev-25507	2	49	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	2	50	company	company	NOUN
inlawrev-25507	2	51	’s	’s	PART
inlawrev-25507	2	52	continued	continue	VERB
inlawrev-25507	2	53	success	success	NOUN
inlawrev-25507	2	54	lies	lie	VERB
inlawrev-25507	2	55	in	in	ADP
inlawrev-25507	2	56	its	its	PRON
inlawrev-25507	2	57	manipulation	manipulation	NOUN
inlawrev-25507	2	58	of	of	ADP
inlawrev-25507	2	59	the	the	DET
inlawrev-25507	2	60	patent	patent	NOUN
inlawrev-25507	2	61	system.3	system.3	NOUN
inlawrev-25507	2	62	the	the	DET
inlawrev-25507	2	63	twenty	twenty	NUM
inlawrev-25507	2	64	-	-	PUNCT
inlawrev-25507	2	65	year	year	NOUN
inlawrev-25507	2	66	exclusivity	exclusivity	NOUN
inlawrev-25507	2	67	restriction	restriction	NOUN
inlawrev-25507	2	68	in	in	ADP
inlawrev-25507	2	69	patent	patent	NOUN
inlawrev-25507	2	70	law	law	NOUN
inlawrev-25507	2	71	ensures	ensure	VERB
inlawrev-25507	2	72	that	that	SCONJ
inlawrev-25507	2	73	society	society	NOUN
inlawrev-25507	2	74	receives	receive	VERB
inlawrev-25507	2	75	the	the	DET
inlawrev-25507	2	76	benefit	benefit	NOUN
inlawrev-25507	2	77	of	of	ADP
inlawrev-25507	2	78	the	the	DET
inlawrev-25507	2	79	drug	drug	NOUN
inlawrev-25507	2	80	as	as	SCONJ
inlawrev-25507	2	81	it	it	PRON
inlawrev-25507	2	82	enters	enter	VERB
inlawrev-25507	2	83	into	into	ADP
inlawrev-25507	2	84	the	the	DET
inlawrev-25507	2	85	public	public	ADJ
inlawrev-25507	2	86	domain.4	domain.4	NOUN
inlawrev-25507	2	87	however	however	ADV
inlawrev-25507	2	88	,	,	PUNCT
inlawrev-25507	2	89	abbvie	abbvie	PROPN
inlawrev-25507	2	90	has	have	AUX
inlawrev-25507	2	91	obtained	obtain	VERB
inlawrev-25507	2	92	more	more	ADJ
inlawrev-25507	2	93	than	than	ADP
inlawrev-25507	2	94	247	247	NUM
inlawrev-25507	2	95	patents	patent	NOUN
inlawrev-25507	2	96	on	on	ADP
inlawrev-25507	2	97	humira	humira	PROPN
inlawrev-25507	2	98	®	®	PROPN
inlawrev-25507	2	99	in	in	ADP
inlawrev-25507	2	100	the	the	DET
inlawrev-25507	2	101	united	united	PROPN
inlawrev-25507	2	102	states	states	PROPN
inlawrev-25507	2	103	alone	alone	ADV
inlawrev-25507	2	104	to	to	PART
inlawrev-25507	2	105	extend	extend	VERB
inlawrev-25507	2	106	its	its	PRON
inlawrev-25507	2	107	own	own	ADJ
inlawrev-25507	2	108	exclusivity	exclusivity	NOUN
inlawrev-25507	2	109	in	in	ADP
inlawrev-25507	2	110	the	the	DET
inlawrev-25507	2	111	drug	drug	NOUN
inlawrev-25507	2	112	’s	’s	PART
inlawrev-25507	2	113	market.5	market.5	NOUN
inlawrev-25507	2	114	additionally	additionally	ADV
inlawrev-25507	2	115	,	,	PUNCT
inlawrev-25507	2	116	abbvie	abbvie	PROPN
inlawrev-25507	2	117	filed	file	VERB
inlawrev-25507	2	118	eighty	eighty	NUM
inlawrev-25507	2	119	-	-	PUNCT
inlawrev-25507	2	120	nine	nine	NUM
inlawrev-25507	2	121	percent	percent	NOUN
inlawrev-25507	2	122	of	of	ADP
inlawrev-25507	2	123	humira	humira	PROPN
inlawrev-25507	2	124	®	®	NOUN
inlawrev-25507	2	125	patents	patent	NOUN
inlawrev-25507	2	126	after	after	SCONJ
inlawrev-25507	2	127	the	the	DET
inlawrev-25507	2	128	drug	drug	NOUN
inlawrev-25507	2	129	was	be	AUX
inlawrev-25507	2	130	introduced	introduce	VERB
inlawrev-25507	2	131	to	to	ADP
inlawrev-25507	2	132	the	the	DET
inlawrev-25507	2	133	public.6	public.6	PROPN
inlawrev-25507	2	134	abbvie	abbvie	PROPN
inlawrev-25507	2	135	filed	file	VERB
inlawrev-25507	2	136	more	more	ADJ
inlawrev-25507	2	137	than	than	ADP
inlawrev-25507	2	138	fifty	fifty	NUM
inlawrev-25507	2	139	percent	percent	NOUN
inlawrev-25507	2	140	of	of	ADP
inlawrev-25507	2	141	the	the	DET
inlawrev-25507	2	142	total	total	ADJ
inlawrev-25507	2	143	applications	application	NOUN
inlawrev-25507	2	144	twenty	twenty	NUM
inlawrev-25507	2	145	years	year	NOUN
inlawrev-25507	2	146	after	after	SCONJ
inlawrev-25507	2	147	initial	initial	ADJ
inlawrev-25507	2	148	research	research	NOUN
inlawrev-25507	2	149	began	begin	VERB
inlawrev-25507	2	150	and	and	CCONJ
inlawrev-25507	2	151	more	more	ADJ
inlawrev-25507	2	152	than	than	ADP
inlawrev-25507	2	153	a	a	PRON
inlawrev-25507	2	154	decade	decade	NOUN
inlawrev-25507	2	155	after	after	SCONJ
inlawrev-25507	2	156	the	the	DET
inlawrev-25507	2	157	drug	drug	NOUN
inlawrev-25507	2	158	was	be	AUX
inlawrev-25507	2	159	initially	initially	ADV
inlawrev-25507	2	160	sold.7	sold.7	VERB
inlawrev-25507	2	161	what	what	PRON
inlawrev-25507	2	162	should	should	AUX
inlawrev-25507	2	163	have	have	AUX
inlawrev-25507	2	164	been	be	AUX
inlawrev-25507	2	165	a	a	DET
inlawrev-25507	2	166	price	price	NOUN
inlawrev-25507	2	167	decrease	decrease	NOUN
inlawrev-25507	2	168	in	in	ADP
inlawrev-25507	2	169	the	the	DET
inlawrev-25507	2	170	drug	drug	NOUN
inlawrev-25507	2	171	in	in	ADP
inlawrev-25507	2	172	2014	2014	NUM
inlawrev-25507	2	173	due	due	ADP
inlawrev-25507	2	174	to	to	ADP
inlawrev-25507	2	175	loss	loss	NOUN
inlawrev-25507	2	176	of	of	ADP
inlawrev-25507	2	177	exclusivity	exclusivity	NOUN
inlawrev-25507	2	178	could	could	AUX
inlawrev-25507	2	179	theoretically	theoretically	ADV
inlawrev-25507	2	180	be	be	AUX
inlawrev-25507	2	181	a	a	DET
inlawrev-25507	2	182	constant	constant	ADJ
inlawrev-25507	2	183	increase	increase	NOUN
inlawrev-25507	2	184	in	in	ADP
inlawrev-25507	2	185	pricing	pricing	NOUN
inlawrev-25507	2	186	until	until	ADP
inlawrev-25507	2	187	*	*	PROPN
inlawrev-25507	2	188	j.d	j.d	PROPN
inlawrev-25507	2	189	.	.	PROPN
inlawrev-25507	2	190	candidate	candidate	NOUN
inlawrev-25507	2	191	,	,	PUNCT
inlawrev-25507	2	192	2021	2021	NUM
inlawrev-25507	2	193	,	,	PUNCT
inlawrev-25507	2	194	indiana	indiana	PROPN
inlawrev-25507	2	195	university	university	PROPN
inlawrev-25507	2	196	robert	robert	PROPN
inlawrev-25507	2	197	h.	h.	PROPN
inlawrev-25507	2	198	mckinney	mckinney	PROPN
inlawrev-25507	2	199	school	school	PROPN
inlawrev-25507	2	200	of	of	ADP
inlawrev-25507	2	201	law	law	NOUN
inlawrev-25507	2	202	;	;	PUNCT
inlawrev-25507	2	203	b.s	b.s	PROPN
inlawrev-25507	2	204	.	.	PROPN
inlawrev-25507	2	205	2017	2017	NUM
inlawrev-25507	2	206	,	,	PUNCT
inlawrev-25507	2	207	indiana	indiana	PROPN
inlawrev-25507	2	208	university	university	PROPN
inlawrev-25507	2	209	purdue	purdue	PROPN
inlawrev-25507	2	210	university	university	PROPN
inlawrev-25507	2	211	indianapolis	indianapolis	PROPN
inlawrev-25507	2	212	–	–	PUNCT
inlawrev-25507	2	213	indianapolis	indianapolis	PROPN
inlawrev-25507	2	214	,	,	PUNCT
inlawrev-25507	2	215	indiana	indiana	PROPN
inlawrev-25507	2	216	.	.	PUNCT
inlawrev-25507	3	1	recipient	recipient	NOUN
inlawrev-25507	3	2	of	of	ADP
inlawrev-25507	3	3	the	the	DET
inlawrev-25507	3	4	papke	papke	PROPN
inlawrev-25507	3	5	prize	prize	PROPN
inlawrev-25507	3	6	for	for	ADP
inlawrev-25507	3	7	best	good	ADJ
inlawrev-25507	3	8	note	note	NOUN
inlawrev-25507	3	9	in	in	ADP
inlawrev-25507	3	10	volume	volume	NOUN
inlawrev-25507	3	11	54	54	NUM
inlawrev-25507	3	12	,	,	PUNCT
inlawrev-25507	3	13	endowed	endow	VERB
inlawrev-25507	3	14	by	by	ADP
inlawrev-25507	3	15	and	and	CCONJ
inlawrev-25507	3	16	named	name	VERB
inlawrev-25507	3	17	in	in	ADP
inlawrev-25507	3	18	honor	honor	NOUN
inlawrev-25507	3	19	of	of	ADP
inlawrev-25507	3	20	david	david	PROPN
inlawrev-25507	3	21	r.	r.	PROPN
inlawrev-25507	3	22	papke	papke	PROPN
inlawrev-25507	3	23	,	,	PUNCT
inlawrev-25507	3	24	former	former	ADJ
inlawrev-25507	3	25	r.	r.	PROPN
inlawrev-25507	3	26	bruce	bruce	PROPN
inlawrev-25507	3	27	townsend	townsend	PROPN
inlawrev-25507	3	28	professor	professor	PROPN
inlawrev-25507	3	29	of	of	ADP
inlawrev-25507	3	30	law	law	NOUN
inlawrev-25507	3	31	and	and	CCONJ
inlawrev-25507	3	32	faculty	faculty	NOUN
inlawrev-25507	3	33	advisor	advisor	NOUN
inlawrev-25507	3	34	to	to	ADP
inlawrev-25507	3	35	the	the	DET
inlawrev-25507	3	36	indiana	indiana	PROPN
inlawrev-25507	3	37	law	law	PROPN
inlawrev-25507	3	38	review	review	PROPN
inlawrev-25507	3	39	.	.	PUNCT
inlawrev-25507	4	1	thank	thank	VERB
inlawrev-25507	4	2	you	you	PRON
inlawrev-25507	4	3	to	to	ADP
inlawrev-25507	4	4	carlos	carlos	PROPN
inlawrev-25507	4	5	garcia	garcia	PROPN
inlawrev-25507	4	6	for	for	ADP
inlawrev-25507	4	7	his	his	PRON
inlawrev-25507	4	8	guidance	guidance	NOUN
inlawrev-25507	4	9	and	and	CCONJ
inlawrev-25507	4	10	mentorship	mentorship	NOUN
inlawrev-25507	4	11	throughout	throughout	ADP
inlawrev-25507	4	12	the	the	DET
inlawrev-25507	4	13	note	note	NOUN
inlawrev-25507	4	14	writing	writing	NOUN
inlawrev-25507	4	15	process	process	NOUN
inlawrev-25507	4	16	,	,	PUNCT
inlawrev-25507	4	17	and	and	CCONJ
inlawrev-25507	4	18	to	to	ADP
inlawrev-25507	4	19	riley	riley	NOUN
inlawrev-25507	4	20	parr	parr	PROPN
inlawrev-25507	4	21	and	and	CCONJ
inlawrev-25507	4	22	cami	cami	NOUN
inlawrev-25507	4	23	trachtman	trachtman	NOUN
inlawrev-25507	4	24	for	for	ADP
inlawrev-25507	4	25	their	their	PRON
inlawrev-25507	4	26	critiques	critique	NOUN
inlawrev-25507	4	27	and	and	CCONJ
inlawrev-25507	4	28	assistance	assistance	NOUN
inlawrev-25507	4	29	in	in	ADP
inlawrev-25507	4	30	developing	develop	VERB
inlawrev-25507	4	31	this	this	DET
inlawrev-25507	4	32	note	note	NOUN
inlawrev-25507	4	33	.	.	PUNCT
inlawrev-25507	5	1	1	1	X
inlawrev-25507	5	2	.	.	X
inlawrev-25507	5	3	abbvie	abbvie	PROPN
inlawrev-25507	5	4	inc	inc	PROPN
inlawrev-25507	5	5	.	.	PROPN
inlawrev-25507	5	6	,	,	PUNCT
inlawrev-25507	5	7	annual	annual	ADJ
inlawrev-25507	5	8	report	report	NOUN
inlawrev-25507	5	9	(	(	PUNCT
inlawrev-25507	5	10	form	form	NOUN
inlawrev-25507	5	11	10	10	NUM
inlawrev-25507	5	12	-	-	PUNCT
inlawrev-25507	5	13	k	k	NOUN
inlawrev-25507	5	14	)	)	PUNCT
inlawrev-25507	5	15	(	(	PUNCT
inlawrev-25507	5	16	feb	feb	PROPN
inlawrev-25507	5	17	.	.	PROPN
inlawrev-25507	5	18	19	19	NUM
inlawrev-25507	5	19	,	,	PUNCT
inlawrev-25507	5	20	2016	2016	NUM
inlawrev-25507	5	21	)	)	PUNCT
inlawrev-25507	5	22	.	.	PUNCT
inlawrev-25507	6	1	2	2	X
inlawrev-25507	6	2	.	.	NUM
inlawrev-25507	6	3	overpatented	overpatente	VERB
inlawrev-25507	6	4	,	,	PUNCT
inlawrev-25507	6	5	overpriced	overprice	VERB
inlawrev-25507	6	6	:	:	PUNCT
inlawrev-25507	6	7	special	special	ADJ
inlawrev-25507	6	8	humira	humira	PROPN
inlawrev-25507	6	9	edition	edition	PROPN
inlawrev-25507	6	10	,	,	PUNCT
inlawrev-25507	6	11	i	i	PROPN
inlawrev-25507	6	12	-	-	PUNCT
inlawrev-25507	6	13	mak	mak	PROPN
inlawrev-25507	6	14	at	at	ADP
inlawrev-25507	6	15	7	7	NUM
inlawrev-25507	6	16	(	(	PUNCT
inlawrev-25507	6	17	sept	sept	PROPN
inlawrev-25507	6	18	.	.	PROPN
inlawrev-25507	6	19	18	18	NUM
inlawrev-25507	6	20	,	,	PUNCT
inlawrev-25507	6	21	2018	2018	NUM
inlawrev-25507	6	22	)	)	PUNCT
inlawrev-25507	6	23	,	,	PUNCT
inlawrev-25507	6	24	h	h	NOUN
inlawrev-25507	6	25	ttp://w	ttp://w	PROPN
inlawrev-25507	6	26	w	w	PROPN
inlawrev-25507	6	27	w	w	PROPN
inlawrev-25507	6	28	.i	.i	PROPN
inlawrev-25507	6	29	-	-	PUNCT
inlawrev-25507	6	30	mak.org	mak.org	NUM
inlawrev-25507	6	31	/	/	SYM
inlawrev-25507	6	32	wp	wp	NOUN
inlawrev-25507	6	33	-	-	PUNCT
inlawrev-25507	6	34	content	content	NOUN
inlawrev-25507	6	35	/	/	SYM
inlawrev-25507	6	36	uploads/2018/09	uploads/2018/09	PROPN
inlawrev-25507	6	37	/	/	SYM
inlawrev-25507	6	38	i	i	NOUN
inlawrev-25507	6	39	-	-	PUNCT
inlawrev-25507	6	40	mak.humira.report.final_0917	mak.humira.report.final_0917	NOUN
inlawrev-25507	6	41	.pdf	.pdf	PUNCT
inlawrev-25507	7	1	[	[	X
inlawrev-25507	7	2	https://perma.cc/34yj-7w79	https://perma.cc/34yj-7w79	X
inlawrev-25507	7	3	]	]	X
inlawrev-25507	7	4	.	.	PUNCT
inlawrev-25507	8	1	3	3	X
inlawrev-25507	8	2	.	.	X
inlawrev-25507	9	1	i	i	PRON
inlawrev-25507	9	2	d.	d.	PROPN
inlawrev-25507	9	3	4	4	NUM
inlawrev-25507	9	4	.	.	PUNCT
inlawrev-25507	10	1	why	why	SCONJ
inlawrev-25507	10	2	do	do	AUX
inlawrev-25507	10	3	patents	patent	NOUN
inlawrev-25507	10	4	expire	expire	VERB
inlawrev-25507	10	5	:	:	PUNCT
inlawrev-25507	10	6	everything	everything	PRON
inlawrev-25507	10	7	you	you	PRON
inlawrev-25507	10	8	need	need	VERB
inlawrev-25507	10	9	to	to	PART
inlawrev-25507	10	10	know	know	VERB
inlawrev-25507	10	11	,	,	PUNCT
inlawrev-25507	10	12	upcouns	upcoun	NOUN
inlawrev-25507	10	13	.	.	PUNCT
inlawrev-25507	10	14	,	,	PUNCT
inlawrev-25507	10	15	https://www	https://www	PROPN
inlawrev-25507	10	16	.	.	PUNCT
inlawrev-25507	11	1	upcounsel.com/why-do-patents-expire	upcounsel.com/why-do-patents-expire	PROPN
inlawrev-25507	11	2	(	(	PUNCT
inlawrev-25507	11	3	last	last	ADV
inlawrev-25507	11	4	visited	visit	VERB
inlawrev-25507	11	5	oct	oct	PROPN
inlawrev-25507	11	6	.	.	PROPN
inlawrev-25507	11	7	7	7	NUM
inlawrev-25507	11	8	,	,	PUNCT
inlawrev-25507	11	9	2019	2019	NUM
inlawrev-25507	11	10	)	)	PUNCT
inlawrev-25507	12	1	[	[	X
inlawrev-25507	12	2	https://perma.cc/aj6m-j7zr	https://perma.cc/aj6m-j7zr	X
inlawrev-25507	12	3	]	]	X
inlawrev-25507	12	4	.	.	PUNCT
inlawrev-25507	13	1	5	5	X
inlawrev-25507	13	2	.	.	NUM
inlawrev-25507	13	3	overpatented	overpatente	VERB
inlawrev-25507	13	4	,	,	PUNCT
inlawrev-25507	13	5	overpriced	overprice	VERB
inlawrev-25507	13	6	:	:	PUNCT
inlawrev-25507	13	7	special	special	ADJ
inlawrev-25507	13	8	humira	humira	PROPN
inlawrev-25507	13	9	edition	edition	PROPN
inlawrev-25507	13	10	,	,	PUNCT
inlawrev-25507	13	11	supra	supra	PROPN
inlawrev-25507	13	12	note	note	NOUN
inlawrev-25507	13	13	2	2	NUM
inlawrev-25507	13	14	,	,	PUNCT
inlawrev-25507	13	15	at	at	ADP
inlawrev-25507	13	16	2	2	NUM
inlawrev-25507	13	17	.	.	NOUN
inlawrev-25507	13	18	6	6	NUM
inlawrev-25507	13	19	.	.	PUNCT
inlawrev-25507	14	1	i	i	PRON
inlawrev-25507	14	2	d.	d.	PROPN
inlawrev-25507	14	3	7	7	NUM
inlawrev-25507	14	4	.	.	PUNCT
inlawrev-25507	15	1	i	i	PRON
inlawrev-25507	15	2	d.	d.	PROPN
inlawrev-25507	15	3	196	196	NUM
inlawrev-25507	15	4	indiana	indiana	PROPN
inlawrev-25507	15	5	law	law	PROPN
inlawrev-25507	15	6	review	review	NOUN
inlawrev-25507	16	1	[	[	X
inlawrev-25507	16	2	vol	vol	NOUN
inlawrev-25507	16	3	.	.	PUNCT
inlawrev-25507	17	1	54:195	54:195	NUM
inlawrev-25507	17	2	2037.8	2037.8	NUM
inlawrev-25507	17	3	similarly	similarly	ADV
inlawrev-25507	17	4	,	,	PUNCT
inlawrev-25507	17	5	sanofi	sanofi	PROPN
inlawrev-25507	17	6	’s	’s	PART
inlawrev-25507	17	7	original	original	ADJ
inlawrev-25507	17	8	patent	patent	NOUN
inlawrev-25507	17	9	on	on	ADP
inlawrev-25507	17	10	one	one	NUM
inlawrev-25507	17	11	of	of	ADP
inlawrev-25507	17	12	its	its	PRON
inlawrev-25507	17	13	drugs	drug	NOUN
inlawrev-25507	17	14	,	,	PUNCT
inlawrev-25507	17	15	lantus	lantus	PROPN
inlawrev-25507	17	16	®	®	NOUN
inlawrev-25507	17	17	,	,	PUNCT
inlawrev-25507	17	18	expired	expire	VERB
inlawrev-25507	17	19	in	in	ADP
inlawrev-25507	17	20	2015.9	2015.9	NUM
inlawrev-25507	17	21	nonetheless	nonetheless	ADV
inlawrev-25507	17	22	,	,	PUNCT
inlawrev-25507	17	23	the	the	DET
inlawrev-25507	17	24	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	17	25	company	company	NOUN
inlawrev-25507	17	26	filed	file	VERB
inlawrev-25507	17	27	an	an	DET
inlawrev-25507	17	28	additional	additional	ADJ
inlawrev-25507	17	29	seventy	seventy	NUM
inlawrev-25507	17	30	-	-	PUNCT
inlawrev-25507	17	31	four	four	NUM
inlawrev-25507	17	32	patent	patent	NOUN
inlawrev-25507	17	33	applications	application	NOUN
inlawrev-25507	17	34	in	in	ADP
inlawrev-25507	17	35	the	the	DET
inlawrev-25507	17	36	united	united	PROPN
inlawrev-25507	17	37	states	states	PROPN
inlawrev-25507	17	38	alone10	alone10	NOUN
inlawrev-25507	17	39	;	;	PUNCT
inlawrev-25507	17	40	this	this	PRON
inlawrev-25507	17	41	could	could	AUX
inlawrev-25507	17	42	extend	extend	VERB
inlawrev-25507	17	43	sanofi	sanofi	PROPN
inlawrev-25507	17	44	’s	’s	PART
inlawrev-25507	17	45	exclusivity	exclusivity	NOUN
inlawrev-25507	17	46	for	for	ADP
inlawrev-25507	17	47	an	an	DET
inlawrev-25507	17	48	additional	additional	ADJ
inlawrev-25507	17	49	thirty	thirty	NUM
inlawrev-25507	17	50	-	-	PUNCT
inlawrev-25507	17	51	seven	seven	NUM
inlawrev-25507	17	52	years.11	years.11	X
inlawrev-25507	17	53	like	like	ADP
inlawrev-25507	17	54	abbvie	abbvie	PROPN
inlawrev-25507	17	55	’s	’s	PART
inlawrev-25507	17	56	impressive	impressive	ADJ
inlawrev-25507	17	57	revenue	revenue	NOUN
inlawrev-25507	17	58	with	with	ADP
inlawrev-25507	17	59	humira	humira	PROPN
inlawrev-25507	17	60	®	®	PROPN
inlawrev-25507	17	61	,	,	PUNCT
inlawrev-25507	17	62	sanofi	sanofi	PROPN
inlawrev-25507	17	63	collects	collect	VERB
inlawrev-25507	17	64	approximately	approximately	ADV
inlawrev-25507	17	65	$	$	SYM
inlawrev-25507	17	66	11,000	11,000	NUM
inlawrev-25507	17	67	per	per	ADP
inlawrev-25507	17	68	minute	minute	NOUN
inlawrev-25507	17	69	on	on	ADP
inlawrev-25507	17	70	lantus	lantus	PROPN
inlawrev-25507	17	71	®	®	NOUN
inlawrev-25507	17	72	alone.12	alone.12	NOUN
inlawrev-25507	17	73	similarly	similarly	ADV
inlawrev-25507	17	74	,	,	PUNCT
inlawrev-25507	17	75	sanofi	sanofi	PROPN
inlawrev-25507	17	76	filed	file	VERB
inlawrev-25507	17	77	ninety	ninety	NUM
inlawrev-25507	17	78	-	-	PUNCT
inlawrev-25507	17	79	five	five	NUM
inlawrev-25507	17	80	percent	percent	NOUN
inlawrev-25507	17	81	of	of	ADP
inlawrev-25507	17	82	the	the	DET
inlawrev-25507	17	83	lantus	lantus	PROPN
inlawrev-25507	17	84	®	®	NOUN
inlawrev-25507	17	85	patents	patent	NOUN
inlawrev-25507	17	86	after	after	SCONJ
inlawrev-25507	17	87	the	the	DET
inlawrev-25507	17	88	drug	drug	NOUN
inlawrev-25507	17	89	came	come	VERB
inlawrev-25507	17	90	to	to	ADP
inlawrev-25507	17	91	market	market	NOUN
inlawrev-25507	17	92	in	in	ADP
inlawrev-25507	17	93	2000.13	2000.13	NUM
inlawrev-25507	17	94	this	this	DET
inlawrev-25507	17	95	patenting	patenting	NOUN
inlawrev-25507	17	96	scheme	scheme	NOUN
inlawrev-25507	17	97	caused	cause	VERB
inlawrev-25507	17	98	total	total	ADJ
inlawrev-25507	17	99	medicare	medicare	PROPN
inlawrev-25507	17	100	and	and	CCONJ
inlawrev-25507	17	101	medicaid	medicaid	PROPN
inlawrev-25507	17	102	spending	spending	NOUN
inlawrev-25507	17	103	on	on	ADP
inlawrev-25507	17	104	lantus	lantus	PROPN
inlawrev-25507	17	105	®	®	NOUN
inlawrev-25507	17	106	to	to	PART
inlawrev-25507	17	107	increase	increase	VERB
inlawrev-25507	17	108	132	132	NUM
inlawrev-25507	17	109	%	%	NOUN
inlawrev-25507	17	110	between	between	ADP
inlawrev-25507	17	111	2012	2012	NUM
inlawrev-25507	17	112	and	and	CCONJ
inlawrev-25507	17	113	2016.14	2016.14	NUM
inlawrev-25507	17	114	during	during	ADP
inlawrev-25507	17	115	this	this	DET
inlawrev-25507	17	116	time	time	NOUN
inlawrev-25507	17	117	,	,	PUNCT
inlawrev-25507	17	118	the	the	DET
inlawrev-25507	17	119	average	average	ADJ
inlawrev-25507	17	120	annual	annual	ADJ
inlawrev-25507	17	121	medicare	medicare	NOUN
inlawrev-25507	17	122	spending	spending	NOUN
inlawrev-25507	17	123	on	on	ADP
inlawrev-25507	17	124	lantus	lantus	PROPN
inlawrev-25507	17	125	®	®	NOUN
inlawrev-25507	17	126	per	per	ADP
inlawrev-25507	17	127	person	person	NOUN
inlawrev-25507	17	128	increased	increase	VERB
inlawrev-25507	17	129	eighty	eighty	NUM
inlawrev-25507	17	130	-	-	PUNCT
inlawrev-25507	17	131	nine	nine	NUM
inlawrev-25507	17	132	percent	percent	NOUN
inlawrev-25507	17	133	—	—	PUNCT
inlawrev-25507	17	134	from	from	ADP
inlawrev-25507	17	135	$	$	SYM
inlawrev-25507	17	136	1,284	1,284	NUM
inlawrev-25507	17	137	to	to	PART
inlawrev-25507	17	138	$	$	SYM
inlawrev-25507	17	139	2,431.15	2,431.15	NUM
inlawrev-25507	17	140	the	the	DET
inlawrev-25507	17	141	top	top	ADJ
inlawrev-25507	17	142	twelve	twelve	NUM
inlawrev-25507	17	143	selling	sell	VERB
inlawrev-25507	17	144	drugs	drug	NOUN
inlawrev-25507	17	145	in	in	ADP
inlawrev-25507	17	146	2017	2017	NUM
inlawrev-25507	17	147	had	have	VERB
inlawrev-25507	17	148	an	an	DET
inlawrev-25507	17	149	average	average	NOUN
inlawrev-25507	17	150	of	of	ADP
inlawrev-25507	17	151	125	125	NUM
inlawrev-25507	17	152	patent	patent	NOUN
inlawrev-25507	17	153	applications	application	NOUN
inlawrev-25507	17	154	filed.16	filed.16	PROPN
inlawrev-25507	17	155	theoretically	theoretically	ADV
inlawrev-25507	17	156	,	,	PUNCT
inlawrev-25507	17	157	these	these	DET
inlawrev-25507	17	158	additional	additional	ADJ
inlawrev-25507	17	159	patents	patent	NOUN
inlawrev-25507	17	160	could	could	AUX
inlawrev-25507	17	161	block	block	VERB
inlawrev-25507	17	162	generic	generic	ADJ
inlawrev-25507	17	163	competition	competition	NOUN
inlawrev-25507	17	164	for	for	ADP
inlawrev-25507	17	165	an	an	DET
inlawrev-25507	17	166	average	average	NOUN
inlawrev-25507	17	167	of	of	ADP
inlawrev-25507	17	168	thirty	thirty	NUM
inlawrev-25507	17	169	-	-	PUNCT
inlawrev-25507	17	170	eight	eight	NUM
inlawrev-25507	17	171	years	year	NOUN
inlawrev-25507	17	172	in	in	ADP
inlawrev-25507	17	173	addition	addition	NOUN
inlawrev-25507	17	174	to	to	ADP
inlawrev-25507	17	175	its	its	PRON
inlawrev-25507	17	176	initial	initial	ADJ
inlawrev-25507	17	177	twentyyear	twentyyear	NOUN
inlawrev-25507	17	178	exclusivity	exclusivity	NOUN
inlawrev-25507	17	179	period.17	period.17	NOUN
inlawrev-25507	17	180	without	without	ADP
inlawrev-25507	17	181	competition	competition	NOUN
inlawrev-25507	17	182	on	on	ADP
inlawrev-25507	17	183	the	the	DET
inlawrev-25507	17	184	market	market	NOUN
inlawrev-25507	17	185	,	,	PUNCT
inlawrev-25507	17	186	the	the	DET
inlawrev-25507	17	187	prices	price	NOUN
inlawrev-25507	17	188	for	for	ADP
inlawrev-25507	17	189	these	these	DET
inlawrev-25507	17	190	drugs	drug	NOUN
inlawrev-25507	17	191	increased	increase	VERB
inlawrev-25507	17	192	on	on	ADP
inlawrev-25507	17	193	average	average	ADJ
inlawrev-25507	17	194	by	by	ADP
inlawrev-25507	17	195	sixty	sixty	NUM
inlawrev-25507	17	196	-	-	PUNCT
inlawrev-25507	17	197	eight	eight	NUM
inlawrev-25507	17	198	percent.1	percent.1	PROPN
inlawrev-25507	17	199	8	8	NUM
inlawrev-25507	17	200	additionally	additionally	ADV
inlawrev-25507	17	201	,	,	PUNCT
inlawrev-25507	17	202	these	these	DET
inlawrev-25507	17	203	topgrossing	topgrosse	VERB
inlawrev-25507	17	204	drugs	drug	NOUN
inlawrev-25507	17	205	have	have	AUX
inlawrev-25507	17	206	already	already	ADV
inlawrev-25507	17	207	been	be	AUX
inlawrev-25507	17	208	on	on	ADP
inlawrev-25507	17	209	the	the	DET
inlawrev-25507	17	210	market	market	NOUN
inlawrev-25507	17	211	for	for	ADP
inlawrev-25507	17	212	fifteen	fifteen	NUM
inlawrev-25507	17	213	years.19	years.19	NOUN
inlawrev-25507	17	214	over	over	ADP
inlawrev-25507	17	215	half	half	NOUN
inlawrev-25507	17	216	of	of	ADP
inlawrev-25507	17	217	the	the	DET
inlawrev-25507	17	218	top	top	ADJ
inlawrev-25507	17	219	twelve	twelve	NUM
inlawrev-25507	17	220	drugs	drug	NOUN
inlawrev-25507	17	221	have	have	VERB
inlawrev-25507	17	222	more	more	ADJ
inlawrev-25507	17	223	than	than	ADP
inlawrev-25507	17	224	100	100	NUM
inlawrev-25507	17	225	attempted	attempt	VERB
inlawrev-25507	17	226	patents	patent	NOUN
inlawrev-25507	17	227	per	per	ADP
inlawrev-25507	17	228	drug.20	drug.20	PROPN
inlawrev-25507	17	229	patents	patent	NOUN
inlawrev-25507	17	230	play	play	VERB
inlawrev-25507	17	231	an	an	DET
inlawrev-25507	17	232	essential	essential	ADJ
inlawrev-25507	17	233	role	role	NOUN
inlawrev-25507	17	234	in	in	ADP
inlawrev-25507	17	235	the	the	DET
inlawrev-25507	17	236	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	17	237	industry	industry	NOUN
inlawrev-25507	17	238	;	;	PUNCT
inlawrev-25507	17	239	the	the	DET
inlawrev-25507	17	240	process	process	NOUN
inlawrev-25507	17	241	of	of	ADP
inlawrev-25507	17	242	developing	develop	VERB
inlawrev-25507	17	243	a	a	DET
inlawrev-25507	17	244	new	new	ADJ
inlawrev-25507	17	245	drug	drug	NOUN
inlawrev-25507	17	246	and	and	CCONJ
inlawrev-25507	17	247	bringing	bring	VERB
inlawrev-25507	17	248	it	it	PRON
inlawrev-25507	17	249	to	to	ADP
inlawrev-25507	17	250	market	market	NOUN
inlawrev-25507	17	251	is	be	AUX
inlawrev-25507	17	252	not	not	PART
inlawrev-25507	17	253	only	only	ADV
inlawrev-25507	17	254	long	long	ADJ
inlawrev-25507	17	255	and	and	CCONJ
inlawrev-25507	17	256	costly	costly	ADJ
inlawrev-25507	17	257	,	,	PUNCT
inlawrev-25507	17	258	but	but	CCONJ
inlawrev-25507	17	259	also	also	ADV
inlawrev-25507	17	260	extremely	extremely	ADV
inlawrev-25507	17	261	tedious.21	tedious.21	VERB
inlawrev-25507	17	262	specifically	specifically	ADV
inlawrev-25507	17	263	,	,	PUNCT
inlawrev-25507	17	264	the	the	DET
inlawrev-25507	17	265	research	research	NOUN
inlawrev-25507	17	266	and	and	CCONJ
inlawrev-25507	17	267	development	development	NOUN
inlawrev-25507	17	268	process	process	NOUN
inlawrev-25507	17	269	can	can	AUX
inlawrev-25507	17	270	8	8	NUM
inlawrev-25507	17	271	.	.	PUNCT
inlawrev-25507	18	1	i	i	PRON
inlawrev-25507	18	2	d.	d.	PROPN
inlawrev-25507	18	3	at	at	ADP
inlawrev-25507	18	4	4	4	NUM
inlawrev-25507	18	5	.	.	NOUN
inlawrev-25507	18	6	9	9	NUM
inlawrev-25507	18	7	.	.	NUM
inlawrev-25507	19	1	overpatented	overpatente	VERB
inlawrev-25507	19	2	,	,	PUNCT
inlawrev-25507	19	3	overpriced	overprice	VERB
inlawrev-25507	19	4	special	special	ADJ
inlawrev-25507	19	5	edition	edition	NOUN
inlawrev-25507	19	6	:	:	PUNCT
inlawrev-25507	19	7	lantus	lantus	PROPN
inlawrev-25507	19	8	(	(	PUNCT
inlawrev-25507	19	9	insulin	insulin	NOUN
inlawrev-25507	19	10	glargine	glargine	NOUN
inlawrev-25507	19	11	)	)	PUNCT
inlawrev-25507	19	12	,	,	PUNCT
inlawrev-25507	19	13	i	i	PROPN
inlawrev-25507	19	14	-	-	PUNCT
inlawrev-25507	19	15	mak	mak	PROPN
inlawrev-25507	19	16	at	at	ADP
inlawrev-25507	19	17	4	4	NUM
inlawrev-25507	19	18	(	(	PUNCT
inlawrev-25507	19	19	nov	nov	PROPN
inlawrev-25507	19	20	.	.	PROPN
inlawrev-25507	19	21	1	1	NUM
inlawrev-25507	19	22	,	,	PUNCT
inlawrev-25507	19	23	2018	2018	NUM
inlawrev-25507	19	24	)	)	PUNCT
inlawrev-25507	19	25	,	,	PUNCT
inlawrev-25507	19	26	http://www.i-mak.org/wp-content/uploads/2018/10/i-mak-lantus-report-2018-1030f.pdf	http://www.i-mak.org/wp-content/uploads/2018/10/i-mak-lantus-report-2018-1030f.pdf	NOUN
inlawrev-25507	20	1	[	[	X
inlawrev-25507	20	2	https://perma.cc/9xnh-mkbx	https://perma.cc/9xnh-mkbx	X
inlawrev-25507	20	3	]	]	X
inlawrev-25507	20	4	.	.	PUNCT
inlawrev-25507	21	1	10	10	NUM
inlawrev-25507	21	2	.	.	PUNCT
inlawrev-25507	22	1	i	i	PRON
inlawrev-25507	22	2	d.	d.	PROPN
inlawrev-25507	22	3	11	11	NUM
inlawrev-25507	22	4	.	.	PUNCT
inlawrev-25507	23	1	i	i	PRON
inlawrev-25507	23	2	d.	d.	PROPN
inlawrev-25507	23	3	12	12	NUM
inlawrev-25507	23	4	.	.	PUNCT
inlawrev-25507	24	1	i	i	PRON
inlawrev-25507	24	2	d.	d.	PROPN
inlawrev-25507	24	3	at	at	ADP
inlawrev-25507	24	4	7	7	NUM
inlawrev-25507	24	5	.	.	NOUN
inlawrev-25507	24	6	13	13	NUM
inlawrev-25507	24	7	.	.	PUNCT
inlawrev-25507	25	1	i	i	PRON
inlawrev-25507	25	2	d.	d.	PROPN
inlawrev-25507	25	3	at	at	ADP
inlawrev-25507	25	4	4	4	NUM
inlawrev-25507	25	5	.	.	NOUN
inlawrev-25507	25	6	14	14	NUM
inlawrev-25507	25	7	.	.	PUNCT
inlawrev-25507	26	1	i	i	PRON
inlawrev-25507	26	2	d.	d.	PROPN
inlawrev-25507	26	3	at	at	ADP
inlawrev-25507	26	4	2	2	NUM
inlawrev-25507	26	5	.	.	NOUN
inlawrev-25507	26	6	15	15	NUM
inlawrev-25507	26	7	.	.	PUNCT
inlawrev-25507	27	1	i	i	PRON
inlawrev-25507	27	2	d.	d.	PROPN
inlawrev-25507	27	3	at	at	ADP
inlawrev-25507	27	4	7	7	NUM
inlawrev-25507	27	5	.	.	NUM
inlawrev-25507	27	6	16	16	NUM
inlawrev-25507	27	7	.	.	PUNCT
inlawrev-25507	28	1	overpatented	overpatente	VERB
inlawrev-25507	28	2	:	:	PUNCT
inlawrev-25507	28	3	(	(	PUNCT
inlawrev-25507	28	4	not	not	PART
inlawrev-25507	28	5	so	so	ADV
inlawrev-25507	28	6	)	)	PUNCT
inlawrev-25507	28	7	average	average	ADJ
inlawrev-25507	28	8	,	,	PUNCT
inlawrev-25507	28	9	i	i	PROPN
inlawrev-25507	28	10	-	-	PUNCT
inlawrev-25507	28	11	mak	mak	PROPN
inlawrev-25507	28	12	(	(	PUNCT
inlawrev-25507	28	13	aug	aug	PROPN
inlawrev-25507	28	14	.	.	PROPN
inlawrev-25507	28	15	2	2	NUM
inlawrev-25507	28	16	,	,	PUNCT
inlawrev-25507	28	17	2018	2018	NUM
inlawrev-25507	28	18	)	)	PUNCT
inlawrev-25507	28	19	,	,	PUNCT
inlawrev-25507	28	20	https://www.i-mak.org/wpcontent/uploads/2018/08/imak.100s.patents.totals-2.png	https://www.i-mak.org/wpcontent/uploads/2018/08/imak.100s.patents.totals-2.png	X
inlawrev-25507	29	1	[	[	X
inlawrev-25507	29	2	https://perma.cc/62xk-zbep	https://perma.cc/62xk-zbep	X
inlawrev-25507	29	3	]	]	X
inlawrev-25507	29	4	(	(	PUNCT
inlawrev-25507	29	5	stating	state	VERB
inlawrev-25507	29	6	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	29	7	drugs	drug	NOUN
inlawrev-25507	29	8	with	with	ADP
inlawrev-25507	29	9	the	the	DET
inlawrev-25507	29	10	largest	large	ADJ
inlawrev-25507	29	11	number	number	NOUN
inlawrev-25507	29	12	of	of	ADP
inlawrev-25507	29	13	secondary	secondary	ADJ
inlawrev-25507	29	14	patents	patent	NOUN
inlawrev-25507	29	15	are	be	AUX
inlawrev-25507	29	16	humira	humira	PROPN
inlawrev-25507	29	17	®	®	NOUN
inlawrev-25507	29	18	with	with	ADP
inlawrev-25507	29	19	247	247	NUM
inlawrev-25507	29	20	,	,	PUNCT
inlawrev-25507	29	21	avastin	avastin	NOUN
inlawrev-25507	29	22	®	®	NOUN
inlawrev-25507	29	23	with	with	ADP
inlawrev-25507	29	24	219	219	NUM
inlawrev-25507	29	25	,	,	PUNCT
inlawrev-25507	29	26	and	and	CCONJ
inlawrev-25507	29	27	rituxan	rituxan	VERB
inlawrev-25507	29	28	®	®	NOUN
inlawrev-25507	29	29	with	with	ADP
inlawrev-25507	29	30	204	204	NUM
inlawrev-25507	29	31	)	)	PUNCT
inlawrev-25507	29	32	.	.	PUNCT
inlawrev-25507	30	1	17	17	NUM
inlawrev-25507	30	2	.	.	PUNCT
inlawrev-25507	31	1	i	i	PRON
inlawrev-25507	31	2	d.	d.	PROPN
inlawrev-25507	31	3	(	(	PUNCT
inlawrev-25507	31	4	stating	state	VERB
inlawrev-25507	31	5	the	the	DET
inlawrev-25507	31	6	“	"	PUNCT
inlawrev-25507	31	7	worst	bad	ADJ
inlawrev-25507	31	8	offenders	offender	NOUN
inlawrev-25507	31	9	”	"	PUNCT
inlawrev-25507	31	10	of	of	ADP
inlawrev-25507	31	11	blocking	block	VERB
inlawrev-25507	31	12	generic	generic	ADJ
inlawrev-25507	31	13	companies	company	NOUN
inlawrev-25507	31	14	are	be	AUX
inlawrev-25507	31	15	herceptin	herceptin	NOUN
inlawrev-25507	31	16	®	®	NOUN
inlawrev-25507	31	17	with	with	ADP
inlawrev-25507	31	18	forty	forty	NUM
inlawrev-25507	31	19	-	-	PUNCT
inlawrev-25507	31	20	eight	eight	NUM
inlawrev-25507	31	21	years	year	NOUN
inlawrev-25507	31	22	,	,	PUNCT
inlawrev-25507	31	23	rituxan	rituxan	NOUN
inlawrev-25507	31	24	®	®	NOUN
inlawrev-25507	31	25	with	with	ADP
inlawrev-25507	31	26	forty	forty	NUM
inlawrev-25507	31	27	-	-	PUNCT
inlawrev-25507	31	28	seven	seven	NUM
inlawrev-25507	31	29	years	year	NOUN
inlawrev-25507	31	30	,	,	PUNCT
inlawrev-25507	31	31	and	and	CCONJ
inlawrev-25507	31	32	avastin	avastin	PROPN
inlawrev-25507	31	33	®	®	NOUN
inlawrev-25507	31	34	with	with	ADP
inlawrev-25507	31	35	forty	forty	NUM
inlawrev-25507	31	36	-	-	PUNCT
inlawrev-25507	31	37	three	three	NUM
inlawrev-25507	31	38	years	year	NOUN
inlawrev-25507	31	39	)	)	PUNCT
inlawrev-25507	31	40	.	.	PUNCT
inlawrev-25507	32	1	18	18	NUM
inlawrev-25507	32	2	.	.	PUNCT
inlawrev-25507	33	1	i	i	PRON
inlawrev-25507	33	2	d.	d.	PROPN
inlawrev-25507	33	3	(	(	PUNCT
inlawrev-25507	33	4	stating	state	VERB
inlawrev-25507	33	5	the	the	DET
inlawrev-25507	33	6	largest	large	ADJ
inlawrev-25507	33	7	price	price	NOUN
inlawrev-25507	33	8	hikes	hike	NOUN
inlawrev-25507	33	9	over	over	ADP
inlawrev-25507	33	10	the	the	DET
inlawrev-25507	33	11	past	past	ADJ
inlawrev-25507	33	12	six	six	NUM
inlawrev-25507	33	13	years	year	NOUN
inlawrev-25507	33	14	include	include	VERB
inlawrev-25507	33	15	lyrica	lyrica	PROPN
inlawrev-25507	33	16	®	®	NOUN
inlawrev-25507	33	17	with	with	ADP
inlawrev-25507	33	18	an	an	DET
inlawrev-25507	33	19	increase	increase	NOUN
inlawrev-25507	33	20	of	of	ADP
inlawrev-25507	33	21	163	163	NUM
inlawrev-25507	33	22	%	%	NOUN
inlawrev-25507	33	23	,	,	PUNCT
inlawrev-25507	33	24	enbrel	enbrel	PROPN
inlawrev-25507	33	25	®	®	NOUN
inlawrev-25507	33	26	with	with	ADP
inlawrev-25507	33	27	an	an	DET
inlawrev-25507	33	28	increase	increase	NOUN
inlawrev-25507	33	29	of	of	ADP
inlawrev-25507	33	30	155	155	NUM
inlawrev-25507	33	31	%	%	NOUN
inlawrev-25507	33	32	,	,	PUNCT
inlawrev-25507	33	33	and	and	CCONJ
inlawrev-25507	33	34	humira	humira	PROPN
inlawrev-25507	33	35	®	®	NOUN
inlawrev-25507	33	36	with	with	ADP
inlawrev-25507	33	37	an	an	DET
inlawrev-25507	33	38	increase	increase	NOUN
inlawrev-25507	33	39	of	of	ADP
inlawrev-25507	33	40	144	144	NUM
inlawrev-25507	33	41	%	%	NOUN
inlawrev-25507	33	42	)	)	PUNCT
inlawrev-25507	33	43	.	.	PUNCT
inlawrev-25507	34	1	19	19	NUM
inlawrev-25507	34	2	.	.	NUM
inlawrev-25507	34	3	overpatented	overpatente	VERB
inlawrev-25507	34	4	,	,	PUNCT
inlawrev-25507	34	5	overpriced	overprice	VERB
inlawrev-25507	34	6	:	:	PUNCT
inlawrev-25507	34	7	how	how	SCONJ
inlawrev-25507	34	8	excessive	excessive	ADJ
inlawrev-25507	34	9	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	34	10	patenting	patenting	NOUN
inlawrev-25507	34	11	is	be	AUX
inlawrev-25507	34	12	extending	extend	VERB
inlawrev-25507	34	13	monopolies	monopoly	NOUN
inlawrev-25507	34	14	and	and	CCONJ
inlawrev-25507	34	15	driving	drive	VERB
inlawrev-25507	34	16	up	up	ADP
inlawrev-25507	34	17	drug	drug	NOUN
inlawrev-25507	34	18	prices	price	NOUN
inlawrev-25507	34	19	,	,	PUNCT
inlawrev-25507	34	20	i	i	PROPN
inlawrev-25507	34	21	-	-	PUNCT
inlawrev-25507	34	22	mak	mak	PROPN
inlawrev-25507	34	23	at	at	ADP
inlawrev-25507	34	24	2	2	NUM
inlawrev-25507	34	25	(	(	PUNCT
inlawrev-25507	34	26	aug	aug	PROPN
inlawrev-25507	34	27	.	.	PROPN
inlawrev-25507	34	28	2	2	NUM
inlawrev-25507	34	29	,	,	PUNCT
inlawrev-25507	34	30	2018	2018	NUM
inlawrev-25507	34	31	)	)	PUNCT
inlawrev-25507	34	32	,	,	PUNCT
inlawrev-25507	34	33	https://www.i-mak.org/wpcontent/uploads/2018/08/i-mak-overpatented-overpriced-report.pdf	https://www.i-mak.org/wpcontent/uploads/2018/08/i-mak-overpatented-overpriced-report.pdf	NOUN
inlawrev-25507	35	1	[	[	X
inlawrev-25507	35	2	https://perma.cc/9uqfrch8	https://perma.cc/9uqfrch8	X
inlawrev-25507	35	3	]	]	X
inlawrev-25507	36	1	[	[	X
inlawrev-25507	36	2	hereinafter	hereinafter	NOUN
inlawrev-25507	36	3	excessive	excessive	ADJ
inlawrev-25507	36	4	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	36	5	patenting	patenting	NOUN
inlawrev-25507	36	6	]	]	PUNCT
inlawrev-25507	36	7	.	.	PUNCT
inlawrev-25507	37	1	20	20	NUM
inlawrev-25507	37	2	.	.	PUNCT
inlawrev-25507	38	1	i	i	PRON
inlawrev-25507	38	2	d.	d.	PROPN
inlawrev-25507	38	3	21	21	NUM
inlawrev-25507	38	4	.	.	PUNCT
inlawrev-25507	39	1	henry	henry	PROPN
inlawrev-25507	39	2	g.	g.	PROPN
inlawrev-25507	39	3	grabowski	grabowski	PROPN
inlawrev-25507	39	4	,	,	PUNCT
inlawrev-25507	39	5	joseph	joseph	PROPN
inlawrev-25507	39	6	a.	a.	PROPN
inlawrev-25507	39	7	dimasi	dimasi	PROPN
inlawrev-25507	39	8	&	&	CCONJ
inlawrev-25507	39	9	genia	genia	PROPN
inlawrev-25507	39	10	long	long	PROPN
inlawrev-25507	39	11	,	,	PUNCT
inlawrev-25507	39	12	the	the	DET
inlawrev-25507	39	13	roles	role	NOUN
inlawrev-25507	39	14	of	of	ADP
inlawrev-25507	39	15	patents	patent	NOUN
inlawrev-25507	39	16	and	and	CCONJ
inlawrev-25507	39	17	2021	2021	NUM
inlawrev-25507	39	18	]	]	PUNCT
inlawrev-25507	39	19	leaving	leave	VERB
inlawrev-25507	39	20	the	the	DET
inlawrev-25507	39	21	evergreening	evergreene	VERB
inlawrev-25507	39	22	problem	problem	NOUN
inlawrev-25507	39	23	to	to	ADP
inlawrev-25507	39	24	the	the	DET
inlawrev-25507	39	25	patent	patent	NOUN
inlawrev-25507	39	26	experts	expert	NOUN
inlawrev-25507	39	27	197	197	NUM
inlawrev-25507	39	28	take	take	VERB
inlawrev-25507	39	29	over	over	ADP
inlawrev-25507	39	30	a	a	DET
inlawrev-25507	39	31	decade	decade	NOUN
inlawrev-25507	39	32	to	to	PART
inlawrev-25507	39	33	complete	complete	VERB
inlawrev-25507	39	34	and	and	CCONJ
inlawrev-25507	39	35	cost	cost	VERB
inlawrev-25507	39	36	over	over	ADP
inlawrev-25507	39	37	a	a	DET
inlawrev-25507	39	38	billion	billion	NUM
inlawrev-25507	39	39	dollars.22	dollars.22	NOUN
inlawrev-25507	39	40	only	only	ADV
inlawrev-25507	39	41	one	one	NUM
inlawrev-25507	39	42	in	in	ADP
inlawrev-25507	39	43	eight	eight	NUM
inlawrev-25507	39	44	drug	drug	NOUN
inlawrev-25507	39	45	candidates	candidate	NOUN
inlawrev-25507	39	46	survives	survive	VERB
inlawrev-25507	39	47	clinal	clinal	ADJ
inlawrev-25507	39	48	testing	testing	NOUN
inlawrev-25507	39	49	,	,	PUNCT
inlawrev-25507	39	50	though	though	SCONJ
inlawrev-25507	39	51	this	this	PRON
inlawrev-25507	39	52	does	do	AUX
inlawrev-25507	39	53	not	not	PART
inlawrev-25507	39	54	necessarily	necessarily	ADV
inlawrev-25507	39	55	mean	mean	VERB
inlawrev-25507	39	56	it	it	PRON
inlawrev-25507	39	57	will	will	AUX
inlawrev-25507	39	58	become	become	VERB
inlawrev-25507	39	59	a	a	DET
inlawrev-25507	39	60	“	"	PUNCT
inlawrev-25507	39	61	blockbuster	blockbuster	NOUN
inlawrev-25507	39	62	”	"	PUNCT
inlawrev-25507	39	63	or	or	CCONJ
inlawrev-25507	39	64	even	even	ADV
inlawrev-25507	39	65	a	a	DET
inlawrev-25507	39	66	profitable	profitable	ADJ
inlawrev-25507	39	67	drug.23	drug.23	PROPN
inlawrev-25507	39	68	after	after	ADP
inlawrev-25507	39	69	the	the	DET
inlawrev-25507	39	70	drug	drug	NOUN
inlawrev-25507	39	71	patent	patent	NOUN
inlawrev-25507	39	72	’s	’s	PART
inlawrev-25507	39	73	expiration	expiration	NOUN
inlawrev-25507	39	74	,	,	PUNCT
inlawrev-25507	39	75	its	its	PRON
inlawrev-25507	39	76	generic	generic	ADJ
inlawrev-25507	39	77	rivals	rival	NOUN
inlawrev-25507	39	78	can	can	AUX
inlawrev-25507	39	79	enter	enter	VERB
inlawrev-25507	39	80	the	the	DET
inlawrev-25507	39	81	market	market	NOUN
inlawrev-25507	39	82	with	with	ADP
inlawrev-25507	39	83	the	the	DET
inlawrev-25507	39	84	same	same	ADJ
inlawrev-25507	39	85	drug	drug	NOUN
inlawrev-25507	39	86	at	at	ADP
inlawrev-25507	39	87	a	a	DET
inlawrev-25507	39	88	greatly	greatly	ADV
inlawrev-25507	39	89	reduced	reduce	VERB
inlawrev-25507	39	90	price.24	price.24	NOUN
inlawrev-25507	39	91	although	although	SCONJ
inlawrev-25507	39	92	this	this	PRON
inlawrev-25507	39	93	greatly	greatly	ADV
inlawrev-25507	39	94	benefits	benefit	VERB
inlawrev-25507	39	95	the	the	DET
inlawrev-25507	39	96	consumer	consumer	NOUN
inlawrev-25507	39	97	,	,	PUNCT
inlawrev-25507	39	98	the	the	DET
inlawrev-25507	39	99	resulting	result	VERB
inlawrev-25507	39	100	competition	competition	NOUN
inlawrev-25507	39	101	heavily	heavily	ADV
inlawrev-25507	39	102	diminishes	diminish	VERB
inlawrev-25507	39	103	the	the	DET
inlawrev-25507	39	104	innovator	innovator	NOUN
inlawrev-25507	39	105	’s	’s	PART
inlawrev-25507	39	106	profits.25	profits.25	VERB
inlawrev-25507	39	107	the	the	DET
inlawrev-25507	39	108	issue	issue	NOUN
inlawrev-25507	39	109	of	of	ADP
inlawrev-25507	39	110	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	39	111	companies	company	NOUN
inlawrev-25507	39	112	extending	extend	VERB
inlawrev-25507	39	113	a	a	DET
inlawrev-25507	39	114	drug	drug	NOUN
inlawrev-25507	39	115	’s	’s	PART
inlawrev-25507	39	116	exclusivity	exclusivity	NOUN
inlawrev-25507	39	117	—	—	PUNCT
inlawrev-25507	39	118	when	when	SCONJ
inlawrev-25507	39	119	based	base	VERB
inlawrev-25507	39	120	on	on	ADP
inlawrev-25507	39	121	abundant	abundant	ADJ
inlawrev-25507	39	122	secondary	secondary	ADJ
inlawrev-25507	39	123	patents	patent	NOUN
inlawrev-25507	39	124	with	with	ADP
inlawrev-25507	39	125	minimal	minimal	ADJ
inlawrev-25507	39	126	variation	variation	NOUN
inlawrev-25507	39	127	from	from	ADP
inlawrev-25507	39	128	the	the	DET
inlawrev-25507	39	129	compound	compound	NOUN
inlawrev-25507	39	130	patent	patent	NOUN
inlawrev-25507	39	131	—	—	PUNCT
inlawrev-25507	39	132	is	be	AUX
inlawrev-25507	39	133	called	call	VERB
inlawrev-25507	39	134	“	"	PUNCT
inlawrev-25507	39	135	evergreening	evergreene	VERB
inlawrev-25507	39	136	.	.	PUNCT
inlawrev-25507	40	1	”26	”26	VERB
inlawrev-25507	40	2	this	this	DET
inlawrev-25507	40	3	results	result	NOUN
inlawrev-25507	40	4	in	in	ADP
inlawrev-25507	40	5	the	the	DET
inlawrev-25507	40	6	delayed	delay	VERB
inlawrev-25507	40	7	arrival	arrival	NOUN
inlawrev-25507	40	8	of	of	ADP
inlawrev-25507	40	9	a	a	DET
inlawrev-25507	40	10	generic	generic	ADJ
inlawrev-25507	40	11	drug	drug	NOUN
inlawrev-25507	40	12	or	or	CCONJ
inlawrev-25507	40	13	biosimilar	biosimilar	NOUN
inlawrev-25507	40	14	in	in	ADP
inlawrev-25507	40	15	a	a	DET
inlawrev-25507	40	16	given	give	VERB
inlawrev-25507	40	17	market	market	NOUN
inlawrev-25507	40	18	;	;	PUNCT
inlawrev-25507	40	19	consequently	consequently	ADV
inlawrev-25507	40	20	,	,	PUNCT
inlawrev-25507	40	21	the	the	DET
inlawrev-25507	40	22	drug	drug	NOUN
inlawrev-25507	40	23	’s	’s	PART
inlawrev-25507	40	24	price	price	NOUN
inlawrev-25507	40	25	will	will	AUX
inlawrev-25507	40	26	likely	likely	ADV
inlawrev-25507	40	27	not	not	PART
inlawrev-25507	40	28	decrease	decrease	VERB
inlawrev-25507	40	29	until	until	ADP
inlawrev-25507	40	30	the	the	DET
inlawrev-25507	40	31	launch	launch	NOUN
inlawrev-25507	40	32	of	of	ADP
inlawrev-25507	40	33	the	the	DET
inlawrev-25507	40	34	generic	generic	ADJ
inlawrev-25507	40	35	or	or	CCONJ
inlawrev-25507	40	36	biosimilar	biosimilar	PROPN
inlawrev-25507	40	37	drug.27	drug.27	VERB
inlawrev-25507	40	38	however	however	ADV
inlawrev-25507	40	39	,	,	PUNCT
inlawrev-25507	40	40	not	not	PART
inlawrev-25507	40	41	every	every	DET
inlawrev-25507	40	42	additional	additional	ADJ
inlawrev-25507	40	43	patent	patent	NOUN
inlawrev-25507	40	44	application	application	NOUN
inlawrev-25507	40	45	is	be	AUX
inlawrev-25507	40	46	an	an	DET
inlawrev-25507	40	47	example	example	NOUN
inlawrev-25507	40	48	of	of	ADP
inlawrev-25507	40	49	evergreening	evergreening	NOUN
inlawrev-25507	40	50	,	,	PUNCT
inlawrev-25507	40	51	as	as	SCONJ
inlawrev-25507	40	52	many	many	ADJ
inlawrev-25507	40	53	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	40	54	companies	company	NOUN
inlawrev-25507	40	55	continue	continue	VERB
inlawrev-25507	40	56	to	to	PART
inlawrev-25507	40	57	perform	perform	VERB
inlawrev-25507	40	58	research	research	NOUN
inlawrev-25507	40	59	and	and	CCONJ
inlawrev-25507	40	60	development	development	NOUN
inlawrev-25507	40	61	which	which	PRON
inlawrev-25507	40	62	may	may	AUX
inlawrev-25507	40	63	yield	yield	VERB
inlawrev-25507	40	64	promising	promise	VERB
inlawrev-25507	40	65	new	new	ADJ
inlawrev-25507	40	66	uses	use	NOUN
inlawrev-25507	40	67	for	for	ADP
inlawrev-25507	40	68	the	the	DET
inlawrev-25507	40	69	drug.28	drug.28	NOUN
inlawrev-25507	40	70	in	in	ADP
inlawrev-25507	40	71	response	response	NOUN
inlawrev-25507	40	72	to	to	ADP
inlawrev-25507	40	73	evergreening	evergreene	VERB
inlawrev-25507	40	74	,	,	PUNCT
inlawrev-25507	40	75	recently	recently	ADV
inlawrev-25507	40	76	proposed	propose	VERB
inlawrev-25507	40	77	legislation	legislation	NOUN
inlawrev-25507	40	78	includes	include	VERB
inlawrev-25507	40	79	,	,	PUNCT
inlawrev-25507	40	80	but	but	CCONJ
inlawrev-25507	40	81	is	be	AUX
inlawrev-25507	40	82	not	not	PART
inlawrev-25507	40	83	limited	limit	VERB
inlawrev-25507	40	84	to	to	ADP
inlawrev-25507	40	85	,	,	PUNCT
inlawrev-25507	40	86	the	the	DET
inlawrev-25507	40	87	reforming	reform	VERB
inlawrev-25507	40	88	evergreening	evergreening	NOUN
inlawrev-25507	40	89	and	and	CCONJ
inlawrev-25507	40	90	manipulation	manipulation	NOUN
inlawrev-25507	40	91	that	that	PRON
inlawrev-25507	40	92	extends	extend	VERB
inlawrev-25507	40	93	drug	drug	NOUN
inlawrev-25507	40	94	years	year	NOUN
inlawrev-25507	40	95	act	act	PROPN
inlawrev-25507	40	96	(	(	PUNCT
inlawrev-25507	40	97	the	the	DET
inlawrev-25507	40	98	“	"	PUNCT
inlawrev-25507	40	99	remedy	remedy	NOUN
inlawrev-25507	40	100	act	act	NOUN
inlawrev-25507	40	101	”	"	PUNCT
inlawrev-25507	40	102	)	)	PUNCT
inlawrev-25507	40	103	,	,	PUNCT
inlawrev-25507	40	104	the	the	DET
inlawrev-25507	40	105	affordable	affordable	ADJ
inlawrev-25507	40	106	prescriptions	prescription	NOUN
inlawrev-25507	40	107	for	for	ADP
inlawrev-25507	40	108	patients	patient	NOUN
inlawrev-25507	40	109	act	act	VERB
inlawrev-25507	40	110	of	of	ADP
inlawrev-25507	40	111	2019	2019	NUM
inlawrev-25507	40	112	(	(	PUNCT
inlawrev-25507	40	113	the	the	DET
inlawrev-25507	40	114	“	"	PUNCT
inlawrev-25507	40	115	app	app	PROPN
inlawrev-25507	40	116	act	act	PROPN
inlawrev-25507	40	117	”	"	PUNCT
inlawrev-25507	40	118	)	)	PUNCT
inlawrev-25507	40	119	,	,	PUNCT
inlawrev-25507	40	120	and	and	CCONJ
inlawrev-25507	40	121	the	the	DET
inlawrev-25507	40	122	terminating	terminate	VERB
inlawrev-25507	40	123	the	the	DET
inlawrev-25507	40	124	extension	extension	NOUN
inlawrev-25507	40	125	of	of	ADP
inlawrev-25507	40	126	rights	right	NOUN
inlawrev-25507	40	127	misappropriated	misappropriate	VERB
inlawrev-25507	40	128	act	act	NOUN
inlawrev-25507	40	129	of	of	ADP
inlawrev-25507	40	130	2019	2019	NUM
inlawrev-25507	40	131	(	(	PUNCT
inlawrev-25507	40	132	the	the	DET
inlawrev-25507	40	133	“	"	PUNCT
inlawrev-25507	40	134	term	term	NOUN
inlawrev-25507	40	135	act”).2	act”).2	NOUN
inlawrev-25507	40	136	9	9	NUM
inlawrev-25507	40	137	each	each	PRON
inlawrev-25507	40	138	of	of	ADP
inlawrev-25507	40	139	these	these	DET
inlawrev-25507	40	140	bills	bill	NOUN
inlawrev-25507	40	141	is	be	AUX
inlawrev-25507	40	142	likely	likely	ADJ
inlawrev-25507	40	143	to	to	PART
inlawrev-25507	40	144	result	result	VERB
inlawrev-25507	40	145	in	in	ADP
inlawrev-25507	40	146	an	an	DET
inlawrev-25507	40	147	incorrect	incorrect	ADJ
inlawrev-25507	40	148	treatment	treatment	NOUN
inlawrev-25507	40	149	of	of	ADP
inlawrev-25507	40	150	most	most	ADJ
inlawrev-25507	40	151	,	,	PUNCT
inlawrev-25507	40	152	if	if	SCONJ
inlawrev-25507	40	153	not	not	PART
inlawrev-25507	40	154	all	all	ADV
inlawrev-25507	40	155	,	,	PUNCT
inlawrev-25507	40	156	secondary	secondary	ADJ
inlawrev-25507	40	157	patents	patent	NOUN
inlawrev-25507	40	158	as	as	ADP
inlawrev-25507	40	159	attempts	attempt	NOUN
inlawrev-25507	40	160	at	at	ADP
inlawrev-25507	40	161	evergreening	evergreening	NOUN
inlawrev-25507	40	162	;	;	PUNCT
inlawrev-25507	40	163	research	research	NOUN
inlawrev-25507	40	164	and	and	CCONJ
inlawrev-25507	40	165	development	development	NOUN
inlawrev-25507	40	166	incentives	incentive	NOUN
inlawrev-25507	40	167	in	in	ADP
inlawrev-25507	40	168	biopharmaceutical	biopharmaceutical	ADJ
inlawrev-25507	40	169	innovation	innovation	NOUN
inlawrev-25507	40	170	,	,	PUNCT
inlawrev-25507	40	171	34	34	NUM
inlawrev-25507	40	172	health	health	NOUN
inlawrev-25507	40	173	aff	aff	PROPN
inlawrev-25507	40	174	.	.	PROPN
inlawrev-25507	40	175	302	302	NUM
inlawrev-25507	40	176	,	,	PUNCT
inlawrev-25507	40	177	302	302	NUM
inlawrev-25507	40	178	(	(	PUNCT
inlawrev-25507	40	179	2015	2015	NUM
inlawrev-25507	40	180	)	)	PUNCT
inlawrev-25507	40	181	,	,	PUNCT
inlawrev-25507	40	182	https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2014.1047	https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2014.1047	NOUN
inlawrev-25507	40	183	[	[	X
inlawrev-25507	40	184	https://perma.cc/vza49fa2	https://perma.cc/vza49fa2	NOUN
inlawrev-25507	40	185	]	]	PUNCT
inlawrev-25507	40	186	.	.	PUNCT
inlawrev-25507	41	1	22	22	NUM
inlawrev-25507	41	2	.	.	PUNCT
inlawrev-25507	42	1	i	i	PRON
inlawrev-25507	42	2	d.	d.	PROPN
inlawrev-25507	42	3	at	at	ADP
inlawrev-25507	42	4	303	303	NUM
inlawrev-25507	42	5	.	.	PUNCT
inlawrev-25507	43	1	23	23	NUM
inlawrev-25507	43	2	.	.	PUNCT
inlawrev-25507	44	1	i	i	PRON
inlawrev-25507	44	2	d.	d.	PROPN
inlawrev-25507	44	3	;	;	PUNCT
inlawrev-25507	44	4	see	see	VERB
inlawrev-25507	44	5	james	james	PROPN
inlawrev-25507	44	6	chen	chen	PROPN
inlawrev-25507	44	7	,	,	PUNCT
inlawrev-25507	44	8	blockbuster	blockbuster	ADJ
inlawrev-25507	44	9	drug	drug	NOUN
inlawrev-25507	44	10	,	,	PUNCT
inlawrev-25507	44	11	investopedia	investopedia	PROPN
inlawrev-25507	44	12	(	(	PUNCT
inlawrev-25507	44	13	jan	jan	PROPN
inlawrev-25507	44	14	.	.	PROPN
inlawrev-25507	44	15	23	23	NUM
inlawrev-25507	44	16	,	,	PUNCT
inlawrev-25507	44	17	2018	2018	NUM
inlawrev-25507	44	18	)	)	PUNCT
inlawrev-25507	44	19	,	,	PUNCT
inlawrev-25507	44	20	https://www.investopedia.com/terms/b/blockbuster-drug.asp	https://www.investopedia.com/terms/b/blockbuster-drug.asp	VERB
inlawrev-25507	44	21	[	[	X
inlawrev-25507	44	22	https://perma.cc/h2tw-hm2x	https://perma.cc/h2tw-hm2x	X
inlawrev-25507	44	23	]	]	X
inlawrev-25507	44	24	(	(	PUNCT
inlawrev-25507	44	25	defining	define	VERB
inlawrev-25507	44	26	blockbuster	blockbuster	NOUN
inlawrev-25507	44	27	drug	drug	NOUN
inlawrev-25507	44	28	as	as	ADP
inlawrev-25507	44	29	any	any	DET
inlawrev-25507	44	30	popular	popular	ADJ
inlawrev-25507	44	31	drug	drug	NOUN
inlawrev-25507	44	32	that	that	PRON
inlawrev-25507	44	33	generates	generate	VERB
inlawrev-25507	44	34	annual	annual	ADJ
inlawrev-25507	44	35	sales	sale	NOUN
inlawrev-25507	44	36	of	of	ADP
inlawrev-25507	44	37	at	at	ADV
inlawrev-25507	44	38	least	least	ADV
inlawrev-25507	44	39	one	one	NUM
inlawrev-25507	44	40	billion	billion	NUM
inlawrev-25507	44	41	dollars	dollar	NOUN
inlawrev-25507	44	42	)	)	PUNCT
inlawrev-25507	44	43	.	.	PUNCT
inlawrev-25507	45	1	24	24	NUM
inlawrev-25507	45	2	.	.	PUNCT
inlawrev-25507	46	1	grabowski	grabowski	PROPN
inlawrev-25507	46	2	,	,	PUNCT
inlawrev-25507	46	3	dimasi	dimasi	PROPN
inlawrev-25507	46	4	&	&	CCONJ
inlawrev-25507	46	5	long	long	PROPN
inlawrev-25507	46	6	,	,	PUNCT
inlawrev-25507	46	7	supra	supra	PROPN
inlawrev-25507	46	8	note	note	NOUN
inlawrev-25507	46	9	21	21	NUM
inlawrev-25507	46	10	,	,	PUNCT
inlawrev-25507	46	11	at	at	ADP
inlawrev-25507	46	12	302	302	NUM
inlawrev-25507	46	13	.	.	PUNCT
inlawrev-25507	46	14	25	25	NUM
inlawrev-25507	46	15	.	.	PUNCT
inlawrev-25507	47	1	i	i	PRON
inlawrev-25507	47	2	d.	d.	PROPN
inlawrev-25507	47	3	26	26	NUM
inlawrev-25507	47	4	.	.	PUNCT
inlawrev-25507	48	1	roger	roger	PROPN
inlawrev-25507	48	2	collier	collier	PROPN
inlawrev-25507	48	3	,	,	PUNCT
inlawrev-25507	48	4	drug	drug	NOUN
inlawrev-25507	48	5	patents	patent	NOUN
inlawrev-25507	48	6	:	:	PUNCT
inlawrev-25507	48	7	the	the	DET
inlawrev-25507	48	8	evergreening	evergreening	NOUN
inlawrev-25507	48	9	problem	problem	NOUN
inlawrev-25507	48	10	,	,	PUNCT
inlawrev-25507	48	11	185(9	185(9	NUM
inlawrev-25507	48	12	)	)	PUNCT
inlawrev-25507	48	13	canadian	canadian	PROPN
inlawrev-25507	48	14	med	med	PROPN
inlawrev-25507	48	15	.	.	PUNCT
inlawrev-25507	49	1	ass’n	ass’n	PROPN
inlawrev-25507	50	1	j.	j.	PROPN
inlawrev-25507	50	2	e385	e385	PROPN
inlawrev-25507	50	3	,	,	PUNCT
inlawrev-25507	50	4	e385	e385	PROPN
inlawrev-25507	50	5	(	(	PUNCT
inlawrev-25507	50	6	2013	2013	NUM
inlawrev-25507	50	7	)	)	PUNCT
inlawrev-25507	50	8	.	.	PUNCT
inlawrev-25507	51	1	27	27	NUM
inlawrev-25507	51	2	.	.	PUNCT
inlawrev-25507	52	1	how	how	SCONJ
inlawrev-25507	52	2	long	long	ADV
inlawrev-25507	52	3	does	do	AUX
inlawrev-25507	52	4	a	a	DET
inlawrev-25507	52	5	drug	drug	NOUN
inlawrev-25507	52	6	patent	patent	NOUN
inlawrev-25507	52	7	last	last	ADJ
inlawrev-25507	52	8	?	?	PUNCT
inlawrev-25507	52	9	,	,	PUNCT
inlawrev-25507	52	10	upcouns	upcoun	NOUN
inlawrev-25507	52	11	.	.	PUNCT
inlawrev-25507	52	12	,	,	PUNCT
inlawrev-25507	52	13	https://www.upcounsel.com/how-longdoes-a-drug-patent-last	https://www.upcounsel.com/how-longdoes-a-drug-patent-last	NOUN
inlawrev-25507	52	14	(	(	PUNCT
inlawrev-25507	52	15	last	last	ADJ
inlawrev-25507	52	16	visited	visit	VERB
inlawrev-25507	52	17	aug	aug	PROPN
inlawrev-25507	52	18	.	.	PROPN
inlawrev-25507	52	19	28	28	NUM
inlawrev-25507	52	20	,	,	PUNCT
inlawrev-25507	52	21	2019	2019	NUM
inlawrev-25507	52	22	)	)	PUNCT
inlawrev-25507	53	1	[	[	X
inlawrev-25507	53	2	https://perma.cc/7d5h-wrwx	https://perma.cc/7d5h-wrwx	X
inlawrev-25507	53	3	]	]	X
inlawrev-25507	53	4	.	.	PUNCT
inlawrev-25507	54	1	for	for	ADP
inlawrev-25507	54	2	an	an	DET
inlawrev-25507	54	3	explanation	explanation	NOUN
inlawrev-25507	54	4	on	on	ADP
inlawrev-25507	54	5	biosimilars	biosimilar	NOUN
inlawrev-25507	54	6	,	,	PUNCT
inlawrev-25507	54	7	see	see	VERB
inlawrev-25507	54	8	biosimilars	biosimilar	NOUN
inlawrev-25507	54	9	,	,	PUNCT
inlawrev-25507	54	10	u.s	u.s	PROPN
inlawrev-25507	54	11	.	.	PROPN
inlawrev-25507	54	12	food	food	PROPN
inlawrev-25507	54	13	&	&	CCONJ
inlawrev-25507	54	14	drug	drug	PROPN
inlawrev-25507	54	15	admin	admin	PROPN
inlawrev-25507	54	16	.	.	PROPN
inlawrev-25507	54	17	,	,	PUNCT
inlawrev-25507	54	18	https://www.fda.gov/	https://www.fda.gov/	PROPN
inlawrev-25507	54	19	drugs	drug	NOUN
inlawrev-25507	54	20	/	/	SYM
inlawrev-25507	54	21	therapeutic	therapeutic	ADJ
inlawrev-25507	54	22	-	-	PUNCT
inlawrev-25507	54	23	biologics	biologic	NOUN
inlawrev-25507	54	24	-	-	PUNCT
inlawrev-25507	54	25	applications	application	NOUN
inlawrev-25507	54	26	-	-	PUNCT
inlawrev-25507	54	27	bla	bla	NOUN
inlawrev-25507	54	28	/	/	SYM
inlawrev-25507	54	29	biosimilars	biosimilars	PROPN
inlawrev-25507	54	30	(	(	PUNCT
inlawrev-25507	54	31	last	last	ADJ
inlawrev-25507	54	32	updated	update	VERB
inlawrev-25507	54	33	feb	feb	PROPN
inlawrev-25507	54	34	.	.	PROPN
inlawrev-25507	54	35	3	3	NUM
inlawrev-25507	54	36	,	,	PUNCT
inlawrev-25507	54	37	2020	2020	NUM
inlawrev-25507	54	38	)	)	PUNCT
inlawrev-25507	55	1	[	[	X
inlawrev-25507	55	2	https://perma	https://perma	X
inlawrev-25507	55	3	.	.	PUNCT
inlawrev-25507	55	4	cc	cc	NOUN
inlawrev-25507	55	5	/	/	SYM
inlawrev-25507	55	6	hfm9	hfm9	ADJ
inlawrev-25507	55	7	-	-	PUNCT
inlawrev-25507	55	8	f32	f32	NOUN
inlawrev-25507	55	9	g	g	NOUN
inlawrev-25507	55	10	]	]	PUNCT
inlawrev-25507	55	11	.	.	PUNCT
inlawrev-25507	56	1	28	28	NUM
inlawrev-25507	56	2	.	.	PUNCT
inlawrev-25507	57	1	frank	frank	PROPN
inlawrev-25507	57	2	bongers	bonger	NOUN
inlawrev-25507	57	3	&	&	CCONJ
inlawrev-25507	57	4	hugo	hugo	PROPN
inlawrev-25507	57	5	carradinha	carradinha	NOUN
inlawrev-25507	57	6	,	,	PUNCT
inlawrev-25507	57	7	how	how	SCONJ
inlawrev-25507	57	8	to	to	PART
inlawrev-25507	57	9	increase	increase	VERB
inlawrev-25507	57	10	patient	patient	ADJ
inlawrev-25507	57	11	access	access	NOUN
inlawrev-25507	57	12	to	to	ADP
inlawrev-25507	57	13	generic	generic	ADJ
inlawrev-25507	57	14	medicines	medicine	NOUN
inlawrev-25507	57	15	in	in	ADP
inlawrev-25507	57	16	european	european	PROPN
inlawrev-25507	57	17	healthcare	healthcare	PROPN
inlawrev-25507	57	18	systems	systems	PROPN
inlawrev-25507	57	19	,	,	PUNCT
inlawrev-25507	57	20	meds	med	NOUN
inlawrev-25507	57	21	.	.	PUNCT
inlawrev-25507	58	1	for	for	ADP
inlawrev-25507	58	2	eur	eur	PROPN
inlawrev-25507	58	3	.	.	PUNCT
inlawrev-25507	59	1	at	at	ADP
inlawrev-25507	59	2	39	39	NUM
inlawrev-25507	59	3	(	(	PUNCT
inlawrev-25507	59	4	2009	2009	NUM
inlawrev-25507	59	5	)	)	PUNCT
inlawrev-25507	59	6	,	,	PUNCT
inlawrev-25507	59	7	https://www	https://www	PROPN
inlawrev-25507	59	8	.	.	PUNCT
inlawrev-25507	59	9	m	m	PROPN
inlawrev-25507	59	10	e	e	X
inlawrev-25507	59	11	d	d	X
inlawrev-25507	59	12	ic	ic	PROPN
inlawrev-25507	59	13	in	in	ADP
inlawrev-25507	59	14	e	e	PROPN
inlawrev-25507	59	15	s	s	PROPN
inlawrev-25507	59	16	f	f	NOUN
inlawrev-25507	59	17	o	o	NOUN
inlawrev-25507	59	18	r	r	NOUN
inlawrev-25507	59	19	e	e	NOUN
inlawrev-25507	59	20	u	u	NOUN
inlawrev-25507	59	21	r	r	NOUN
inlawrev-25507	59	22	o	o	NOUN
inlawrev-25507	59	23	p	p	X
inlawrev-25507	59	24	e	e	NOUN
inlawrev-25507	59	25	.	.	PUNCT
inlawrev-25507	60	1	c	c	NOUN
inlawrev-25507	61	1	o	o	NOUN
inlawrev-25507	62	1	m	m	VERB
inlawrev-25507	62	2	/	/	SYM
inlawrev-25507	62	3	w	w	PROPN
inlawrev-25507	62	4	p	p	PROPN
inlawrev-25507	62	5	-c	-c	X
inlawrev-25507	63	1	o	o	X
inlawrev-25507	63	2	n	n	ADP
inlawrev-25507	63	3	t	t	X
inlawrev-25507	63	4	e	e	X
inlawrev-25507	63	5	n	n	PROPN
inlawrev-25507	63	6	t	t	PROPN
inlawrev-25507	63	7	/	/	SYM
inlawrev-25507	63	8	u	u	PROPN
inlawrev-25507	63	9	p	p	X
inlawrev-25507	63	10	loads/2	loads/2	ADP
inlawrev-25507	63	11	0	0	NUM
inlawrev-25507	63	12	1	1	NUM
inlawrev-25507	63	13	6	6	NUM
inlawrev-25507	63	14	/0	/0	NOUN
inlawrev-25507	63	15	3	3	NUM
inlawrev-25507	63	16	/	/	SYM
inlawrev-25507	63	17	m	m	VERB
inlawrev-25507	63	18	a	a	DET
inlawrev-25507	63	19	r	r	NOUN
inlawrev-25507	63	20	k	k	NOUN
inlawrev-25507	63	21	e	e	NOUN
inlawrev-25507	63	22	t	t	NOUN
inlawrev-25507	63	23	_	_	PUNCT
inlawrev-25507	64	1	b	b	X
inlawrev-25507	64	2	a	a	DET
inlawrev-25507	64	3	r	r	NOUN
inlawrev-25507	64	4	r	r	NOUN
inlawrev-25507	64	5	ie	ie	ADP
inlawrev-25507	64	6	r	r	NOUN
inlawrev-25507	64	7	s	s	PART
inlawrev-25507	64	8	_	_	NOUN
inlawrev-25507	65	1	r	r	NOUN
inlawrev-25507	65	2	e	e	NOUN
inlawrev-25507	65	3	p	p	NOUN
inlawrev-25507	65	4	o	o	NOUN
inlawrev-25507	65	5	r	r	NOUN
inlawrev-25507	65	6	t	t	NOUN
inlawrev-25507	65	7	_	_	PUNCT
inlawrev-25507	66	1	f	f	X
inlawrev-25507	67	1	i	i	PRON
inlawrev-25507	67	2	n	n	CCONJ
inlawrev-25507	67	3	a	a	DET
inlawrev-25507	67	4	l	l	NOUN
inlawrev-25507	67	5	_	_	PUNCT
inlawrev-25507	68	1	u	u	NOUN
inlawrev-25507	68	2	p	p	PROPN
inlawrev-25507	68	3	d	d	X
inlawrev-25507	68	4	a	a	DET
inlawrev-25507	68	5	t	t	NOUN
inlawrev-25507	68	6	e	e	NOUN
inlawrev-25507	68	7	_	_	PUNCT
inlawrev-25507	68	8	h	h	NOUN
inlawrev-25507	69	1	o	o	X
inlawrev-25507	69	2	w	w	NOUN
inlawrev-25507	70	1	_	_	PUNCT
inlawrev-25507	71	1	t	t	NOUN
inlawrev-25507	72	1	o	o	NOUN
inlawrev-25507	72	2	_	_	PUNCT
inlawrev-25507	73	1	i	i	PRON
inlawrev-25507	73	2	n	n	VERB
inlawrev-25507	73	3	c	c	NOUN
inlawrev-25507	73	4	r	r	NOUN
inlawrev-25507	73	5	e	e	X
inlawrev-25507	73	6	a	a	DET
inlawrev-25507	73	7	s	s	X
inlawrev-25507	73	8	e	e	NOUN
inlawrev-25507	73	9	_	_	PUNCT
inlawrev-25507	74	1	p	p	NOUN
inlawrev-25507	74	2	a	a	DET
inlawrev-25507	74	3	t	t	NOUN
inlawrev-25507	74	4	ie	ie	X
inlawrev-25507	74	5	n	n	X
inlawrev-25507	74	6	t	t	NOUN
inlawrev-25507	74	7	_	_	PUNCT
inlawrev-25507	75	1	ac	ac	PROPN
inlawrev-25507	76	1	c	c	X
inlawrev-25507	76	2	e	e	X
inlawrev-25507	76	3	s	s	PROPN
inlawrev-25507	76	4	s	s	X
inlawrev-25507	76	5	_	_	NOUN
inlawrev-25507	77	1	t	t	NOUN
inlawrev-25507	77	2	o	o	NOUN
inlawrev-25507	77	3	_	_	PUNCT
inlawrev-25507	78	1	g	g	NOUN
inlawrev-25507	78	2	e	e	PROPN
inlawrev-25507	78	3	n	n	PROPN
inlawrev-25507	78	4	e	e	NOUN
inlawrev-25507	78	5	r	r	NOUN
inlawrev-25507	78	6	i	i	NOUN
inlawrev-25507	78	7	c	c	VERB
inlawrev-25507	78	8	_	_	PUNCT
inlawrev-25507	79	1	m	m	VERB
inlawrev-25507	79	2	e	e	X
inlawrev-25507	80	1	d	d	NOUN
inlawrev-25507	80	2	i	i	PRON
inlawrev-25507	80	3	c	c	VERB
inlawrev-25507	80	4	i	i	PRON
inlawrev-25507	80	5	n	n	VERB
inlawrev-25507	80	6	e	e	NOUN
inlawrev-25507	80	7	s	s	X
inlawrev-25507	80	8	.	.	PUNCT
inlawrev-25507	81	1	p	p	X
inlawrev-25507	82	1	d	d	X
inlawrev-25507	82	2	f	f	X
inlawrev-25507	83	1	[	[	X
inlawrev-25507	83	2	https://perma.cc/zpg4-wfgk	https://perma.cc/zpg4-wfgk	PROPN
inlawrev-25507	83	3	]	]	X
inlawrev-25507	83	4	.	.	PUNCT
inlawrev-25507	84	1	29	29	NUM
inlawrev-25507	84	2	.	.	PUNCT
inlawrev-25507	85	1	s.	s.	PROPN
inlawrev-25507	85	2	1209	1209	NUM
inlawrev-25507	85	3	,	,	PUNCT
inlawrev-25507	85	4	116th	116th	PROPN
inlawrev-25507	85	5	cong	cong	NOUN
inlawrev-25507	85	6	.	.	PUNCT
inlawrev-25507	86	1	§	§	PROPN
inlawrev-25507	86	2	3	3	NUM
inlawrev-25507	86	3	(	(	PUNCT
inlawrev-25507	86	4	2019	2019	NUM
inlawrev-25507	86	5	)	)	PUNCT
inlawrev-25507	86	6	;	;	PUNCT
inlawrev-25507	86	7	s.	s.	PROPN
inlawrev-25507	86	8	1416	1416	NUM
inlawrev-25507	86	9	,	,	PUNCT
inlawrev-25507	86	10	116th	116th	PROPN
inlawrev-25507	86	11	cong	cong	NOUN
inlawrev-25507	86	12	.	.	PUNCT
inlawrev-25507	87	1	(	(	PUNCT
inlawrev-25507	87	2	2019	2019	NUM
inlawrev-25507	87	3	)	)	PUNCT
inlawrev-25507	87	4	;	;	PUNCT
inlawrev-25507	87	5	h.r	h.r	PROPN
inlawrev-25507	87	6	.	.	PROPN
inlawrev-25507	87	7	3199	3199	NUM
inlawrev-25507	87	8	,	,	PUNCT
inlawrev-25507	87	9	116th	116th	PROPN
inlawrev-25507	87	10	cong	cong	NOUN
inlawrev-25507	87	11	.	.	PUNCT
inlawrev-25507	88	1	(	(	PUNCT
inlawrev-25507	88	2	2019	2019	NUM
inlawrev-25507	88	3	)	)	PUNCT
inlawrev-25507	88	4	.	.	PUNCT
inlawrev-25507	89	1	198	198	NUM
inlawrev-25507	89	2	indiana	indiana	PROPN
inlawrev-25507	89	3	law	law	NOUN
inlawrev-25507	89	4	review	review	NOUN
inlawrev-25507	89	5	[	[	X
inlawrev-25507	89	6	vol	vol	NOUN
inlawrev-25507	89	7	.	.	PUNCT
inlawrev-25507	90	1	54:195	54:195	NUM
inlawrev-25507	90	2	therefore	therefore	ADV
inlawrev-25507	90	3	,	,	PUNCT
inlawrev-25507	90	4	they	they	PRON
inlawrev-25507	90	5	would	would	AUX
inlawrev-25507	90	6	be	be	AUX
inlawrev-25507	90	7	detrimental	detrimental	ADJ
inlawrev-25507	90	8	to	to	ADP
inlawrev-25507	90	9	the	the	DET
inlawrev-25507	90	10	patent	patent	NOUN
inlawrev-25507	90	11	system	system	NOUN
inlawrev-25507	90	12	and	and	CCONJ
inlawrev-25507	90	13	the	the	DET
inlawrev-25507	90	14	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	90	15	industry	industry	NOUN
inlawrev-25507	90	16	.	.	PUNCT
inlawrev-25507	91	1	i.	i.	PROPN
inlawrev-25507	91	2	the	the	DET
inlawrev-25507	91	3	evergreening	evergreene	VERB
inlawrev-25507	91	4	problem	problem	NOUN
inlawrev-25507	91	5	a.	a.	NOUN
inlawrev-25507	91	6	exclusivity	exclusivity	NOUN
inlawrev-25507	91	7	and	and	CCONJ
inlawrev-25507	91	8	secondary	secondary	ADJ
inlawrev-25507	91	9	patents	patent	NOUN
inlawrev-25507	91	10	35	35	NUM
inlawrev-25507	91	11	u.s.c	u.s.c	ADJ
inlawrev-25507	91	12	.	.	PUNCT
inlawrev-25507	92	1	§	§	PROPN
inlawrev-25507	92	2	154	154	NUM
inlawrev-25507	92	3	guarantees	guarantee	VERB
inlawrev-25507	92	4	an	an	DET
inlawrev-25507	92	5	inventor	inventor	NOUN
inlawrev-25507	92	6	twenty	twenty	NUM
inlawrev-25507	92	7	years	year	NOUN
inlawrev-25507	92	8	of	of	ADP
inlawrev-25507	92	9	exclusivity	exclusivity	NOUN
inlawrev-25507	92	10	from	from	ADP
inlawrev-25507	92	11	the	the	DET
inlawrev-25507	92	12	filing	filing	NOUN
inlawrev-25507	92	13	date	date	NOUN
inlawrev-25507	92	14	of	of	ADP
inlawrev-25507	92	15	a	a	DET
inlawrev-25507	92	16	patent.30	patent.30	NOUN
inlawrev-25507	92	17	the	the	DET
inlawrev-25507	92	18	exclusivity	exclusivity	NOUN
inlawrev-25507	92	19	provides	provide	VERB
inlawrev-25507	92	20	incentives	incentive	NOUN
inlawrev-25507	92	21	for	for	SCONJ
inlawrev-25507	92	22	inventors	inventor	NOUN
inlawrev-25507	92	23	to	to	PART
inlawrev-25507	92	24	present	present	VERB
inlawrev-25507	92	25	their	their	PRON
inlawrev-25507	92	26	inventions	invention	NOUN
inlawrev-25507	92	27	to	to	ADP
inlawrev-25507	92	28	the	the	DET
inlawrev-25507	92	29	public.31	public.31	PROPN
inlawrev-25507	92	30	this	this	DET
inlawrev-25507	92	31	motivation	motivation	NOUN
inlawrev-25507	92	32	draws	draw	VERB
inlawrev-25507	92	33	many	many	ADJ
inlawrev-25507	92	34	inventors	inventor	NOUN
inlawrev-25507	92	35	away	away	ADV
inlawrev-25507	92	36	from	from	ADP
inlawrev-25507	92	37	the	the	DET
inlawrev-25507	92	38	trade	trade	NOUN
inlawrev-25507	92	39	secret	secret	ADJ
inlawrev-25507	92	40	track	track	NOUN
inlawrev-25507	92	41	,	,	PUNCT
inlawrev-25507	92	42	as	as	ADV
inlawrev-25507	92	43	once	once	ADV
inlawrev-25507	92	44	a	a	DET
inlawrev-25507	92	45	trade	trade	NOUN
inlawrev-25507	92	46	secret	secret	NOUN
inlawrev-25507	92	47	is	be	AUX
inlawrev-25507	92	48	public	public	ADJ
inlawrev-25507	92	49	knowledge	knowledge	NOUN
inlawrev-25507	92	50	,	,	PUNCT
inlawrev-25507	92	51	there	there	PRON
inlawrev-25507	92	52	is	be	VERB
inlawrev-25507	92	53	no	no	DET
inlawrev-25507	92	54	recourse	recourse	NOUN
inlawrev-25507	92	55	that	that	PRON
inlawrev-25507	92	56	is	be	AUX
inlawrev-25507	92	57	as	as	ADV
inlawrev-25507	92	58	strong	strong	ADJ
inlawrev-25507	92	59	as	as	SCONJ
inlawrev-25507	92	60	patent	patent	NOUN
inlawrev-25507	92	61	protection.32	protection.32	VERB
inlawrev-25507	92	62	the	the	DET
inlawrev-25507	92	63	patent	patent	NOUN
inlawrev-25507	92	64	system	system	NOUN
inlawrev-25507	92	65	incentivizes	incentivize	VERB
inlawrev-25507	92	66	innovation	innovation	NOUN
inlawrev-25507	92	67	and	and	CCONJ
inlawrev-25507	92	68	disclosure	disclosure	NOUN
inlawrev-25507	92	69	,	,	PUNCT
inlawrev-25507	92	70	allowing	allow	VERB
inlawrev-25507	92	71	the	the	DET
inlawrev-25507	92	72	public	public	NOUN
inlawrev-25507	92	73	to	to	PART
inlawrev-25507	92	74	consistently	consistently	ADV
inlawrev-25507	92	75	improve	improve	VERB
inlawrev-25507	92	76	on	on	ADP
inlawrev-25507	92	77	society	society	NOUN
inlawrev-25507	92	78	’s	’s	PART
inlawrev-25507	92	79	discoveries.33	discoveries.33	NOUN
inlawrev-25507	92	80	in	in	ADP
inlawrev-25507	92	81	the	the	DET
inlawrev-25507	92	82	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	92	83	industry	industry	NOUN
inlawrev-25507	92	84	,	,	PUNCT
inlawrev-25507	92	85	the	the	DET
inlawrev-25507	92	86	innovator	innovator	NOUN
inlawrev-25507	92	87	receives	receive	VERB
inlawrev-25507	92	88	an	an	DET
inlawrev-25507	92	89	exclusivity	exclusivity	NOUN
inlawrev-25507	92	90	term	term	NOUN
inlawrev-25507	92	91	for	for	ADP
inlawrev-25507	92	92	providing	provide	VERB
inlawrev-25507	92	93	the	the	DET
inlawrev-25507	92	94	public	public	NOUN
inlawrev-25507	92	95	with	with	ADP
inlawrev-25507	92	96	a	a	DET
inlawrev-25507	92	97	beneficial	beneficial	ADJ
inlawrev-25507	92	98	drug	drug	NOUN
inlawrev-25507	92	99	,	,	PUNCT
inlawrev-25507	92	100	while	while	SCONJ
inlawrev-25507	92	101	the	the	DET
inlawrev-25507	92	102	public	public	NOUN
inlawrev-25507	92	103	gets	get	VERB
inlawrev-25507	92	104	access	access	NOUN
inlawrev-25507	92	105	to	to	ADP
inlawrev-25507	92	106	the	the	DET
inlawrev-25507	92	107	drug	drug	NOUN
inlawrev-25507	92	108	for	for	ADP
inlawrev-25507	92	109	the	the	DET
inlawrev-25507	92	110	exclusivity	exclusivity	NOUN
inlawrev-25507	92	111	period.34	period.34	NOUN
inlawrev-25507	92	112	additionally	additionally	ADV
inlawrev-25507	92	113	,	,	PUNCT
inlawrev-25507	92	114	after	after	ADP
inlawrev-25507	92	115	the	the	DET
inlawrev-25507	92	116	exclusivity	exclusivity	NOUN
inlawrev-25507	92	117	period	period	NOUN
inlawrev-25507	92	118	,	,	PUNCT
inlawrev-25507	92	119	the	the	DET
inlawrev-25507	92	120	public	public	NOUN
inlawrev-25507	92	121	will	will	AUX
inlawrev-25507	92	122	likely	likely	ADV
inlawrev-25507	92	123	get	get	VERB
inlawrev-25507	92	124	access	access	NOUN
inlawrev-25507	92	125	to	to	ADP
inlawrev-25507	92	126	the	the	DET
inlawrev-25507	92	127	drug	drug	NOUN
inlawrev-25507	92	128	at	at	ADP
inlawrev-25507	92	129	a	a	DET
inlawrev-25507	92	130	much	much	ADV
inlawrev-25507	92	131	lower	low	ADJ
inlawrev-25507	92	132	price	price	NOUN
inlawrev-25507	92	133	due	due	ADP
inlawrev-25507	92	134	to	to	ADP
inlawrev-25507	92	135	the	the	DET
inlawrev-25507	92	136	generic	generic	ADJ
inlawrev-25507	92	137	competition	competition	NOUN
inlawrev-25507	92	138	entering	enter	VERB
inlawrev-25507	92	139	the	the	DET
inlawrev-25507	92	140	market	market	NOUN
inlawrev-25507	92	141	,	,	PUNCT
inlawrev-25507	92	142	and	and	CCONJ
inlawrev-25507	92	143	the	the	DET
inlawrev-25507	92	144	generic	generic	ADJ
inlawrev-25507	92	145	company	company	NOUN
inlawrev-25507	92	146	will	will	AUX
inlawrev-25507	92	147	be	be	AUX
inlawrev-25507	92	148	able	able	ADJ
inlawrev-25507	92	149	to	to	PART
inlawrev-25507	92	150	profit	profit	VERB
inlawrev-25507	92	151	off	off	ADP
inlawrev-25507	92	152	of	of	ADP
inlawrev-25507	92	153	the	the	DET
inlawrev-25507	92	154	drug	drug	NOUN
inlawrev-25507	92	155	while	while	SCONJ
inlawrev-25507	92	156	providing	provide	VERB
inlawrev-25507	92	157	it	it	PRON
inlawrev-25507	92	158	at	at	ADP
inlawrev-25507	92	159	a	a	DET
inlawrev-25507	92	160	lower	low	ADJ
inlawrev-25507	92	161	price	price	NOUN
inlawrev-25507	92	162	than	than	SCONJ
inlawrev-25507	92	163	offered	offer	VERB
inlawrev-25507	92	164	by	by	ADP
inlawrev-25507	92	165	the	the	DET
inlawrev-25507	92	166	innovator	innovator	NOUN
inlawrev-25507	92	167	company.35	company.35	NOUN
inlawrev-25507	92	168	the	the	DET
inlawrev-25507	92	169	ability	ability	NOUN
inlawrev-25507	92	170	for	for	SCONJ
inlawrev-25507	92	171	the	the	DET
inlawrev-25507	92	172	drug	drug	NOUN
inlawrev-25507	92	173	developer	developer	NOUN
inlawrev-25507	92	174	to	to	PART
inlawrev-25507	92	175	obtain	obtain	VERB
inlawrev-25507	92	176	secondary	secondary	ADJ
inlawrev-25507	92	177	patents	patent	NOUN
inlawrev-25507	92	178	on	on	ADP
inlawrev-25507	92	179	the	the	DET
inlawrev-25507	92	180	same	same	ADJ
inlawrev-25507	92	181	drug	drug	NOUN
inlawrev-25507	92	182	provides	provide	VERB
inlawrev-25507	92	183	drug	drug	NOUN
inlawrev-25507	92	184	developers	developer	NOUN
inlawrev-25507	92	185	with	with	ADP
inlawrev-25507	92	186	an	an	DET
inlawrev-25507	92	187	important	important	ADJ
inlawrev-25507	92	188	opportunity.36	opportunity.36	NOUN
inlawrev-25507	92	189	while	while	SCONJ
inlawrev-25507	92	190	the	the	DET
inlawrev-25507	92	191	primary	primary	ADJ
inlawrev-25507	92	192	patent	patent	NOUN
inlawrev-25507	92	193	protects	protect	VERB
inlawrev-25507	92	194	the	the	DET
inlawrev-25507	92	195	active	active	ADJ
inlawrev-25507	92	196	drug	drug	NOUN
inlawrev-25507	92	197	,	,	PUNCT
inlawrev-25507	92	198	secondary	secondary	ADJ
inlawrev-25507	92	199	patents	patent	NOUN
inlawrev-25507	92	200	can	can	AUX
inlawrev-25507	92	201	protect	protect	VERB
inlawrev-25507	92	202	ranges	range	NOUN
inlawrev-25507	92	203	of	of	ADP
inlawrev-25507	92	204	chemicals	chemical	NOUN
inlawrev-25507	92	205	involved	involve	VERB
inlawrev-25507	92	206	in	in	ADP
inlawrev-25507	92	207	the	the	DET
inlawrev-25507	92	208	active	active	ADJ
inlawrev-25507	92	209	drug	drug	NOUN
inlawrev-25507	92	210	,	,	PUNCT
inlawrev-25507	92	211	methods	method	NOUN
inlawrev-25507	92	212	of	of	ADP
inlawrev-25507	92	213	using	use	VERB
inlawrev-25507	92	214	the	the	DET
inlawrev-25507	92	215	drug	drug	NOUN
inlawrev-25507	92	216	,	,	PUNCT
inlawrev-25507	92	217	formulations	formulation	NOUN
inlawrev-25507	92	218	,	,	PUNCT
inlawrev-25507	92	219	dosages	dosage	NOUN
inlawrev-25507	92	220	,	,	PUNCT
inlawrev-25507	92	221	and	and	CCONJ
inlawrev-25507	92	222	methods	method	NOUN
inlawrev-25507	92	223	of	of	ADP
inlawrev-25507	92	224	manufacturing.37	manufacturing.37	PROPN
inlawrev-25507	92	225	generally	generally	ADV
inlawrev-25507	92	226	,	,	PUNCT
inlawrev-25507	92	227	secondary	secondary	ADJ
inlawrev-25507	92	228	patents	patent	NOUN
inlawrev-25507	92	229	are	be	AUX
inlawrev-25507	92	230	granted	grant	VERB
inlawrev-25507	92	231	in	in	ADP
inlawrev-25507	92	232	order	order	NOUN
inlawrev-25507	92	233	to	to	PART
inlawrev-25507	92	234	encourage	encourage	VERB
inlawrev-25507	92	235	further	further	ADJ
inlawrev-25507	92	236	discoveries	discovery	NOUN
inlawrev-25507	92	237	that	that	PRON
inlawrev-25507	92	238	can	can	AUX
inlawrev-25507	92	239	result	result	VERB
inlawrev-25507	92	240	from	from	ADP
inlawrev-25507	92	241	additional	additional	ADJ
inlawrev-25507	92	242	research	research	NOUN
inlawrev-25507	92	243	and	and	CCONJ
inlawrev-25507	92	244	development	development	NOUN
inlawrev-25507	92	245	on	on	ADP
inlawrev-25507	92	246	a	a	DET
inlawrev-25507	92	247	known	know	VERB
inlawrev-25507	92	248	drug.38	drug.38	NOUN
inlawrev-25507	92	249	notably	notably	ADV
inlawrev-25507	92	250	,	,	PUNCT
inlawrev-25507	92	251	these	these	DET
inlawrev-25507	92	252	secondary	secondary	ADJ
inlawrev-25507	92	253	patents	patent	NOUN
inlawrev-25507	92	254	30	30	NUM
inlawrev-25507	92	255	.	.	NOUN
inlawrev-25507	92	256	35	35	NUM
inlawrev-25507	92	257	u.s.c	u.s.c	NOUN
inlawrev-25507	92	258	.	.	PUNCT
inlawrev-25507	93	1	§	§	PROPN
inlawrev-25507	93	2	154	154	NUM
inlawrev-25507	93	3	(	(	PUNCT
inlawrev-25507	93	4	1952	1952	NUM
inlawrev-25507	93	5	)	)	PUNCT
inlawrev-25507	93	6	.	.	PUNCT
inlawrev-25507	94	1	31	31	NUM
inlawrev-25507	94	2	.	.	PUNCT
inlawrev-25507	95	1	frequently	frequently	ADV
inlawrev-25507	95	2	asked	ask	VERB
inlawrev-25507	95	3	questions	question	NOUN
inlawrev-25507	95	4	:	:	PUNCT
inlawrev-25507	95	5	patents	patent	NOUN
inlawrev-25507	95	6	,	,	PUNCT
inlawrev-25507	95	7	world	world	NOUN
inlawrev-25507	95	8	intell	intell	PROPN
inlawrev-25507	95	9	.	.	PUNCT
inlawrev-25507	96	1	prop	prop	NOUN
inlawrev-25507	96	2	.	.	PUNCT
inlawrev-25507	97	1	org	org	PROPN
inlawrev-25507	97	2	.	.	PROPN
inlawrev-25507	97	3	,	,	PUNCT
inlawrev-25507	97	4	https://www.wipo	https://www.wipo	PROPN
inlawrev-25507	97	5	.	.	PUNCT
inlawrev-25507	98	1	int	int	NOUN
inlawrev-25507	98	2	/	/	SYM
inlawrev-25507	98	3	patents	patent	NOUN
inlawrev-25507	98	4	/	/	SYM
inlawrev-25507	98	5	en	en	X
inlawrev-25507	98	6	/	/	SYM
inlawrev-25507	98	7	faq_patents.html	faq_patents.html	X
inlawrev-25507	98	8	(	(	PUNCT
inlawrev-25507	98	9	last	last	ADJ
inlawrev-25507	98	10	visited	visit	VERB
inlawrev-25507	98	11	oct	oct	PROPN
inlawrev-25507	98	12	.	.	PROPN
inlawrev-25507	98	13	9	9	NUM
inlawrev-25507	98	14	,	,	PUNCT
inlawrev-25507	98	15	2019	2019	NUM
inlawrev-25507	98	16	)	)	PUNCT
inlawrev-25507	99	1	[	[	X
inlawrev-25507	99	2	https://perma.cc/nny7-gv4w	https://perma.cc/nny7-gv4w	X
inlawrev-25507	99	3	]	]	PUNCT
inlawrev-25507	99	4	.	.	PUNCT
inlawrev-25507	100	1	32	32	NUM
inlawrev-25507	100	2	.	.	PUNCT
inlawrev-25507	101	1	orly	orly	PROPN
inlawrev-25507	101	2	lobel	lobel	PROPN
inlawrev-25507	101	3	,	,	PUNCT
inlawrev-25507	101	4	filing	file	VERB
inlawrev-25507	101	5	for	for	ADP
inlawrev-25507	101	6	a	a	DET
inlawrev-25507	101	7	patent	patent	NOUN
inlawrev-25507	101	8	versus	versus	ADP
inlawrev-25507	101	9	keeping	keep	VERB
inlawrev-25507	101	10	your	your	PRON
inlawrev-25507	101	11	invention	invention	NOUN
inlawrev-25507	101	12	a	a	DET
inlawrev-25507	101	13	trade	trade	NOUN
inlawrev-25507	101	14	secret	secret	NOUN
inlawrev-25507	101	15	,	,	PUNCT
inlawrev-25507	101	16	harv	harv	NOUN
inlawrev-25507	101	17	.	.	PUNCT
inlawrev-25507	102	1	bus	bus	NOUN
inlawrev-25507	102	2	.	.	PUNCT
inlawrev-25507	103	1	rev	rev	PROPN
inlawrev-25507	103	2	.	.	PUNCT
inlawrev-25507	104	1	(	(	PUNCT
inlawrev-25507	104	2	nov	nov	PROPN
inlawrev-25507	104	3	.	.	PROPN
inlawrev-25507	104	4	21	21	NUM
inlawrev-25507	104	5	,	,	PUNCT
inlawrev-25507	104	6	2013	2013	NUM
inlawrev-25507	104	7	)	)	PUNCT
inlawrev-25507	104	8	,	,	PUNCT
inlawrev-25507	104	9	https://hbr.org/2013/11/filing-for-a-patent-versus-keeping-yourinvention-a-trade-secret	https://hbr.org/2013/11/filing-for-a-patent-versus-keeping-yourinvention-a-trade-secret	NOUN
inlawrev-25507	105	1	[	[	X
inlawrev-25507	105	2	https://perma.cc/7db7-9bfs	https://perma.cc/7db7-9bfs	ADP
inlawrev-25507	105	3	]	]	X
inlawrev-25507	105	4	.	.	PUNCT
inlawrev-25507	106	1	33	33	NUM
inlawrev-25507	106	2	.	.	X
inlawrev-25507	106	3	patent	patent	NOUN
inlawrev-25507	106	4	,	,	PUNCT
inlawrev-25507	106	5	cornell	cornell	PROPN
inlawrev-25507	106	6	l.	l.	PROPN
inlawrev-25507	106	7	sch	sch	PROPN
inlawrev-25507	106	8	.	.	PROPN
inlawrev-25507	106	9	,	,	PUNCT
inlawrev-25507	106	10	https://www.law.cornell.edu/wex/patent	https://www.law.cornell.edu/wex/patent	X
inlawrev-25507	106	11	(	(	PUNCT
inlawrev-25507	106	12	last	last	ADV
inlawrev-25507	106	13	visited	visit	VERB
inlawrev-25507	106	14	oct	oct	PROPN
inlawrev-25507	106	15	.	.	PROPN
inlawrev-25507	106	16	17	17	NUM
inlawrev-25507	106	17	,	,	PUNCT
inlawrev-25507	106	18	2019	2019	NUM
inlawrev-25507	106	19	)	)	PUNCT
inlawrev-25507	107	1	[	[	X
inlawrev-25507	107	2	https://perma.cc/pe9t-f2ta	https://perma.cc/pe9t-f2ta	X
inlawrev-25507	107	3	]	]	PUNCT
inlawrev-25507	107	4	.	.	PUNCT
inlawrev-25507	108	1	34	34	NUM
inlawrev-25507	108	2	.	.	PUNCT
inlawrev-25507	109	1	grabowski	grabowski	PROPN
inlawrev-25507	109	2	,	,	PUNCT
inlawrev-25507	109	3	dimasi	dimasi	PROPN
inlawrev-25507	109	4	&	&	CCONJ
inlawrev-25507	109	5	long	long	PROPN
inlawrev-25507	109	6	,	,	PUNCT
inlawrev-25507	109	7	supra	supra	PROPN
inlawrev-25507	109	8	note	note	NOUN
inlawrev-25507	109	9	21	21	NUM
inlawrev-25507	109	10	,	,	PUNCT
inlawrev-25507	109	11	at	at	ADP
inlawrev-25507	109	12	302	302	NUM
inlawrev-25507	109	13	.	.	NOUN
inlawrev-25507	109	14	35	35	NUM
inlawrev-25507	109	15	.	.	PUNCT
inlawrev-25507	110	1	i	i	PRON
inlawrev-25507	110	2	d.	d.	PROPN
inlawrev-25507	110	3	36	36	NUM
inlawrev-25507	110	4	.	.	PUNCT
inlawrev-25507	111	1	sarah	sarah	PROPN
inlawrev-25507	111	2	jane	jane	PROPN
inlawrev-25507	111	3	tribble	tribble	PROPN
inlawrev-25507	111	4	,	,	PUNCT
inlawrev-25507	111	5	drugmakers	drugmaker	NOUN
inlawrev-25507	111	6	play	play	VERB
inlawrev-25507	111	7	the	the	DET
inlawrev-25507	111	8	patent	patent	NOUN
inlawrev-25507	111	9	game	game	NOUN
inlawrev-25507	111	10	to	to	PART
inlawrev-25507	111	11	ward	ward	VERB
inlawrev-25507	111	12	off	off	ADP
inlawrev-25507	111	13	competitors	competitor	NOUN
inlawrev-25507	111	14	,	,	PUNCT
inlawrev-25507	111	15	nbc	nbc	PROPN
inlawrev-25507	111	16	news	news	PROPN
inlawrev-25507	111	17	(	(	PUNCT
inlawrev-25507	111	18	oct	oct	PROPN
inlawrev-25507	111	19	.	.	PROPN
inlawrev-25507	111	20	2	2	NUM
inlawrev-25507	111	21	,	,	PUNCT
inlawrev-25507	111	22	2018	2018	NUM
inlawrev-25507	111	23	)	)	PUNCT
inlawrev-25507	111	24	,	,	PUNCT
inlawrev-25507	111	25	https://www.nbcnews.com/health/health-news/drugmakers-play-patent-gameward-competitors-n915911	https://www.nbcnews.com/health/health-news/drugmakers-play-patent-gameward-competitors-n915911	PROPN
inlawrev-25507	112	1	[	[	X
inlawrev-25507	112	2	https://perma.cc/l7ft-6f2z	https://perma.cc/l7ft-6f2z	X
inlawrev-25507	112	3	]	]	PUNCT
inlawrev-25507	113	1	[	[	X
inlawrev-25507	113	2	hereinafter	hereinafter	NOUN
inlawrev-25507	113	3	tribble	tribble	NOUN
inlawrev-25507	113	4	,	,	PUNCT
inlawrev-25507	113	5	drugmakers	drugmaker	NOUN
inlawrev-25507	113	6	play	play	VERB
inlawrev-25507	113	7	the	the	DET
inlawrev-25507	113	8	patent	patent	NOUN
inlawrev-25507	113	9	game	game	NOUN
inlawrev-25507	113	10	]	]	X
inlawrev-25507	113	11	.	.	PUNCT
inlawrev-25507	114	1	37	37	NUM
inlawrev-25507	114	2	.	.	PUNCT
inlawrev-25507	115	1	maría	maría	PROPN
inlawrev-25507	115	2	josé	josé	PROPN
inlawrev-25507	115	3	abud	abud	PROPN
inlawrev-25507	115	4	sittler	sittler	PROPN
inlawrev-25507	115	5	et	et	PROPN
inlawrev-25507	115	6	al	al	PROPN
inlawrev-25507	115	7	.	.	PROPN
inlawrev-25507	115	8	,	,	PUNCT
inlawrev-25507	115	9	study	study	VERB
inlawrev-25507	115	10	on	on	ADP
inlawrev-25507	115	11	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	115	12	patents	patent	NOUN
inlawrev-25507	115	13	in	in	ADP
inlawrev-25507	115	14	chile	chile	PROPN
inlawrev-25507	115	15	,	,	PUNCT
inlawrev-25507	115	16	world	world	NOUN
inlawrev-25507	115	17	intell	intell	PROPN
inlawrev-25507	115	18	.	.	PUNCT
inlawrev-25507	116	1	prop	prop	NOUN
inlawrev-25507	116	2	.	.	PUNCT
inlawrev-25507	117	1	org	org	PROPN
inlawrev-25507	117	2	.	.	PUNCT
inlawrev-25507	118	1	at	at	ADP
inlawrev-25507	118	2	1	1	NUM
inlawrev-25507	118	3	(	(	PUNCT
inlawrev-25507	118	4	2015	2015	NUM
inlawrev-25507	118	5	)	)	PUNCT
inlawrev-25507	118	6	,	,	PUNCT
inlawrev-25507	118	7	https://www.wipo.int/edocs/mdocs/mdocs/en/cdip_15/cdip_15_inf_2.docx	https://www.wipo.int/edocs/mdocs/mdocs/en/cdip_15/cdip_15_inf_2.docx	VERB
inlawrev-25507	118	8	[	[	X
inlawrev-25507	118	9	https://perma.cc/wu2m-u3nu	https://perma.cc/wu2m-u3nu	X
inlawrev-25507	118	10	]	]	X
inlawrev-25507	118	11	.	.	PUNCT
inlawrev-25507	119	1	38	38	NUM
inlawrev-25507	119	2	.	.	PUNCT
inlawrev-25507	119	3	christopher	christopher	PROPN
inlawrev-25507	119	4	holman	holman	PROPN
inlawrev-25507	119	5	,	,	PUNCT
inlawrev-25507	119	6	inside	inside	ADJ
inlawrev-25507	119	7	views	view	NOUN
inlawrev-25507	119	8	:	:	PUNCT
inlawrev-25507	119	9	why	why	SCONJ
inlawrev-25507	119	10	follow	follow	VERB
inlawrev-25507	119	11	-	-	PUNCT
inlawrev-25507	119	12	on	on	ADP
inlawrev-25507	119	13	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	119	14	innovations	innovation	NOUN
inlawrev-25507	119	15	should	should	AUX
inlawrev-25507	119	16	2021	2021	NUM
inlawrev-25507	119	17	]	]	PUNCT
inlawrev-25507	119	18	leaving	leave	VERB
inlawrev-25507	119	19	the	the	DET
inlawrev-25507	119	20	evergreening	evergreene	VERB
inlawrev-25507	119	21	problem	problem	NOUN
inlawrev-25507	119	22	to	to	ADP
inlawrev-25507	119	23	the	the	DET
inlawrev-25507	119	24	patent	patent	NOUN
inlawrev-25507	119	25	experts	expert	NOUN
inlawrev-25507	119	26	199	199	NUM
inlawrev-25507	119	27	can	can	AUX
inlawrev-25507	119	28	extend	extend	VERB
inlawrev-25507	119	29	the	the	DET
inlawrev-25507	119	30	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	119	31	company	company	NOUN
inlawrev-25507	119	32	’s	’s	PART
inlawrev-25507	119	33	exclusivity	exclusivity	NOUN
inlawrev-25507	119	34	even	even	ADV
inlawrev-25507	119	35	beyond	beyond	ADP
inlawrev-25507	119	36	the	the	DET
inlawrev-25507	119	37	original	original	ADJ
inlawrev-25507	119	38	twenty	twenty	NUM
inlawrev-25507	119	39	years.39	years.39	NOUN
inlawrev-25507	119	40	the	the	DET
inlawrev-25507	119	41	implication	implication	NOUN
inlawrev-25507	119	42	for	for	ADP
inlawrev-25507	119	43	the	the	DET
inlawrev-25507	119	44	public	public	NOUN
inlawrev-25507	119	45	is	be	AUX
inlawrev-25507	119	46	higher	high	ADJ
inlawrev-25507	119	47	prices	price	NOUN
inlawrev-25507	119	48	for	for	ADP
inlawrev-25507	119	49	an	an	DET
inlawrev-25507	119	50	extended	extended	ADJ
inlawrev-25507	119	51	period	period	NOUN
inlawrev-25507	119	52	of	of	ADP
inlawrev-25507	119	53	time40	time40	NOUN
inlawrev-25507	119	54	;	;	PUNCT
inlawrev-25507	119	55	additionally	additionally	ADV
inlawrev-25507	119	56	,	,	PUNCT
inlawrev-25507	119	57	this	this	DET
inlawrev-25507	119	58	patent	patent	NOUN
inlawrev-25507	119	59	scheme	scheme	NOUN
inlawrev-25507	119	60	could	could	AUX
inlawrev-25507	119	61	theoretically	theoretically	ADV
inlawrev-25507	119	62	allow	allow	VERB
inlawrev-25507	119	63	a	a	DET
inlawrev-25507	119	64	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	119	65	company	company	NOUN
inlawrev-25507	119	66	to	to	PART
inlawrev-25507	119	67	continuously	continuously	ADV
inlawrev-25507	119	68	extend	extend	VERB
inlawrev-25507	119	69	its	its	PRON
inlawrev-25507	119	70	exclusivity	exclusivity	NOUN
inlawrev-25507	119	71	by	by	ADP
inlawrev-25507	119	72	making	make	VERB
inlawrev-25507	119	73	insubstantial	insubstantial	ADJ
inlawrev-25507	119	74	changes	change	NOUN
inlawrev-25507	119	75	to	to	ADP
inlawrev-25507	119	76	its	its	PRON
inlawrev-25507	119	77	subsequent	subsequent	ADJ
inlawrev-25507	119	78	applications	application	NOUN
inlawrev-25507	119	79	on	on	ADP
inlawrev-25507	119	80	the	the	DET
inlawrev-25507	119	81	same	same	ADJ
inlawrev-25507	119	82	drug.41	drug.41	NOUN
inlawrev-25507	119	83	in	in	ADP
inlawrev-25507	119	84	some	some	DET
inlawrev-25507	119	85	instances	instance	NOUN
inlawrev-25507	119	86	,	,	PUNCT
inlawrev-25507	119	87	where	where	SCONJ
inlawrev-25507	119	88	the	the	DET
inlawrev-25507	119	89	drug	drug	NOUN
inlawrev-25507	119	90	is	be	AUX
inlawrev-25507	119	91	a	a	DET
inlawrev-25507	119	92	natural	natural	ADJ
inlawrev-25507	119	93	product	product	NOUN
inlawrev-25507	119	94	,	,	PUNCT
inlawrev-25507	119	95	only	only	ADV
inlawrev-25507	119	96	secondary	secondary	ADJ
inlawrev-25507	119	97	patents	patent	NOUN
inlawrev-25507	119	98	are	be	AUX
inlawrev-25507	119	99	likely	likely	ADJ
inlawrev-25507	119	100	to	to	PART
inlawrev-25507	119	101	provide	provide	VERB
inlawrev-25507	119	102	any	any	DET
inlawrev-25507	119	103	patent	patent	NOUN
inlawrev-25507	119	104	exclusivity	exclusivity	NOUN
inlawrev-25507	119	105	for	for	ADP
inlawrev-25507	119	106	the	the	DET
inlawrev-25507	119	107	drug.42	drug.42	NOUN
inlawrev-25507	119	108	the	the	DET
inlawrev-25507	119	109	initial	initial	ADJ
inlawrev-25507	119	110	reasoning	reasoning	NOUN
inlawrev-25507	119	111	behind	behind	ADP
inlawrev-25507	119	112	allowing	allow	VERB
inlawrev-25507	119	113	secondary	secondary	ADJ
inlawrev-25507	119	114	patents	patent	NOUN
inlawrev-25507	119	115	sought	seek	VERB
inlawrev-25507	119	116	to	to	PART
inlawrev-25507	119	117	protect	protect	VERB
inlawrev-25507	119	118	genuine	genuine	ADJ
inlawrev-25507	119	119	innovation.43	innovation.43	NOUN
inlawrev-25507	119	120	for	for	ADP
inlawrev-25507	119	121	example	example	NOUN
inlawrev-25507	119	122	,	,	PUNCT
inlawrev-25507	119	123	zidovudine	zidovudine	PROPN
inlawrev-25507	119	124	(	(	PUNCT
inlawrev-25507	119	125	azt	azt	PROPN
inlawrev-25507	119	126	)	)	PUNCT
inlawrev-25507	119	127	initially	initially	ADV
inlawrev-25507	119	128	failed	fail	VERB
inlawrev-25507	119	129	as	as	SCONJ
inlawrev-25507	119	130	a	a	DET
inlawrev-25507	119	131	cancer	cancer	NOUN
inlawrev-25507	119	132	drug.44	drug.44	VERB
inlawrev-25507	119	133	however	however	ADV
inlawrev-25507	119	134	,	,	PUNCT
inlawrev-25507	119	135	after	after	ADP
inlawrev-25507	119	136	years	year	NOUN
inlawrev-25507	119	137	of	of	ADP
inlawrev-25507	119	138	additional	additional	ADJ
inlawrev-25507	119	139	research	research	NOUN
inlawrev-25507	119	140	,	,	PUNCT
inlawrev-25507	119	141	scientists	scientist	NOUN
inlawrev-25507	119	142	discovered	discover	VERB
inlawrev-25507	119	143	azt	azt	PROPN
inlawrev-25507	119	144	’s	’s	PART
inlawrev-25507	119	145	potential	potential	NOUN
inlawrev-25507	119	146	against	against	ADP
inlawrev-25507	119	147	acquired	acquire	VERB
inlawrev-25507	119	148	immune	immune	ADJ
inlawrev-25507	119	149	deficiency	deficiency	NOUN
inlawrev-25507	119	150	syndrome	syndrome	NOUN
inlawrev-25507	119	151	(	(	PUNCT
inlawrev-25507	119	152	aids).45	aids).45	VERB
inlawrev-25507	119	153	additional	additional	ADJ
inlawrev-25507	119	154	examples	example	NOUN
inlawrev-25507	119	155	of	of	ADP
inlawrev-25507	119	156	discovered	discover	VERB
inlawrev-25507	119	157	drug	drug	NOUN
inlawrev-25507	119	158	uses	use	VERB
inlawrev-25507	119	159	due	due	ADP
inlawrev-25507	119	160	to	to	ADP
inlawrev-25507	119	161	the	the	DET
inlawrev-25507	119	162	allowance	allowance	NOUN
inlawrev-25507	119	163	of	of	ADP
inlawrev-25507	119	164	secondary	secondary	ADJ
inlawrev-25507	119	165	patents	patent	NOUN
inlawrev-25507	119	166	include	include	VERB
inlawrev-25507	119	167	evista	evista	ADJ
inlawrev-25507	119	168	®	®	NOUN
inlawrev-25507	119	169	(	(	PUNCT
inlawrev-25507	119	170	used	use	VERB
inlawrev-25507	119	171	for	for	ADP
inlawrev-25507	119	172	treatment	treatment	NOUN
inlawrev-25507	119	173	of	of	ADP
inlawrev-25507	119	174	osteoporosis	osteoporosis	NOUN
inlawrev-25507	119	175	and	and	CCONJ
inlawrev-25507	119	176	breast	breast	NOUN
inlawrev-25507	119	177	cancer	cancer	NOUN
inlawrev-25507	119	178	)	)	PUNCT
inlawrev-25507	119	179	and	and	CCONJ
inlawrev-25507	119	180	zyprexa	zyprexa	PROPN
inlawrev-25507	119	181	®	®	PROPN
inlawrev-25507	119	182	(	(	PUNCT
inlawrev-25507	119	183	used	use	VERB
inlawrev-25507	119	184	for	for	ADP
inlawrev-25507	119	185	treatment	treatment	NOUN
inlawrev-25507	119	186	of	of	ADP
inlawrev-25507	119	187	schizophrenia).46	schizophrenia).46	PROPN
inlawrev-25507	119	188	nevertheless	nevertheless	ADV
inlawrev-25507	119	189	,	,	PUNCT
inlawrev-25507	119	190	instances	instance	NOUN
inlawrev-25507	119	191	exist	exist	VERB
inlawrev-25507	119	192	that	that	PRON
inlawrev-25507	119	193	seem	seem	VERB
inlawrev-25507	119	194	to	to	PART
inlawrev-25507	119	195	be	be	AUX
inlawrev-25507	119	196	distinct	distinct	ADJ
inlawrev-25507	119	197	cases	case	NOUN
inlawrev-25507	119	198	of	of	ADP
inlawrev-25507	119	199	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	119	200	companies	company	NOUN
inlawrev-25507	119	201	evergreening	evergreene	VERB
inlawrev-25507	119	202	in	in	ADP
inlawrev-25507	119	203	order	order	NOUN
inlawrev-25507	119	204	to	to	PART
inlawrev-25507	119	205	extend	extend	VERB
inlawrev-25507	119	206	their	their	PRON
inlawrev-25507	119	207	monopolies.47	monopolies.47	ADJ
inlawrev-25507	119	208	famous	famous	ADJ
inlawrev-25507	119	209	examples	example	NOUN
inlawrev-25507	119	210	include	include	VERB
inlawrev-25507	119	211	making	make	VERB
inlawrev-25507	119	212	minimal	minimal	ADJ
inlawrev-25507	119	213	changes	change	NOUN
inlawrev-25507	119	214	to	to	ADP
inlawrev-25507	119	215	the	the	DET
inlawrev-25507	119	216	drug	drug	NOUN
inlawrev-25507	119	217	formula	formula	NOUN
inlawrev-25507	119	218	,	,	PUNCT
inlawrev-25507	119	219	lowering	lower	VERB
inlawrev-25507	119	220	the	the	DET
inlawrev-25507	119	221	dosage	dosage	NOUN
inlawrev-25507	119	222	of	of	ADP
inlawrev-25507	119	223	the	the	DET
inlawrev-25507	119	224	drug	drug	NOUN
inlawrev-25507	119	225	,	,	PUNCT
inlawrev-25507	119	226	and	and	CCONJ
inlawrev-25507	119	227	reformulating	reformulate	VERB
inlawrev-25507	119	228	the	the	DET
inlawrev-25507	119	229	drug	drug	NOUN
inlawrev-25507	119	230	to	to	PART
inlawrev-25507	119	231	be	be	AUX
inlawrev-25507	119	232	taken	take	VERB
inlawrev-25507	119	233	once	once	ADV
inlawrev-25507	119	234	a	a	DET
inlawrev-25507	119	235	day	day	NOUN
inlawrev-25507	119	236	instead	instead	ADV
inlawrev-25507	119	237	of	of	ADP
inlawrev-25507	119	238	twice	twice	DET
inlawrev-25507	119	239	a	a	DET
inlawrev-25507	119	240	day.48	day.48	NOUN
inlawrev-25507	119	241	additionally	additionally	ADV
inlawrev-25507	119	242	,	,	PUNCT
inlawrev-25507	119	243	the	the	DET
inlawrev-25507	119	244	number	number	NOUN
inlawrev-25507	119	245	of	of	ADP
inlawrev-25507	119	246	secondary	secondary	ADJ
inlawrev-25507	119	247	patents	patent	NOUN
inlawrev-25507	119	248	filed	file	VERB
inlawrev-25507	119	249	on	on	ADP
inlawrev-25507	119	250	a	a	DET
inlawrev-25507	119	251	particular	particular	ADJ
inlawrev-25507	119	252	drug	drug	NOUN
inlawrev-25507	119	253	can	can	AUX
inlawrev-25507	119	254	be	be	AUX
inlawrev-25507	119	255	an	an	DET
inlawrev-25507	119	256	indication	indication	NOUN
inlawrev-25507	119	257	of	of	ADP
inlawrev-25507	119	258	whether	whether	SCONJ
inlawrev-25507	119	259	there	there	PRON
inlawrev-25507	119	260	was	be	VERB
inlawrev-25507	119	261	an	an	DET
inlawrev-25507	119	262	attempt	attempt	NOUN
inlawrev-25507	119	263	to	to	PART
inlawrev-25507	119	264	evergreen	evergreen	VERB
inlawrev-25507	119	265	or	or	CCONJ
inlawrev-25507	119	266	whether	whether	SCONJ
inlawrev-25507	119	267	there	there	PRON
inlawrev-25507	119	268	was	be	VERB
inlawrev-25507	119	269	genuine	genuine	ADJ
inlawrev-25507	119	270	further	further	ADJ
inlawrev-25507	119	271	research	research	NOUN
inlawrev-25507	119	272	on	on	ADP
inlawrev-25507	119	273	the	the	DET
inlawrev-25507	119	274	drug.49	drug.49	PROPN
inlawrev-25507	119	275	be	be	AUX
inlawrev-25507	119	276	eligible	eligible	ADJ
inlawrev-25507	119	277	for	for	ADP
inlawrev-25507	119	278	patent	patent	NOUN
inlawrev-25507	119	279	protection	protection	NOUN
inlawrev-25507	119	280	,	,	PUNCT
inlawrev-25507	119	281	intell	intell	PROPN
inlawrev-25507	119	282	.	.	PUNCT
inlawrev-25507	120	1	prop	prop	PROPN
inlawrev-25507	120	2	.	.	PUNCT
inlawrev-25507	121	1	watch	watch	PROPN
inlawrev-25507	121	2	(	(	PUNCT
inlawrev-25507	121	3	sept	sept	PROPN
inlawrev-25507	121	4	.	.	PROPN
inlawrev-25507	121	5	21	21	NUM
inlawrev-25507	121	6	,	,	PUNCT
inlawrev-25507	121	7	2018	2018	NUM
inlawrev-25507	121	8	)	)	PUNCT
inlawrev-25507	121	9	,	,	PUNCT
inlawrev-25507	121	10	https://www.ipw	https://www.ipw	PROPN
inlawrev-25507	121	11	atch	atch	PROPN
inlawrev-25507	121	12	.org/2	.org/2	PROPN
inlawrev-25507	121	13	0	0	NUM
inlawrev-25507	121	14	1	1	NUM
inlawrev-25507	121	15	8	8	NUM
inlawrev-25507	121	16	/0	/0	NOUN
inlawrev-25507	121	17	9	9	NUM
inlawrev-25507	121	18	/2	/2	SYM
inlawrev-25507	121	19	1	1	NUM
inlawrev-25507	121	20	/follow	/follow	NOUN
inlawrev-25507	121	21	-ph	-ph	VERB
inlawrev-25507	121	22	arm	arm	NOUN
inlawrev-25507	121	23	aceutical	aceutical	ADJ
inlawrev-25507	121	24	-	-	PUNCT
inlawrev-25507	121	25	innovation	innovation	NOUN
inlawrev-25507	121	26	s	s	NOUN
inlawrev-25507	121	27	-	-	ADJ
inlawrev-25507	121	28	eligible	eligible	ADJ
inlawrev-25507	121	29	-	-	PUNCT
inlawrev-25507	121	30	paten	paten	ADJ
inlawrev-25507	121	31	t	t	PROPN
inlawrev-25507	121	32	-	-	PUNCT
inlawrev-25507	121	33	protection	protection	NOUN
inlawrev-25507	121	34	/	/	PUNCT
inlawrev-25507	122	1	[	[	X
inlawrev-25507	122	2	https://perma.cc/s775-ud87	https://perma.cc/s775-ud87	NOUN
inlawrev-25507	122	3	]	]	PUNCT
inlawrev-25507	122	4	.	.	PUNCT
inlawrev-25507	123	1	39	39	NUM
inlawrev-25507	123	2	.	.	PUNCT
inlawrev-25507	124	1	sittler	sittler	PROPN
inlawrev-25507	124	2	et	et	PROPN
inlawrev-25507	124	3	al	al	PROPN
inlawrev-25507	124	4	.	.	PROPN
inlawrev-25507	124	5	,	,	PUNCT
inlawrev-25507	124	6	supra	supra	PROPN
inlawrev-25507	124	7	note	note	VERB
inlawrev-25507	124	8	37	37	NUM
inlawrev-25507	124	9	,	,	PUNCT
inlawrev-25507	124	10	at	at	ADP
inlawrev-25507	124	11	4	4	NUM
inlawrev-25507	124	12	.	.	PUNCT
inlawrev-25507	125	1	but	but	CCONJ
inlawrev-25507	125	2	see	see	VERB
inlawrev-25507	125	3	carlos	carlos	PROPN
inlawrev-25507	125	4	a.	a.	PROPN
inlawrev-25507	125	5	garcia	garcia	PROPN
inlawrev-25507	125	6	&	&	CCONJ
inlawrev-25507	125	7	jonathan	jonathan	PROPN
inlawrev-25507	125	8	stroud	stroud	PROPN
inlawrev-25507	125	9	,	,	PUNCT
inlawrev-25507	125	10	ships	ship	NOUN
inlawrev-25507	125	11	in	in	ADP
inlawrev-25507	125	12	the	the	DET
inlawrev-25507	125	13	night	night	NOUN
inlawrev-25507	125	14	:	:	PUNCT
inlawrev-25507	125	15	resolving	resolve	VERB
inlawrev-25507	125	16	administrative	administrative	ADJ
inlawrev-25507	125	17	conflict	conflict	NOUN
inlawrev-25507	125	18	between	between	ADP
inlawrev-25507	125	19	fdaand	fdaand	PROPN
inlawrev-25507	125	20	patent	patent	NOUN
inlawrev-25507	125	21	-	-	PUNCT
inlawrev-25507	125	22	related	relate	VERB
inlawrev-25507	125	23	legislation	legislation	NOUN
inlawrev-25507	125	24	,	,	PUNCT
inlawrev-25507	125	25	68	68	NUM
inlawrev-25507	125	26	am	am	NOUN
inlawrev-25507	125	27	.	.	PUNCT
inlawrev-25507	126	1	u.	u.	PROPN
inlawrev-25507	126	2	l.	l.	PROPN
inlawrev-25507	126	3	rev	rev	PROPN
inlawrev-25507	126	4	.	.	PROPN
inlawrev-25507	126	5	1111	1111	NUM
inlawrev-25507	126	6	,	,	PUNCT
inlawrev-25507	126	7	1143–46	1143–46	NUM
inlawrev-25507	126	8	(	(	PUNCT
inlawrev-25507	126	9	2019	2019	NUM
inlawrev-25507	126	10	)	)	PUNCT
inlawrev-25507	126	11	(	(	PUNCT
inlawrev-25507	126	12	discussing	discuss	VERB
inlawrev-25507	126	13	how	how	SCONJ
inlawrev-25507	126	14	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	126	15	products	product	NOUN
inlawrev-25507	126	16	rarely	rarely	ADV
inlawrev-25507	126	17	get	get	VERB
inlawrev-25507	126	18	to	to	PART
inlawrev-25507	126	19	enjoy	enjoy	VERB
inlawrev-25507	126	20	the	the	DET
inlawrev-25507	126	21	full	full	ADJ
inlawrev-25507	126	22	exclusivity	exclusivity	NOUN
inlawrev-25507	126	23	their	their	PRON
inlawrev-25507	126	24	patent	patent	NOUN
inlawrev-25507	126	25	offers	offer	NOUN
inlawrev-25507	126	26	)	)	PUNCT
inlawrev-25507	126	27	.	.	PUNCT
inlawrev-25507	127	1	40	40	NUM
inlawrev-25507	127	2	.	.	PUNCT
inlawrev-25507	128	1	grabowski	grabowski	PROPN
inlawrev-25507	128	2	,	,	PUNCT
inlawrev-25507	128	3	dimasi	dimasi	PROPN
inlawrev-25507	128	4	&	&	CCONJ
inlawrev-25507	128	5	long	long	PROPN
inlawrev-25507	128	6	,	,	PUNCT
inlawrev-25507	128	7	supra	supra	PROPN
inlawrev-25507	128	8	note	note	NOUN
inlawrev-25507	128	9	21	21	NUM
inlawrev-25507	128	10	,	,	PUNCT
inlawrev-25507	128	11	at	at	ADP
inlawrev-25507	128	12	302	302	NUM
inlawrev-25507	128	13	.	.	PUNCT
inlawrev-25507	128	14	41	41	NUM
inlawrev-25507	128	15	.	.	PUNCT
inlawrev-25507	129	1	tahir	tahir	PROPN
inlawrev-25507	129	2	amin	amin	PROPN
inlawrev-25507	129	3	,	,	PUNCT
inlawrev-25507	129	4	the	the	DET
inlawrev-25507	129	5	problem	problem	NOUN
inlawrev-25507	129	6	with	with	ADP
inlawrev-25507	129	7	high	high	ADJ
inlawrev-25507	129	8	drug	drug	NOUN
inlawrev-25507	129	9	prices	price	NOUN
inlawrev-25507	129	10	is	be	AUX
inlawrev-25507	129	11	n’t	n’t	ADJ
inlawrev-25507	129	12	‘	'	PUNCT
inlawrev-25507	129	13	foreign	foreign	ADJ
inlawrev-25507	129	14	freeloading	freeloading	NOUN
inlawrev-25507	129	15	,	,	PUNCT
inlawrev-25507	129	16	’	'	PUNCT
inlawrev-25507	129	17	it	it	PRON
inlawrev-25507	129	18	’s	’	VERB
inlawrev-25507	129	19	the	the	DET
inlawrev-25507	129	20	patent	patent	NOUN
inlawrev-25507	129	21	system	system	NOUN
inlawrev-25507	129	22	,	,	PUNCT
inlawrev-25507	129	23	cnbc	cnbc	PROPN
inlawrev-25507	129	24	(	(	PUNCT
inlawrev-25507	129	25	june	june	PROPN
inlawrev-25507	129	26	27	27	NUM
inlawrev-25507	129	27	,	,	PUNCT
inlawrev-25507	129	28	2018	2018	NUM
inlawrev-25507	129	29	)	)	PUNCT
inlawrev-25507	129	30	,	,	PUNCT
inlawrev-25507	129	31	https://www.cnbc.com/2018/06/25/high-drug-prices-causedby-us-patent-system.html	https://www.cnbc.com/2018/06/25/high-drug-prices-causedby-us-patent-system.html	PROPN
inlawrev-25507	130	1	[	[	X
inlawrev-25507	130	2	https://perma.cc/ux2f-hr62	https://perma.cc/ux2f-hr62	X
inlawrev-25507	130	3	]	]	X
inlawrev-25507	130	4	.	.	PUNCT
inlawrev-25507	131	1	42	42	NUM
inlawrev-25507	131	2	.	.	PUNCT
inlawrev-25507	132	1	see	see	VERB
inlawrev-25507	132	2	maximilienne	maximilienne	PROPN
inlawrev-25507	132	3	giannelli	giannelli	PROPN
inlawrev-25507	132	4	&	&	CCONJ
inlawrev-25507	132	5	amana	amana	PROPN
inlawrev-25507	132	6	abdulwakeel	abdulwakeel	PROPN
inlawrev-25507	132	7	,	,	PUNCT
inlawrev-25507	132	8	puzzling	puzzle	VERB
inlawrev-25507	132	9	out	out	ADP
inlawrev-25507	132	10	the	the	DET
inlawrev-25507	132	11	patent	patent	NOUN
inlawrev-25507	132	12	-	-	PUNCT
inlawrev-25507	132	13	eligibility	eligibility	NOUN
inlawrev-25507	132	14	of	of	ADP
inlawrev-25507	132	15	natural	natural	ADJ
inlawrev-25507	132	16	products	product	NOUN
inlawrev-25507	132	17	,	,	PUNCT
inlawrev-25507	132	18	finnegan	finnegan	PROPN
inlawrev-25507	132	19	(	(	PUNCT
inlawrev-25507	132	20	nov	nov	PROPN
inlawrev-25507	132	21	.	.	PROPN
inlawrev-25507	132	22	9	9	NUM
inlawrev-25507	132	23	,	,	PUNCT
inlawrev-25507	132	24	2018	2018	NUM
inlawrev-25507	132	25	)	)	PUNCT
inlawrev-25507	132	26	,	,	PUNCT
inlawrev-25507	132	27	https://www.finnegan.com/en/insights/puzzlingout-the-patent-eligibility-of-natural-products.html	https://www.finnegan.com/en/insights/puzzlingout-the-patent-eligibility-of-natural-products.html	PROPN
inlawrev-25507	133	1	[	[	X
inlawrev-25507	133	2	https://perma.cc/fh3u-f37d	https://perma.cc/fh3u-f37d	X
inlawrev-25507	133	3	]	]	X
inlawrev-25507	133	4	.	.	PUNCT
inlawrev-25507	134	1	43	43	NUM
inlawrev-25507	134	2	.	.	PUNCT
inlawrev-25507	135	1	sittler	sittler	PROPN
inlawrev-25507	135	2	et	et	PROPN
inlawrev-25507	135	3	al	al	PROPN
inlawrev-25507	135	4	.	.	PROPN
inlawrev-25507	135	5	,	,	PUNCT
inlawrev-25507	135	6	supra	supra	PROPN
inlawrev-25507	135	7	note	note	VERB
inlawrev-25507	135	8	37	37	NUM
inlawrev-25507	135	9	,	,	PUNCT
inlawrev-25507	135	10	at	at	ADP
inlawrev-25507	135	11	2	2	NUM
inlawrev-25507	135	12	.	.	NUM
inlawrev-25507	135	13	44	44	NUM
inlawrev-25507	135	14	.	.	PUNCT
inlawrev-25507	136	1	holman	holman	PROPN
inlawrev-25507	136	2	,	,	PUNCT
inlawrev-25507	136	3	supra	supra	PROPN
inlawrev-25507	136	4	note	note	PROPN
inlawrev-25507	136	5	38	38	NUM
inlawrev-25507	136	6	.	.	PUNCT
inlawrev-25507	137	1	45	45	NUM
inlawrev-25507	137	2	.	.	PUNCT
inlawrev-25507	138	1	i	i	PRON
inlawrev-25507	138	2	d.	d.	PROPN
inlawrev-25507	138	3	46	46	NUM
inlawrev-25507	138	4	.	.	PUNCT
inlawrev-25507	139	1	i	i	PRON
inlawrev-25507	139	2	d.	d.	PROPN
inlawrev-25507	139	3	47	47	NUM
inlawrev-25507	139	4	.	.	PUNCT
inlawrev-25507	140	1	tribble	tribble	PROPN
inlawrev-25507	140	2	,	,	PUNCT
inlawrev-25507	140	3	drugmakers	drugmaker	NOUN
inlawrev-25507	140	4	play	play	VERB
inlawrev-25507	140	5	the	the	DET
inlawrev-25507	140	6	patent	patent	NOUN
inlawrev-25507	140	7	game	game	NOUN
inlawrev-25507	140	8	,	,	PUNCT
inlawrev-25507	140	9	supra	supra	PROPN
inlawrev-25507	140	10	note	note	NOUN
inlawrev-25507	140	11	36	36	NUM
inlawrev-25507	140	12	.	.	PUNCT
inlawrev-25507	141	1	48	48	NUM
inlawrev-25507	141	2	.	.	PUNCT
inlawrev-25507	142	1	i	i	PRON
inlawrev-25507	142	2	d.	d.	PROPN
inlawrev-25507	142	3	49	49	NUM
inlawrev-25507	142	4	.	.	PUNCT
inlawrev-25507	143	1	excessive	excessive	ADJ
inlawrev-25507	143	2	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	143	3	patenting	patenting	NOUN
inlawrev-25507	143	4	,	,	PUNCT
inlawrev-25507	143	5	supra	supra	PROPN
inlawrev-25507	143	6	note	note	PROPN
inlawrev-25507	143	7	19	19	NUM
inlawrev-25507	143	8	,	,	PUNCT
inlawrev-25507	143	9	at	at	ADP
inlawrev-25507	143	10	4	4	NUM
inlawrev-25507	143	11	.	.	NOUN
inlawrev-25507	143	12	200	200	NUM
inlawrev-25507	143	13	indiana	indiana	PROPN
inlawrev-25507	143	14	law	law	NOUN
inlawrev-25507	143	15	review	review	NOUN
inlawrev-25507	143	16	[	[	X
inlawrev-25507	143	17	vol	vol	NOUN
inlawrev-25507	143	18	.	.	PUNCT
inlawrev-25507	144	1	54:195	54:195	NUM
inlawrev-25507	144	2	b.	b.	NOUN
inlawrev-25507	144	3	the	the	DET
inlawrev-25507	144	4	effects	effect	NOUN
inlawrev-25507	144	5	of	of	ADP
inlawrev-25507	144	6	evergreening	evergreene	VERB
inlawrev-25507	144	7	on	on	ADP
inlawrev-25507	144	8	drug	drug	NOUN
inlawrev-25507	144	9	prices	price	NOUN
inlawrev-25507	144	10	during	during	ADP
inlawrev-25507	144	11	the	the	DET
inlawrev-25507	144	12	exclusivity	exclusivity	NOUN
inlawrev-25507	144	13	period	period	NOUN
inlawrev-25507	144	14	,	,	PUNCT
inlawrev-25507	144	15	in	in	ADP
inlawrev-25507	144	16	terms	term	NOUN
inlawrev-25507	144	17	of	of	ADP
inlawrev-25507	144	18	the	the	DET
inlawrev-25507	144	19	primary	primary	ADJ
inlawrev-25507	144	20	compound	compound	NOUN
inlawrev-25507	144	21	patent	patent	NOUN
inlawrev-25507	144	22	,	,	PUNCT
inlawrev-25507	144	23	the	the	DET
inlawrev-25507	144	24	drug	drug	NOUN
inlawrev-25507	144	25	developer	developer	NOUN
inlawrev-25507	144	26	generally	generally	ADV
inlawrev-25507	144	27	enjoys	enjoy	VERB
inlawrev-25507	144	28	a	a	DET
inlawrev-25507	144	29	competition	competition	NOUN
inlawrev-25507	144	30	-	-	PUNCT
inlawrev-25507	144	31	free	free	ADJ
inlawrev-25507	144	32	market	market	NOUN
inlawrev-25507	144	33	in	in	ADP
inlawrev-25507	144	34	return	return	NOUN
inlawrev-25507	144	35	for	for	ADP
inlawrev-25507	144	36	its	its	PRON
inlawrev-25507	144	37	disclosure	disclosure	NOUN
inlawrev-25507	144	38	of	of	ADP
inlawrev-25507	144	39	the	the	DET
inlawrev-25507	144	40	drug	drug	NOUN
inlawrev-25507	144	41	to	to	ADP
inlawrev-25507	144	42	the	the	DET
inlawrev-25507	144	43	public.50	public.50	NOUN
inlawrev-25507	144	44	after	after	SCONJ
inlawrev-25507	144	45	this	this	DET
inlawrev-25507	144	46	period	period	NOUN
inlawrev-25507	144	47	is	be	AUX
inlawrev-25507	144	48	over	over	ADV
inlawrev-25507	144	49	,	,	PUNCT
inlawrev-25507	144	50	generic	generic	ADJ
inlawrev-25507	144	51	companies	company	NOUN
inlawrev-25507	144	52	may	may	AUX
inlawrev-25507	144	53	produce	produce	VERB
inlawrev-25507	144	54	the	the	DET
inlawrev-25507	144	55	same	same	ADJ
inlawrev-25507	144	56	drug	drug	NOUN
inlawrev-25507	144	57	at	at	ADP
inlawrev-25507	144	58	lower	low	ADJ
inlawrev-25507	144	59	prices.51	prices.51	NOUN
inlawrev-25507	144	60	however	however	ADV
inlawrev-25507	144	61	,	,	PUNCT
inlawrev-25507	144	62	evergreening	evergreene	VERB
inlawrev-25507	144	63	not	not	PART
inlawrev-25507	144	64	only	only	ADV
inlawrev-25507	144	65	allows	allow	VERB
inlawrev-25507	144	66	for	for	ADP
inlawrev-25507	144	67	extended	extended	ADJ
inlawrev-25507	144	68	exclusivity	exclusivity	NOUN
inlawrev-25507	144	69	,	,	PUNCT
inlawrev-25507	144	70	but	but	CCONJ
inlawrev-25507	144	71	also	also	ADV
inlawrev-25507	144	72	increases	increase	VERB
inlawrev-25507	144	73	litigation	litigation	NOUN
inlawrev-25507	144	74	costs	cost	NOUN
inlawrev-25507	144	75	to	to	ADP
inlawrev-25507	144	76	the	the	DET
inlawrev-25507	144	77	challenger	challenger	NOUN
inlawrev-25507	144	78	which	which	PRON
inlawrev-25507	144	79	may	may	AUX
inlawrev-25507	144	80	discourage	discourage	VERB
inlawrev-25507	144	81	generic	generic	ADJ
inlawrev-25507	144	82	drug	drug	NOUN
inlawrev-25507	144	83	developers	developer	NOUN
inlawrev-25507	144	84	from	from	ADP
inlawrev-25507	144	85	entering	enter	VERB
inlawrev-25507	144	86	the	the	DET
inlawrev-25507	144	87	market	market	NOUN
inlawrev-25507	144	88	of	of	ADP
inlawrev-25507	144	89	a	a	DET
inlawrev-25507	144	90	particular	particular	ADJ
inlawrev-25507	144	91	drug.52	drug.52	NOUN
inlawrev-25507	144	92	the	the	DET
inlawrev-25507	144	93	issue	issue	NOUN
inlawrev-25507	144	94	with	with	ADP
inlawrev-25507	144	95	evergreening	evergreening	NOUN
inlawrev-25507	144	96	is	be	AUX
inlawrev-25507	144	97	not	not	PART
inlawrev-25507	144	98	necessarily	necessarily	ADV
inlawrev-25507	144	99	that	that	SCONJ
inlawrev-25507	144	100	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	144	101	companies	company	NOUN
inlawrev-25507	144	102	are	be	AUX
inlawrev-25507	144	103	patenting	patent	VERB
inlawrev-25507	144	104	small	small	ADJ
inlawrev-25507	144	105	or	or	CCONJ
inlawrev-25507	144	106	trivial	trivial	ADJ
inlawrev-25507	144	107	distinctions	distinction	NOUN
inlawrev-25507	144	108	from	from	ADP
inlawrev-25507	144	109	their	their	PRON
inlawrev-25507	144	110	primary	primary	NOUN
inlawrev-25507	144	111	to	to	ADP
inlawrev-25507	144	112	secondary	secondary	ADJ
inlawrev-25507	144	113	patents	patent	NOUN
inlawrev-25507	144	114	;	;	PUNCT
inlawrev-25507	144	115	rather	rather	ADV
inlawrev-25507	144	116	,	,	PUNCT
inlawrev-25507	144	117	it	it	PRON
inlawrev-25507	144	118	is	be	AUX
inlawrev-25507	144	119	the	the	DET
inlawrev-25507	144	120	massive	massive	ADJ
inlawrev-25507	144	121	number	number	NOUN
inlawrev-25507	144	122	of	of	ADP
inlawrev-25507	144	123	patents	patent	NOUN
inlawrev-25507	144	124	a	a	DET
inlawrev-25507	144	125	company	company	NOUN
inlawrev-25507	144	126	receives	receive	VERB
inlawrev-25507	144	127	on	on	ADP
inlawrev-25507	144	128	the	the	DET
inlawrev-25507	144	129	drug	drug	NOUN
inlawrev-25507	144	130	that	that	PRON
inlawrev-25507	144	131	could	could	AUX
inlawrev-25507	144	132	be	be	AUX
inlawrev-25507	144	133	asserted	assert	VERB
inlawrev-25507	144	134	against	against	ADP
inlawrev-25507	144	135	a	a	DET
inlawrev-25507	144	136	potential	potential	ADJ
inlawrev-25507	144	137	infringer.53	infringer.53	NOUN
inlawrev-25507	144	138	the	the	DET
inlawrev-25507	144	139	median	median	ADJ
inlawrev-25507	144	140	cost	cost	NOUN
inlawrev-25507	144	141	of	of	ADP
inlawrev-25507	144	142	a	a	DET
inlawrev-25507	144	143	patent	patent	NOUN
inlawrev-25507	144	144	litigation	litigation	NOUN
inlawrev-25507	144	145	case	case	NOUN
inlawrev-25507	144	146	is	be	AUX
inlawrev-25507	144	147	over	over	ADP
inlawrev-25507	144	148	$	$	SYM
inlawrev-25507	144	149	3	3	NUM
inlawrev-25507	144	150	million	million	NUM
inlawrev-25507	144	151	alone.54	alone.54	PROPN
inlawrev-25507	144	152	for	for	ADP
inlawrev-25507	144	153	example	example	NOUN
inlawrev-25507	144	154	,	,	PUNCT
inlawrev-25507	144	155	in	in	ADP
inlawrev-25507	144	156	order	order	NOUN
inlawrev-25507	144	157	to	to	PART
inlawrev-25507	144	158	eliminate	eliminate	VERB
inlawrev-25507	144	159	all	all	PRON
inlawrev-25507	144	160	of	of	ADP
inlawrev-25507	144	161	the	the	DET
inlawrev-25507	144	162	humira	humira	PROPN
inlawrev-25507	144	163	®	®	PROPN
inlawrev-25507	144	164	secondary	secondary	ADJ
inlawrev-25507	144	165	patents	patent	NOUN
inlawrev-25507	144	166	,	,	PUNCT
inlawrev-25507	144	167	a	a	DET
inlawrev-25507	144	168	competitor	competitor	NOUN
inlawrev-25507	144	169	would	would	AUX
inlawrev-25507	144	170	need	need	VERB
inlawrev-25507	144	171	to	to	PART
inlawrev-25507	144	172	spend	spend	VERB
inlawrev-25507	144	173	over	over	ADP
inlawrev-25507	144	174	$	$	SYM
inlawrev-25507	144	175	741	741	NUM
inlawrev-25507	144	176	million.55	million.55	NOUN
inlawrev-25507	144	177	additionally	additionally	ADV
inlawrev-25507	144	178	,	,	PUNCT
inlawrev-25507	144	179	each	each	DET
inlawrev-25507	144	180	patent	patent	NOUN
inlawrev-25507	144	181	case	case	NOUN
inlawrev-25507	144	182	can	can	AUX
inlawrev-25507	144	183	last	last	VERB
inlawrev-25507	144	184	for	for	ADP
inlawrev-25507	144	185	two	two	NUM
inlawrev-25507	144	186	or	or	CCONJ
inlawrev-25507	144	187	more	more	ADJ
inlawrev-25507	144	188	years.56	years.56	NOUN
inlawrev-25507	144	189	not	not	PART
inlawrev-25507	144	190	only	only	ADV
inlawrev-25507	144	191	is	be	AUX
inlawrev-25507	144	192	it	it	PRON
inlawrev-25507	144	193	unlikely	unlikely	ADJ
inlawrev-25507	144	194	that	that	SCONJ
inlawrev-25507	144	195	a	a	DET
inlawrev-25507	144	196	generic	generic	ADJ
inlawrev-25507	144	197	company	company	NOUN
inlawrev-25507	144	198	will	will	AUX
inlawrev-25507	144	199	want	want	VERB
inlawrev-25507	144	200	to	to	PART
inlawrev-25507	144	201	spend	spend	VERB
inlawrev-25507	144	202	this	this	DET
inlawrev-25507	144	203	amount	amount	NOUN
inlawrev-25507	144	204	of	of	ADP
inlawrev-25507	144	205	time	time	NOUN
inlawrev-25507	144	206	and	and	CCONJ
inlawrev-25507	144	207	money	money	NOUN
inlawrev-25507	144	208	on	on	ADP
inlawrev-25507	144	209	litigating	litigate	VERB
inlawrev-25507	144	210	against	against	ADP
inlawrev-25507	144	211	the	the	DET
inlawrev-25507	144	212	innovator	innovator	NOUN
inlawrev-25507	144	213	company	company	NOUN
inlawrev-25507	144	214	,	,	PUNCT
inlawrev-25507	144	215	but	but	CCONJ
inlawrev-25507	144	216	one	one	NUM
inlawrev-25507	144	217	generic	generic	ADJ
inlawrev-25507	144	218	company	company	NOUN
inlawrev-25507	144	219	would	would	AUX
inlawrev-25507	144	220	rarely	rarely	ADV
inlawrev-25507	144	221	agree	agree	VERB
inlawrev-25507	144	222	to	to	PART
inlawrev-25507	144	223	do	do	VERB
inlawrev-25507	144	224	this	this	PRON
inlawrev-25507	144	225	just	just	ADV
inlawrev-25507	144	226	so	so	ADV
inlawrev-25507	144	227	other	other	ADJ
inlawrev-25507	144	228	generic	generic	ADJ
inlawrev-25507	144	229	companies	company	NOUN
inlawrev-25507	144	230	can	can	AUX
inlawrev-25507	144	231	enter	enter	VERB
inlawrev-25507	144	232	the	the	DET
inlawrev-25507	144	233	market	market	NOUN
inlawrev-25507	144	234	without	without	ADP
inlawrev-25507	144	235	spending	spend	VERB
inlawrev-25507	144	236	as	as	ADP
inlawrev-25507	144	237	much.57	much.57	NOUN
inlawrev-25507	144	238	this	this	PRON
inlawrev-25507	144	239	means	mean	VERB
inlawrev-25507	144	240	the	the	DET
inlawrev-25507	144	241	innovator	innovator	NOUN
inlawrev-25507	144	242	then	then	ADV
inlawrev-25507	144	243	has	have	VERB
inlawrev-25507	144	244	the	the	DET
inlawrev-25507	144	245	power	power	NOUN
inlawrev-25507	144	246	to	to	PART
inlawrev-25507	144	247	force	force	VERB
inlawrev-25507	144	248	competitors	competitor	NOUN
inlawrev-25507	144	249	either	either	CCONJ
inlawrev-25507	144	250	to	to	PART
inlawrev-25507	144	251	wait	wait	VERB
inlawrev-25507	144	252	until	until	SCONJ
inlawrev-25507	144	253	the	the	DET
inlawrev-25507	144	254	secondary	secondary	ADJ
inlawrev-25507	144	255	patents	patent	NOUN
inlawrev-25507	144	256	expire	expire	VERB
inlawrev-25507	144	257	to	to	PART
inlawrev-25507	144	258	enter	enter	VERB
inlawrev-25507	144	259	the	the	DET
inlawrev-25507	144	260	market	market	NOUN
inlawrev-25507	144	261	or	or	CCONJ
inlawrev-25507	144	262	to	to	PART
inlawrev-25507	144	263	settle	settle	VERB
inlawrev-25507	144	264	with	with	ADP
inlawrev-25507	144	265	a	a	DET
inlawrev-25507	144	266	non	non	ADJ
inlawrev-25507	144	267	-	-	ADJ
inlawrev-25507	144	268	exclusive	exclusive	ADJ
inlawrev-25507	144	269	license	license	NOUN
inlawrev-25507	144	270	that	that	PRON
inlawrev-25507	144	271	stalls	stall	VERB
inlawrev-25507	144	272	the	the	DET
inlawrev-25507	144	273	competitor	competitor	NOUN
inlawrev-25507	144	274	from	from	ADP
inlawrev-25507	144	275	entering	enter	VERB
inlawrev-25507	144	276	the	the	DET
inlawrev-25507	144	277	market	market	NOUN
inlawrev-25507	144	278	until	until	ADP
inlawrev-25507	144	279	a	a	DET
inlawrev-25507	144	280	predetermined	predetermine	VERB
inlawrev-25507	144	281	date	date	NOUN
inlawrev-25507	144	282	,	,	PUNCT
inlawrev-25507	144	283	and	and	CCONJ
inlawrev-25507	144	284	,	,	PUNCT
inlawrev-25507	144	285	when	when	SCONJ
inlawrev-25507	144	286	it	it	PRON
inlawrev-25507	144	287	enters	enter	VERB
inlawrev-25507	144	288	,	,	PUNCT
inlawrev-25507	144	289	to	to	PART
inlawrev-25507	144	290	give	give	VERB
inlawrev-25507	144	291	the	the	DET
inlawrev-25507	144	292	innovator	innovator	NOUN
inlawrev-25507	144	293	50	50	NUM
inlawrev-25507	144	294	.	.	PUNCT
inlawrev-25507	145	1	tahir	tahir	PROPN
inlawrev-25507	145	2	amin	amin	PROPN
inlawrev-25507	145	3	&	&	CCONJ
inlawrev-25507	145	4	aaron	aaron	PROPN
inlawrev-25507	145	5	s.	s.	PROPN
inlawrev-25507	145	6	kesselheim	kesselheim	PROPN
inlawrev-25507	145	7	,	,	PUNCT
inlawrev-25507	145	8	secondary	secondary	ADJ
inlawrev-25507	145	9	patenting	patenting	NOUN
inlawrev-25507	145	10	of	of	ADP
inlawrev-25507	145	11	branded	brand	VERB
inlawrev-25507	145	12	pharmaceuticals	pharmaceutical	NOUN
inlawrev-25507	145	13	:	:	PUNCT
inlawrev-25507	145	14	a	a	DET
inlawrev-25507	145	15	case	case	NOUN
inlawrev-25507	145	16	study	study	NOUN
inlawrev-25507	145	17	of	of	ADP
inlawrev-25507	145	18	how	how	SCONJ
inlawrev-25507	145	19	patents	patent	NOUN
inlawrev-25507	145	20	on	on	ADP
inlawrev-25507	145	21	two	two	NUM
inlawrev-25507	145	22	hiv	hiv	NOUN
inlawrev-25507	145	23	drugs	drug	NOUN
inlawrev-25507	145	24	could	could	AUX
inlawrev-25507	145	25	be	be	AUX
inlawrev-25507	145	26	extended	extend	VERB
inlawrev-25507	145	27	for	for	ADP
inlawrev-25507	145	28	decades	decade	NOUN
inlawrev-25507	145	29	,	,	PUNCT
inlawrev-25507	145	30	31	31	NUM
inlawrev-25507	145	31	health	health	NOUN
inlawrev-25507	145	32	aff	aff	NOUN
inlawrev-25507	145	33	.	.	PUNCT
inlawrev-25507	145	34	2286	2286	NUM
inlawrev-25507	145	35	,	,	PUNCT
inlawrev-25507	145	36	2286	2286	NUM
inlawrev-25507	145	37	(	(	PUNCT
inlawrev-25507	145	38	oct	oct	PROPN
inlawrev-25507	145	39	.	.	PROPN
inlawrev-25507	145	40	2012	2012	NUM
inlawrev-25507	145	41	)	)	PUNCT
inlawrev-25507	145	42	,	,	PUNCT
inlawrev-25507	145	43	https://www.healthaffairs.org/doi/pdf/10.1377/hlthaff.2012.0107	https://www.healthaffairs.org/doi/pdf/10.1377/hlthaff.2012.0107	PROPN
inlawrev-25507	146	1	[	[	X
inlawrev-25507	146	2	https://	https://	PROPN
inlawrev-25507	146	3	perma.cc/hf4s-dvgt	perma.cc/hf4s-dvgt	NOUN
inlawrev-25507	146	4	]	]	PUNCT
inlawrev-25507	146	5	.	.	PUNCT
inlawrev-25507	147	1	51	51	NUM
inlawrev-25507	147	2	.	.	PUNCT
inlawrev-25507	148	1	i	i	PRON
inlawrev-25507	148	2	d.	d.	PROPN
inlawrev-25507	148	3	52	52	NUM
inlawrev-25507	148	4	.	.	PUNCT
inlawrev-25507	149	1	i	i	PRON
inlawrev-25507	149	2	d.	d.	PROPN
inlawrev-25507	149	3	at	at	ADP
inlawrev-25507	149	4	2287	2287	NUM
inlawrev-25507	149	5	.	.	PUNCT
inlawrev-25507	150	1	53	53	NUM
inlawrev-25507	150	2	.	.	PUNCT
inlawrev-25507	150	3	excessive	excessive	ADJ
inlawrev-25507	150	4	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	150	5	patenting	patenting	NOUN
inlawrev-25507	150	6	,	,	PUNCT
inlawrev-25507	150	7	supra	supra	PROPN
inlawrev-25507	150	8	note	note	PROPN
inlawrev-25507	150	9	19	19	NUM
inlawrev-25507	150	10	,	,	PUNCT
inlawrev-25507	150	11	at	at	ADP
inlawrev-25507	150	12	5	5	NUM
inlawrev-25507	150	13	.	.	PUNCT
inlawrev-25507	150	14	54	54	NUM
inlawrev-25507	150	15	.	.	PUNCT
inlawrev-25507	151	1	malathi	malathi	PROPN
inlawrev-25507	151	2	nayak	nayak	PROPN
inlawrev-25507	151	3	,	,	PUNCT
inlawrev-25507	151	4	costs	cost	VERB
inlawrev-25507	151	5	soar	soar	VERB
inlawrev-25507	151	6	for	for	ADP
inlawrev-25507	151	7	trade	trade	NOUN
inlawrev-25507	151	8	secrets	secret	NOUN
inlawrev-25507	151	9	,	,	PUNCT
inlawrev-25507	151	10	pharma	pharma	PROPN
inlawrev-25507	151	11	patent	patent	NOUN
inlawrev-25507	151	12	suits	suit	NOUN
inlawrev-25507	151	13	,	,	PUNCT
inlawrev-25507	151	14	survey	survey	NOUN
inlawrev-25507	151	15	finds	find	VERB
inlawrev-25507	151	16	,	,	PUNCT
inlawrev-25507	152	1	bloomberg	bloomberg	PROPN
inlawrev-25507	152	2	l.	l.	PROPN
inlawrev-25507	152	3	(	(	PUNCT
inlawrev-25507	152	4	sept	sept	PROPN
inlawrev-25507	152	5	.	.	PROPN
inlawrev-25507	152	6	10	10	NUM
inlawrev-25507	152	7	,	,	PUNCT
inlawrev-25507	152	8	2019	2019	NUM
inlawrev-25507	152	9	)	)	PUNCT
inlawrev-25507	152	10	,	,	PUNCT
inlawrev-25507	152	11	https://news.bloomberglaw.com/ip-law/costs-soar-for-tradesecrets-pharma-patent-suits-survey-finds	https://news.bloomberglaw.com/ip-law/costs-soar-for-tradesecrets-pharma-patent-suits-survey-find	VERB
inlawrev-25507	152	12	[	[	X
inlawrev-25507	152	13	https://perma.cc/s22x-l2xx	https://perma.cc/s22x-l2xx	PROPN
inlawrev-25507	152	14	]	]	X
inlawrev-25507	152	15	.	.	PUNCT
inlawrev-25507	153	1	55	55	NUM
inlawrev-25507	153	2	.	.	PUNCT
inlawrev-25507	154	1	see	see	AUX
inlawrev-25507	154	2	overpatented	overpatente	VERB
inlawrev-25507	154	3	,	,	PUNCT
inlawrev-25507	154	4	overpriced	overprice	VERB
inlawrev-25507	154	5	:	:	PUNCT
inlawrev-25507	154	6	special	special	ADJ
inlawrev-25507	154	7	humira	humira	PROPN
inlawrev-25507	154	8	edition	edition	PROPN
inlawrev-25507	154	9	,	,	PUNCT
inlawrev-25507	154	10	supra	supra	PROPN
inlawrev-25507	154	11	note	note	NOUN
inlawrev-25507	154	12	2	2	NUM
inlawrev-25507	154	13	,	,	PUNCT
inlawrev-25507	154	14	at	at	ADP
inlawrev-25507	154	15	8	8	NUM
inlawrev-25507	154	16	(	(	PUNCT
inlawrev-25507	154	17	discussing	discuss	VERB
inlawrev-25507	154	18	the	the	DET
inlawrev-25507	154	19	247	247	NUM
inlawrev-25507	154	20	secondary	secondary	ADJ
inlawrev-25507	154	21	patents	patent	NOUN
inlawrev-25507	154	22	abbvie	abbvie	NOUN
inlawrev-25507	154	23	has	have	AUX
inlawrev-25507	154	24	been	be	AUX
inlawrev-25507	154	25	granted	grant	VERB
inlawrev-25507	154	26	on	on	ADP
inlawrev-25507	154	27	humira	humira	PROPN
inlawrev-25507	154	28	®	®	PROPN
inlawrev-25507	154	29	)	)	PUNCT
inlawrev-25507	154	30	.	.	PUNCT
inlawrev-25507	155	1	the	the	DET
inlawrev-25507	155	2	total	total	NOUN
inlawrev-25507	155	3	of	of	ADP
inlawrev-25507	155	4	$	$	SYM
inlawrev-25507	155	5	741	741	NUM
inlawrev-25507	155	6	million	million	NUM
inlawrev-25507	155	7	was	be	AUX
inlawrev-25507	155	8	calculated	calculate	VERB
inlawrev-25507	155	9	by	by	ADP
inlawrev-25507	155	10	multiplying	multiply	VERB
inlawrev-25507	155	11	abbvie	abbvie	PROPN
inlawrev-25507	155	12	’s	’s	PART
inlawrev-25507	155	13	247	247	NUM
inlawrev-25507	155	14	secondary	secondary	ADJ
inlawrev-25507	155	15	patents	patent	NOUN
inlawrev-25507	155	16	on	on	ADP
inlawrev-25507	155	17	humira	humira	PROPN
inlawrev-25507	155	18	®	®	NOUN
inlawrev-25507	155	19	by	by	ADP
inlawrev-25507	155	20	$	$	SYM
inlawrev-25507	155	21	3	3	NUM
inlawrev-25507	155	22	million	million	NUM
inlawrev-25507	155	23	.	.	PUNCT
inlawrev-25507	156	1	56	56	NUM
inlawrev-25507	156	2	.	.	PUNCT
inlawrev-25507	156	3	maria	maria	PROPN
inlawrev-25507	156	4	luisa	luisa	PROPN
inlawrev-25507	156	5	palmese	palmese	PROPN
inlawrev-25507	156	6	,	,	PUNCT
inlawrev-25507	156	7	patent	patent	NOUN
inlawrev-25507	156	8	litigation	litigation	NOUN
inlawrev-25507	156	9	in	in	ADP
inlawrev-25507	156	10	the	the	DET
inlawrev-25507	156	11	united	united	PROPN
inlawrev-25507	156	12	states	states	PROPN
inlawrev-25507	156	13	:	:	PUNCT
inlawrev-25507	156	14	overview	overview	VERB
inlawrev-25507	156	15	,	,	PUNCT
inlawrev-25507	156	16	thomson	thomson	PROPN
inlawrev-25507	156	17	reuters	reuters	PROPN
inlawrev-25507	156	18	prac	prac	PROPN
inlawrev-25507	156	19	.	.	PUNCT
inlawrev-25507	157	1	l.	l.	PROPN
inlawrev-25507	157	2	,	,	PUNCT
inlawrev-25507	157	3	https://www.wg-law.com/publications/patent-litigation-united-states-overview/	https://www.wg-law.com/publications/patent-litigation-united-states-overview/	PUNCT
inlawrev-25507	157	4	(	(	PUNCT
inlawrev-25507	157	5	last	last	ADJ
inlawrev-25507	157	6	updated	update	VERB
inlawrev-25507	157	7	july	july	PROPN
inlawrev-25507	157	8	1	1	NUM
inlawrev-25507	157	9	,	,	PUNCT
inlawrev-25507	157	10	2018	2018	NUM
inlawrev-25507	157	11	)	)	PUNCT
inlawrev-25507	158	1	[	[	X
inlawrev-25507	158	2	https://perma.cc/z3md-9emj	https://perma.cc/z3md-9emj	X
inlawrev-25507	158	3	]	]	PUNCT
inlawrev-25507	158	4	.	.	PUNCT
inlawrev-25507	159	1	57	57	NUM
inlawrev-25507	159	2	.	.	PUNCT
inlawrev-25507	159	3	christopher	christopher	PROPN
inlawrev-25507	159	4	rowland	rowland	PROPN
inlawrev-25507	159	5	,	,	PUNCT
inlawrev-25507	159	6	why	why	SCONJ
inlawrev-25507	159	7	price	price	NOUN
inlawrev-25507	159	8	of	of	ADP
inlawrev-25507	159	9	humira	humira	PROPN
inlawrev-25507	159	10	keeps	keeps	AUX
inlawrev-25507	159	11	rising	rise	VERB
inlawrev-25507	159	12	despite	despite	SCONJ
inlawrev-25507	159	13	fda	fda	PROPN
inlawrev-25507	159	14	approval	approval	NOUN
inlawrev-25507	159	15	of	of	ADP
inlawrev-25507	159	16	generic	generic	ADJ
inlawrev-25507	159	17	competition	competition	NOUN
inlawrev-25507	159	18	,	,	PUNCT
inlawrev-25507	159	19	wash	wash	NOUN
inlawrev-25507	159	20	.	.	PUNCT
inlawrev-25507	160	1	post	post	NOUN
inlawrev-25507	160	2	(	(	PUNCT
inlawrev-25507	160	3	jan	jan	PROPN
inlawrev-25507	160	4	.	.	PROPN
inlawrev-25507	160	5	8	8	NUM
inlawrev-25507	160	6	,	,	PUNCT
inlawrev-25507	160	7	2020	2020	NUM
inlawrev-25507	160	8	,	,	PUNCT
inlawrev-25507	160	9	7:00	7:00	NUM
inlawrev-25507	160	10	am	am	NOUN
inlawrev-25507	160	11	)	)	PUNCT
inlawrev-25507	160	12	,	,	PUNCT
inlawrev-25507	160	13	https://www.washingtonpost.com/	https://www.washingtonpost.com/	NOUN
inlawrev-25507	160	14	bu	bu	PROPN
inlawrev-25507	160	15	s	s	PROPN
inlawrev-25507	160	16	in	in	ADP
inlawrev-25507	160	17	e	e	PROPN
inlawrev-25507	160	18	s	s	PROPN
inlawrev-25507	160	19	s	s	PROPN
inlawrev-25507	160	20	/	/	SYM
inlawrev-25507	160	21	econ	econ	PROPN
inlawrev-25507	160	22	omy	omy	PROPN
inlawrev-25507	160	23	/	/	SYM
inlawrev-25507	160	24	w	w	PROPN
inlawrev-25507	160	25	h	h	PROPN
inlawrev-25507	161	1	y	y	PROPN
inlawrev-25507	161	2	-	-	PUNCT
inlawrev-25507	161	3	h	h	NOUN
inlawrev-25507	161	4	u	u	NOUN
inlawrev-25507	161	5	m	m	VERB
inlawrev-25507	161	6	iras	ira	NOUN
inlawrev-25507	161	7	-	-	PUNCT
inlawrev-25507	161	8	price	price	NOUN
inlawrev-25507	161	9	-	-	PUNCT
inlawrev-25507	161	10	keeps	keep	NOUN
inlawrev-25507	161	11	-	-	PUNCT
inlawrev-25507	161	12	risin	risin	NOUN
inlawrev-25507	161	13	g	g	NOUN
inlawrev-25507	161	14	-	-	PUNCT
inlawrev-25507	161	15	despite	despite	SCONJ
inlawrev-25507	161	16	-	-	PUNCT
inlawrev-25507	161	17	fda	fda	NOUN
inlawrev-25507	161	18	-	-	PUNCT
inlawrev-25507	161	19	approval	approval	NOUN
inlawrev-25507	161	20	-	-	PUNCT
inlawrev-25507	161	21	of	of	ADP
inlawrev-25507	161	22	-	-	PUNCT
inlawrev-25507	161	23	gen	gen	NOUN
inlawrev-25507	161	24	ericc	ericc	NOUN
inlawrev-25507	161	25	o	o	NOUN
inlawrev-25507	161	26	m	m	VERB
inlawrev-25507	161	27	p	p	NOUN
inlawrev-25507	162	1	e	e	NOUN
inlawrev-25507	162	2	t	t	NOUN
inlawrev-25507	163	1	i	i	PRON
inlawrev-25507	163	2	t	t	VERB
inlawrev-25507	164	1	i	i	PRON
inlawrev-25507	164	2	o	o	VERB
inlawrev-25507	164	3	n	n	CCONJ
inlawrev-25507	164	4	/	/	SYM
inlawrev-25507	164	5	2	2	NUM
inlawrev-25507	164	6	0	0	NUM
inlawrev-25507	164	7	2	2	NUM
inlawrev-25507	164	8	0	0	NUM
inlawrev-25507	164	9	/	/	SYM
inlawrev-25507	164	10	0	0	NUM
inlawrev-25507	164	11	1	1	NUM
inlawrev-25507	164	12	/	/	SYM
inlawrev-25507	164	13	0	0	NUM
inlawrev-25507	164	14	7	7	NUM
inlawrev-25507	164	15	/	/	SYM
inlawrev-25507	164	16	5	5	NUM
inlawrev-25507	164	17	4	4	NUM
inlawrev-25507	164	18	9	9	NUM
inlawrev-25507	164	19	e	e	NOUN
inlawrev-25507	164	20	d	d	X
inlawrev-25507	164	21	0	0	PROPN
inlawrev-25507	164	22	c	c	NOUN
inlawrev-25507	164	23	e	e	X
inlawrev-25507	164	24	-2	-2	NOUN
inlawrev-25507	164	25	e	e	X
inlawrev-25507	164	26	3	3	NUM
inlawrev-25507	164	27	a	a	PRON
inlawrev-25507	164	28	-1	-1	NOUN
inlawrev-25507	164	29	1	1	NUM
inlawrev-25507	164	30	e	e	NOUN
inlawrev-25507	164	31	a	a	X
inlawrev-25507	164	32	-b	-b	X
inlawrev-25507	164	33	c	c	NOUN
inlawrev-25507	164	34	b	b	PROPN
inlawrev-25507	164	35	3	3	NUM
inlawrev-25507	164	36	-a	-a	SYM
inlawrev-25507	164	37	c	c	NOUN
inlawrev-25507	164	38	6	6	NUM
inlawrev-25507	164	39	4	4	NUM
inlawrev-25507	164	40	8	8	NUM
inlawrev-25507	164	41	2	2	NUM
inlawrev-25507	164	42	c	c	NOUN
inlawrev-25507	164	43	4	4	NUM
inlawrev-25507	164	44	a	a	DET
inlawrev-25507	164	45	9	9	NUM
inlawrev-25507	164	46	2	2	NUM
inlawrev-25507	164	47	f	f	NOUN
inlawrev-25507	164	48	_	_	PRON
inlawrev-25507	164	49	s	s	VERB
inlawrev-25507	164	50	t	t	NOUN
inlawrev-25507	164	51	o	o	NOUN
inlawrev-25507	164	52	r	r	NOUN
inlawrev-25507	164	53	y	y	PROPN
inlawrev-25507	164	54	.	.	PUNCT
inlawrev-25507	165	1	h	h	PROPN
inlawrev-25507	165	2	t	t	NOUN
inlawrev-25507	165	3	m	m	VERB
inlawrev-25507	165	4	l	l	NOUN
inlawrev-25507	166	1	[	[	X
inlawrev-25507	166	2	https://perma.cc/92ht-55rx	https://perma.cc/92ht-55rx	PROPN
inlawrev-25507	166	3	]	]	PUNCT
inlawrev-25507	166	4	.	.	PUNCT
inlawrev-25507	166	5	2021	2021	NUM
inlawrev-25507	166	6	]	]	PUNCT
inlawrev-25507	166	7	leaving	leave	VERB
inlawrev-25507	166	8	the	the	DET
inlawrev-25507	166	9	evergreening	evergreene	VERB
inlawrev-25507	166	10	problem	problem	NOUN
inlawrev-25507	166	11	to	to	ADP
inlawrev-25507	166	12	the	the	DET
inlawrev-25507	166	13	patent	patent	NOUN
inlawrev-25507	166	14	experts	expert	NOUN
inlawrev-25507	166	15	201	201	NUM
inlawrev-25507	166	16	royalties.58	royalties.58	NOUN
inlawrev-25507	166	17	both	both	CCONJ
inlawrev-25507	166	18	potential	potential	ADJ
inlawrev-25507	166	19	outcomes	outcome	NOUN
inlawrev-25507	166	20	encourage	encourage	VERB
inlawrev-25507	166	21	innovator	innovator	NOUN
inlawrev-25507	166	22	companies	company	NOUN
inlawrev-25507	166	23	to	to	PART
inlawrev-25507	166	24	try	try	VERB
inlawrev-25507	166	25	to	to	PART
inlawrev-25507	166	26	evergreen	evergreen	VERB
inlawrev-25507	166	27	on	on	ADP
inlawrev-25507	166	28	their	their	PRON
inlawrev-25507	166	29	most	most	ADV
inlawrev-25507	166	30	successful	successful	ADJ
inlawrev-25507	166	31	drugs	drug	NOUN
inlawrev-25507	166	32	,	,	PUNCT
inlawrev-25507	166	33	as	as	SCONJ
inlawrev-25507	166	34	they	they	PRON
inlawrev-25507	166	35	end	end	VERB
inlawrev-25507	166	36	up	up	ADP
inlawrev-25507	166	37	with	with	ADP
inlawrev-25507	166	38	either	either	CCONJ
inlawrev-25507	166	39	an	an	DET
inlawrev-25507	166	40	extended	extended	ADJ
inlawrev-25507	166	41	exclusivity	exclusivity	NOUN
inlawrev-25507	166	42	period	period	NOUN
inlawrev-25507	166	43	,	,	PUNCT
inlawrev-25507	166	44	royalties	royalty	NOUN
inlawrev-25507	166	45	from	from	ADP
inlawrev-25507	166	46	generic	generic	ADJ
inlawrev-25507	166	47	companies	company	NOUN
inlawrev-25507	166	48	that	that	PRON
inlawrev-25507	166	49	will	will	AUX
inlawrev-25507	166	50	eventually	eventually	ADV
inlawrev-25507	166	51	enter	enter	VERB
inlawrev-25507	166	52	the	the	DET
inlawrev-25507	166	53	market	market	NOUN
inlawrev-25507	166	54	,	,	PUNCT
inlawrev-25507	166	55	or	or	CCONJ
inlawrev-25507	166	56	both.59	both.59	PROPN
inlawrev-25507	166	57	notably	notably	ADV
inlawrev-25507	166	58	,	,	PUNCT
inlawrev-25507	166	59	a	a	DET
inlawrev-25507	166	60	secondary	secondary	ADJ
inlawrev-25507	166	61	patent	patent	NOUN
inlawrev-25507	166	62	does	do	AUX
inlawrev-25507	166	63	not	not	PART
inlawrev-25507	166	64	technically	technically	ADV
inlawrev-25507	166	65	extend	extend	VERB
inlawrev-25507	166	66	the	the	DET
inlawrev-25507	166	67	exclusivity	exclusivity	NOUN
inlawrev-25507	166	68	of	of	ADP
inlawrev-25507	166	69	the	the	DET
inlawrev-25507	166	70	primary	primary	ADJ
inlawrev-25507	166	71	patent.60	patent.60	NOUN
inlawrev-25507	166	72	for	for	ADP
inlawrev-25507	166	73	example	example	NOUN
inlawrev-25507	166	74	,	,	PUNCT
inlawrev-25507	166	75	the	the	DET
inlawrev-25507	166	76	exclusivity	exclusivity	NOUN
inlawrev-25507	166	77	associated	associate	VERB
inlawrev-25507	166	78	with	with	ADP
inlawrev-25507	166	79	a	a	DET
inlawrev-25507	166	80	secondary	secondary	ADJ
inlawrev-25507	166	81	patent	patent	NOUN
inlawrev-25507	166	82	on	on	ADP
inlawrev-25507	166	83	a	a	DET
inlawrev-25507	166	84	new	new	ADJ
inlawrev-25507	166	85	dosage	dosage	NOUN
inlawrev-25507	166	86	or	or	CCONJ
inlawrev-25507	166	87	new	new	ADJ
inlawrev-25507	166	88	method	method	NOUN
inlawrev-25507	166	89	of	of	ADP
inlawrev-25507	166	90	manufacture	manufacture	NOUN
inlawrev-25507	166	91	will	will	AUX
inlawrev-25507	166	92	be	be	AUX
inlawrev-25507	166	93	limited	limit	VERB
inlawrev-25507	166	94	to	to	ADP
inlawrev-25507	166	95	only	only	ADV
inlawrev-25507	166	96	that	that	DET
inlawrev-25507	166	97	improvement.6	improvement.6	NOUN
inlawrev-25507	166	98	1	1	NUM
inlawrev-25507	166	99	however	however	ADV
inlawrev-25507	166	100	,	,	PUNCT
inlawrev-25507	166	101	excessive	excessive	ADJ
inlawrev-25507	166	102	secondary	secondary	ADJ
inlawrev-25507	166	103	patents	patent	NOUN
inlawrev-25507	166	104	on	on	ADP
inlawrev-25507	166	105	a	a	DET
inlawrev-25507	166	106	drug	drug	NOUN
inlawrev-25507	166	107	not	not	PART
inlawrev-25507	166	108	only	only	ADV
inlawrev-25507	166	109	aim	aim	VERB
inlawrev-25507	166	110	to	to	PART
inlawrev-25507	166	111	extend	extend	VERB
inlawrev-25507	166	112	the	the	DET
inlawrev-25507	166	113	company	company	NOUN
inlawrev-25507	166	114	’s	’s	PART
inlawrev-25507	166	115	exclusivity	exclusivity	NOUN
inlawrev-25507	166	116	,	,	PUNCT
inlawrev-25507	166	117	but	but	CCONJ
inlawrev-25507	166	118	also	also	ADV
inlawrev-25507	166	119	aspire	aspire	VERB
inlawrev-25507	166	120	to	to	PART
inlawrev-25507	166	121	deter	deter	VERB
inlawrev-25507	166	122	generic	generic	ADJ
inlawrev-25507	166	123	companies	company	NOUN
inlawrev-25507	166	124	from	from	ADP
inlawrev-25507	166	125	engaging	engage	VERB
inlawrev-25507	166	126	in	in	ADP
inlawrev-25507	166	127	expensive	expensive	ADJ
inlawrev-25507	166	128	litigation	litigation	NOUN
inlawrev-25507	166	129	and	and	CCONJ
inlawrev-25507	166	130	to	to	PART
inlawrev-25507	166	131	keep	keep	VERB
inlawrev-25507	166	132	the	the	DET
inlawrev-25507	166	133	prices	price	NOUN
inlawrev-25507	166	134	high	high	ADJ
inlawrev-25507	166	135	for	for	ADP
inlawrev-25507	166	136	consumers.62	consumers.62	NOUN
inlawrev-25507	166	137	in	in	ADP
inlawrev-25507	166	138	order	order	NOUN
inlawrev-25507	166	139	to	to	PART
inlawrev-25507	166	140	solve	solve	VERB
inlawrev-25507	166	141	this	this	DET
inlawrev-25507	166	142	issue	issue	NOUN
inlawrev-25507	166	143	,	,	PUNCT
inlawrev-25507	166	144	legislation	legislation	NOUN
inlawrev-25507	166	145	has	have	AUX
inlawrev-25507	166	146	been	be	AUX
inlawrev-25507	166	147	recently	recently	ADV
inlawrev-25507	166	148	proposed	propose	VERB
inlawrev-25507	166	149	including	including	ADP
inlawrev-25507	166	150	,	,	PUNCT
inlawrev-25507	166	151	but	but	CCONJ
inlawrev-25507	166	152	not	not	PART
inlawrev-25507	166	153	limited	limit	VERB
inlawrev-25507	166	154	to	to	ADP
inlawrev-25507	166	155	,	,	PUNCT
inlawrev-25507	166	156	the	the	DET
inlawrev-25507	166	157	remedy	remedy	NOUN
inlawrev-25507	166	158	act	act	PROPN
inlawrev-25507	166	159	,	,	PUNCT
inlawrev-25507	166	160	the	the	DET
inlawrev-25507	166	161	app	app	PROPN
inlawrev-25507	166	162	act	act	PROPN
inlawrev-25507	166	163	,	,	PUNCT
inlawrev-25507	166	164	and	and	CCONJ
inlawrev-25507	166	165	the	the	DET
inlawrev-25507	166	166	term	term	NOUN
inlawrev-25507	166	167	act.63	act.63	X
inlawrev-25507	166	168	however	however	ADV
inlawrev-25507	166	169	,	,	PUNCT
inlawrev-25507	166	170	deciding	decide	VERB
inlawrev-25507	166	171	which	which	PRON
inlawrev-25507	166	172	secondary	secondary	ADJ
inlawrev-25507	166	173	patents	patent	NOUN
inlawrev-25507	166	174	are	be	AUX
inlawrev-25507	166	175	an	an	DET
inlawrev-25507	166	176	attempt	attempt	NOUN
inlawrev-25507	166	177	to	to	PART
inlawrev-25507	166	178	evergreen	evergreen	VERB
inlawrev-25507	166	179	and	and	CCONJ
inlawrev-25507	166	180	which	which	PRON
inlawrev-25507	166	181	protect	protect	VERB
inlawrev-25507	166	182	genuine	genuine	ADJ
inlawrev-25507	166	183	innovation	innovation	NOUN
inlawrev-25507	166	184	is	be	AUX
inlawrev-25507	166	185	very	very	ADV
inlawrev-25507	166	186	difficult.64	difficult.64	NOUN
inlawrev-25507	166	187	as	as	ADP
inlawrev-25507	166	188	a	a	DET
inlawrev-25507	166	189	result	result	NOUN
inlawrev-25507	166	190	,	,	PUNCT
inlawrev-25507	166	191	blanket	blanket	NOUN
inlawrev-25507	166	192	legislation	legislation	NOUN
inlawrev-25507	166	193	aimed	aim	VERB
inlawrev-25507	166	194	at	at	ADP
inlawrev-25507	166	195	preventing	prevent	VERB
inlawrev-25507	166	196	evergreening	evergreening	NOUN
inlawrev-25507	166	197	would	would	AUX
inlawrev-25507	166	198	likely	likely	ADV
inlawrev-25507	166	199	impede	impede	VERB
inlawrev-25507	166	200	goals	goal	NOUN
inlawrev-25507	166	201	of	of	ADP
inlawrev-25507	166	202	research	research	NOUN
inlawrev-25507	166	203	and	and	CCONJ
inlawrev-25507	166	204	development	development	NOUN
inlawrev-25507	166	205	of	of	ADP
inlawrev-25507	166	206	many	many	ADJ
inlawrev-25507	166	207	drugs.65	drugs.65	NOUN
inlawrev-25507	166	208	the	the	DET
inlawrev-25507	166	209	following	follow	VERB
inlawrev-25507	166	210	proposed	propose	VERB
inlawrev-25507	166	211	legislation	legislation	NOUN
inlawrev-25507	166	212	would	would	AUX
inlawrev-25507	166	213	not	not	PART
inlawrev-25507	166	214	only	only	ADV
inlawrev-25507	166	215	discourage	discourage	VERB
inlawrev-25507	166	216	innovator	innovator	NOUN
inlawrev-25507	166	217	companies	company	NOUN
inlawrev-25507	166	218	from	from	ADP
inlawrev-25507	166	219	performing	perform	VERB
inlawrev-25507	166	220	any	any	DET
inlawrev-25507	166	221	further	further	ADJ
inlawrev-25507	166	222	research	research	NOUN
inlawrev-25507	166	223	and	and	CCONJ
inlawrev-25507	166	224	development	development	NOUN
inlawrev-25507	166	225	on	on	ADP
inlawrev-25507	166	226	known	know	VERB
inlawrev-25507	166	227	drugs	drug	NOUN
inlawrev-25507	166	228	,	,	PUNCT
inlawrev-25507	166	229	but	but	CCONJ
inlawrev-25507	166	230	would	would	AUX
inlawrev-25507	166	231	also	also	ADV
inlawrev-25507	166	232	likely	likely	ADV
inlawrev-25507	166	233	not	not	PART
inlawrev-25507	166	234	solve	solve	VERB
inlawrev-25507	166	235	the	the	DET
inlawrev-25507	166	236	evergreening	evergreene	VERB
inlawrev-25507	166	237	issue	issue	NOUN
inlawrev-25507	166	238	that	that	PRON
inlawrev-25507	166	239	is	be	AUX
inlawrev-25507	166	240	preventing	prevent	VERB
inlawrev-25507	166	241	decreases	decrease	NOUN
inlawrev-25507	166	242	in	in	ADP
inlawrev-25507	166	243	drug	drug	NOUN
inlawrev-25507	166	244	prices	price	NOUN
inlawrev-25507	166	245	.	.	PUNCT
inlawrev-25507	167	1	ii	ii	PROPN
inlawrev-25507	167	2	.	.	PUNCT
inlawrev-25507	168	1	addressing	address	VERB
inlawrev-25507	168	2	the	the	DET
inlawrev-25507	168	3	proposed	propose	VERB
inlawrev-25507	168	4	legislation	legislation	NOUN
inlawrev-25507	168	5	a.	a.	NOUN
inlawrev-25507	168	6	the	the	DET
inlawrev-25507	168	7	remedy	remedy	NOUN
inlawrev-25507	168	8	act	act	VERB
inlawrev-25507	168	9	the	the	DET
inlawrev-25507	168	10	remedy	remedy	NOUN
inlawrev-25507	168	11	act	act	NOUN
inlawrev-25507	168	12	is	be	AUX
inlawrev-25507	168	13	a	a	DET
inlawrev-25507	168	14	bipartisan	bipartisan	ADJ
inlawrev-25507	168	15	bill	bill	NOUN
inlawrev-25507	168	16	that	that	PRON
inlawrev-25507	168	17	legislators	legislator	NOUN
inlawrev-25507	168	18	introduced	introduce	VERB
inlawrev-25507	168	19	to	to	PART
inlawrev-25507	168	20	“	"	PUNCT
inlawrev-25507	168	21	tackle	tackle	VERB
inlawrev-25507	168	22	the	the	DET
inlawrev-25507	168	23	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	168	24	industry	industry	NOUN
inlawrev-25507	168	25	’s	’s	PART
inlawrev-25507	168	26	practice	practice	NOUN
inlawrev-25507	168	27	of	of	ADP
inlawrev-25507	168	28	gaming	game	VERB
inlawrev-25507	168	29	the	the	DET
inlawrev-25507	168	30	patent	patent	NOUN
inlawrev-25507	168	31	system	system	NOUN
inlawrev-25507	168	32	to	to	PART
inlawrev-25507	168	33	extend	extend	VERB
inlawrev-25507	168	34	monopolies	monopoly	NOUN
inlawrev-25507	168	35	on	on	ADP
inlawrev-25507	168	36	lifesaving	lifesave	VERB
inlawrev-25507	168	37	drugs	drug	NOUN
inlawrev-25507	168	38	.	.	PUNCT
inlawrev-25507	169	1	”66	”66	NOUN
inlawrev-25507	169	2	according	accord	VERB
inlawrev-25507	169	3	to	to	ADP
inlawrev-25507	169	4	senators	senator	NOUN
inlawrev-25507	169	5	dick	dick	PROPN
inlawrev-25507	169	6	durbin	durbin	PROPN
inlawrev-25507	169	7	and	and	CCONJ
inlawrev-25507	169	8	bill	bill	PROPN
inlawrev-25507	169	9	58	58	NUM
inlawrev-25507	169	10	.	.	PUNCT
inlawrev-25507	169	11	manogna	manogna	PROPN
inlawrev-25507	169	12	maddipatla	maddipatla	PROPN
inlawrev-25507	169	13	&	&	CCONJ
inlawrev-25507	169	14	saumya	saumya	PROPN
inlawrev-25507	169	15	sibi	sibi	PROPN
inlawrev-25507	169	16	joseph	joseph	PROPN
inlawrev-25507	169	17	,	,	PUNCT
inlawrev-25507	169	18	abbvie	abbvie	PROPN
inlawrev-25507	169	19	settles	settles	PROPN
inlawrev-25507	169	20	humira	humira	PROPN
inlawrev-25507	169	21	patent	patent	NOUN
inlawrev-25507	169	22	disputes	dispute	NOUN
inlawrev-25507	169	23	with	with	ADP
inlawrev-25507	169	24	novartis	novartis	NOUN
inlawrev-25507	169	25	unit	unit	NOUN
inlawrev-25507	169	26	,	,	PUNCT
inlawrev-25507	169	27	reuters	reuters	PROPN
inlawrev-25507	169	28	(	(	PUNCT
inlawrev-25507	169	29	oct	oct	PROPN
inlawrev-25507	169	30	.	.	PROPN
inlawrev-25507	169	31	11	11	NUM
inlawrev-25507	169	32	,	,	PUNCT
inlawrev-25507	169	33	2018	2018	NUM
inlawrev-25507	169	34	)	)	PUNCT
inlawrev-25507	169	35	,	,	PUNCT
inlawrev-25507	169	36	https://www.reuters.com/article/us-abbvie-novartish	https://www.reuters.com/article/us-abbvie-novartish	PUNCT
inlawrev-25507	169	37	u	u	PROPN
inlawrev-25507	169	38	m	m	PROPN
inlawrev-25507	169	39	ira	ira	PROPN
inlawrev-25507	169	40	/	/	SYM
inlawrev-25507	169	41	abbvie	abbvie	NOUN
inlawrev-25507	169	42	-	-	PUNCT
inlawrev-25507	169	43	settles	settle	NOUN
inlawrev-25507	169	44	-	-	PUNCT
inlawrev-25507	169	45	h	h	NOUN
inlawrev-25507	169	46	u	u	NOUN
inlawrev-25507	169	47	mira	mira	NOUN
inlawrev-25507	169	48	-	-	PUNCT
inlawrev-25507	169	49	paten	paten	ADJ
inlawrev-25507	169	50	t	t	PROPN
inlawrev-25507	169	51	-	-	PUNCT
inlawrev-25507	169	52	dispu	dispu	NOUN
inlawrev-25507	169	53	tes	tes	PROPN
inlawrev-25507	169	54	-	-	PROPN
inlawrev-25507	169	55	w	w	PROPN
inlawrev-25507	169	56	ith	ith	PROPN
inlawrev-25507	169	57	-n	-n	PUNCT
inlawrev-25507	169	58	ovartis	ovartis	NOUN
inlawrev-25507	169	59	-	-	PUNCT
inlawrev-25507	169	60	u	u	NOUN
inlawrev-25507	169	61	n	n	CCONJ
inlawrev-25507	169	62	it	it	PRON
inlawrev-25507	169	63	-	-	PUNCT
inlawrev-25507	169	64	iduskc	iduskc	NOUN
inlawrev-25507	169	65	n	n	NOUN
inlawrev-25507	169	66	1	1	NUM
inlawrev-25507	169	67	ml3	ml3	PROPN
inlawrev-25507	170	1	1	1	NUM
inlawrev-25507	170	2	b	b	PROPN
inlawrev-25507	171	1	[	[	X
inlawrev-25507	171	2	https://perma.cc/p8nx-h22a	https://perma.cc/p8nx-h22a	X
inlawrev-25507	171	3	]	]	X
inlawrev-25507	171	4	.	.	PUNCT
inlawrev-25507	172	1	59	59	NUM
inlawrev-25507	172	2	.	.	PUNCT
inlawrev-25507	173	1	i	i	PRON
inlawrev-25507	173	2	d.	d.	PROPN
inlawrev-25507	173	3	60	60	NUM
inlawrev-25507	173	4	.	.	PUNCT
inlawrev-25507	174	1	holman	holman	PROPN
inlawrev-25507	174	2	,	,	PUNCT
inlawrev-25507	174	3	supra	supra	PROPN
inlawrev-25507	174	4	note	note	PROPN
inlawrev-25507	174	5	38	38	NUM
inlawrev-25507	174	6	.	.	NOUN
inlawrev-25507	174	7	61	61	NUM
inlawrev-25507	174	8	.	.	PUNCT
inlawrev-25507	175	1	i	i	PRON
inlawrev-25507	175	2	d.	d.	PROPN
inlawrev-25507	175	3	62	62	NUM
inlawrev-25507	175	4	.	.	PUNCT
inlawrev-25507	176	1	adam	adam	PROPN
inlawrev-25507	176	2	houldsworth	houldsworth	PROPN
inlawrev-25507	176	3	,	,	PUNCT
inlawrev-25507	176	4	pressure	pressure	NOUN
inlawrev-25507	176	5	piles	pile	NOUN
inlawrev-25507	176	6	on	on	ADP
inlawrev-25507	176	7	us	us	PROPN
inlawrev-25507	176	8	pharma	pharma	PROPN
inlawrev-25507	176	9	and	and	CCONJ
inlawrev-25507	176	10	biotech	biotech	ADJ
inlawrev-25507	176	11	ip	ip	PRON
inlawrev-25507	176	12	owners	owner	NOUN
inlawrev-25507	176	13	,	,	PUNCT
inlawrev-25507	176	14	iam	iam	PROPN
inlawrev-25507	176	15	media	medium	NOUN
inlawrev-25507	176	16	(	(	PUNCT
inlawrev-25507	176	17	jan	jan	PROPN
inlawrev-25507	176	18	.	.	PROPN
inlawrev-25507	176	19	31	31	NUM
inlawrev-25507	176	20	,	,	PUNCT
inlawrev-25507	176	21	2019	2019	NUM
inlawrev-25507	176	22	)	)	PUNCT
inlawrev-25507	176	23	,	,	PUNCT
inlawrev-25507	176	24	https://www.iam-media.com/law-policy/why-evergreening-not-dirty-word	https://www.iam-media.com/law-policy/why-evergreening-not-dirty-word	PROPN
inlawrev-25507	177	1	[	[	X
inlawrev-25507	177	2	https://	https://	PROPN
inlawrev-25507	177	3	perma.cc/xvz2-dcn4	perma.cc/xvz2-dcn4	PROPN
inlawrev-25507	177	4	]	]	PUNCT
inlawrev-25507	177	5	.	.	PUNCT
inlawrev-25507	178	1	63	63	NUM
inlawrev-25507	178	2	.	.	PUNCT
inlawrev-25507	179	1	s.	s.	PROPN
inlawrev-25507	179	2	1209	1209	NUM
inlawrev-25507	179	3	,	,	PUNCT
inlawrev-25507	179	4	116th	116th	PROPN
inlawrev-25507	179	5	cong	cong	NOUN
inlawrev-25507	179	6	.	.	PUNCT
inlawrev-25507	180	1	(	(	PUNCT
inlawrev-25507	180	2	2019	2019	NUM
inlawrev-25507	180	3	)	)	PUNCT
inlawrev-25507	180	4	;	;	PUNCT
inlawrev-25507	180	5	s.	s.	PROPN
inlawrev-25507	180	6	1416	1416	NUM
inlawrev-25507	180	7	,	,	PUNCT
inlawrev-25507	180	8	116th	116th	PROPN
inlawrev-25507	180	9	cong	cong	NOUN
inlawrev-25507	180	10	.	.	PUNCT
inlawrev-25507	181	1	§	§	PROPN
inlawrev-25507	181	2	3	3	NUM
inlawrev-25507	181	3	(	(	PUNCT
inlawrev-25507	181	4	2019	2019	NUM
inlawrev-25507	181	5	)	)	PUNCT
inlawrev-25507	181	6	;	;	PUNCT
inlawrev-25507	181	7	h.r	h.r	PROPN
inlawrev-25507	181	8	.	.	PROPN
inlawrev-25507	181	9	3199	3199	NUM
inlawrev-25507	181	10	§	§	PROPN
inlawrev-25507	181	11	2	2	NUM
inlawrev-25507	181	12	(	(	PUNCT
inlawrev-25507	181	13	2019	2019	NUM
inlawrev-25507	181	14	)	)	PUNCT
inlawrev-25507	181	15	.	.	PUNCT
inlawrev-25507	182	1	64	64	NUM
inlawrev-25507	182	2	.	.	PUNCT
inlawrev-25507	183	1	see	see	VERB
inlawrev-25507	183	2	sittler	sittler	PROPN
inlawrev-25507	183	3	et	et	PROPN
inlawrev-25507	183	4	al	al	PROPN
inlawrev-25507	183	5	.	.	PROPN
inlawrev-25507	183	6	,	,	PUNCT
inlawrev-25507	183	7	supra	supra	PROPN
inlawrev-25507	183	8	note	note	VERB
inlawrev-25507	183	9	37	37	NUM
inlawrev-25507	183	10	,	,	PUNCT
inlawrev-25507	183	11	at	at	ADP
inlawrev-25507	183	12	4	4	NUM
inlawrev-25507	183	13	.	.	NOUN
inlawrev-25507	183	14	65	65	NUM
inlawrev-25507	183	15	.	.	PUNCT
inlawrev-25507	184	1	holman	holman	PROPN
inlawrev-25507	184	2	,	,	PUNCT
inlawrev-25507	184	3	supra	supra	PROPN
inlawrev-25507	184	4	note	note	PROPN
inlawrev-25507	184	5	38	38	NUM
inlawrev-25507	184	6	.	.	PUNCT
inlawrev-25507	185	1	66	66	NUM
inlawrev-25507	185	2	.	.	PUNCT
inlawrev-25507	186	1	durbin	durbin	ADJ
inlawrev-25507	186	2	,	,	PUNCT
inlawrev-25507	186	3	cassidy	cassidy	VERB
inlawrev-25507	186	4	introduce	introduce	NOUN
inlawrev-25507	186	5	remedy	remedy	NOUN
inlawrev-25507	186	6	act	act	NOUN
inlawrev-25507	186	7	to	to	ADP
inlawrev-25507	186	8	lower	low	ADJ
inlawrev-25507	186	9	drug	drug	NOUN
inlawrev-25507	186	10	prices	price	NOUN
inlawrev-25507	186	11	by	by	ADP
inlawrev-25507	186	12	curbing	curb	VERB
inlawrev-25507	186	13	patent	patent	NOUN
inlawrev-25507	186	14	manipulation	manipulation	NOUN
inlawrev-25507	186	15	,	,	PUNCT
inlawrev-25507	186	16	promoting	promote	VERB
inlawrev-25507	186	17	generic	generic	ADJ
inlawrev-25507	186	18	competition	competition	NOUN
inlawrev-25507	186	19	,	,	PUNCT
inlawrev-25507	186	20	dick	dick	PROPN
inlawrev-25507	186	21	durbin	durbin	PROPN
inlawrev-25507	186	22	,	,	PUNCT
inlawrev-25507	186	23	u.	u.	PROPN
inlawrev-25507	186	24	s.	s.	PROPN
inlawrev-25507	186	25	senator	senator	PROPN
inlawrev-25507	186	26	ill	ill	PROPN
inlawrev-25507	186	27	.	.	PUNCT
inlawrev-25507	187	1	(	(	PUNCT
inlawrev-25507	187	2	apr	apr	NOUN
inlawrev-25507	187	3	.	.	PROPN
inlawrev-25507	187	4	11	11	NUM
inlawrev-25507	187	5	,	,	PUNCT
inlawrev-25507	187	6	2019	2019	NUM
inlawrev-25507	187	7	)	)	PUNCT
inlawrev-25507	187	8	,	,	PUNCT
inlawrev-25507	187	9	https://www.durbin.senate.gov/newsroom/press-releases/durbin-cassidy-introduce-remedy-act-tolow	https://www.durbin.senate.gov/newsroom/press-releases/durbin-cassidy-introduce-remedy-act-tolow	PUNCT
inlawrev-25507	187	10	er	er	INTJ
inlawrev-25507	187	11	-	-	PUNCT
inlawrev-25507	187	12	dru	dru	NOUN
inlawrev-25507	187	13	g	g	NOUN
inlawrev-25507	187	14	-	-	PUNCT
inlawrev-25507	187	15	prices	price	NOUN
inlawrev-25507	187	16	-	-	PUNCT
inlawrev-25507	187	17	by	by	ADP
inlawrev-25507	187	18	-	-	PUNCT
inlawrev-25507	187	19	cu	cu	NOUN
inlawrev-25507	187	20	rbin	rbin	NOUN
inlawrev-25507	187	21	g	g	NOUN
inlawrev-25507	187	22	-	-	PUNCT
inlawrev-25507	187	23	p	p	NOUN
inlawrev-25507	187	24	a	a	DET
inlawrev-25507	187	25	t	t	NOUN
inlawrev-25507	187	26	e	e	NOUN
inlawrev-25507	187	27	n	n	ADP
inlawrev-25507	187	28	t	t	PROPN
inlawrev-25507	187	29	-m	-m	PUNCT
inlawrev-25507	187	30	a	a	PRON
inlawrev-25507	187	31	n	n	NOUN
inlawrev-25507	187	32	ip	ip	NOUN
inlawrev-25507	187	33	u	u	NOUN
inlawrev-25507	187	34	la	la	PROPN
inlawrev-25507	187	35	t	t	PROPN
inlawrev-25507	187	36	io	io	PROPN
inlawrev-25507	188	1	n	n	PRON
inlawrev-25507	188	2	-p	-p	PROPN
inlawrev-25507	189	1	r	r	NOUN
inlawrev-25507	189	2	o	o	NOUN
inlawrev-25507	189	3	m	m	VERB
inlawrev-25507	189	4	o	o	NOUN
inlawrev-25507	189	5	t	t	NOUN
inlawrev-25507	189	6	in	in	ADP
inlawrev-25507	189	7	g	g	PROPN
inlawrev-25507	189	8	-g	-g	PROPN
inlawrev-25507	189	9	e	e	PROPN
inlawrev-25507	189	10	n	n	CCONJ
inlawrev-25507	189	11	eric	eric	PROPN
inlawrev-25507	189	12	-	-	PUNCT
inlawrev-25507	189	13	com	com	NOUN
inlawrev-25507	189	14	petition	petition	NOUN
inlawrev-25507	189	15	202	202	NUM
inlawrev-25507	189	16	indiana	indiana	PROPN
inlawrev-25507	189	17	law	law	PROPN
inlawrev-25507	189	18	review	review	NOUN
inlawrev-25507	190	1	[	[	X
inlawrev-25507	190	2	vol	vol	NOUN
inlawrev-25507	190	3	.	.	PUNCT
inlawrev-25507	190	4	54:195	54:195	NUM
inlawrev-25507	190	5	cassidy	cassidy	NOUN
inlawrev-25507	190	6	,	,	PUNCT
inlawrev-25507	190	7	the	the	DET
inlawrev-25507	190	8	act	act	NOUN
inlawrev-25507	190	9	would	would	AUX
inlawrev-25507	190	10	lower	lower	VERB
inlawrev-25507	190	11	drug	drug	NOUN
inlawrev-25507	190	12	prices	price	NOUN
inlawrev-25507	190	13	and	and	CCONJ
inlawrev-25507	190	14	promote	promote	VERB
inlawrev-25507	190	15	competition	competition	NOUN
inlawrev-25507	190	16	by	by	ADP
inlawrev-25507	190	17	removing	remove	VERB
inlawrev-25507	190	18	barriers	barrier	NOUN
inlawrev-25507	190	19	to	to	ADP
inlawrev-25507	190	20	food	food	NOUN
inlawrev-25507	190	21	and	and	CCONJ
inlawrev-25507	190	22	drug	drug	PROPN
inlawrev-25507	190	23	administration	administration	PROPN
inlawrev-25507	190	24	(	(	PUNCT
inlawrev-25507	190	25	fda	fda	PROPN
inlawrev-25507	190	26	)	)	PUNCT
inlawrev-25507	190	27	approval	approval	NOUN
inlawrev-25507	190	28	for	for	ADP
inlawrev-25507	190	29	lower	low	ADJ
inlawrev-25507	190	30	-	-	PUNCT
inlawrev-25507	190	31	cost	cost	NOUN
inlawrev-25507	190	32	generic	generic	ADJ
inlawrev-25507	190	33	drugs.67	drugs.67	NOUN
inlawrev-25507	190	34	particularly	particularly	ADV
inlawrev-25507	190	35	,	,	PUNCT
inlawrev-25507	190	36	the	the	DET
inlawrev-25507	190	37	senators	senator	NOUN
inlawrev-25507	190	38	allege	allege	VERB
inlawrev-25507	190	39	that	that	SCONJ
inlawrev-25507	190	40	the	the	DET
inlawrev-25507	190	41	act	act	NOUN
inlawrev-25507	190	42	would	would	AUX
inlawrev-25507	190	43	“	"	PUNCT
inlawrev-25507	190	44	crack	crack	VERB
inlawrev-25507	190	45	down	down	ADP
inlawrev-25507	190	46	on	on	ADP
inlawrev-25507	190	47	[	[	X
inlawrev-25507	190	48	]	]	X
inlawrev-25507	190	49	abusive	abusive	ADJ
inlawrev-25507	190	50	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	190	51	monopolies	monopoly	NOUN
inlawrev-25507	190	52	”	"	PUNCT
inlawrev-25507	190	53	that	that	PRON
inlawrev-25507	190	54	are	be	AUX
inlawrev-25507	190	55	attempts	attempt	NOUN
inlawrev-25507	190	56	to	to	PART
inlawrev-25507	190	57	evergreen.68	evergreen.68	VERB
inlawrev-25507	190	58	the	the	DET
inlawrev-25507	190	59	senators	senator	NOUN
inlawrev-25507	190	60	maintain	maintain	VERB
inlawrev-25507	190	61	that	that	SCONJ
inlawrev-25507	190	62	incentives	incentive	NOUN
inlawrev-25507	190	63	for	for	SCONJ
inlawrev-25507	190	64	drug	drug	NOUN
inlawrev-25507	190	65	manufacturers	manufacturer	NOUN
inlawrev-25507	190	66	to	to	PART
inlawrev-25507	190	67	file	file	VERB
inlawrev-25507	190	68	excessive	excessive	ADJ
inlawrev-25507	190	69	patents	patent	NOUN
inlawrev-25507	190	70	would	would	AUX
inlawrev-25507	190	71	be	be	AUX
inlawrev-25507	190	72	removed	remove	VERB
inlawrev-25507	190	73	by	by	ADP
inlawrev-25507	190	74	amending	amend	VERB
inlawrev-25507	190	75	fda	fda	PROPN
inlawrev-25507	190	76	statutes	statute	NOUN
inlawrev-25507	190	77	as	as	ADV
inlawrev-25507	190	78	well	well	ADV
inlawrev-25507	190	79	as	as	ADP
inlawrev-25507	190	80	by	by	ADP
inlawrev-25507	190	81	lifting	lift	VERB
inlawrev-25507	190	82	“	"	PUNCT
inlawrev-25507	190	83	barriers	barrier	NOUN
inlawrev-25507	190	84	that	that	PRON
inlawrev-25507	190	85	delay	delay	VERB
inlawrev-25507	190	86	generic	generic	ADJ
inlawrev-25507	190	87	market	market	NOUN
inlawrev-25507	190	88	entry	entry	NOUN
inlawrev-25507	190	89	.	.	PUNCT
inlawrev-25507	191	1	”69	”69	VERB
inlawrev-25507	191	2	the	the	DET
inlawrev-25507	191	3	senators	senator	NOUN
inlawrev-25507	191	4	declare	declare	VERB
inlawrev-25507	191	5	that	that	SCONJ
inlawrev-25507	191	6	“	"	PUNCT
inlawrev-25507	191	7	once	once	SCONJ
inlawrev-25507	191	8	the	the	DET
inlawrev-25507	191	9	substance	substance	NOUN
inlawrev-25507	191	10	patent	patent	NOUN
inlawrev-25507	191	11	and	and	CCONJ
inlawrev-25507	191	12	all	all	DET
inlawrev-25507	191	13	exclusivities	exclusivitie	NOUN
inlawrev-25507	191	14	expire	expire	VERB
inlawrev-25507	191	15	,	,	PUNCT
inlawrev-25507	191	16	generic	generic	ADJ
inlawrev-25507	191	17	manufacturers	manufacturer	NOUN
inlawrev-25507	191	18	would	would	AUX
inlawrev-25507	191	19	be	be	AUX
inlawrev-25507	191	20	allowed	allow	VERB
inlawrev-25507	191	21	to	to	PART
inlawrev-25507	191	22	enter	enter	VERB
inlawrev-25507	191	23	the	the	DET
inlawrev-25507	191	24	market	market	NOUN
inlawrev-25507	191	25	more	more	ADV
inlawrev-25507	191	26	easily	easily	ADV
inlawrev-25507	191	27	.	.	PUNCT
inlawrev-25507	192	1	”70	”70	PUNCT
inlawrev-25507	192	2	additionally	additionally	ADV
inlawrev-25507	192	3	,	,	PUNCT
inlawrev-25507	192	4	the	the	DET
inlawrev-25507	192	5	act	act	NOUN
inlawrev-25507	192	6	would	would	AUX
inlawrev-25507	192	7	attempt	attempt	VERB
inlawrev-25507	192	8	to	to	PART
inlawrev-25507	192	9	increase	increase	VERB
inlawrev-25507	192	10	transparency	transparency	NOUN
inlawrev-25507	192	11	by	by	ADP
inlawrev-25507	192	12	updating	update	VERB
inlawrev-25507	192	13	fda	fda	PROPN
inlawrev-25507	192	14	listings	listing	NOUN
inlawrev-25507	192	15	once	once	SCONJ
inlawrev-25507	192	16	a	a	DET
inlawrev-25507	192	17	patent	patent	NOUN
inlawrev-25507	192	18	is	be	AUX
inlawrev-25507	192	19	invalidated	invalidate	VERB
inlawrev-25507	192	20	by	by	ADP
inlawrev-25507	192	21	the	the	DET
inlawrev-25507	192	22	united	united	PROPN
inlawrev-25507	192	23	states	states	PROPN
inlawrev-25507	192	24	patent	patent	PROPN
inlawrev-25507	192	25	and	and	CCONJ
inlawrev-25507	192	26	trademark	trademark	NOUN
inlawrev-25507	192	27	office	office	NOUN
inlawrev-25507	192	28	(	(	PUNCT
inlawrev-25507	192	29	uspto).71	uspto).71	PROPN
inlawrev-25507	192	30	although	although	SCONJ
inlawrev-25507	192	31	the	the	DET
inlawrev-25507	192	32	act	act	NOUN
inlawrev-25507	192	33	has	have	AUX
inlawrev-25507	192	34	gained	gain	VERB
inlawrev-25507	192	35	momentum	momentum	NOUN
inlawrev-25507	192	36	from	from	ADP
inlawrev-25507	192	37	endorsements	endorsement	NOUN
inlawrev-25507	192	38	like	like	ADP
inlawrev-25507	192	39	the	the	DET
inlawrev-25507	192	40	campaign	campaign	NOUN
inlawrev-25507	192	41	for	for	ADP
inlawrev-25507	192	42	sustainable	sustainable	ADJ
inlawrev-25507	192	43	rx	rx	X
inlawrev-25507	192	44	pricing	pricing	NOUN
inlawrev-25507	192	45	and	and	CCONJ
inlawrev-25507	192	46	american	american	ADJ
inlawrev-25507	192	47	association	association	PROPN
inlawrev-25507	192	48	of	of	ADP
inlawrev-25507	192	49	retired	retire	VERB
inlawrev-25507	192	50	persons	person	NOUN
inlawrev-25507	192	51	(	(	PUNCT
inlawrev-25507	192	52	aarp),72	aarp),72	ADP
inlawrev-25507	192	53	some	some	DET
inlawrev-25507	192	54	patent	patent	NOUN
inlawrev-25507	192	55	experts	expert	NOUN
inlawrev-25507	192	56	view	view	VERB
inlawrev-25507	192	57	the	the	DET
inlawrev-25507	192	58	bill	bill	NOUN
inlawrev-25507	192	59	as	as	ADP
inlawrev-25507	192	60	“	"	PUNCT
inlawrev-25507	192	61	ill	ill	ADV
inlawrev-25507	192	62	conceived	conceive	VERB
inlawrev-25507	192	63	and	and	CCONJ
inlawrev-25507	192	64	unlikely	unlikely	ADJ
inlawrev-25507	192	65	to	to	PART
inlawrev-25507	192	66	have	have	VERB
inlawrev-25507	192	67	anything	anything	PRON
inlawrev-25507	192	68	more	more	ADJ
inlawrev-25507	192	69	than	than	ADP
inlawrev-25507	192	70	a	a	DET
inlawrev-25507	192	71	cosmetic	cosmetic	ADJ
inlawrev-25507	192	72	effect	effect	NOUN
inlawrev-25507	192	73	.	.	PUNCT
inlawrev-25507	193	1	”73	”73	PROPN
inlawrev-25507	193	2	particularly	particularly	ADV
inlawrev-25507	193	3	,	,	PUNCT
inlawrev-25507	193	4	critics	critic	NOUN
inlawrev-25507	193	5	of	of	ADP
inlawrev-25507	193	6	the	the	DET
inlawrev-25507	193	7	act	act	NOUN
inlawrev-25507	193	8	point	point	VERB
inlawrev-25507	193	9	out	out	ADP
inlawrev-25507	193	10	that	that	SCONJ
inlawrev-25507	193	11	if	if	SCONJ
inlawrev-25507	193	12	this	this	DET
inlawrev-25507	193	13	proposal	proposal	NOUN
inlawrev-25507	193	14	became	become	VERB
inlawrev-25507	193	15	law	law	NOUN
inlawrev-25507	193	16	,	,	PUNCT
inlawrev-25507	193	17	an	an	DET
inlawrev-25507	193	18	innovator	innovator	NOUN
inlawrev-25507	193	19	company	company	NOUN
inlawrev-25507	193	20	“	"	PUNCT
inlawrev-25507	193	21	would	would	AUX
inlawrev-25507	193	22	only	only	ADV
inlawrev-25507	193	23	be	be	AUX
inlawrev-25507	193	24	able	able	ADJ
inlawrev-25507	193	25	to	to	PART
inlawrev-25507	193	26	have	have	VERB
inlawrev-25507	193	27	the	the	DET
inlawrev-25507	193	28	benefit	benefit	NOUN
inlawrev-25507	193	29	of	of	ADP
inlawrev-25507	193	30	the	the	DET
inlawrev-25507	193	31	30	30	NUM
inlawrev-25507	193	32	-	-	PUNCT
inlawrev-25507	193	33	month	month	NOUN
inlawrev-25507	193	34	stay	stay	NOUN
inlawrev-25507	193	35	enshrined	enshrine	VERB
inlawrev-25507	193	36	in	in	ADP
inlawrev-25507	193	37	these	these	DET
inlawrev-25507	193	38	provisions	provision	NOUN
inlawrev-25507	193	39	of	of	ADP
inlawrev-25507	193	40	the	the	DET
inlawrev-25507	193	41	hatch	hatch	NOUN
inlawrev-25507	193	42	-	-	PUNCT
inlawrev-25507	193	43	waxman	waxman	PROPN
inlawrev-25507	193	44	act	act	NOUN
inlawrev-25507	193	45	for	for	ADP
inlawrev-25507	193	46	patents	patent	NOUN
inlawrev-25507	193	47	claiming	claim	VERB
inlawrev-25507	193	48	a	a	DET
inlawrev-25507	193	49	drug	drug	NOUN
inlawrev-25507	193	50	substance	substance	NOUN
inlawrev-25507	193	51	itself	itself	PRON
inlawrev-25507	193	52	,	,	PUNCT
inlawrev-25507	193	53	but	but	CCONJ
inlawrev-25507	193	54	not	not	PART
inlawrev-25507	193	55	formulations	formulation	NOUN
inlawrev-25507	193	56	or	or	CCONJ
inlawrev-25507	193	57	methods	method	NOUN
inlawrev-25507	193	58	of	of	ADP
inlawrev-25507	193	59	treatment	treatment	NOUN
inlawrev-25507	193	60	using	use	VERB
inlawrev-25507	193	61	a	a	DET
inlawrev-25507	193	62	patented	patented	ADJ
inlawrev-25507	193	63	,	,	PUNCT
inlawrev-25507	193	64	branded	brand	VERB
inlawrev-25507	193	65	drug	drug	NOUN
inlawrev-25507	193	66	under	under	ADP
inlawrev-25507	193	67	an	an	DET
inlawrev-25507	193	68	nda	nda	NOUN
inlawrev-25507	193	69	.	.	PUNCT
inlawrev-25507	193	70	”74	”74	PROPN
inlawrev-25507	194	1	a	a	DET
inlawrev-25507	194	2	generic	generic	ADJ
inlawrev-25507	194	3	company	company	NOUN
inlawrev-25507	194	4	would	would	AUX
inlawrev-25507	194	5	be	be	AUX
inlawrev-25507	194	6	in	in	ADP
inlawrev-25507	194	7	a	a	DET
inlawrev-25507	194	8	“	"	PUNCT
inlawrev-25507	194	9	launch	launch	NOUN
inlawrev-25507	194	10	at	at	ADP
inlawrev-25507	194	11	risk	risk	NOUN
inlawrev-25507	194	12	”	"	PUNCT
inlawrev-25507	194	13	scenario	scenario	NOUN
inlawrev-25507	194	14	,	,	PUNCT
inlawrev-25507	194	15	and	and	CCONJ
inlawrev-25507	194	16	the	the	DET
inlawrev-25507	194	17	company	company	NOUN
inlawrev-25507	194	18	would	would	AUX
inlawrev-25507	194	19	risk	risk	VERB
inlawrev-25507	194	20	both	both	DET
inlawrev-25507	194	21	an	an	DET
inlawrev-25507	194	22	injunction	injunction	NOUN
inlawrev-25507	194	23	and	and	CCONJ
inlawrev-25507	194	24	treble	treble	ADJ
inlawrev-25507	194	25	damages	damage	NOUN
inlawrev-25507	194	26	for	for	ADP
inlawrev-25507	194	27	willful	willful	ADJ
inlawrev-25507	194	28	infringement.75	infringement.75	NOUN
inlawrev-25507	194	29	many	many	ADJ
inlawrev-25507	194	30	attorneys	attorney	NOUN
inlawrev-25507	194	31	believe	believe	VERB
inlawrev-25507	194	32	this	this	PRON
inlawrev-25507	194	33	is	be	AUX
inlawrev-25507	194	34	not	not	PART
inlawrev-25507	194	35	as	as	ADV
inlawrev-25507	194	36	attractive	attractive	ADJ
inlawrev-25507	194	37	to	to	ADP
inlawrev-25507	194	38	generic	generic	ADJ
inlawrev-25507	194	39	companies	company	NOUN
inlawrev-25507	194	40	as	as	ADP
inlawrev-25507	194	41	the	the	DET
inlawrev-25507	194	42	senators	senator	NOUN
inlawrev-25507	194	43	assert.76	assert.76	PROPN
inlawrev-25507	194	44	additionally	additionally	ADV
inlawrev-25507	194	45	,	,	PUNCT
inlawrev-25507	194	46	critics	critic	NOUN
inlawrev-25507	194	47	of	of	ADP
inlawrev-25507	194	48	the	the	DET
inlawrev-25507	194	49	bill	bill	NOUN
inlawrev-25507	194	50	note	note	VERB
inlawrev-25507	194	51	that	that	SCONJ
inlawrev-25507	194	52	it	it	PRON
inlawrev-25507	194	53	is	be	AUX
inlawrev-25507	194	54	unclear	unclear	ADJ
inlawrev-25507	194	55	whether	whether	SCONJ
inlawrev-25507	194	56	any	any	PRON
inlawrev-25507	194	57	of	of	ADP
inlawrev-25507	194	58	the	the	DET
inlawrev-25507	194	59	proposed	propose	VERB
inlawrev-25507	194	60	changes	change	NOUN
inlawrev-25507	194	61	will	will	AUX
inlawrev-25507	194	62	remedy	remedy	VERB
inlawrev-25507	194	63	any	any	DET
inlawrev-25507	194	64	actual	actual	ADJ
inlawrev-25507	194	65	issues	issue	NOUN
inlawrev-25507	194	66	in	in	ADP
inlawrev-25507	194	67	patent	patent	NOUN
inlawrev-25507	194	68	law	law	NOUN
inlawrev-25507	194	69	,	,	PUNCT
inlawrev-25507	194	70	including	include	VERB
inlawrev-25507	194	71	the	the	DET
inlawrev-25507	194	72	issue	issue	NOUN
inlawrev-25507	194	73	[	[	X
inlawrev-25507	194	74	https://perma.cc/qv7j-fz6	https://perma.cc/qv7j-fz6	NOUN
inlawrev-25507	194	75	t	t	X
inlawrev-25507	194	76	]	]	PUNCT
inlawrev-25507	194	77	.	.	PUNCT
inlawrev-25507	195	1	67	67	NUM
inlawrev-25507	195	2	.	.	PUNCT
inlawrev-25507	196	1	i	i	PRON
inlawrev-25507	196	2	d.	d.	PROPN
inlawrev-25507	196	3	68	68	NUM
inlawrev-25507	196	4	.	.	PUNCT
inlawrev-25507	197	1	i	i	PRON
inlawrev-25507	197	2	d.	d.	PROPN
inlawrev-25507	197	3	69	69	NUM
inlawrev-25507	197	4	.	.	PUNCT
inlawrev-25507	198	1	i	i	PRON
inlawrev-25507	198	2	d.	d.	PROPN
inlawrev-25507	198	3	70	70	NUM
inlawrev-25507	198	4	.	.	PUNCT
inlawrev-25507	199	1	i	i	PRON
inlawrev-25507	199	2	d.	d.	PROPN
inlawrev-25507	199	3	71	71	NUM
inlawrev-25507	199	4	.	.	PUNCT
inlawrev-25507	200	1	i	i	PRON
inlawrev-25507	200	2	d.	d.	PROPN
inlawrev-25507	200	3	72	72	NUM
inlawrev-25507	200	4	.	.	PUNCT
inlawrev-25507	201	1	jon	jon	PROPN
inlawrev-25507	201	2	conradi	conradi	PROPN
inlawrev-25507	201	3	,	,	PUNCT
inlawrev-25507	201	4	csrxp	csrxp	PROPN
inlawrev-25507	201	5	applauds	applaud	VERB
inlawrev-25507	201	6	introduction	introduction	NOUN
inlawrev-25507	201	7	of	of	ADP
inlawrev-25507	201	8	cassidy	cassidy	ADJ
inlawrev-25507	201	9	-	-	ADJ
inlawrev-25507	201	10	durbin	durbin	ADJ
inlawrev-25507	201	11	“	"	PUNCT
inlawrev-25507	201	12	remedy	remedy	NOUN
inlawrev-25507	201	13	act	act	NOUN
inlawrev-25507	201	14	”	"	PUNCT
inlawrev-25507	201	15	,	,	PUNCT
inlawrev-25507	201	16	campaign	campaign	NOUN
inlawrev-25507	201	17	for	for	ADP
inlawrev-25507	201	18	sustainable	sustainable	ADJ
inlawrev-25507	201	19	rx	rx	ADJ
inlawrev-25507	201	20	pricing	pricing	NOUN
inlawrev-25507	201	21	,	,	PUNCT
inlawrev-25507	201	22	https://www.csrxp.org/csrxp-applauds-introduction-ofcassidy-durbin-remedy-act/	https://www.csrxp.org/csrxp-applauds-introduction-ofcassidy-durbin-remedy-act/	PROPN
inlawrev-25507	201	23	(	(	PUNCT
inlawrev-25507	201	24	last	last	ADJ
inlawrev-25507	201	25	visited	visit	VERB
inlawrev-25507	201	26	nov	nov	PROPN
inlawrev-25507	201	27	.	.	PROPN
inlawrev-25507	201	28	28	28	NUM
inlawrev-25507	201	29	,	,	PUNCT
inlawrev-25507	201	30	2019	2019	NUM
inlawrev-25507	201	31	)	)	PUNCT
inlawrev-25507	202	1	[	[	X
inlawrev-25507	202	2	https://perma.cc/sw65-qcvh	https://perma.cc/sw65-qcvh	X
inlawrev-25507	202	3	]	]	X
inlawrev-25507	202	4	;	;	PUNCT
inlawrev-25507	202	5	see	see	VERB
inlawrev-25507	202	6	also	also	ADV
inlawrev-25507	202	7	letter	letter	VERB
inlawrev-25507	202	8	from	from	ADP
inlawrev-25507	202	9	david	david	PROPN
inlawrev-25507	202	10	certner	certner	PROPN
inlawrev-25507	202	11	,	,	PUNCT
inlawrev-25507	202	12	legislative	legislative	ADJ
inlawrev-25507	202	13	counsel	counsel	NOUN
inlawrev-25507	202	14	&	&	CCONJ
inlawrev-25507	202	15	legislative	legislative	ADJ
inlawrev-25507	202	16	policy	policy	NOUN
inlawrev-25507	202	17	director	director	NOUN
inlawrev-25507	202	18	,	,	PUNCT
inlawrev-25507	202	19	governmental	governmental	ADJ
inlawrev-25507	202	20	affairs	affair	NOUN
inlawrev-25507	202	21	,	,	PUNCT
inlawrev-25507	202	22	to	to	ADP
inlawrev-25507	202	23	bill	bill	PROPN
inlawrev-25507	202	24	cassidy	cassidy	PROPN
inlawrev-25507	202	25	&	&	CCONJ
inlawrev-25507	202	26	richard	richard	PROPN
inlawrev-25507	202	27	j.	j.	PROPN
inlawrev-25507	202	28	durbin	durbin	PROPN
inlawrev-25507	202	29	,	,	PUNCT
inlawrev-25507	202	30	senators	senator	NOUN
inlawrev-25507	202	31	(	(	PUNCT
inlawrev-25507	202	32	june	june	PROPN
inlawrev-25507	202	33	25	25	NUM
inlawrev-25507	202	34	,	,	PUNCT
inlawrev-25507	202	35	2019	2019	NUM
inlawrev-25507	202	36	)	)	PUNCT
inlawrev-25507	202	37	,	,	PUNCT
inlawrev-25507	202	38	https://www.aarp	https://www.aarp	NOUN
inlawrev-25507	202	39	.	.	PUNCT
inlawrev-25507	203	1	org	org	ADJ
inlawrev-25507	203	2	/	/	SYM
inlawrev-25507	203	3	content	content	NOUN
inlawrev-25507	203	4	/	/	SYM
inlawrev-25507	203	5	dam	dam	NOUN
inlawrev-25507	203	6	/	/	SYM
inlawrev-25507	203	7	aarp	aarp	NOUN
inlawrev-25507	203	8	/	/	SYM
inlawrev-25507	203	9	politics	politic	NOUN
inlawrev-25507	203	10	/	/	SYM
inlawrev-25507	203	11	advocacy/2019/06/062519	advocacy/2019/06/062519	ADJ
inlawrev-25507	203	12	-	-	PUNCT
inlawrev-25507	203	13	endorsement	endorsement	NOUN
inlawrev-25507	203	14	-	-	PUNCT
inlawrev-25507	203	15	letter	letter	NOUN
inlawrev-25507	203	16	-	-	PUNCT
inlawrev-25507	203	17	for	for	ADP
inlawrev-25507	203	18	-	-	PUNCT
inlawrev-25507	203	19	remedy	remedy	NOUN
inlawrev-25507	203	20	-	-	PUNCT
inlawrev-25507	203	21	actfinal.pdf	actfinal.pdf	X
inlawrev-25507	203	22	[	[	X
inlawrev-25507	203	23	https://perma.cc/e2hq-ja3r	https://perma.cc/e2hq-ja3r	X
inlawrev-25507	203	24	]	]	X
inlawrev-25507	203	25	.	.	PUNCT
inlawrev-25507	204	1	73	73	NUM
inlawrev-25507	204	2	.	.	PUNCT
inlawrev-25507	205	1	kevin	kevin	PROPN
inlawrev-25507	205	2	e.	e.	PROPN
inlawrev-25507	205	3	noonan	noonan	PROPN
inlawrev-25507	205	4	,	,	PUNCT
inlawrev-25507	205	5	more	more	ADV
inlawrev-25507	205	6	ill	ill	ADV
inlawrev-25507	205	7	-	-	PUNCT
inlawrev-25507	205	8	conceived	conceive	VERB
inlawrev-25507	205	9	remedies	remedy	NOUN
inlawrev-25507	205	10	from	from	ADP
inlawrev-25507	205	11	congress	congress	PROPN
inlawrev-25507	205	12	regarding	regard	VERB
inlawrev-25507	205	13	prescription	prescription	NOUN
inlawrev-25507	205	14	drug	drug	NOUN
inlawrev-25507	205	15	costs	cost	NOUN
inlawrev-25507	205	16	,	,	PUNCT
inlawrev-25507	206	1	pat	pat	PROPN
inlawrev-25507	206	2	.	.	PROPN
inlawrev-25507	206	3	docs	docs	PROPN
inlawrev-25507	206	4	(	(	PUNCT
inlawrev-25507	206	5	apr	apr	PROPN
inlawrev-25507	206	6	.	.	PROPN
inlawrev-25507	206	7	21	21	NUM
inlawrev-25507	206	8	,	,	PUNCT
inlawrev-25507	206	9	2019	2019	NUM
inlawrev-25507	206	10	)	)	PUNCT
inlawrev-25507	206	11	,	,	PUNCT
inlawrev-25507	206	12	https://www.patentdocs.org/2019/04/more-ill-conceivedremedies-from-congress-regarding-prescription-drug-costs.html	https://www.patentdocs.org/2019/04/more-ill-conceivedremedies-from-congress-regarding-prescription-drug-costs.html	X
inlawrev-25507	207	1	[	[	X
inlawrev-25507	207	2	https://perma.cc/4gqq-wqkd	https://perma.cc/4gqq-wqkd	X
inlawrev-25507	207	3	]	]	X
inlawrev-25507	207	4	.	.	PUNCT
inlawrev-25507	208	1	74	74	NUM
inlawrev-25507	208	2	.	.	PUNCT
inlawrev-25507	209	1	i	i	PRON
inlawrev-25507	209	2	d.	d.	PROPN
inlawrev-25507	209	3	75	75	NUM
inlawrev-25507	209	4	.	.	PUNCT
inlawrev-25507	210	1	i	i	PRON
inlawrev-25507	210	2	d.	d.	PROPN
inlawrev-25507	210	3	76	76	NUM
inlawrev-25507	210	4	.	.	PUNCT
inlawrev-25507	211	1	i	i	PRON
inlawrev-25507	211	2	d.	d.	PROPN
inlawrev-25507	211	3	2021	2021	NUM
inlawrev-25507	211	4	]	]	PUNCT
inlawrev-25507	212	1	leaving	leave	VERB
inlawrev-25507	212	2	the	the	DET
inlawrev-25507	212	3	evergreening	evergreene	VERB
inlawrev-25507	212	4	problem	problem	NOUN
inlawrev-25507	212	5	to	to	ADP
inlawrev-25507	212	6	the	the	DET
inlawrev-25507	212	7	patent	patent	NOUN
inlawrev-25507	212	8	experts	expert	NOUN
inlawrev-25507	212	9	203	203	NUM
inlawrev-25507	212	10	of	of	ADP
inlawrev-25507	212	11	evergreening.77	evergreening.77	NOUN
inlawrev-25507	212	12	further	far	ADV
inlawrev-25507	212	13	,	,	PUNCT
inlawrev-25507	212	14	these	these	DET
inlawrev-25507	212	15	critics	critic	NOUN
inlawrev-25507	212	16	note	note	VERB
inlawrev-25507	212	17	that	that	SCONJ
inlawrev-25507	212	18	the	the	DET
inlawrev-25507	212	19	answer	answer	NOUN
inlawrev-25507	212	20	to	to	ADP
inlawrev-25507	212	21	systematic	systematic	ADJ
inlawrev-25507	212	22	problems	problem	NOUN
inlawrev-25507	212	23	,	,	PUNCT
inlawrev-25507	212	24	such	such	ADJ
inlawrev-25507	212	25	as	as	ADP
inlawrev-25507	212	26	evergreening	evergreene	VERB
inlawrev-25507	212	27	in	in	ADP
inlawrev-25507	212	28	patent	patent	NOUN
inlawrev-25507	212	29	law	law	NOUN
inlawrev-25507	212	30	,	,	PUNCT
inlawrev-25507	212	31	is	be	AUX
inlawrev-25507	212	32	not	not	PART
inlawrev-25507	212	33	through	through	ADP
inlawrev-25507	212	34	quick	quick	ADJ
inlawrev-25507	212	35	or	or	CCONJ
inlawrev-25507	212	36	simple	simple	ADJ
inlawrev-25507	212	37	changes	change	NOUN
inlawrev-25507	212	38	in	in	ADP
inlawrev-25507	212	39	the	the	DET
inlawrev-25507	212	40	law	law	NOUN
inlawrev-25507	212	41	,	,	PUNCT
inlawrev-25507	212	42	as	as	SCONJ
inlawrev-25507	212	43	this	this	DET
inlawrev-25507	212	44	bill	bill	NOUN
inlawrev-25507	212	45	is	be	AUX
inlawrev-25507	212	46	attempting	attempt	VERB
inlawrev-25507	212	47	to	to	PART
inlawrev-25507	212	48	make.78	make.78	VERB
inlawrev-25507	212	49	others	other	NOUN
inlawrev-25507	212	50	note	note	VERB
inlawrev-25507	212	51	that	that	SCONJ
inlawrev-25507	212	52	targeting	target	VERB
inlawrev-25507	212	53	the	the	DET
inlawrev-25507	212	54	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	212	55	industry	industry	NOUN
inlawrev-25507	212	56	because	because	SCONJ
inlawrev-25507	212	57	of	of	ADP
inlawrev-25507	212	58	its	its	PRON
inlawrev-25507	212	59	products	product	NOUN
inlawrev-25507	212	60	discriminates	discriminate	VERB
inlawrev-25507	212	61	against	against	ADP
inlawrev-25507	212	62	the	the	DET
inlawrev-25507	212	63	industry	industry	NOUN
inlawrev-25507	212	64	and	and	CCONJ
inlawrev-25507	212	65	could	could	AUX
inlawrev-25507	212	66	impede	impede	VERB
inlawrev-25507	212	67	“	"	PUNCT
inlawrev-25507	212	68	innovation	innovation	NOUN
inlawrev-25507	212	69	and	and	CCONJ
inlawrev-25507	212	70	new	new	ADJ
inlawrev-25507	212	71	product	product	NOUN
inlawrev-25507	212	72	development	development	NOUN
inlawrev-25507	212	73	.	.	PUNCT
inlawrev-25507	213	1	”79	”79	PROPN
inlawrev-25507	213	2	labeling	label	VERB
inlawrev-25507	213	3	patent	patent	NOUN
inlawrev-25507	213	4	extensions	extension	NOUN
inlawrev-25507	213	5	as	as	ADP
inlawrev-25507	213	6	either	either	CCONJ
inlawrev-25507	213	7	anticompetitive	anticompetitive	ADJ
inlawrev-25507	213	8	or	or	CCONJ
inlawrev-25507	213	9	unethical	unethical	ADJ
inlawrev-25507	213	10	will	will	AUX
inlawrev-25507	213	11	likely	likely	ADV
inlawrev-25507	213	12	cause	cause	VERB
inlawrev-25507	213	13	innovator	innovator	NOUN
inlawrev-25507	213	14	companies	company	NOUN
inlawrev-25507	213	15	to	to	PART
inlawrev-25507	213	16	discontinue	discontinue	VERB
inlawrev-25507	213	17	research	research	NOUN
inlawrev-25507	213	18	on	on	ADP
inlawrev-25507	213	19	a	a	DET
inlawrev-25507	213	20	known	know	VERB
inlawrev-25507	213	21	drug.80	drug.80	NOUN
inlawrev-25507	213	22	failure	failure	NOUN
inlawrev-25507	213	23	to	to	PART
inlawrev-25507	213	24	investigate	investigate	VERB
inlawrev-25507	213	25	new	new	ADJ
inlawrev-25507	213	26	applications	application	NOUN
inlawrev-25507	213	27	of	of	ADP
inlawrev-25507	213	28	existing	exist	VERB
inlawrev-25507	213	29	drugs	drug	NOUN
inlawrev-25507	213	30	will	will	AUX
inlawrev-25507	213	31	inevitably	inevitably	ADV
inlawrev-25507	213	32	lead	lead	VERB
inlawrev-25507	213	33	to	to	ADP
inlawrev-25507	213	34	patients	patient	NOUN
inlawrev-25507	213	35	“	"	PUNCT
inlawrev-25507	213	36	los[ing	los[e	VERB
inlawrev-25507	213	37	]	]	PUNCT
inlawrev-25507	213	38	out	out	ADP
inlawrev-25507	213	39	on	on	ADP
inlawrev-25507	213	40	potentially	potentially	ADV
inlawrev-25507	213	41	life	life	NOUN
inlawrev-25507	213	42	-	-	PUNCT
inlawrev-25507	213	43	saving	save	VERB
inlawrev-25507	213	44	treatments	treatment	NOUN
inlawrev-25507	213	45	.	.	PUNCT
inlawrev-25507	214	1	”81	”81	PROPN
inlawrev-25507	214	2	b.	b.	PROPN
inlawrev-25507	214	3	the	the	DET
inlawrev-25507	214	4	app	app	PROPN
inlawrev-25507	214	5	act	act	NOUN
inlawrev-25507	214	6	the	the	DET
inlawrev-25507	214	7	app	app	PROPN
inlawrev-25507	214	8	act	act	NOUN
inlawrev-25507	214	9	would	would	AUX
inlawrev-25507	214	10	prevent	prevent	VERB
inlawrev-25507	214	11	innovator	innovator	NOUN
inlawrev-25507	214	12	companies	company	NOUN
inlawrev-25507	214	13	from	from	ADP
inlawrev-25507	214	14	their	their	PRON
inlawrev-25507	214	15	“	"	PUNCT
inlawrev-25507	214	16	anticompetitive	anticompetitive	ADJ
inlawrev-25507	214	17	use	use	NOUN
inlawrev-25507	214	18	of	of	ADP
inlawrev-25507	214	19	patents	patent	NOUN
inlawrev-25507	214	20	to	to	PART
inlawrev-25507	214	21	protect	protect	VERB
inlawrev-25507	214	22	their	their	PRON
inlawrev-25507	214	23	prescription	prescription	NOUN
inlawrev-25507	214	24	drugs	drug	NOUN
inlawrev-25507	214	25	and	and	CCONJ
inlawrev-25507	214	26	prevent	prevent	VERB
inlawrev-25507	214	27	generic	generic	ADJ
inlawrev-25507	214	28	and	and	CCONJ
inlawrev-25507	214	29	biosimilar	biosimilar	ADJ
inlawrev-25507	214	30	competition	competition	NOUN
inlawrev-25507	214	31	from	from	ADP
inlawrev-25507	214	32	coming	come	VERB
inlawrev-25507	214	33	to	to	ADP
inlawrev-25507	214	34	market	market	NOUN
inlawrev-25507	214	35	.	.	PUNCT
inlawrev-25507	215	1	”82	”82	VERB
inlawrev-25507	215	2	the	the	DET
inlawrev-25507	215	3	purpose	purpose	NOUN
inlawrev-25507	215	4	of	of	ADP
inlawrev-25507	215	5	the	the	DET
inlawrev-25507	215	6	bill	bill	NOUN
inlawrev-25507	215	7	is	be	AUX
inlawrev-25507	215	8	to	to	PART
inlawrev-25507	215	9	encourage	encourage	VERB
inlawrev-25507	215	10	competition	competition	NOUN
inlawrev-25507	215	11	and	and	CCONJ
inlawrev-25507	215	12	to	to	PART
inlawrev-25507	215	13	give	give	VERB
inlawrev-25507	215	14	patients	patient	NOUN
inlawrev-25507	215	15	access	access	NOUN
inlawrev-25507	215	16	to	to	ADP
inlawrev-25507	215	17	prescriptions	prescription	NOUN
inlawrev-25507	215	18	at	at	ADP
inlawrev-25507	215	19	lower	low	ADJ
inlawrev-25507	215	20	prices	price	NOUN
inlawrev-25507	215	21	“	"	PUNCT
inlawrev-25507	215	22	without	without	ADP
inlawrev-25507	215	23	stifling	stifle	VERB
inlawrev-25507	215	24	innovation	innovation	NOUN
inlawrev-25507	215	25	or	or	CCONJ
inlawrev-25507	215	26	infringing	infringe	VERB
inlawrev-25507	215	27	on	on	ADP
inlawrev-25507	215	28	patent	patent	NOUN
inlawrev-25507	215	29	rights	right	NOUN
inlawrev-25507	215	30	.	.	PUNCT
inlawrev-25507	216	1	”83	”83	NOUN
inlawrev-25507	216	2	specifically	specifically	ADV
inlawrev-25507	216	3	,	,	PUNCT
inlawrev-25507	216	4	the	the	DET
inlawrev-25507	216	5	act	act	NOUN
inlawrev-25507	216	6	would	would	AUX
inlawrev-25507	216	7	change	change	VERB
inlawrev-25507	216	8	the	the	DET
inlawrev-25507	216	9	definitions	definition	NOUN
inlawrev-25507	216	10	of	of	ADP
inlawrev-25507	216	11	product	product	NOUN
inlawrev-25507	216	12	hopping	hopping	NOUN
inlawrev-25507	216	13	and	and	CCONJ
inlawrev-25507	216	14	patent	patent	NOUN
inlawrev-25507	216	15	thicketing	thicketing	NOUN
inlawrev-25507	216	16	,	,	PUNCT
inlawrev-25507	216	17	which	which	PRON
inlawrev-25507	216	18	are	be	AUX
inlawrev-25507	216	19	other	other	ADJ
inlawrev-25507	216	20	names	name	NOUN
inlawrev-25507	216	21	for	for	ADP
inlawrev-25507	216	22	evergreening	evergreening	NOUN
inlawrev-25507	216	23	,	,	PUNCT
inlawrev-25507	216	24	within	within	ADP
inlawrev-25507	216	25	the	the	DET
inlawrev-25507	216	26	federal	federal	PROPN
inlawrev-25507	216	27	trade	trade	PROPN
inlawrev-25507	216	28	commission	commission	PROPN
inlawrev-25507	216	29	(	(	PUNCT
inlawrev-25507	216	30	“	"	PUNCT
inlawrev-25507	216	31	ftc”).84	ftc”).84	ADV
inlawrev-25507	216	32	the	the	DET
inlawrev-25507	216	33	ftc	ftc	PROPN
inlawrev-25507	216	34	would	would	AUX
inlawrev-25507	216	35	then	then	ADV
inlawrev-25507	216	36	be	be	AUX
inlawrev-25507	216	37	able	able	ADJ
inlawrev-25507	216	38	to	to	PART
inlawrev-25507	216	39	challenge	challenge	VERB
inlawrev-25507	216	40	the	the	DET
inlawrev-25507	216	41	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	216	42	companies	company	NOUN
inlawrev-25507	216	43	as	as	ADP
inlawrev-25507	216	44	anti	anti	ADJ
inlawrev-25507	216	45	-	-	ADJ
inlawrev-25507	216	46	competitive	competitive	ADJ
inlawrev-25507	216	47	and	and	CCONJ
inlawrev-25507	216	48	bring	bring	VERB
inlawrev-25507	216	49	antitrust	antitrust	ADJ
inlawrev-25507	216	50	suits	suit	NOUN
inlawrev-25507	216	51	against	against	ADP
inlawrev-25507	216	52	the	the	DET
inlawrev-25507	216	53	companies	company	NOUN
inlawrev-25507	216	54	who	who	PRON
inlawrev-25507	216	55	are	be	AUX
inlawrev-25507	216	56	capitalizing	capitalize	VERB
inlawrev-25507	216	57	on	on	ADP
inlawrev-25507	216	58	their	their	PRON
inlawrev-25507	216	59	“	"	PUNCT
inlawrev-25507	216	60	abuse	abuse	NOUN
inlawrev-25507	216	61	of	of	ADP
inlawrev-25507	216	62	the	the	DET
inlawrev-25507	216	63	system	system	NOUN
inlawrev-25507	216	64	.	.	PUNCT
inlawrev-25507	217	1	”85	”85	VERB
inlawrev-25507	217	2	additionally	additionally	ADV
inlawrev-25507	217	3	,	,	PUNCT
inlawrev-25507	217	4	the	the	DET
inlawrev-25507	217	5	bill	bill	NOUN
inlawrev-25507	217	6	would	would	AUX
inlawrev-25507	217	7	limit	limit	VERB
inlawrev-25507	217	8	the	the	DET
inlawrev-25507	217	9	number	number	NOUN
inlawrev-25507	217	10	of	of	ADP
inlawrev-25507	217	11	patents	patent	NOUN
inlawrev-25507	217	12	that	that	PRON
inlawrev-25507	217	13	can	can	AUX
inlawrev-25507	217	14	be	be	AUX
inlawrev-25507	217	15	litigated	litigate	VERB
inlawrev-25507	217	16	under	under	ADP
inlawrev-25507	217	17	the	the	DET
inlawrev-25507	217	18	biologics	biologic	NOUN
inlawrev-25507	217	19	price	price	NOUN
inlawrev-25507	217	20	competition	competition	NOUN
inlawrev-25507	217	21	and	and	CCONJ
inlawrev-25507	217	22	innovation	innovation	NOUN
inlawrev-25507	217	23	act	act	NOUN
inlawrev-25507	217	24	of	of	ADP
inlawrev-25507	217	25	2009	2009	NUM
inlawrev-25507	217	26	(	(	PUNCT
inlawrev-25507	217	27	the	the	DET
inlawrev-25507	217	28	“	"	PUNCT
inlawrev-25507	217	29	bpcia	bpcia	NOUN
inlawrev-25507	217	30	”	"	PUNCT
inlawrev-25507	217	31	)	)	PUNCT
inlawrev-25507	217	32	and	and	CCONJ
inlawrev-25507	217	33	would	would	AUX
inlawrev-25507	217	34	impose	impose	VERB
inlawrev-25507	217	35	a	a	DET
inlawrev-25507	217	36	private	private	ADJ
inlawrev-25507	217	37	sector	sector	NOUN
inlawrev-25507	217	38	mandate	mandate	NOUN
inlawrev-25507	217	39	limiting	limit	VERB
inlawrev-25507	217	40	the	the	DET
inlawrev-25507	217	41	number	number	NOUN
inlawrev-25507	217	42	of	of	ADP
inlawrev-25507	217	43	patents	patent	NOUN
inlawrev-25507	217	44	that	that	PRON
inlawrev-25507	217	45	could	could	AUX
inlawrev-25507	217	46	be	be	AUX
inlawrev-25507	217	47	asserted	assert	VERB
inlawrev-25507	217	48	for	for	ADP
inlawrev-25507	217	49	biological	biological	ADJ
inlawrev-25507	217	50	77	77	NUM
inlawrev-25507	217	51	.	.	PUNCT
inlawrev-25507	218	1	i	i	PRON
inlawrev-25507	218	2	d.	d.	PROPN
inlawrev-25507	218	3	78	78	NUM
inlawrev-25507	218	4	.	.	PUNCT
inlawrev-25507	219	1	i	i	PRON
inlawrev-25507	219	2	d.	d.	PROPN
inlawrev-25507	219	3	79	79	NUM
inlawrev-25507	219	4	.	.	PUNCT
inlawrev-25507	220	1	should	should	AUX
inlawrev-25507	220	2	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	220	3	companies	company	NOUN
inlawrev-25507	220	4	be	be	AUX
inlawrev-25507	220	5	prohibited	prohibit	VERB
inlawrev-25507	220	6	from	from	ADP
inlawrev-25507	220	7	‘	'	PUNCT
inlawrev-25507	220	8	patent	patent	NOUN
inlawrev-25507	220	9	evergreening	evergreening	NOUN
inlawrev-25507	220	10	’	'	PUNCT
inlawrev-25507	220	11	?	?	PUNCT
inlawrev-25507	220	12	,	,	PUNCT
inlawrev-25507	220	13	countable	countable	ADJ
inlawrev-25507	220	14	,	,	PUNCT
inlawrev-25507	220	15	https://www.countable.us/bills/s1209-116-reforming-evergreening-and-manipulationthat-extends-drug-years-act	https://www.countable.us/bills/s1209-116-reforming-evergreening-and-manipulationthat-extends-drug-years-act	NOUN
inlawrev-25507	220	16	(	(	PUNCT
inlawrev-25507	220	17	last	last	ADV
inlawrev-25507	220	18	visited	visit	VERB
inlawrev-25507	220	19	oct	oct	PROPN
inlawrev-25507	220	20	.	.	PROPN
inlawrev-25507	220	21	12	12	NUM
inlawrev-25507	220	22	,	,	PUNCT
inlawrev-25507	220	23	2020	2020	NUM
inlawrev-25507	220	24	)	)	PUNCT
inlawrev-25507	221	1	[	[	X
inlawrev-25507	221	2	https://perma.cc/67a5-wjf7	https://perma.cc/67a5-wjf7	NOUN
inlawrev-25507	221	3	]	]	X
inlawrev-25507	221	4	.	.	PUNCT
inlawrev-25507	222	1	80	80	NUM
inlawrev-25507	222	2	.	.	PUNCT
inlawrev-25507	223	1	i	i	PRON
inlawrev-25507	223	2	d.	d.	PROPN
inlawrev-25507	223	3	81	81	NUM
inlawrev-25507	223	4	.	.	PUNCT
inlawrev-25507	224	1	i	i	PRON
inlawrev-25507	224	2	d.	d.	PROPN
inlawrev-25507	224	3	82	82	NUM
inlawrev-25507	224	4	.	.	PUNCT
inlawrev-25507	225	1	cornyn	cornyn	PROPN
inlawrev-25507	225	2	,	,	PUNCT
inlawrev-25507	225	3	blumenthal	blumenthal	PROPN
inlawrev-25507	225	4	introduce	introduce	NOUN
inlawrev-25507	225	5	bill	bill	NOUN
inlawrev-25507	225	6	to	to	PART
inlawrev-25507	225	7	prevent	prevent	VERB
inlawrev-25507	225	8	drug	drug	NOUN
inlawrev-25507	225	9	companies	company	NOUN
inlawrev-25507	225	10	from	from	ADP
inlawrev-25507	225	11	abusing	abuse	VERB
inlawrev-25507	225	12	patent	patent	NOUN
inlawrev-25507	225	13	system	system	NOUN
inlawrev-25507	225	14	,	,	PUNCT
inlawrev-25507	225	15	john	john	PROPN
inlawrev-25507	225	16	cornyn	cornyn	PROPN
inlawrev-25507	225	17	u.s	u.s	PROPN
inlawrev-25507	225	18	.	.	PROPN
inlawrev-25507	225	19	sen	sen	PROPN
inlawrev-25507	225	20	.	.	PROPN
inlawrev-25507	225	21	for	for	ADP
inlawrev-25507	225	22	texas	texas	PROPN
inlawrev-25507	225	23	.	.	PUNCT
inlawrev-25507	226	1	(	(	PUNCT
inlawrev-25507	226	2	may	may	PROPN
inlawrev-25507	226	3	9	9	NUM
inlawrev-25507	226	4	,	,	PUNCT
inlawrev-25507	226	5	2019	2019	NUM
inlawrev-25507	226	6	)	)	PUNCT
inlawrev-25507	226	7	,	,	PUNCT
inlawrev-25507	226	8	https://www.cornyn.senate.gov/	https://www.cornyn.senate.gov/	PROPN
inlawrev-25507	226	9	content	content	NOUN
inlawrev-25507	226	10	/	/	SYM
inlawrev-25507	226	11	news	news	NOUN
inlawrev-25507	226	12	/	/	SYM
inlawrev-25507	226	13	cornyn	cornyn	NOUN
inlawrev-25507	226	14	-	-	PUNCT
inlawrev-25507	226	15	blumenthal	blumenthal	NOUN
inlawrev-25507	226	16	-	-	PUNCT
inlawrev-25507	226	17	introduce	introduce	NOUN
inlawrev-25507	226	18	-	-	PUNCT
inlawrev-25507	226	19	bill	bill	NOUN
inlawrev-25507	226	20	-	-	PUNCT
inlawrev-25507	226	21	prevent	prevent	NOUN
inlawrev-25507	226	22	-	-	PUNCT
inlawrev-25507	226	23	drug	drug	NOUN
inlawrev-25507	226	24	-	-	PUNCT
inlawrev-25507	226	25	companies	company	NOUN
inlawrev-25507	226	26	-	-	PUNCT
inlawrev-25507	226	27	abusing	abuse	VERB
inlawrev-25507	226	28	-	-	PUNCT
inlawrev-25507	226	29	patent	patent	NOUN
inlawrev-25507	226	30	-	-	PUNCT
inlawrev-25507	226	31	system	system	NOUN
inlawrev-25507	226	32	[	[	X
inlawrev-25507	226	33	https://perma.cc/ul77-aklg	https://perma.cc/ul77-aklg	X
inlawrev-25507	226	34	]	]	X
inlawrev-25507	227	1	[	[	X
inlawrev-25507	227	2	hereinafter	hereinafter	NOUN
inlawrev-25507	227	3	cornyn	cornyn	NOUN
inlawrev-25507	227	4	,	,	PUNCT
inlawrev-25507	227	5	blumenthal	blumenthal	PROPN
inlawrev-25507	227	6	introduce	introduce	NOUN
inlawrev-25507	227	7	bill	bill	NOUN
inlawrev-25507	227	8	]	]	PUNCT
inlawrev-25507	227	9	.	.	PUNCT
inlawrev-25507	228	1	83	83	NUM
inlawrev-25507	228	2	.	.	PUNCT
inlawrev-25507	229	1	i	i	PRON
inlawrev-25507	229	2	d.	d.	PROPN
inlawrev-25507	229	3	84	84	NUM
inlawrev-25507	229	4	.	.	PUNCT
inlawrev-25507	230	1	i	i	PRON
inlawrev-25507	230	2	d.	d.	PROPN
inlawrev-25507	230	3	;	;	PUNCT
inlawrev-25507	230	4	affordable	affordable	ADJ
inlawrev-25507	230	5	prescriptions	prescription	NOUN
inlawrev-25507	230	6	for	for	ADP
inlawrev-25507	230	7	patients	patient	NOUN
inlawrev-25507	230	8	act	act	AUX
inlawrev-25507	230	9	introduced	introduce	VERB
inlawrev-25507	230	10	in	in	ADP
inlawrev-25507	230	11	the	the	DET
inlawrev-25507	230	12	senate	senate	PROPN
inlawrev-25507	230	13	,	,	PUNCT
inlawrev-25507	230	14	goodwin	goodwin	PROPN
inlawrev-25507	230	15	(	(	PUNCT
inlawrev-25507	230	16	may	may	PROPN
inlawrev-25507	230	17	15	15	NUM
inlawrev-25507	230	18	,	,	PUNCT
inlawrev-25507	230	19	2019	2019	NUM
inlawrev-25507	230	20	)	)	PUNCT
inlawrev-25507	230	21	,	,	PUNCT
inlawrev-25507	230	22	https://www.bigmoleculewatch.com/2019/05/15/affordable-prescriptions-for-patientsact-introduced-in-the-senate/	https://www.bigmoleculewatch.com/2019/05/15/affordable-prescriptions-for-patientsact-introduced-in-the-senate/	PROPN
inlawrev-25507	231	1	[	[	X
inlawrev-25507	231	2	https://perma.cc/k5fs-pbhs	https://perma.cc/k5fs-pbhs	X
inlawrev-25507	231	3	]	]	X
inlawrev-25507	231	4	(	(	PUNCT
inlawrev-25507	231	5	defining	define	VERB
inlawrev-25507	231	6	“	"	PUNCT
inlawrev-25507	231	7	product	product	NOUN
inlawrev-25507	231	8	hopping	hopping	NOUN
inlawrev-25507	231	9	”	"	PUNCT
inlawrev-25507	231	10	as	as	ADP
inlawrev-25507	231	11	“	"	PUNCT
inlawrev-25507	231	12	producing	produce	VERB
inlawrev-25507	231	13	iterative	iterative	NOUN
inlawrev-25507	231	14	minor	minor	ADJ
inlawrev-25507	231	15	reformulations	reformulation	NOUN
inlawrev-25507	231	16	of	of	ADP
inlawrev-25507	231	17	a	a	DET
inlawrev-25507	231	18	drug	drug	NOUN
inlawrev-25507	231	19	”	"	PUNCT
inlawrev-25507	231	20	and	and	CCONJ
inlawrev-25507	231	21	“	"	PUNCT
inlawrev-25507	231	22	patent	patent	NOUN
inlawrev-25507	231	23	thicketing	thicketing	NOUN
inlawrev-25507	231	24	”	"	PUNCT
inlawrev-25507	231	25	as	as	ADP
inlawrev-25507	231	26	“	"	PUNCT
inlawrev-25507	231	27	generating	generate	VERB
inlawrev-25507	231	28	many	many	ADJ
inlawrev-25507	231	29	patents	patent	NOUN
inlawrev-25507	231	30	on	on	ADP
inlawrev-25507	231	31	a	a	DET
inlawrev-25507	231	32	single	single	ADJ
inlawrev-25507	231	33	product	product	NOUN
inlawrev-25507	231	34	”	"	PUNCT
inlawrev-25507	231	35	)	)	PUNCT
inlawrev-25507	231	36	.	.	PUNCT
inlawrev-25507	232	1	85	85	NUM
inlawrev-25507	232	2	.	.	PUNCT
inlawrev-25507	233	1	cornyn	cornyn	NOUN
inlawrev-25507	233	2	,	,	PUNCT
inlawrev-25507	233	3	blumenthal	blumenthal	PROPN
inlawrev-25507	233	4	introduce	introduce	NOUN
inlawrev-25507	233	5	bill	bill	NOUN
inlawrev-25507	233	6	,	,	PUNCT
inlawrev-25507	233	7	supra	supra	PROPN
inlawrev-25507	233	8	note	note	NOUN
inlawrev-25507	233	9	82	82	NUM
inlawrev-25507	233	10	.	.	SYM
inlawrev-25507	233	11	204	204	NUM
inlawrev-25507	233	12	indiana	indiana	PROPN
inlawrev-25507	233	13	law	law	PROPN
inlawrev-25507	233	14	review	review	NOUN
inlawrev-25507	234	1	[	[	X
inlawrev-25507	234	2	vol	vol	NOUN
inlawrev-25507	234	3	.	.	PUNCT
inlawrev-25507	235	1	54:195	54:195	NUM
inlawrev-25507	235	2	products	product	NOUN
inlawrev-25507	235	3	in	in	ADP
inlawrev-25507	235	4	infringement	infringement	NOUN
inlawrev-25507	235	5	claims.86	claims.86	NOUN
inlawrev-25507	235	6	however	however	ADV
inlawrev-25507	235	7	,	,	PUNCT
inlawrev-25507	235	8	whether	whether	SCONJ
inlawrev-25507	235	9	a	a	DET
inlawrev-25507	235	10	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	235	11	company	company	NOUN
inlawrev-25507	235	12	is	be	AUX
inlawrev-25507	235	13	evergreening	evergreene	VERB
inlawrev-25507	235	14	is	be	AUX
inlawrev-25507	235	15	rarely	rarely	ADV
inlawrev-25507	235	16	obvious.87	obvious.87	VERB
inlawrev-25507	235	17	the	the	DET
inlawrev-25507	235	18	repercussion	repercussion	NOUN
inlawrev-25507	235	19	of	of	ADP
inlawrev-25507	235	20	blanket	blanket	NOUN
inlawrev-25507	235	21	legislation	legislation	NOUN
inlawrev-25507	235	22	such	such	ADJ
inlawrev-25507	235	23	as	as	ADP
inlawrev-25507	235	24	the	the	DET
inlawrev-25507	235	25	app	app	PROPN
inlawrev-25507	235	26	act	act	NOUN
inlawrev-25507	235	27	would	would	AUX
inlawrev-25507	235	28	“	"	PUNCT
inlawrev-25507	235	29	impact	impact	VERB
inlawrev-25507	235	30	the	the	DET
inlawrev-25507	235	31	enforcement	enforcement	NOUN
inlawrev-25507	235	32	of	of	ADP
inlawrev-25507	235	33	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	235	34	patents	patent	NOUN
inlawrev-25507	235	35	,	,	PUNCT
inlawrev-25507	235	36	the	the	DET
inlawrev-25507	235	37	prosecution	prosecution	NOUN
inlawrev-25507	235	38	of	of	ADP
inlawrev-25507	235	39	those	those	DET
inlawrev-25507	235	40	patents	patent	NOUN
inlawrev-25507	235	41	,	,	PUNCT
inlawrev-25507	235	42	and	and	CCONJ
inlawrev-25507	235	43	the	the	DET
inlawrev-25507	235	44	desire	desire	NOUN
inlawrev-25507	235	45	of	of	ADP
inlawrev-25507	235	46	companies	company	NOUN
inlawrev-25507	235	47	to	to	PART
inlawrev-25507	235	48	improve	improve	VERB
inlawrev-25507	235	49	known	known	ADJ
inlawrev-25507	235	50	drugs	drug	NOUN
inlawrev-25507	235	51	.	.	PUNCT
inlawrev-25507	236	1	”88	”88	ADJ
inlawrev-25507	236	2	the	the	DET
inlawrev-25507	236	3	bill	bill	NOUN
inlawrev-25507	236	4	would	would	AUX
inlawrev-25507	236	5	allow	allow	VERB
inlawrev-25507	236	6	manufacturers	manufacturer	NOUN
inlawrev-25507	236	7	to	to	PART
inlawrev-25507	236	8	rebut	rebut	VERB
inlawrev-25507	236	9	ftc	ftc	PROPN
inlawrev-25507	236	10	determinations	determination	NOUN
inlawrev-25507	236	11	based	base	VERB
inlawrev-25507	236	12	on	on	ADP
inlawrev-25507	236	13	the	the	DET
inlawrev-25507	236	14	following	follow	VERB
inlawrev-25507	236	15	four	four	NUM
inlawrev-25507	236	16	criteria	criterion	NOUN
inlawrev-25507	236	17	:	:	PUNCT
inlawrev-25507	236	18	(	(	PUNCT
inlawrev-25507	236	19	1	1	X
inlawrev-25507	236	20	)	)	PUNCT
inlawrev-25507	236	21	clinically	clinically	ADV
inlawrev-25507	236	22	meaningful	meaningful	ADJ
inlawrev-25507	236	23	and	and	CCONJ
inlawrev-25507	236	24	significant	significant	ADJ
inlawrev-25507	236	25	therapeutic	therapeutic	ADJ
inlawrev-25507	236	26	or	or	CCONJ
inlawrev-25507	236	27	safety	safety	NOUN
inlawrev-25507	236	28	benefits	benefit	NOUN
inlawrev-25507	236	29	;	;	PUNCT
inlawrev-25507	236	30	(	(	PUNCT
inlawrev-25507	236	31	2	2	X
inlawrev-25507	236	32	)	)	PUNCT
inlawrev-25507	236	33	significantly	significantly	ADV
inlawrev-25507	236	34	improved	improve	VERB
inlawrev-25507	236	35	purity	purity	NOUN
inlawrev-25507	236	36	or	or	CCONJ
inlawrev-25507	236	37	potency	potency	NOUN
inlawrev-25507	236	38	of	of	ADP
inlawrev-25507	236	39	the	the	DET
inlawrev-25507	236	40	drug	drug	NOUN
inlawrev-25507	236	41	;	;	PUNCT
inlawrev-25507	236	42	(	(	PUNCT
inlawrev-25507	236	43	3	3	X
inlawrev-25507	236	44	)	)	PUNCT
inlawrev-25507	236	45	significant	significant	ADJ
inlawrev-25507	236	46	gains	gain	NOUN
inlawrev-25507	236	47	in	in	ADP
inlawrev-25507	236	48	efficiencies	efficiency	NOUN
inlawrev-25507	236	49	of	of	ADP
inlawrev-25507	236	50	manufacturing	manufacturing	NOUN
inlawrev-25507	236	51	;	;	PUNCT
inlawrev-25507	236	52	or	or	CCONJ
inlawrev-25507	236	53	(	(	PUNCT
inlawrev-25507	236	54	4	4	X
inlawrev-25507	236	55	)	)	PUNCT
inlawrev-25507	236	56	any	any	DET
inlawrev-25507	236	57	other	other	ADJ
inlawrev-25507	236	58	improved	improved	ADJ
inlawrev-25507	236	59	attributes	attribute	NOUN
inlawrev-25507	236	60	that	that	PRON
inlawrev-25507	236	61	could	could	AUX
inlawrev-25507	236	62	produce	produce	VERB
inlawrev-25507	236	63	substantial	substantial	ADJ
inlawrev-25507	236	64	benefits	benefit	NOUN
inlawrev-25507	236	65	for	for	ADP
inlawrev-25507	236	66	consumers	consumer	NOUN
inlawrev-25507	236	67	and	and	CCONJ
inlawrev-25507	236	68	patients.89	patients.89	NOUN
inlawrev-25507	236	69	this	this	PRON
inlawrev-25507	236	70	creates	create	VERB
inlawrev-25507	236	71	a	a	DET
inlawrev-25507	236	72	risk	risk	NOUN
inlawrev-25507	236	73	that	that	SCONJ
inlawrev-25507	236	74	one	one	NUM
inlawrev-25507	236	75	type	type	NOUN
inlawrev-25507	236	76	of	of	ADP
inlawrev-25507	236	77	litigation	litigation	NOUN
inlawrev-25507	236	78	,	,	PUNCT
inlawrev-25507	236	79	alleging	allege	VERB
inlawrev-25507	236	80	patent	patent	NOUN
inlawrev-25507	236	81	infringement	infringement	NOUN
inlawrev-25507	236	82	,	,	PUNCT
inlawrev-25507	236	83	would	would	AUX
inlawrev-25507	236	84	essentially	essentially	ADV
inlawrev-25507	236	85	be	be	AUX
inlawrev-25507	236	86	replaced	replace	VERB
inlawrev-25507	236	87	by	by	ADP
inlawrev-25507	236	88	litigation	litigation	NOUN
inlawrev-25507	236	89	between	between	ADP
inlawrev-25507	236	90	the	the	DET
inlawrev-25507	236	91	alleged	allege	VERB
inlawrev-25507	236	92	malefactor	malefactor	PROPN
inlawrev-25507	236	93	drug	drug	PROPN
inlawrev-25507	236	94	company	company	NOUN
inlawrev-25507	236	95	and	and	CCONJ
inlawrev-25507	236	96	the	the	DET
inlawrev-25507	236	97	ftc.90	ftc.90	NOUN
inlawrev-25507	236	98	in	in	ADP
inlawrev-25507	236	99	addition	addition	NOUN
inlawrev-25507	236	100	,	,	PUNCT
inlawrev-25507	236	101	manufacturers	manufacturer	NOUN
inlawrev-25507	236	102	can	can	AUX
inlawrev-25507	236	103	rebut	rebut	VERB
inlawrev-25507	236	104	evergreening	evergreene	VERB
inlawrev-25507	236	105	allegations	allegation	NOUN
inlawrev-25507	236	106	by	by	ADP
inlawrev-25507	236	107	exhibiting	exhibit	VERB
inlawrev-25507	236	108	evidence	evidence	NOUN
inlawrev-25507	236	109	of	of	ADP
inlawrev-25507	236	110	the	the	DET
inlawrev-25507	236	111	recent	recent	ADJ
inlawrev-25507	236	112	discovery	discovery	NOUN
inlawrev-25507	236	113	providing	provide	VERB
inlawrev-25507	236	114	a	a	DET
inlawrev-25507	236	115	significant	significant	ADJ
inlawrev-25507	236	116	health	health	NOUN
inlawrev-25507	236	117	benefit	benefit	NOUN
inlawrev-25507	236	118	,	,	PUNCT
inlawrev-25507	236	119	by	by	ADP
inlawrev-25507	236	120	showing	show	VERB
inlawrev-25507	236	121	that	that	SCONJ
inlawrev-25507	236	122	it	it	PRON
inlawrev-25507	236	123	is	be	AUX
inlawrev-25507	236	124	the	the	DET
inlawrev-25507	236	125	least	least	ADV
inlawrev-25507	236	126	likely	likely	ADJ
inlawrev-25507	236	127	route	route	NOUN
inlawrev-25507	236	128	to	to	PART
inlawrev-25507	236	129	reduce	reduce	VERB
inlawrev-25507	236	130	potential	potential	ADJ
inlawrev-25507	236	131	competition	competition	NOUN
inlawrev-25507	236	132	,	,	PUNCT
inlawrev-25507	236	133	and	and	CCONJ
inlawrev-25507	236	134	by	by	ADP
inlawrev-25507	236	135	showing	show	VERB
inlawrev-25507	236	136	that	that	SCONJ
inlawrev-25507	236	137	the	the	DET
inlawrev-25507	236	138	manufacturer	manufacturer	NOUN
inlawrev-25507	236	139	had	have	VERB
inlawrev-25507	236	140	financial	financial	ADJ
inlawrev-25507	236	141	motivation	motivation	NOUN
inlawrev-25507	236	142	besides	besides	SCONJ
inlawrev-25507	236	143	reducing	reduce	VERB
inlawrev-25507	236	144	competition	competition	NOUN
inlawrev-25507	236	145	to	to	PART
inlawrev-25507	236	146	patent	patent	VERB
inlawrev-25507	236	147	the	the	DET
inlawrev-25507	236	148	recent	recent	ADJ
inlawrev-25507	236	149	discovery.91	discovery.91	NOUN
inlawrev-25507	236	150	however	however	ADV
inlawrev-25507	236	151	,	,	PUNCT
inlawrev-25507	236	152	disclosures	disclosure	NOUN
inlawrev-25507	236	153	like	like	ADP
inlawrev-25507	236	154	these	these	PRON
inlawrev-25507	236	155	are	be	AUX
inlawrev-25507	236	156	usually	usually	ADV
inlawrev-25507	236	157	made	make	VERB
inlawrev-25507	236	158	at	at	ADP
inlawrev-25507	236	159	the	the	DET
inlawrev-25507	236	160	uspto	uspto	PROPN
inlawrev-25507	236	161	to	to	PART
inlawrev-25507	236	162	prove	prove	VERB
inlawrev-25507	236	163	that	that	SCONJ
inlawrev-25507	236	164	the	the	DET
inlawrev-25507	236	165	recent	recent	ADJ
inlawrev-25507	236	166	discovery	discovery	NOUN
inlawrev-25507	236	167	is	be	AUX
inlawrev-25507	236	168	non	non	ADJ
inlawrev-25507	236	169	-	-	ADJ
inlawrev-25507	236	170	obvious	obvious	ADJ
inlawrev-25507	236	171	and	and	CCONJ
inlawrev-25507	236	172	novel.92	novel.92	NOUN
inlawrev-25507	236	173	because	because	SCONJ
inlawrev-25507	236	174	similar	similar	ADJ
inlawrev-25507	236	175	information	information	NOUN
inlawrev-25507	236	176	could	could	AUX
inlawrev-25507	236	177	be	be	AUX
inlawrev-25507	236	178	used	use	VERB
inlawrev-25507	236	179	by	by	ADP
inlawrev-25507	236	180	innovation	innovation	NOUN
inlawrev-25507	236	181	companies	company	NOUN
inlawrev-25507	236	182	for	for	ADP
inlawrev-25507	236	183	both	both	DET
inlawrev-25507	236	184	patent	patent	NOUN
inlawrev-25507	236	185	prosecution	prosecution	NOUN
inlawrev-25507	236	186	and	and	CCONJ
inlawrev-25507	236	187	against	against	ADP
inlawrev-25507	236	188	an	an	DET
inlawrev-25507	236	189	antitrust	antitrust	ADJ
inlawrev-25507	236	190	suit	suit	NOUN
inlawrev-25507	236	191	,	,	PUNCT
inlawrev-25507	236	192	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	236	193	companies	company	NOUN
inlawrev-25507	236	194	are	be	AUX
inlawrev-25507	236	195	more	more	ADV
inlawrev-25507	236	196	likely	likely	ADJ
inlawrev-25507	236	197	to	to	PART
inlawrev-25507	236	198	be	be	AUX
inlawrev-25507	236	199	careful	careful	ADJ
inlawrev-25507	236	200	with	with	ADP
inlawrev-25507	236	201	their	their	PRON
inlawrev-25507	236	202	disclosures	disclosure	NOUN
inlawrev-25507	236	203	so	so	SCONJ
inlawrev-25507	236	204	as	as	SCONJ
inlawrev-25507	236	205	not	not	PART
inlawrev-25507	236	206	to	to	PART
inlawrev-25507	236	207	harm	harm	VERB
inlawrev-25507	236	208	themselves	themselves	PRON
inlawrev-25507	236	209	in	in	ADP
inlawrev-25507	236	210	an	an	DET
inlawrev-25507	236	211	antitrust	antitrust	ADJ
inlawrev-25507	236	212	suit.93	suit.93	NOUN
inlawrev-25507	236	213	additionally	additionally	ADV
inlawrev-25507	236	214	,	,	PUNCT
inlawrev-25507	236	215	the	the	DET
inlawrev-25507	236	216	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	236	217	industry	industry	NOUN
inlawrev-25507	236	218	spends	spend	VERB
inlawrev-25507	236	219	millions	million	NOUN
inlawrev-25507	236	220	of	of	ADP
inlawrev-25507	236	221	dollars	dollar	NOUN
inlawrev-25507	236	222	in	in	ADP
inlawrev-25507	236	223	researching	research	VERB
inlawrev-25507	236	224	new	new	ADJ
inlawrev-25507	236	225	uses	use	NOUN
inlawrev-25507	236	226	or	or	CCONJ
inlawrev-25507	236	227	safer	safe	ADJ
inlawrev-25507	236	228	ways	way	NOUN
inlawrev-25507	236	229	to	to	PART
inlawrev-25507	236	230	administer	administer	VERB
inlawrev-25507	236	231	known	know	VERB
inlawrev-25507	236	232	drugs.94	drugs.94	VERB
inlawrev-25507	236	233	a	a	DET
inlawrev-25507	236	234	new	new	ADJ
inlawrev-25507	236	235	use	use	NOUN
inlawrev-25507	236	236	or	or	CCONJ
inlawrev-25507	236	237	method	method	NOUN
inlawrev-25507	236	238	of	of	ADP
inlawrev-25507	236	239	administering	administer	VERB
inlawrev-25507	236	240	or	or	CCONJ
inlawrev-25507	236	241	making	make	VERB
inlawrev-25507	236	242	a	a	DET
inlawrev-25507	236	243	known	know	VERB
inlawrev-25507	236	244	drug	drug	NOUN
inlawrev-25507	236	245	should	should	AUX
inlawrev-25507	236	246	be	be	AUX
inlawrev-25507	236	247	rewarded	reward	VERB
inlawrev-25507	236	248	with	with	ADP
inlawrev-25507	236	249	a	a	DET
inlawrev-25507	236	250	patent	patent	NOUN
inlawrev-25507	236	251	;	;	PUNCT
inlawrev-25507	236	252	if	if	SCONJ
inlawrev-25507	236	253	not	not	PART
inlawrev-25507	236	254	,	,	PUNCT
inlawrev-25507	236	255	many	many	ADJ
inlawrev-25507	236	256	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	236	257	companies	company	NOUN
inlawrev-25507	236	258	will	will	AUX
inlawrev-25507	236	259	treat	treat	VERB
inlawrev-25507	236	260	the	the	DET
inlawrev-25507	236	261	discovered	discover	VERB
inlawrev-25507	236	262	drugs	drug	NOUN
inlawrev-25507	236	263	as	as	ADP
inlawrev-25507	236	264	86	86	NUM
inlawrev-25507	236	265	.	.	PUNCT
inlawrev-25507	237	1	s.	s.	PROPN
inlawrev-25507	237	2	1416	1416	NUM
inlawrev-25507	237	3	,	,	PUNCT
inlawrev-25507	237	4	affordable	affordable	ADJ
inlawrev-25507	237	5	prescriptions	prescription	NOUN
inlawrev-25507	237	6	for	for	ADP
inlawrev-25507	237	7	patients	patient	NOUN
inlawrev-25507	237	8	act	act	VERB
inlawrev-25507	237	9	of	of	ADP
inlawrev-25507	237	10	2019	2019	NUM
inlawrev-25507	237	11	,	,	PUNCT
inlawrev-25507	237	12	cong	cong	NOUN
inlawrev-25507	237	13	.	.	PUNCT
inlawrev-25507	238	1	budget	budget	NOUN
inlawrev-25507	238	2	off	off	ADP
inlawrev-25507	238	3	.	.	PUNCT
inlawrev-25507	239	1	(	(	PUNCT
inlawrev-25507	239	2	july	july	PROPN
inlawrev-25507	239	3	19	19	NUM
inlawrev-25507	239	4	,	,	PUNCT
inlawrev-25507	239	5	2019	2019	NUM
inlawrev-25507	239	6	)	)	PUNCT
inlawrev-25507	239	7	,	,	PUNCT
inlawrev-25507	239	8	https://www.cbo.gov/publication/55472	https://www.cbo.gov/publication/55472	X
inlawrev-25507	240	1	[	[	X
inlawrev-25507	240	2	https://perma.cc/np4j-tard	https://perma.cc/np4j-tard	X
inlawrev-25507	240	3	]	]	X
inlawrev-25507	240	4	.	.	PUNCT
inlawrev-25507	241	1	87	87	NUM
inlawrev-25507	241	2	.	.	PUNCT
inlawrev-25507	242	1	see	see	VERB
inlawrev-25507	242	2	sittler	sittler	PROPN
inlawrev-25507	242	3	et	et	PROPN
inlawrev-25507	242	4	al	al	PROPN
inlawrev-25507	242	5	.	.	PROPN
inlawrev-25507	242	6	,	,	PUNCT
inlawrev-25507	242	7	supra	supra	PROPN
inlawrev-25507	242	8	note	note	PROPN
inlawrev-25507	242	9	37	37	NUM
inlawrev-25507	242	10	;	;	PUNCT
inlawrev-25507	242	11	see	see	VERB
inlawrev-25507	242	12	also	also	ADV
inlawrev-25507	242	13	anna	anna	PROPN
inlawrev-25507	242	14	edney	edney	PROPN
inlawrev-25507	242	15	,	,	PUNCT
inlawrev-25507	242	16	senate	senate	PROPN
inlawrev-25507	242	17	targets	target	VERB
inlawrev-25507	242	18	hoarding	hoarding	NOUN
inlawrev-25507	242	19	of	of	ADP
inlawrev-25507	242	20	drug	drug	NOUN
inlawrev-25507	242	21	patents	patent	NOUN
inlawrev-25507	242	22	to	to	PART
inlawrev-25507	242	23	deter	deter	VERB
inlawrev-25507	242	24	competition	competition	NOUN
inlawrev-25507	242	25	,	,	PUNCT
inlawrev-25507	242	26	bloomberg	bloomberg	PROPN
inlawrev-25507	242	27	(	(	PUNCT
inlawrev-25507	242	28	may	may	PROPN
inlawrev-25507	242	29	9	9	NUM
inlawrev-25507	242	30	,	,	PUNCT
inlawrev-25507	242	31	2019	2019	NUM
inlawrev-25507	242	32	,	,	PUNCT
inlawrev-25507	242	33	2:42	2:42	NUM
inlawrev-25507	242	34	pm	pm	NOUN
inlawrev-25507	242	35	)	)	PUNCT
inlawrev-25507	242	36	,	,	PUNCT
inlawrev-25507	242	37	https://www.bloomberg.com/	https://www.bloomberg.com/	NOUN
inlawrev-25507	242	38	news	news	NOUN
inlawrev-25507	242	39	/	/	SYM
inlawrev-25507	242	40	articles/2019	articles/2019	PROPN
inlawrev-25507	242	41	-	-	PUNCT
inlawrev-25507	242	42	05	05	NUM
inlawrev-25507	242	43	-	-	PUNCT
inlawrev-25507	242	44	09	09	NUM
inlawrev-25507	242	45	/	/	SYM
inlawrev-25507	242	46	hoarding	hoarding	NOUN
inlawrev-25507	242	47	-	-	PUNCT
inlawrev-25507	242	48	drug	drug	NOUN
inlawrev-25507	242	49	-	-	PUNCT
inlawrev-25507	242	50	patents	patent	NOUN
inlawrev-25507	242	51	-	-	PUNCT
inlawrev-25507	242	52	to	to	ADP
inlawrev-25507	242	53	-	-	PUNCT
inlawrev-25507	242	54	deter	deter	VERB
inlawrev-25507	242	55	-	-	PUNCT
inlawrev-25507	242	56	competition	competition	NOUN
inlawrev-25507	242	57	-	-	PUNCT
inlawrev-25507	242	58	is	be	AUX
inlawrev-25507	242	59	-	-	PUNCT
inlawrev-25507	242	60	targeted	target	VERB
inlawrev-25507	242	61	-	-	PUNCT
inlawrev-25507	242	62	by	by	ADP
inlawrev-25507	242	63	-	-	PUNCT
inlawrev-25507	242	64	senate	senate	NOUN
inlawrev-25507	242	65	[	[	X
inlawrev-25507	242	66	https://perma.cc/l4fc-znxs	https://perma.cc/l4fc-znxs	NOUN
inlawrev-25507	242	67	]	]	X
inlawrev-25507	242	68	.	.	PUNCT
inlawrev-25507	243	1	88	88	NUM
inlawrev-25507	243	2	.	.	PUNCT
inlawrev-25507	244	1	steve	steve	PROPN
inlawrev-25507	244	2	brachmann	brachmann	PROPN
inlawrev-25507	244	3	,	,	PUNCT
inlawrev-25507	244	4	affordable	affordable	ADJ
inlawrev-25507	244	5	prescriptions	prescription	NOUN
inlawrev-25507	244	6	for	for	ADP
inlawrev-25507	244	7	patients	patient	NOUN
inlawrev-25507	244	8	act	act	VERB
inlawrev-25507	244	9	would	would	AUX
inlawrev-25507	244	10	allow	allow	VERB
inlawrev-25507	244	11	ftc	ftc	PROPN
inlawrev-25507	244	12	to	to	PART
inlawrev-25507	244	13	prosecute	prosecute	VERB
inlawrev-25507	244	14	pharma	pharma	PROPN
inlawrev-25507	244	15	patent	patent	NOUN
inlawrev-25507	244	16	thickets	thicket	NOUN
inlawrev-25507	244	17	,	,	PUNCT
inlawrev-25507	244	18	product	product	NOUN
inlawrev-25507	244	19	hopping	hopping	NOUN
inlawrev-25507	244	20	,	,	PUNCT
inlawrev-25507	244	21	ipwatchdog	ipwatchdog	PROPN
inlawrev-25507	244	22	(	(	PUNCT
inlawrev-25507	244	23	may	may	PROPN
inlawrev-25507	244	24	20	20	NUM
inlawrev-25507	244	25	,	,	PUNCT
inlawrev-25507	244	26	2019	2019	NUM
inlawrev-25507	244	27	)	)	PUNCT
inlawrev-25507	244	28	,	,	PUNCT
inlawrev-25507	244	29	https://www	https://www	PROPN
inlawrev-25507	244	30	.	.	PUNCT
inlawrev-25507	245	1	ipwatchdog.com/2019/05	ipwatchdog.com/2019/05	PROPN
inlawrev-25507	245	2	/2	/2	NUM
inlawrev-25507	245	3	0	0	NUM
inlawrev-25507	245	4	/affordable	/affordable	ADJ
inlawrev-25507	245	5	-	-	PUNCT
inlawrev-25507	245	6	prescription	prescription	NOUN
inlawrev-25507	245	7	s	s	NOUN
inlawrev-25507	245	8	-	-	PUNCT
inlawrev-25507	245	9	patients	patient	NOUN
inlawrev-25507	245	10	-	-	PUNCT
inlawrev-25507	245	11	act	act	NOUN
inlawrev-25507	245	12	-	-	PUNCT
inlawrev-25507	245	13	allow	allow	VERB
inlawrev-25507	245	14	-	-	PUNCT
inlawrev-25507	245	15	ftc	ftc	NOUN
inlawrev-25507	245	16	-	-	PUNCT
inlawrev-25507	245	17	prosecutepharmaceutical	prosecutepharmaceutical	ADJ
inlawrev-25507	245	18	-	-	PUNCT
inlawrev-25507	245	19	patent	patent	NOUN
inlawrev-25507	245	20	-	-	PUNCT
inlawrev-25507	245	21	thickets	thicket	NOUN
inlawrev-25507	245	22	-	-	PUNCT
inlawrev-25507	245	23	product	product	NOUN
inlawrev-25507	245	24	-	-	PUNCT
inlawrev-25507	245	25	hopping	hop	VERB
inlawrev-25507	245	26	/	/	SYM
inlawrev-25507	245	27	id=109384/	id=109384/	NOUN
inlawrev-25507	246	1	[	[	X
inlawrev-25507	246	2	https://perma.cc/xl3x-ejnv	https://perma.cc/xl3x-ejnv	X
inlawrev-25507	246	3	]	]	X
inlawrev-25507	246	4	[	[	X
inlawrev-25507	246	5	hereinafter	hereinafter	NOUN
inlawrev-25507	246	6	brachmann	brachmann	NOUN
inlawrev-25507	246	7	,	,	PUNCT
inlawrev-25507	246	8	affordable	affordable	ADJ
inlawrev-25507	246	9	prescriptions	prescription	NOUN
inlawrev-25507	246	10	for	for	ADP
inlawrev-25507	246	11	patients	patient	NOUN
inlawrev-25507	246	12	act	act	VERB
inlawrev-25507	246	13	]	]	PUNCT
inlawrev-25507	246	14	(	(	PUNCT
inlawrev-25507	246	15	discussing	discuss	VERB
inlawrev-25507	246	16	the	the	DET
inlawrev-25507	246	17	opinion	opinion	NOUN
inlawrev-25507	246	18	of	of	ADP
inlawrev-25507	246	19	a	a	DET
inlawrev-25507	246	20	patent	patent	NOUN
inlawrev-25507	246	21	attorney	attorney	NOUN
inlawrev-25507	246	22	that	that	PRON
inlawrev-25507	246	23	has	have	AUX
inlawrev-25507	246	24	represented	represent	VERB
inlawrev-25507	246	25	both	both	CCONJ
inlawrev-25507	246	26	branded	brand	VERB
inlawrev-25507	246	27	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	246	28	companies	company	NOUN
inlawrev-25507	246	29	and	and	CCONJ
inlawrev-25507	246	30	generic	generic	ADJ
inlawrev-25507	246	31	manufacturers	manufacturer	NOUN
inlawrev-25507	246	32	)	)	PUNCT
inlawrev-25507	246	33	.	.	PUNCT
inlawrev-25507	247	1	89	89	NUM
inlawrev-25507	247	2	.	.	PUNCT
inlawrev-25507	248	1	i	i	PRON
inlawrev-25507	248	2	d.	d.	PROPN
inlawrev-25507	248	3	90	90	NUM
inlawrev-25507	248	4	.	.	PUNCT
inlawrev-25507	249	1	i	i	PRON
inlawrev-25507	249	2	d.	d.	PROPN
inlawrev-25507	249	3	91	91	NUM
inlawrev-25507	249	4	.	.	PUNCT
inlawrev-25507	250	1	i	i	PRON
inlawrev-25507	250	2	d.	d.	PROPN
inlawrev-25507	250	3	92	92	NUM
inlawrev-25507	250	4	.	.	PUNCT
inlawrev-25507	251	1	i	i	PRON
inlawrev-25507	251	2	d.	d.	PROPN
inlawrev-25507	251	3	93	93	NUM
inlawrev-25507	251	4	.	.	PUNCT
inlawrev-25507	252	1	i	i	PRON
inlawrev-25507	252	2	d.	d.	PROPN
inlawrev-25507	252	3	94	94	NUM
inlawrev-25507	252	4	.	.	PUNCT
inlawrev-25507	253	1	i	i	PRON
inlawrev-25507	253	2	d.	d.	PROPN
inlawrev-25507	253	3	2021	2021	NUM
inlawrev-25507	253	4	]	]	PUNCT
inlawrev-25507	254	1	leaving	leave	VERB
inlawrev-25507	254	2	the	the	DET
inlawrev-25507	254	3	evergreening	evergreene	VERB
inlawrev-25507	254	4	problem	problem	NOUN
inlawrev-25507	254	5	to	to	ADP
inlawrev-25507	254	6	the	the	DET
inlawrev-25507	254	7	patent	patent	NOUN
inlawrev-25507	254	8	experts	expert	NOUN
inlawrev-25507	254	9	205	205	NUM
inlawrev-25507	254	10	“	"	PUNCT
inlawrev-25507	254	11	one	one	NUM
inlawrev-25507	254	12	-	-	PUNCT
inlawrev-25507	254	13	and	and	CCONJ
inlawrev-25507	254	14	-	-	PUNCT
inlawrev-25507	254	15	dones	done	NOUN
inlawrev-25507	254	16	.	.	PUNCT
inlawrev-25507	254	17	”9	”9	NOUN
inlawrev-25507	254	18	5	5	NUM
inlawrev-25507	254	19	patents	patent	NOUN
inlawrev-25507	254	20	are	be	AUX
inlawrev-25507	254	21	meant	mean	VERB
inlawrev-25507	254	22	to	to	PART
inlawrev-25507	254	23	be	be	AUX
inlawrev-25507	254	24	issued	issue	VERB
inlawrev-25507	254	25	for	for	ADP
inlawrev-25507	254	26	innovations	innovation	NOUN
inlawrev-25507	254	27	,	,	PUNCT
inlawrev-25507	254	28	not	not	PART
inlawrev-25507	254	29	for	for	ADP
inlawrev-25507	254	30	products.96	products.96	NOUN
inlawrev-25507	254	31	just	just	ADV
inlawrev-25507	254	32	because	because	SCONJ
inlawrev-25507	254	33	a	a	DET
inlawrev-25507	254	34	patent	patent	NOUN
inlawrev-25507	254	35	is	be	AUX
inlawrev-25507	254	36	granted	grant	VERB
inlawrev-25507	254	37	on	on	ADP
inlawrev-25507	254	38	a	a	DET
inlawrev-25507	254	39	medicine	medicine	NOUN
inlawrev-25507	254	40	does	do	AUX
inlawrev-25507	254	41	not	not	PART
inlawrev-25507	254	42	mean	mean	VERB
inlawrev-25507	254	43	that	that	SCONJ
inlawrev-25507	254	44	the	the	DET
inlawrev-25507	254	45	innovation	innovation	NOUN
inlawrev-25507	254	46	relating	relate	VERB
inlawrev-25507	254	47	to	to	ADP
inlawrev-25507	254	48	the	the	DET
inlawrev-25507	254	49	drug	drug	NOUN
inlawrev-25507	254	50	ends	end	VERB
inlawrev-25507	254	51	;	;	PUNCT
inlawrev-25507	254	52	in	in	ADP
inlawrev-25507	254	53	fact	fact	NOUN
inlawrev-25507	254	54	,	,	PUNCT
inlawrev-25507	254	55	many	many	ADJ
inlawrev-25507	254	56	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	254	57	companies	company	NOUN
inlawrev-25507	254	58	continue	continue	VERB
inlawrev-25507	254	59	to	to	PART
inlawrev-25507	254	60	research	research	VERB
inlawrev-25507	254	61	“	"	PUNCT
inlawrev-25507	254	62	new	new	ADJ
inlawrev-25507	254	63	ways	way	NOUN
inlawrev-25507	254	64	to	to	PART
inlawrev-25507	254	65	make	make	VERB
inlawrev-25507	254	66	the	the	DET
inlawrev-25507	254	67	medicine	medicine	NOUN
inlawrev-25507	254	68	,	,	PUNCT
inlawrev-25507	254	69	new	new	ADJ
inlawrev-25507	254	70	populations	population	NOUN
inlawrev-25507	254	71	who	who	PRON
inlawrev-25507	254	72	can	can	AUX
inlawrev-25507	254	73	benefit	benefit	VERB
inlawrev-25507	254	74	from	from	ADP
inlawrev-25507	254	75	its	its	PRON
inlawrev-25507	254	76	use	use	NOUN
inlawrev-25507	254	77	,	,	PUNCT
inlawrev-25507	254	78	better	well	ADJ
inlawrev-25507	254	79	ways	way	NOUN
inlawrev-25507	254	80	to	to	PART
inlawrev-25507	254	81	get	get	VERB
inlawrev-25507	254	82	it	it	PRON
inlawrev-25507	254	83	to	to	ADP
inlawrev-25507	254	84	and	and	CCONJ
inlawrev-25507	254	85	into	into	ADP
inlawrev-25507	254	86	patients	patient	NOUN
inlawrev-25507	254	87	,	,	PUNCT
inlawrev-25507	254	88	and	and	CCONJ
inlawrev-25507	254	89	new	new	ADJ
inlawrev-25507	254	90	versions	version	NOUN
inlawrev-25507	254	91	that	that	PRON
inlawrev-25507	254	92	expand	expand	VERB
inlawrev-25507	254	93	options	option	NOUN
inlawrev-25507	254	94	for	for	ADP
inlawrev-25507	254	95	patents	patent	NOUN
inlawrev-25507	254	96	.	.	PUNCT
inlawrev-25507	255	1	”97	”97	NOUN
inlawrev-25507	255	2	the	the	DET
inlawrev-25507	255	3	effect	effect	NOUN
inlawrev-25507	255	4	of	of	ADP
inlawrev-25507	255	5	this	this	DET
inlawrev-25507	255	6	legislation	legislation	NOUN
inlawrev-25507	255	7	,	,	PUNCT
inlawrev-25507	255	8	if	if	SCONJ
inlawrev-25507	255	9	enacted	enact	VERB
inlawrev-25507	255	10	,	,	PUNCT
inlawrev-25507	255	11	likely	likely	ADV
inlawrev-25507	255	12	would	would	AUX
inlawrev-25507	255	13	be	be	AUX
inlawrev-25507	255	14	to	to	PART
inlawrev-25507	255	15	focus	focus	VERB
inlawrev-25507	255	16	on	on	ADP
inlawrev-25507	255	17	lowering	lower	VERB
inlawrev-25507	255	18	the	the	DET
inlawrev-25507	255	19	price	price	NOUN
inlawrev-25507	255	20	of	of	ADP
inlawrev-25507	255	21	medicine	medicine	NOUN
inlawrev-25507	255	22	for	for	ADP
inlawrev-25507	255	23	patients	patient	NOUN
inlawrev-25507	255	24	at	at	ADP
inlawrev-25507	255	25	the	the	DET
inlawrev-25507	255	26	cost	cost	NOUN
inlawrev-25507	255	27	of	of	ADP
inlawrev-25507	255	28	denying	deny	VERB
inlawrev-25507	255	29	rightful	rightful	ADJ
inlawrev-25507	255	30	patents	patent	NOUN
inlawrev-25507	255	31	to	to	ADP
inlawrev-25507	255	32	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	255	33	companies	company	NOUN
inlawrev-25507	255	34	that	that	PRON
inlawrev-25507	255	35	could	could	AUX
inlawrev-25507	255	36	have	have	AUX
inlawrev-25507	255	37	made	make	VERB
inlawrev-25507	255	38	new	new	ADJ
inlawrev-25507	255	39	medical	medical	ADJ
inlawrev-25507	255	40	advances	advance	NOUN
inlawrev-25507	255	41	for	for	ADP
inlawrev-25507	255	42	the	the	DET
inlawrev-25507	255	43	good	good	NOUN
inlawrev-25507	255	44	of	of	ADP
inlawrev-25507	255	45	society.98	society.98	NOUN
inlawrev-25507	255	46	any	any	DET
inlawrev-25507	255	47	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	255	48	company	company	NOUN
inlawrev-25507	255	49	would	would	AUX
inlawrev-25507	255	50	be	be	AUX
inlawrev-25507	255	51	scrutinized	scrutinize	VERB
inlawrev-25507	255	52	for	for	ADP
inlawrev-25507	255	53	any	any	DET
inlawrev-25507	255	54	additional	additional	ADJ
inlawrev-25507	255	55	innovation	innovation	NOUN
inlawrev-25507	255	56	of	of	ADP
inlawrev-25507	255	57	a	a	DET
inlawrev-25507	255	58	drug	drug	NOUN
inlawrev-25507	255	59	and	and	CCONJ
inlawrev-25507	255	60	may	may	AUX
inlawrev-25507	255	61	be	be	AUX
inlawrev-25507	255	62	subject	subject	ADJ
inlawrev-25507	255	63	to	to	ADP
inlawrev-25507	255	64	penalties.99	penalties.99	NOUN
inlawrev-25507	255	65	eventually	eventually	ADV
inlawrev-25507	255	66	,	,	PUNCT
inlawrev-25507	255	67	this	this	PRON
inlawrev-25507	255	68	means	mean	VERB
inlawrev-25507	255	69	that	that	SCONJ
inlawrev-25507	255	70	the	the	DET
inlawrev-25507	255	71	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	255	72	companies	company	NOUN
inlawrev-25507	255	73	could	could	AUX
inlawrev-25507	255	74	halt	halt	VERB
inlawrev-25507	255	75	further	further	ADJ
inlawrev-25507	255	76	research	research	NOUN
inlawrev-25507	255	77	on	on	ADP
inlawrev-25507	255	78	any	any	DET
inlawrev-25507	255	79	patented	patent	VERB
inlawrev-25507	255	80	drug	drug	NOUN
inlawrev-25507	255	81	,	,	PUNCT
inlawrev-25507	255	82	even	even	ADV
inlawrev-25507	255	83	if	if	SCONJ
inlawrev-25507	255	84	there	there	PRON
inlawrev-25507	255	85	is	be	VERB
inlawrev-25507	255	86	a	a	DET
inlawrev-25507	255	87	better	well	ADJ
inlawrev-25507	255	88	,	,	PUNCT
inlawrev-25507	255	89	undiscovered	undiscovered	ADJ
inlawrev-25507	255	90	use	use	NOUN
inlawrev-25507	255	91	for	for	ADP
inlawrev-25507	255	92	that	that	DET
inlawrev-25507	255	93	drug.100	drug.100	PROPN
inlawrev-25507	255	94	if	if	SCONJ
inlawrev-25507	255	95	enacted	enact	VERB
inlawrev-25507	255	96	,	,	PUNCT
inlawrev-25507	255	97	the	the	DET
inlawrev-25507	255	98	legislation	legislation	NOUN
inlawrev-25507	255	99	could	could	AUX
inlawrev-25507	255	100	also	also	ADV
inlawrev-25507	255	101	“	"	PUNCT
inlawrev-25507	255	102	erode	erode	VERB
inlawrev-25507	255	103	[	[	X
inlawrev-25507	255	104	]	]	X
inlawrev-25507	255	105	incentives	incentive	NOUN
inlawrev-25507	255	106	and	and	CCONJ
inlawrev-25507	255	107	threaten	threaten	VERB
inlawrev-25507	255	108	[	[	X
inlawrev-25507	255	109	]	]	X
inlawrev-25507	255	110	innovation	innovation	NOUN
inlawrev-25507	255	111	,	,	PUNCT
inlawrev-25507	255	112	”	"	PUNCT
inlawrev-25507	255	113	which	which	PRON
inlawrev-25507	255	114	is	be	AUX
inlawrev-25507	255	115	what	what	PRON
inlawrev-25507	255	116	the	the	DET
inlawrev-25507	255	117	patent	patent	NOUN
inlawrev-25507	255	118	system	system	NOUN
inlawrev-25507	255	119	was	be	AUX
inlawrev-25507	255	120	created	create	VERB
inlawrev-25507	255	121	to	to	ADP
inlawrev-25507	255	122	protect.101	protect.101	PROPN
inlawrev-25507	255	123	c.	c.	NOUN
inlawrev-25507	255	124	the	the	DET
inlawrev-25507	255	125	term	term	NOUN
inlawrev-25507	255	126	act	act	VERB
inlawrev-25507	255	127	the	the	DET
inlawrev-25507	255	128	proposed	propose	VERB
inlawrev-25507	255	129	term	term	NOUN
inlawrev-25507	255	130	act	act	NOUN
inlawrev-25507	255	131	aims	aim	VERB
inlawrev-25507	255	132	to	to	PART
inlawrev-25507	255	133	lower	lower	VERB
inlawrev-25507	255	134	drug	drug	NOUN
inlawrev-25507	255	135	prices	price	NOUN
inlawrev-25507	255	136	and	and	CCONJ
inlawrev-25507	255	137	reduce	reduce	VERB
inlawrev-25507	255	138	the	the	DET
inlawrev-25507	255	139	evergreening	evergreening	NOUN
inlawrev-25507	255	140	problem	problem	NOUN
inlawrev-25507	255	141	by	by	ADP
inlawrev-25507	255	142	shifting	shift	VERB
inlawrev-25507	255	143	the	the	DET
inlawrev-25507	255	144	burden	burden	NOUN
inlawrev-25507	255	145	of	of	ADP
inlawrev-25507	255	146	proving	prove	VERB
inlawrev-25507	255	147	why	why	SCONJ
inlawrev-25507	255	148	a	a	DET
inlawrev-25507	255	149	new	new	ADJ
inlawrev-25507	255	150	patent	patent	NOUN
inlawrev-25507	255	151	on	on	ADP
inlawrev-25507	255	152	a	a	DET
inlawrev-25507	255	153	known	know	VERB
inlawrev-25507	255	154	drug	drug	NOUN
inlawrev-25507	255	155	should	should	AUX
inlawrev-25507	255	156	be	be	AUX
inlawrev-25507	255	157	granted.102	granted.102	NOUN
inlawrev-25507	255	158	specifically	specifically	ADV
inlawrev-25507	255	159	,	,	PUNCT
inlawrev-25507	255	160	the	the	DET
inlawrev-25507	255	161	act	act	NOUN
inlawrev-25507	255	162	aims	aim	VERB
inlawrev-25507	255	163	to	to	PART
inlawrev-25507	255	164	prevent	prevent	VERB
inlawrev-25507	255	165	innovator	innovator	NOUN
inlawrev-25507	255	166	companies	company	NOUN
inlawrev-25507	255	167	from	from	ADP
inlawrev-25507	255	168	evergreening.1	evergreening.1	PROPN
inlawrev-25507	255	169	0	0	NUM
inlawrev-25507	255	170	3	3	NUM
inlawrev-25507	255	171	this	this	DET
inlawrev-25507	255	172	bipartisan	bipartisan	ADJ
inlawrev-25507	255	173	legislation	legislation	NOUN
inlawrev-25507	255	174	would	would	AUX
inlawrev-25507	255	175	create	create	VERB
inlawrev-25507	255	176	a	a	DET
inlawrev-25507	255	177	presumption	presumption	NOUN
inlawrev-25507	255	178	that	that	SCONJ
inlawrev-25507	255	179	“	"	PUNCT
inlawrev-25507	255	180	a	a	DET
inlawrev-25507	255	181	patentee	patentee	NOUN
inlawrev-25507	255	182	has	have	AUX
inlawrev-25507	255	183	disclaimed	disclaim	VERB
inlawrev-25507	255	184	the	the	DET
inlawrev-25507	255	185	portion	portion	NOUN
inlawrev-25507	255	186	of	of	ADP
inlawrev-25507	255	187	any	any	DET
inlawrev-25507	255	188	patent	patent	NOUN
inlawrev-25507	255	189	term	term	NOUN
inlawrev-25507	255	190	that	that	PRON
inlawrev-25507	255	191	extends	extend	VERB
inlawrev-25507	255	192	beyond	beyond	ADP
inlawrev-25507	255	193	the	the	DET
inlawrev-25507	255	194	term	term	NOUN
inlawrev-25507	255	195	of	of	ADP
inlawrev-25507	255	196	the	the	DET
inlawrev-25507	255	197	earliest	early	ADV
inlawrev-25507	255	198	-	-	PUNCT
inlawrev-25507	255	199	expiring	expire	VERB
inlawrev-25507	255	200	patent	patent	NOUN
inlawrev-25507	255	201	.	.	PUNCT
inlawrev-25507	256	1	”104	”104	PROPN
inlawrev-25507	256	2	currently	currently	ADV
inlawrev-25507	256	3	,	,	PUNCT
inlawrev-25507	256	4	generic	generic	PROPN
inlawrev-25507	256	5	95	95	NUM
inlawrev-25507	256	6	.	.	PUNCT
inlawrev-25507	257	1	i	i	PRON
inlawrev-25507	257	2	d.	d.	PROPN
inlawrev-25507	257	3	96	96	NUM
inlawrev-25507	257	4	.	.	PUNCT
inlawrev-25507	258	1	tom	tom	PROPN
inlawrev-25507	258	2	giovanetti	giovanetti	VERB
inlawrev-25507	258	3	et	et	PROPN
inlawrev-25507	258	4	al	al	PROPN
inlawrev-25507	258	5	.	.	PROPN
inlawrev-25507	258	6	,	,	PUNCT
inlawrev-25507	258	7	coalition	coalition	NOUN
inlawrev-25507	258	8	letter	letter	NOUN
inlawrev-25507	258	9	expressing	express	VERB
inlawrev-25507	258	10	concerns	concern	NOUN
inlawrev-25507	258	11	with	with	ADP
inlawrev-25507	258	12	s.1416	s.1416	NOUN
inlawrev-25507	258	13	,	,	PUNCT
inlawrev-25507	258	14	the	the	DET
inlawrev-25507	258	15	“	"	PUNCT
inlawrev-25507	258	16	affordable	affordable	ADJ
inlawrev-25507	258	17	prescriptions	prescription	NOUN
inlawrev-25507	258	18	for	for	ADP
inlawrev-25507	258	19	patients	patient	NOUN
inlawrev-25507	258	20	act	act	VERB
inlawrev-25507	258	21	of	of	ADP
inlawrev-25507	258	22	2019	2019	NUM
inlawrev-25507	258	23	”	"	PUNCT
inlawrev-25507	258	24	,	,	PUNCT
inlawrev-25507	258	25	inst	inst	PROPN
inlawrev-25507	258	26	.	.	PROPN
inlawrev-25507	259	1	for	for	ADP
inlawrev-25507	259	2	pol’y	pol’y	NOUN
inlawrev-25507	259	3	innovation	innovation	NOUN
inlawrev-25507	259	4	(	(	PUNCT
inlawrev-25507	259	5	june	june	PROPN
inlawrev-25507	259	6	25	25	NUM
inlawrev-25507	259	7	,	,	PUNCT
inlawrev-25507	259	8	2019	2019	NUM
inlawrev-25507	259	9	)	)	PUNCT
inlawrev-25507	259	10	,	,	PUNCT
inlawrev-25507	259	11	https://www.ipi.org/ipi_issues/detail/coalition-letter-expressing-concerns-with-s1416-theaffordable-prescriptions-for-patients-act-of-2019	https://www.ipi.org/ipi_issues/detail/coalition-letter-expressing-concerns-with-s1416-theaffordable-prescriptions-for-patients-act-of-2019	X
inlawrev-25507	260	1	[	[	X
inlawrev-25507	260	2	https://perma.cc/l4u9-mavp	https://perma.cc/l4u9-mavp	VERB
inlawrev-25507	260	3	]	]	PUNCT
inlawrev-25507	260	4	.	.	PUNCT
inlawrev-25507	261	1	97	97	NUM
inlawrev-25507	261	2	.	.	PUNCT
inlawrev-25507	262	1	see	see	VERB
inlawrev-25507	262	2	i	i	PROPN
inlawrev-25507	262	3	d.	d.	PROPN
inlawrev-25507	262	4	;	;	PUNCT
inlawrev-25507	262	5	brachmann	brachmann	PROPN
inlawrev-25507	262	6	,	,	PUNCT
inlawrev-25507	262	7	affordable	affordable	ADJ
inlawrev-25507	262	8	prescriptions	prescription	NOUN
inlawrev-25507	262	9	for	for	ADP
inlawrev-25507	262	10	patients	patient	NOUN
inlawrev-25507	262	11	act	act	VERB
inlawrev-25507	262	12	,	,	PUNCT
inlawrev-25507	262	13	supra	supra	PROPN
inlawrev-25507	262	14	note	note	NOUN
inlawrev-25507	262	15	88	88	NUM
inlawrev-25507	262	16	.	.	PUNCT
inlawrev-25507	263	1	98	98	NUM
inlawrev-25507	263	2	.	.	PUNCT
inlawrev-25507	264	1	brachmann	brachmann	PROPN
inlawrev-25507	264	2	,	,	PUNCT
inlawrev-25507	264	3	affordable	affordable	ADJ
inlawrev-25507	264	4	prescriptions	prescription	NOUN
inlawrev-25507	264	5	for	for	ADP
inlawrev-25507	264	6	patients	patient	NOUN
inlawrev-25507	264	7	act	act	VERB
inlawrev-25507	264	8	,	,	PUNCT
inlawrev-25507	264	9	supra	supra	PROPN
inlawrev-25507	264	10	note	note	NOUN
inlawrev-25507	264	11	88	88	NUM
inlawrev-25507	264	12	.	.	PUNCT
inlawrev-25507	264	13	99	99	NUM
inlawrev-25507	264	14	.	.	PUNCT
inlawrev-25507	265	1	giovanetti	giovanetti	VERB
inlawrev-25507	265	2	et	et	PROPN
inlawrev-25507	265	3	al	al	PROPN
inlawrev-25507	265	4	.	.	PROPN
inlawrev-25507	265	5	,	,	PUNCT
inlawrev-25507	265	6	supra	supra	PROPN
inlawrev-25507	265	7	note	note	VERB
inlawrev-25507	265	8	96	96	NUM
inlawrev-25507	265	9	.	.	NOUN
inlawrev-25507	265	10	100	100	NUM
inlawrev-25507	265	11	.	.	PUNCT
inlawrev-25507	266	1	see	see	VERB
inlawrev-25507	266	2	brachmann	brachmann	NOUN
inlawrev-25507	266	3	,	,	PUNCT
inlawrev-25507	266	4	affordable	affordable	ADJ
inlawrev-25507	266	5	prescriptions	prescription	NOUN
inlawrev-25507	266	6	for	for	ADP
inlawrev-25507	266	7	patients	patient	NOUN
inlawrev-25507	266	8	act	act	VERB
inlawrev-25507	266	9	,	,	PUNCT
inlawrev-25507	266	10	supra	supra	PROPN
inlawrev-25507	266	11	note	note	NOUN
inlawrev-25507	266	12	88	88	NUM
inlawrev-25507	266	13	.	.	PUNCT
inlawrev-25507	267	1	101	101	NUM
inlawrev-25507	267	2	.	.	PUNCT
inlawrev-25507	268	1	giovanetti	giovanetti	VERB
inlawrev-25507	268	2	et	et	PROPN
inlawrev-25507	268	3	al	al	PROPN
inlawrev-25507	268	4	.	.	PROPN
inlawrev-25507	268	5	,	,	PUNCT
inlawrev-25507	268	6	supra	supra	PROPN
inlawrev-25507	268	7	note	note	VERB
inlawrev-25507	268	8	96	96	NUM
inlawrev-25507	268	9	.	.	NOUN
inlawrev-25507	269	1	102	102	NUM
inlawrev-25507	269	2	.	.	PUNCT
inlawrev-25507	270	1	rep	rep	PROPN
inlawrev-25507	270	2	.	.	PROPN
inlawrev-25507	270	3	jeffries	jeffries	PROPN
inlawrev-25507	270	4	introduces	introduce	VERB
inlawrev-25507	270	5	bipartisan	bipartisan	ADJ
inlawrev-25507	270	6	legislation	legislation	NOUN
inlawrev-25507	270	7	to	to	PART
inlawrev-25507	270	8	lower	lower	VERB
inlawrev-25507	270	9	skyrocketing	skyrocket	VERB
inlawrev-25507	270	10	cost	cost	NOUN
inlawrev-25507	270	11	of	of	ADP
inlawrev-25507	270	12	prescription	prescription	NOUN
inlawrev-25507	270	13	drugs	drug	NOUN
inlawrev-25507	270	14	,	,	PUNCT
inlawrev-25507	270	15	u.s	u.s	PROPN
inlawrev-25507	270	16	.	.	PROPN
inlawrev-25507	270	17	congressman	congressman	PROPN
inlawrev-25507	270	18	hakeem	hakeem	VERB
inlawrev-25507	270	19	jeffries	jeffrie	NOUN
inlawrev-25507	270	20	for	for	ADP
inlawrev-25507	270	21	8th	8th	ADJ
inlawrev-25507	270	22	district	district	PROPN
inlawrev-25507	270	23	n.y	n.y	PROPN
inlawrev-25507	270	24	.	.	PROPN
inlawrev-25507	271	1	(	(	PUNCT
inlawrev-25507	271	2	june	june	PROPN
inlawrev-25507	271	3	12	12	NUM
inlawrev-25507	271	4	,	,	PUNCT
inlawrev-25507	271	5	2019	2019	NUM
inlawrev-25507	271	6	)	)	PUNCT
inlawrev-25507	271	7	,	,	PUNCT
inlawrev-25507	271	8	https://jeffries.house.gov/media-center/press-releases/reps-jeffries-collins-introducebipartisan-legislation-to-lower	https://jeffries.house.gov/media-center/press-releases/reps-jeffries-collins-introducebipartisan-legislation-to-lower	X
inlawrev-25507	272	1	[	[	X
inlawrev-25507	272	2	https://perma.cc/hy5w-bpcg	https://perma.cc/hy5w-bpcg	X
inlawrev-25507	272	3	]	]	X
inlawrev-25507	272	4	[	[	X
inlawrev-25507	272	5	hereinafter	hereinafter	NOUN
inlawrev-25507	272	6	bipartisan	bipartisan	ADJ
inlawrev-25507	272	7	legislation	legislation	NOUN
inlawrev-25507	272	8	]	]	PUNCT
inlawrev-25507	272	9	.	.	PUNCT
inlawrev-25507	273	1	103	103	NUM
inlawrev-25507	273	2	.	.	PUNCT
inlawrev-25507	274	1	i	i	PRON
inlawrev-25507	274	2	d.	d.	PROPN
inlawrev-25507	274	3	;	;	PUNCT
inlawrev-25507	274	4	todd	todd	PROPN
inlawrev-25507	274	5	s.	s.	PROPN
inlawrev-25507	274	6	werner	werner	PROPN
inlawrev-25507	274	7	,	,	PUNCT
inlawrev-25507	274	8	term	term	NOUN
inlawrev-25507	274	9	act	act	NOUN
inlawrev-25507	274	10	would	would	AUX
inlawrev-25507	274	11	presume	presume	VERB
inlawrev-25507	274	12	all	all	DET
inlawrev-25507	274	13	patents	patent	NOUN
inlawrev-25507	274	14	covering	cover	VERB
inlawrev-25507	274	15	a	a	DET
inlawrev-25507	274	16	branded	brand	VERB
inlawrev-25507	274	17	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	274	18	product	product	NOUN
inlawrev-25507	274	19	are	be	AUX
inlawrev-25507	274	20	not	not	PART
inlawrev-25507	274	21	patentably	patentably	ADV
inlawrev-25507	274	22	distinct	distinct	ADJ
inlawrev-25507	274	23	,	,	PUNCT
inlawrev-25507	274	24	carlson	carlson	PROPN
inlawrev-25507	274	25	caspers	caspers	PROPN
inlawrev-25507	274	26	(	(	PUNCT
inlawrev-25507	274	27	june	june	PROPN
inlawrev-25507	274	28	29	29	NUM
inlawrev-25507	274	29	,	,	PUNCT
inlawrev-25507	274	30	2019	2019	NUM
inlawrev-25507	274	31	)	)	PUNCT
inlawrev-25507	274	32	,	,	PUNCT
inlawrev-25507	274	33	https://www.carlsoncaspers.com/term-act-would-presume-all-patents-covering-a-brandedpharmaceutical-product-are-not-patentably-distinct/	https://www.carlsoncaspers.com/term-act-would-presume-all-patents-covering-a-brandedpharmaceutical-product-are-not-patentably-distinct/	X
inlawrev-25507	275	1	[	[	X
inlawrev-25507	275	2	https://perma.cc/b6pc-nyyd	https://perma.cc/b6pc-nyyd	X
inlawrev-25507	275	3	]	]	X
inlawrev-25507	275	4	.	.	PUNCT
inlawrev-25507	276	1	104	104	NUM
inlawrev-25507	276	2	.	.	PUNCT
inlawrev-25507	277	1	jonathan	jonathan	PROPN
inlawrev-25507	277	2	bachand	bachand	PROPN
inlawrev-25507	277	3	&	&	CCONJ
inlawrev-25507	277	4	cassie	cassie	PROPN
inlawrev-25507	277	5	gourash	gourash	PROPN
inlawrev-25507	277	6	,	,	PUNCT
inlawrev-25507	277	7	“	"	PUNCT
inlawrev-25507	277	8	term	term	NOUN
inlawrev-25507	277	9	act	act	NOUN
inlawrev-25507	277	10	of	of	ADP
inlawrev-25507	277	11	2019	2019	NUM
inlawrev-25507	277	12	”	"	PUNCT
inlawrev-25507	277	13	proposes	propose	VERB
inlawrev-25507	277	14	shifting	shift	VERB
inlawrev-25507	277	15	patent	patent	NOUN
inlawrev-25507	277	16	challenge	challenge	NOUN
inlawrev-25507	277	17	burdens	burden	NOUN
inlawrev-25507	277	18	to	to	ADP
inlawrev-25507	277	19	branded	brand	VERB
inlawrev-25507	277	20	companies	company	NOUN
inlawrev-25507	277	21	,	,	PUNCT
inlawrev-25507	277	22	knobbe	knobbe	NOUN
inlawrev-25507	277	23	martens	marten	NOUN
inlawrev-25507	277	24	(	(	PUNCT
inlawrev-25507	277	25	june	june	PROPN
inlawrev-25507	277	26	18	18	NUM
inlawrev-25507	277	27	,	,	PUNCT
inlawrev-25507	277	28	2019	2019	NUM
inlawrev-25507	277	29	)	)	PUNCT
inlawrev-25507	277	30	,	,	PUNCT
inlawrev-25507	277	31	https://www	https://www	PROPN
inlawrev-25507	277	32	.	.	PUNCT
inlawrev-25507	278	1	knobbe.com/news/2019/06/%e2%80%9cterm-act-2019%e2%80%9d-proposes-shifting-patent206	knobbe.com/news/2019/06/%e2%80%9cterm-act-2019%e2%80%9d-proposes-shifting-patent206	PROPN
inlawrev-25507	278	2	indiana	indiana	PROPN
inlawrev-25507	278	3	law	law	PROPN
inlawrev-25507	278	4	review	review	NOUN
inlawrev-25507	279	1	[	[	X
inlawrev-25507	279	2	vol	vol	NOUN
inlawrev-25507	279	3	.	.	PUNCT
inlawrev-25507	280	1	54:195	54:195	NUM
inlawrev-25507	280	2	drug	drug	NOUN
inlawrev-25507	280	3	manufacturers	manufacturer	NOUN
inlawrev-25507	280	4	bear	bear	VERB
inlawrev-25507	280	5	the	the	DET
inlawrev-25507	280	6	burden	burden	NOUN
inlawrev-25507	280	7	and	and	CCONJ
inlawrev-25507	280	8	generally	generally	ADV
inlawrev-25507	280	9	aim	aim	VERB
inlawrev-25507	280	10	to	to	PART
inlawrev-25507	280	11	prove	prove	VERB
inlawrev-25507	280	12	why	why	SCONJ
inlawrev-25507	280	13	a	a	DET
inlawrev-25507	280	14	new	new	ADJ
inlawrev-25507	280	15	patent	patent	NOUN
inlawrev-25507	280	16	should	should	AUX
inlawrev-25507	280	17	not	not	PART
inlawrev-25507	280	18	be	be	AUX
inlawrev-25507	280	19	granted.105	granted.105	NOUN
inlawrev-25507	280	20	finally	finally	ADV
inlawrev-25507	280	21	,	,	PUNCT
inlawrev-25507	280	22	the	the	DET
inlawrev-25507	280	23	bill	bill	NOUN
inlawrev-25507	280	24	would	would	AUX
inlawrev-25507	280	25	instruct	instruct	VERB
inlawrev-25507	280	26	the	the	DET
inlawrev-25507	280	27	uspto	uspto	NOUN
inlawrev-25507	280	28	to	to	PART
inlawrev-25507	280	29	reevaluate	reevaluate	VERB
inlawrev-25507	280	30	its	its	PRON
inlawrev-25507	280	31	examination	examination	NOUN
inlawrev-25507	280	32	procedures	procedure	NOUN
inlawrev-25507	280	33	for	for	ADP
inlawrev-25507	280	34	patents	patent	NOUN
inlawrev-25507	280	35	relating	relate	VERB
inlawrev-25507	280	36	to	to	ADP
inlawrev-25507	280	37	the	the	DET
inlawrev-25507	280	38	same	same	ADJ
inlawrev-25507	280	39	drug	drug	NOUN
inlawrev-25507	280	40	or	or	CCONJ
inlawrev-25507	280	41	biological	biological	ADJ
inlawrev-25507	280	42	product	product	NOUN
inlawrev-25507	280	43	and	and	CCONJ
inlawrev-25507	280	44	“	"	PUNCT
inlawrev-25507	280	45	determine	determine	VERB
inlawrev-25507	280	46	whether	whether	SCONJ
inlawrev-25507	280	47	improvements	improvement	NOUN
inlawrev-25507	280	48	can	can	AUX
inlawrev-25507	280	49	be	be	AUX
inlawrev-25507	280	50	made	make	VERB
inlawrev-25507	280	51	to	to	PART
inlawrev-25507	280	52	reduce	reduce	VERB
inlawrev-25507	280	53	instances	instance	NOUN
inlawrev-25507	280	54	of	of	ADP
inlawrev-25507	280	55	double	double	ADJ
inlawrev-25507	280	56	patenting	patenting	NOUN
inlawrev-25507	280	57	.	.	PUNCT
inlawrev-25507	280	58	”106	”106	PUNCT
inlawrev-25507	281	1	the	the	DET
inlawrev-25507	281	2	apparent	apparent	ADJ
inlawrev-25507	281	3	purpose	purpose	NOUN
inlawrev-25507	281	4	of	of	ADP
inlawrev-25507	281	5	the	the	DET
inlawrev-25507	281	6	term	term	NOUN
inlawrev-25507	281	7	act	act	NOUN
inlawrev-25507	281	8	is	be	AUX
inlawrev-25507	281	9	to	to	PART
inlawrev-25507	281	10	reduce	reduce	VERB
inlawrev-25507	281	11	“	"	PUNCT
inlawrev-25507	281	12	patent	patent	NOUN
inlawrev-25507	281	13	abuses	abuse	NOUN
inlawrev-25507	281	14	in	in	ADP
inlawrev-25507	281	15	order	order	NOUN
inlawrev-25507	281	16	to	to	PART
inlawrev-25507	281	17	expedite	expedite	VERB
inlawrev-25507	281	18	the	the	DET
inlawrev-25507	281	19	entrance	entrance	NOUN
inlawrev-25507	281	20	of	of	ADP
inlawrev-25507	281	21	lower	low	ADJ
inlawrev-25507	281	22	cost	cost	NOUN
inlawrev-25507	281	23	generic	generic	ADJ
inlawrev-25507	281	24	drugs	drug	NOUN
inlawrev-25507	281	25	to	to	ADP
inlawrev-25507	281	26	market	market	NOUN
inlawrev-25507	281	27	.	.	PUNCT
inlawrev-25507	281	28	”107	”107	PUNCT
inlawrev-25507	282	1	like	like	ADP
inlawrev-25507	282	2	the	the	DET
inlawrev-25507	282	3	app	app	PROPN
inlawrev-25507	282	4	act	act	PROPN
inlawrev-25507	282	5	,	,	PUNCT
inlawrev-25507	282	6	if	if	SCONJ
inlawrev-25507	282	7	enacted	enact	VERB
inlawrev-25507	282	8	,	,	PUNCT
inlawrev-25507	282	9	the	the	DET
inlawrev-25507	282	10	term	term	NOUN
inlawrev-25507	282	11	act	act	NOUN
inlawrev-25507	282	12	would	would	AUX
inlawrev-25507	282	13	impair	impair	VERB
inlawrev-25507	282	14	innovation	innovation	NOUN
inlawrev-25507	282	15	on	on	ADP
inlawrev-25507	282	16	known	know	VERB
inlawrev-25507	282	17	medicines.108	medicines.108	NOUN
inlawrev-25507	282	18	procedurally	procedurally	ADV
inlawrev-25507	282	19	,	,	PUNCT
inlawrev-25507	282	20	the	the	DET
inlawrev-25507	282	21	act	act	NOUN
inlawrev-25507	282	22	would	would	AUX
inlawrev-25507	282	23	create	create	VERB
inlawrev-25507	282	24	“	"	PUNCT
inlawrev-25507	282	25	a	a	DET
inlawrev-25507	282	26	default	default	NOUN
inlawrev-25507	282	27	forfeiture	forfeiture	NOUN
inlawrev-25507	282	28	of	of	ADP
inlawrev-25507	282	29	serial	serial	ADJ
inlawrev-25507	282	30	patent	patent	NOUN
inlawrev-25507	282	31	terms	term	NOUN
inlawrev-25507	282	32	”	"	PUNCT
inlawrev-25507	282	33	and	and	CCONJ
inlawrev-25507	282	34	would	would	AUX
inlawrev-25507	282	35	presume	presume	VERB
inlawrev-25507	282	36	that	that	SCONJ
inlawrev-25507	282	37	obviousness	obviousness	NOUN
inlawrev-25507	282	38	-	-	PUNCT
inlawrev-25507	282	39	type	type	NOUN
inlawrev-25507	282	40	double	double	ADJ
inlawrev-25507	282	41	patenting	patenting	NOUN
inlawrev-25507	282	42	exists	exist	VERB
inlawrev-25507	282	43	unless	unless	SCONJ
inlawrev-25507	282	44	the	the	DET
inlawrev-25507	282	45	patentee	patentee	NOUN
inlawrev-25507	282	46	proves	prove	VERB
inlawrev-25507	282	47	otherwise	otherwise	ADV
inlawrev-25507	282	48	,	,	PUNCT
inlawrev-25507	282	49	even	even	ADV
inlawrev-25507	282	50	though	though	SCONJ
inlawrev-25507	282	51	current	current	ADJ
inlawrev-25507	282	52	patent	patent	NOUN
inlawrev-25507	282	53	law	law	NOUN
inlawrev-25507	282	54	places	place	VERB
inlawrev-25507	282	55	the	the	DET
inlawrev-25507	282	56	burden	burden	NOUN
inlawrev-25507	282	57	of	of	ADP
inlawrev-25507	282	58	proof	proof	NOUN
inlawrev-25507	282	59	of	of	ADP
inlawrev-25507	282	60	obviousness	obviousness	NOUN
inlawrev-25507	282	61	-	-	PUNCT
inlawrev-25507	282	62	type	type	NOUN
inlawrev-25507	282	63	double	double	ADJ
inlawrev-25507	282	64	patenting	patenting	NOUN
inlawrev-25507	282	65	on	on	ADP
inlawrev-25507	282	66	the	the	DET
inlawrev-25507	282	67	examiner	examiner	NOUN
inlawrev-25507	282	68	or	or	CCONJ
inlawrev-25507	282	69	challenger	challenger	NOUN
inlawrev-25507	282	70	of	of	ADP
inlawrev-25507	282	71	the	the	DET
inlawrev-25507	282	72	patent.109	patent.109	NOUN
inlawrev-25507	282	73	additionally	additionally	ADV
inlawrev-25507	282	74	,	,	PUNCT
inlawrev-25507	282	75	the	the	DET
inlawrev-25507	282	76	bill	bill	NOUN
inlawrev-25507	282	77	presumes	presume	VERB
inlawrev-25507	282	78	that	that	SCONJ
inlawrev-25507	282	79	the	the	DET
inlawrev-25507	282	80	uspto	uspto	NOUN
inlawrev-25507	282	81	and	and	CCONJ
inlawrev-25507	282	82	its	its	PRON
inlawrev-25507	282	83	examiners	examiner	NOUN
inlawrev-25507	282	84	are	be	AUX
inlawrev-25507	282	85	neglecting	neglect	VERB
inlawrev-25507	282	86	their	their	PRON
inlawrev-25507	282	87	duties	duty	NOUN
inlawrev-25507	282	88	to	to	PART
inlawrev-25507	282	89	present	present	VERB
inlawrev-25507	282	90	obviousness	obviousness	ADJ
inlawrev-25507	282	91	rejections	rejection	NOUN
inlawrev-25507	282	92	to	to	PART
inlawrev-25507	282	93	patentees.110	patentees.110	VERB
inlawrev-25507	282	94	further	far	ADV
inlawrev-25507	282	95	,	,	PUNCT
inlawrev-25507	282	96	many	many	ADJ
inlawrev-25507	282	97	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	282	98	companies	company	NOUN
inlawrev-25507	282	99	already	already	ADV
inlawrev-25507	282	100	settle	settle	VERB
inlawrev-25507	282	101	for	for	ADP
inlawrev-25507	282	102	terminal	terminal	ADJ
inlawrev-25507	282	103	disclaimers	disclaimer	NOUN
inlawrev-25507	282	104	when	when	SCONJ
inlawrev-25507	282	105	given	give	VERB
inlawrev-25507	282	106	obviousness	obviousness	ADJ
inlawrev-25507	282	107	-	-	PUNCT
inlawrev-25507	282	108	type	type	NOUN
inlawrev-25507	282	109	double	double	ADJ
inlawrev-25507	282	110	patenting	patenting	NOUN
inlawrev-25507	282	111	rejections.111	rejections.111	NOUN
inlawrev-25507	282	112	the	the	DET
inlawrev-25507	282	113	act	act	NOUN
inlawrev-25507	282	114	shows	show	VERB
inlawrev-25507	282	115	how	how	SCONJ
inlawrev-25507	282	116	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	282	117	companies	company	NOUN
inlawrev-25507	282	118	receive	receive	VERB
inlawrev-25507	282	119	scrutiny	scrutiny	NOUN
inlawrev-25507	282	120	in	in	ADP
inlawrev-25507	282	121	terms	term	NOUN
inlawrev-25507	282	122	of	of	ADP
inlawrev-25507	282	123	their	their	PRON
inlawrev-25507	282	124	patent	patent	NOUN
inlawrev-25507	282	125	strategies	strategy	NOUN
inlawrev-25507	282	126	for	for	ADP
inlawrev-25507	282	127	the	the	DET
inlawrev-25507	282	128	high	high	ADJ
inlawrev-25507	282	129	costs	cost	NOUN
inlawrev-25507	282	130	of	of	ADP
inlawrev-25507	282	131	medicines	medicine	NOUN
inlawrev-25507	282	132	,	,	PUNCT
inlawrev-25507	282	133	but	but	CCONJ
inlawrev-25507	282	134	other	other	ADJ
inlawrev-25507	282	135	fields	field	NOUN
inlawrev-25507	282	136	such	such	ADJ
inlawrev-25507	282	137	as	as	ADP
inlawrev-25507	282	138	pharmacy	pharmacy	NOUN
inlawrev-25507	282	139	benefit	benefit	NOUN
inlawrev-25507	282	140	managers	manager	NOUN
inlawrev-25507	282	141	and	and	CCONJ
inlawrev-25507	282	142	insurance	insurance	NOUN
inlawrev-25507	282	143	companies	company	NOUN
inlawrev-25507	282	144	do	do	AUX
inlawrev-25507	282	145	not.112	not.112	VERB
inlawrev-25507	282	146	further	far	ADV
inlawrev-25507	282	147	,	,	PUNCT
inlawrev-25507	282	148	placing	place	VERB
inlawrev-25507	282	149	the	the	DET
inlawrev-25507	282	150	burden	burden	NOUN
inlawrev-25507	282	151	of	of	ADP
inlawrev-25507	282	152	proof	proof	NOUN
inlawrev-25507	282	153	on	on	ADP
inlawrev-25507	282	154	the	the	DET
inlawrev-25507	282	155	generic	generic	ADJ
inlawrev-25507	282	156	company	company	NOUN
inlawrev-25507	282	157	is	be	AUX
inlawrev-25507	282	158	necessary	necessary	ADJ
inlawrev-25507	282	159	since	since	SCONJ
inlawrev-25507	282	160	not	not	PART
inlawrev-25507	282	161	every	every	DET
inlawrev-25507	282	162	patent	patent	NOUN
inlawrev-25507	282	163	on	on	ADP
inlawrev-25507	282	164	a	a	DET
inlawrev-25507	282	165	drug	drug	NOUN
inlawrev-25507	282	166	is	be	AUX
inlawrev-25507	282	167	called	call	VERB
inlawrev-25507	282	168	to	to	PART
inlawrev-25507	282	169	be	be	AUX
inlawrev-25507	282	170	invalidated	invalidated	ADJ
inlawrev-25507	282	171	;	;	PUNCT
inlawrev-25507	282	172	generic	generic	ADJ
inlawrev-25507	282	173	manufacturers	manufacturer	NOUN
inlawrev-25507	282	174	generally	generally	ADV
inlawrev-25507	282	175	try	try	VERB
inlawrev-25507	282	176	to	to	PART
inlawrev-25507	282	177	invalidate	invalidate	VERB
inlawrev-25507	282	178	a	a	DET
inlawrev-25507	282	179	patent	patent	NOUN
inlawrev-25507	282	180	if	if	SCONJ
inlawrev-25507	282	181	(	(	PUNCT
inlawrev-25507	282	182	1	1	X
inlawrev-25507	282	183	)	)	PUNCT
inlawrev-25507	282	184	they	they	PRON
inlawrev-25507	282	185	want	want	VERB
inlawrev-25507	282	186	to	to	PART
inlawrev-25507	282	187	enter	enter	VERB
inlawrev-25507	282	188	the	the	DET
inlawrev-25507	282	189	particular	particular	ADJ
inlawrev-25507	282	190	market	market	NOUN
inlawrev-25507	282	191	before	before	SCONJ
inlawrev-25507	282	192	the	the	DET
inlawrev-25507	282	193	patent	patent	NOUN
inlawrev-25507	282	194	in	in	ADP
inlawrev-25507	282	195	question	question	NOUN
inlawrev-25507	282	196	expires	expire	NOUN
inlawrev-25507	282	197	,	,	PUNCT
inlawrev-25507	282	198	and	and	CCONJ
inlawrev-25507	282	199	(	(	PUNCT
inlawrev-25507	282	200	2	2	X
inlawrev-25507	282	201	)	)	PUNCT
inlawrev-25507	282	202	it	it	PRON
inlawrev-25507	282	203	is	be	AUX
inlawrev-25507	282	204	impossible	impossible	ADJ
inlawrev-25507	282	205	to	to	PART
inlawrev-25507	282	206	sell	sell	VERB
inlawrev-25507	282	207	the	the	DET
inlawrev-25507	282	208	drug	drug	NOUN
inlawrev-25507	282	209	without	without	ADP
inlawrev-25507	282	210	infringing	infringe	VERB
inlawrev-25507	282	211	the	the	DET
inlawrev-25507	282	212	patent.113	patent.113	NOUN
inlawrev-25507	282	213	additionally	additionally	ADV
inlawrev-25507	282	214	,	,	PUNCT
inlawrev-25507	282	215	the	the	DET
inlawrev-25507	282	216	term	term	NOUN
inlawrev-25507	282	217	act	act	NOUN
inlawrev-25507	282	218	would	would	AUX
inlawrev-25507	282	219	apply	apply	VERB
inlawrev-25507	282	220	in	in	ADP
inlawrev-25507	282	221	proceedings	proceeding	NOUN
inlawrev-25507	282	222	challenging	challenge	VERB
inlawrev-25507	282	223	the	the	DET
inlawrev-25507	282	224	validity	validity	NOUN
inlawrev-25507	282	225	of	of	ADP
inlawrev-25507	282	226	the	the	DET
inlawrev-25507	282	227	patent	patent	NOUN
inlawrev-25507	282	228	,	,	PUNCT
inlawrev-25507	282	229	but	but	CCONJ
inlawrev-25507	282	230	generic	generic	ADJ
inlawrev-25507	282	231	manufacturers	manufacturer	NOUN
inlawrev-25507	282	232	are	be	AUX
inlawrev-25507	282	233	challenge	challenge	ADJ
inlawrev-25507	282	234	-	-	PUNCT
inlawrev-25507	282	235	burdens	burden	NOUN
inlawrev-25507	282	236	-	-	PUNCT
inlawrev-25507	282	237	branded	brand	VERB
inlawrev-25507	282	238	-	-	PUNCT
inlawrev-25507	282	239	companies	company	NOUN
inlawrev-25507	282	240	[	[	X
inlawrev-25507	282	241	https://perma.cc/tv2d-srcy	https://perma.cc/tv2d-srcy	X
inlawrev-25507	282	242	]	]	PUNCT
inlawrev-25507	282	243	.	.	PUNCT
inlawrev-25507	283	1	105	105	NUM
inlawrev-25507	283	2	.	.	PUNCT
inlawrev-25507	284	1	bipartisan	bipartisan	ADJ
inlawrev-25507	284	2	legislation	legislation	NOUN
inlawrev-25507	284	3	,	,	PUNCT
inlawrev-25507	284	4	supra	supra	PROPN
inlawrev-25507	284	5	note	note	VERB
inlawrev-25507	284	6	102	102	NUM
inlawrev-25507	284	7	.	.	PUNCT
inlawrev-25507	285	1	106	106	NUM
inlawrev-25507	285	2	.	.	PUNCT
inlawrev-25507	286	1	bachand	bachand	PROPN
inlawrev-25507	286	2	&	&	CCONJ
inlawrev-25507	286	3	gourash	gourash	PROPN
inlawrev-25507	286	4	,	,	PUNCT
inlawrev-25507	286	5	supra	supra	PROPN
inlawrev-25507	286	6	note	note	NOUN
inlawrev-25507	286	7	104	104	NUM
inlawrev-25507	286	8	.	.	PUNCT
inlawrev-25507	287	1	107	107	NUM
inlawrev-25507	287	2	.	.	PUNCT
inlawrev-25507	288	1	bipartisan	bipartisan	ADJ
inlawrev-25507	288	2	legislation	legislation	NOUN
inlawrev-25507	288	3	,	,	PUNCT
inlawrev-25507	288	4	supra	supra	PROPN
inlawrev-25507	288	5	note	note	VERB
inlawrev-25507	288	6	102	102	NUM
inlawrev-25507	288	7	.	.	X
inlawrev-25507	288	8	108	108	NUM
inlawrev-25507	288	9	.	.	PUNCT
inlawrev-25507	289	1	see	see	VERB
inlawrev-25507	289	2	steve	steve	PROPN
inlawrev-25507	289	3	brachmann	brachmann	PROPN
inlawrev-25507	289	4	,	,	PUNCT
inlawrev-25507	289	5	congress	congress	PROPN
inlawrev-25507	289	6	adds	add	VERB
inlawrev-25507	289	7	term	term	NOUN
inlawrev-25507	289	8	act	act	NOUN
inlawrev-25507	289	9	and	and	CCONJ
inlawrev-25507	289	10	no	no	DET
inlawrev-25507	289	11	combination	combination	NOUN
inlawrev-25507	289	12	drug	drug	NOUN
inlawrev-25507	289	13	patents	patent	NOUN
inlawrev-25507	289	14	act	act	VERB
inlawrev-25507	289	15	to	to	ADP
inlawrev-25507	289	16	list	list	NOUN
inlawrev-25507	289	17	of	of	ADP
inlawrev-25507	289	18	drug	drug	NOUN
inlawrev-25507	289	19	patent	patent	NOUN
inlawrev-25507	289	20	bills	bill	NOUN
inlawrev-25507	289	21	being	be	AUX
inlawrev-25507	289	22	considered	consider	VERB
inlawrev-25507	289	23	,	,	PUNCT
inlawrev-25507	289	24	ipwatchdog	ipwatchdog	PROPN
inlawrev-25507	289	25	(	(	PUNCT
inlawrev-25507	289	26	june	june	PROPN
inlawrev-25507	289	27	20	20	NUM
inlawrev-25507	289	28	,	,	PUNCT
inlawrev-25507	289	29	2019	2019	NUM
inlawrev-25507	289	30	)	)	PUNCT
inlawrev-25507	289	31	,	,	PUNCT
inlawrev-25507	290	1	https://www	https://www	PROPN
inlawrev-25507	290	2	.	.	PUNCT
inlawrev-25507	290	3	ipwatchdog.com/2019/06/20/congress-term-act-no-combination-drug-patents-act-added-list-drugpatent-bills-considered/id=110525/	ipwatchdog.com/2019/06/20/congress-term-act-no-combination-drug-patents-act-added-list-drugpatent-bills-considered/id=110525/	PROPN
inlawrev-25507	291	1	[	[	X
inlawrev-25507	291	2	https://perma.cc/964l-5r54	https://perma.cc/964l-5r54	X
inlawrev-25507	291	3	]	]	X
inlawrev-25507	292	1	[	[	X
inlawrev-25507	292	2	hereinafter	hereinafter	NOUN
inlawrev-25507	292	3	brachmann	brachmann	NOUN
inlawrev-25507	292	4	,	,	PUNCT
inlawrev-25507	292	5	congress	congress	PROPN
inlawrev-25507	292	6	adds	add	VERB
inlawrev-25507	292	7	term	term	NOUN
inlawrev-25507	292	8	act	act	PROPN
inlawrev-25507	292	9	]	]	PUNCT
inlawrev-25507	292	10	.	.	PUNCT
inlawrev-25507	293	1	109	109	NUM
inlawrev-25507	293	2	.	.	PUNCT
inlawrev-25507	293	3	werner	werner	PROPN
inlawrev-25507	293	4	,	,	PUNCT
inlawrev-25507	293	5	supra	supra	PROPN
inlawrev-25507	293	6	note	note	PROPN
inlawrev-25507	293	7	103	103	NUM
inlawrev-25507	293	8	;	;	PUNCT
inlawrev-25507	293	9	mpep	mpep	PROPN
inlawrev-25507	293	10	§	§	PROPN
inlawrev-25507	293	11	1504.06	1504.06	NUM
inlawrev-25507	293	12	(	(	PUNCT
inlawrev-25507	293	13	9th	9th	ADJ
inlawrev-25507	293	14	ed	ed	NOUN
inlawrev-25507	293	15	.	.	PUNCT
inlawrev-25507	293	16	rev	rev	PROPN
inlawrev-25507	293	17	.	.	PROPN
inlawrev-25507	293	18	10.2019	10.2019	NUM
inlawrev-25507	293	19	,	,	PUNCT
inlawrev-25507	293	20	june	june	PROPN
inlawrev-25507	293	21	2020	2020	NUM
inlawrev-25507	293	22	)	)	PUNCT
inlawrev-25507	293	23	.	.	PUNCT
inlawrev-25507	294	1	for	for	ADP
inlawrev-25507	294	2	a	a	DET
inlawrev-25507	294	3	definition	definition	NOUN
inlawrev-25507	294	4	and	and	CCONJ
inlawrev-25507	294	5	discussion	discussion	NOUN
inlawrev-25507	294	6	of	of	ADP
inlawrev-25507	294	7	obviousness	obviousness	NOUN
inlawrev-25507	294	8	-	-	PUNCT
inlawrev-25507	294	9	type	type	NOUN
inlawrev-25507	294	10	double	double	ADJ
inlawrev-25507	294	11	patenting	patenting	NOUN
inlawrev-25507	294	12	,	,	PUNCT
inlawrev-25507	294	13	see	see	VERB
inlawrev-25507	294	14	aaron	aaron	PROPN
inlawrev-25507	294	15	reinhardt	reinhardt	PROPN
inlawrev-25507	294	16	,	,	PUNCT
inlawrev-25507	294	17	obviousnesstype	obviousnesstype	NOUN
inlawrev-25507	294	18	double	double	ADJ
inlawrev-25507	294	19	patenting	patenting	NOUN
inlawrev-25507	294	20	considerations	consideration	NOUN
inlawrev-25507	294	21	,	,	PUNCT
inlawrev-25507	294	22	ipwatchdog	ipwatchdog	NOUN
inlawrev-25507	294	23	(	(	PUNCT
inlawrev-25507	294	24	july	july	PROPN
inlawrev-25507	294	25	19	19	NUM
inlawrev-25507	294	26	,	,	PUNCT
inlawrev-25507	294	27	2017	2017	NUM
inlawrev-25507	294	28	)	)	PUNCT
inlawrev-25507	294	29	,	,	PUNCT
inlawrev-25507	294	30	https://www.ipwatchdog	https://www.ipwatchdog	PROPN
inlawrev-25507	294	31	.	.	PUNCT
inlawrev-25507	295	1	c	c	X
inlawrev-25507	296	1	o	o	NOUN
inlawrev-25507	296	2	m	m	VERB
inlawrev-25507	296	3	/	/	SYM
inlawrev-25507	296	4	2	2	NUM
inlawrev-25507	296	5	0	0	NUM
inlawrev-25507	296	6	1	1	NUM
inlawrev-25507	296	7	7	7	NUM
inlawrev-25507	296	8	/	/	SYM
inlawrev-25507	296	9	0	0	NUM
inlawrev-25507	296	10	7	7	NUM
inlawrev-25507	296	11	/	/	SYM
inlawrev-25507	296	12	1	1	NUM
inlawrev-25507	296	13	9	9	NUM
inlawrev-25507	296	14	/	/	SYM
inlawrev-25507	296	15	o	o	X
inlawrev-25507	296	16	b	b	X
inlawrev-25507	296	17	v	v	ADP
inlawrev-25507	296	18	io	io	X
inlawrev-25507	296	19	u	u	PROPN
inlawrev-25507	296	20	s	s	PART
inlawrev-25507	296	21	n	n	ADP
inlawrev-25507	296	22	e	e	NOUN
inlawrev-25507	296	23	s	s	X
inlawrev-25507	296	24	s	s	X
inlawrev-25507	296	25	-t	-t	NOUN
inlawrev-25507	296	26	yp	yp	X
inlawrev-25507	297	1	e	e	X
inlawrev-25507	297	2	-d	-d	PUNCT
inlawrev-25507	297	3	o	o	X
inlawrev-25507	297	4	u	u	X
inlawrev-25507	297	5	b	b	X
inlawrev-25507	297	6	le	le	INTJ
inlawrev-25507	297	7	-p	-p	SYM
inlawrev-25507	297	8	a	a	DET
inlawrev-25507	297	9	t	t	X
inlawrev-25507	297	10	e	e	NOUN
inlawrev-25507	297	11	n	n	ADP
inlawrev-25507	297	12	t	t	PROPN
inlawrev-25507	297	13	i	i	PRON
inlawrev-25507	297	14	n	n	ADV
inlawrev-25507	297	15	g	g	NOUN
inlawrev-25507	297	16	c	c	NOUN
inlawrev-25507	297	17	o	o	NOUN
inlawrev-25507	298	1	n	n	X
inlawrev-25507	298	2	s	s	X
inlawrev-25507	298	3	i	i	NOUN
inlawrev-25507	298	4	d	d	X
inlawrev-25507	298	5	e	e	X
inlawrev-25507	298	6	r	r	NOUN
inlawrev-25507	298	7	a	a	PROPN
inlawrev-25507	298	8	t	t	NOUN
inlawrev-25507	299	1	i	i	PRON
inlawrev-25507	299	2	o	o	INTJ
inlawrev-25507	300	1	n	n	X
inlawrev-25507	300	2	s	s	NOUN
inlawrev-25507	300	3	/	/	SYM
inlawrev-25507	300	4	i	i	NOUN
inlawrev-25507	300	5	d	d	NOUN
inlawrev-25507	300	6	=	=	SYM
inlawrev-25507	300	7	8	8	NUM
inlawrev-25507	300	8	5	5	NUM
inlawrev-25507	300	9	7	7	NUM
inlawrev-25507	300	10	9	9	NUM
inlawrev-25507	300	11	1	1	NUM
inlawrev-25507	300	12	/	/	SYM
inlawrev-25507	301	1	[	[	X
inlawrev-25507	301	2	https://perma.cc/r26c-n55x	https://perma.cc/r26c-n55x	X
inlawrev-25507	301	3	]	]	PUNCT
inlawrev-25507	301	4	.	.	PUNCT
inlawrev-25507	302	1	110	110	NUM
inlawrev-25507	302	2	.	.	PUNCT
inlawrev-25507	302	3	werner	werner	PROPN
inlawrev-25507	302	4	,	,	PUNCT
inlawrev-25507	302	5	supra	supra	PROPN
inlawrev-25507	302	6	note	note	PROPN
inlawrev-25507	302	7	103	103	NUM
inlawrev-25507	302	8	;	;	PUNCT
inlawrev-25507	302	9	see	see	VERB
inlawrev-25507	302	10	also	also	ADV
inlawrev-25507	302	11	courtenay	courtenay	PROPN
inlawrev-25507	302	12	c.	c.	PROPN
inlawrev-25507	302	13	brinckerhoff	brinckerhoff	PROPN
inlawrev-25507	302	14	,	,	PUNCT
inlawrev-25507	302	15	why	why	SCONJ
inlawrev-25507	302	16	the	the	DET
inlawrev-25507	302	17	term	term	NOUN
inlawrev-25507	302	18	act	act	NOUN
inlawrev-25507	302	19	is	be	AUX
inlawrev-25507	302	20	a	a	DET
inlawrev-25507	302	21	misguided	misguided	ADJ
inlawrev-25507	302	22	solution	solution	NOUN
inlawrev-25507	302	23	to	to	ADP
inlawrev-25507	302	24	a	a	DET
inlawrev-25507	302	25	different	different	ADJ
inlawrev-25507	302	26	problem	problem	NOUN
inlawrev-25507	302	27	,	,	PUNCT
inlawrev-25507	302	28	jd	jd	PROPN
inlawrev-25507	302	29	supra	supra	PROPN
inlawrev-25507	302	30	(	(	PUNCT
inlawrev-25507	302	31	june	june	PROPN
inlawrev-25507	302	32	18	18	NUM
inlawrev-25507	302	33	,	,	PUNCT
inlawrev-25507	302	34	2019	2019	NUM
inlawrev-25507	302	35	)	)	PUNCT
inlawrev-25507	302	36	,	,	PUNCT
inlawrev-25507	302	37	https://www.jdsupra	https://www.jdsupra	PROPN
inlawrev-25507	302	38	.	.	PUNCT
inlawrev-25507	302	39	com	com	NOUN
inlawrev-25507	302	40	/	/	SYM
inlawrev-25507	302	41	legalnews	legalnew	NOUN
inlawrev-25507	302	42	/	/	SYM
inlawrev-25507	302	43	why	why	SCONJ
inlawrev-25507	302	44	-	-	PUNCT
inlawrev-25507	302	45	the	the	DET
inlawrev-25507	302	46	-	-	PUNCT
inlawrev-25507	302	47	term	term	NOUN
inlawrev-25507	302	48	-	-	PUNCT
inlawrev-25507	302	49	act	act	NOUN
inlawrev-25507	302	50	-	-	PUNCT
inlawrev-25507	302	51	is	be	AUX
inlawrev-25507	302	52	-	-	PUNCT
inlawrev-25507	302	53	a	a	DET
inlawrev-25507	302	54	-	-	PUNCT
inlawrev-25507	302	55	misguided-56742/	misguided-56742/	NOUN
inlawrev-25507	303	1	[	[	X
inlawrev-25507	303	2	https://perma.cc/7rbx-xf8	https://perma.cc/7rbx-xf8	NOUN
inlawrev-25507	303	3	g	g	NOUN
inlawrev-25507	303	4	]	]	X
inlawrev-25507	303	5	.	.	PUNCT
inlawrev-25507	304	1	111	111	NUM
inlawrev-25507	304	2	.	.	PUNCT
inlawrev-25507	304	3	werner	werner	PROPN
inlawrev-25507	304	4	,	,	PUNCT
inlawrev-25507	304	5	supra	supra	PROPN
inlawrev-25507	304	6	note	note	NOUN
inlawrev-25507	304	7	103	103	NUM
inlawrev-25507	304	8	.	.	PUNCT
inlawrev-25507	305	1	112	112	NUM
inlawrev-25507	305	2	.	.	PUNCT
inlawrev-25507	306	1	i	i	PRON
inlawrev-25507	306	2	d.	d.	PROPN
inlawrev-25507	306	3	113	113	NUM
inlawrev-25507	306	4	.	.	PUNCT
inlawrev-25507	307	1	brinckerhoff	brinckerhoff	PROPN
inlawrev-25507	307	2	,	,	PUNCT
inlawrev-25507	307	3	supra	supra	PROPN
inlawrev-25507	307	4	note	note	NOUN
inlawrev-25507	307	5	110	110	NUM
inlawrev-25507	307	6	.	.	NOUN
inlawrev-25507	307	7	2021	2021	NUM
inlawrev-25507	307	8	]	]	PUNCT
inlawrev-25507	308	1	leaving	leave	VERB
inlawrev-25507	308	2	the	the	DET
inlawrev-25507	308	3	evergreening	evergreene	VERB
inlawrev-25507	308	4	problem	problem	NOUN
inlawrev-25507	308	5	to	to	ADP
inlawrev-25507	308	6	the	the	DET
inlawrev-25507	308	7	patent	patent	NOUN
inlawrev-25507	308	8	experts	expert	NOUN
inlawrev-25507	308	9	207	207	NUM
inlawrev-25507	308	10	already	already	ADV
inlawrev-25507	308	11	able	able	ADJ
inlawrev-25507	308	12	to	to	PART
inlawrev-25507	308	13	raise	raise	VERB
inlawrev-25507	308	14	questions	question	NOUN
inlawrev-25507	308	15	of	of	ADP
inlawrev-25507	308	16	obviousness	obviousness	NOUN
inlawrev-25507	308	17	-	-	PUNCT
inlawrev-25507	308	18	type	type	NOUN
inlawrev-25507	308	19	double	double	ADJ
inlawrev-25507	308	20	patenting	patenting	NOUN
inlawrev-25507	308	21	in	in	ADP
inlawrev-25507	308	22	these	these	DET
inlawrev-25507	308	23	proceedings.114	proceedings.114	NOUN
inlawrev-25507	308	24	although	although	SCONJ
inlawrev-25507	308	25	it	it	PRON
inlawrev-25507	308	26	is	be	AUX
inlawrev-25507	308	27	clear	clear	ADJ
inlawrev-25507	308	28	that	that	SCONJ
inlawrev-25507	308	29	the	the	DET
inlawrev-25507	308	30	act	act	NOUN
inlawrev-25507	308	31	would	would	AUX
inlawrev-25507	308	32	decrease	decrease	VERB
inlawrev-25507	308	33	further	further	ADJ
inlawrev-25507	308	34	innovation	innovation	NOUN
inlawrev-25507	308	35	on	on	ADP
inlawrev-25507	308	36	already	already	ADV
inlawrev-25507	308	37	-	-	PUNCT
inlawrev-25507	308	38	known	know	VERB
inlawrev-25507	308	39	drugs	drug	NOUN
inlawrev-25507	308	40	,	,	PUNCT
inlawrev-25507	308	41	it	it	PRON
inlawrev-25507	308	42	is	be	AUX
inlawrev-25507	308	43	not	not	PART
inlawrev-25507	308	44	clear	clear	ADJ
inlawrev-25507	308	45	if	if	SCONJ
inlawrev-25507	308	46	this	this	DET
inlawrev-25507	308	47	act	act	NOUN
inlawrev-25507	308	48	would	would	AUX
inlawrev-25507	308	49	realistically	realistically	ADV
inlawrev-25507	308	50	be	be	AUX
inlawrev-25507	308	51	effective	effective	ADJ
inlawrev-25507	308	52	against	against	ADP
inlawrev-25507	308	53	the	the	DET
inlawrev-25507	308	54	evergreening	evergreene	VERB
inlawrev-25507	308	55	issue.115	issue.115	PROPN
inlawrev-25507	308	56	iii	iii	NOUN
inlawrev-25507	308	57	.	.	PUNCT
inlawrev-25507	309	1	leaving	leave	VERB
inlawrev-25507	309	2	the	the	DET
inlawrev-25507	309	3	evergreening	evergreene	VERB
inlawrev-25507	309	4	issue	issue	NOUN
inlawrev-25507	309	5	to	to	ADP
inlawrev-25507	309	6	the	the	DET
inlawrev-25507	309	7	uspto	uspto	NOUN
inlawrev-25507	309	8	,	,	PUNCT
inlawrev-25507	309	9	the	the	DET
inlawrev-25507	309	10	ptab	ptab	NOUN
inlawrev-25507	309	11	,	,	PUNCT
inlawrev-25507	309	12	and	and	CCONJ
inlawrev-25507	309	13	the	the	DET
inlawrev-25507	309	14	court	court	NOUN
inlawrev-25507	309	15	of	of	ADP
inlawrev-25507	309	16	appeals	appeal	NOUN
inlawrev-25507	309	17	for	for	ADP
inlawrev-25507	309	18	the	the	DET
inlawrev-25507	309	19	federal	federal	ADJ
inlawrev-25507	309	20	circuit	circuit	PROPN
inlawrev-25507	309	21	a.	a.	NOUN
inlawrev-25507	309	22	implement	implement	VERB
inlawrev-25507	309	23	a	a	DET
inlawrev-25507	309	24	balancing	balancing	NOUN
inlawrev-25507	309	25	test	test	NOUN
inlawrev-25507	309	26	to	to	PART
inlawrev-25507	309	27	determine	determine	VERB
inlawrev-25507	309	28	if	if	SCONJ
inlawrev-25507	309	29	evergreening	evergreene	VERB
inlawrev-25507	309	30	exists	exist	NOUN
inlawrev-25507	309	31	although	although	SCONJ
inlawrev-25507	309	32	evergreening	evergreene	VERB
inlawrev-25507	309	33	is	be	AUX
inlawrev-25507	309	34	an	an	DET
inlawrev-25507	309	35	issue	issue	NOUN
inlawrev-25507	309	36	that	that	PRON
inlawrev-25507	309	37	should	should	AUX
inlawrev-25507	309	38	be	be	AUX
inlawrev-25507	309	39	addressed	address	VERB
inlawrev-25507	309	40	,	,	PUNCT
inlawrev-25507	309	41	the	the	DET
inlawrev-25507	309	42	legislature	legislature	NOUN
inlawrev-25507	309	43	is	be	AUX
inlawrev-25507	309	44	not	not	PART
inlawrev-25507	309	45	the	the	DET
inlawrev-25507	309	46	branch	branch	NOUN
inlawrev-25507	309	47	that	that	PRON
inlawrev-25507	309	48	should	should	AUX
inlawrev-25507	309	49	address	address	VERB
inlawrev-25507	309	50	it	it	PRON
inlawrev-25507	309	51	.	.	PUNCT
inlawrev-25507	310	1	this	this	DET
inlawrev-25507	310	2	problem	problem	NOUN
inlawrev-25507	310	3	should	should	AUX
inlawrev-25507	310	4	be	be	AUX
inlawrev-25507	310	5	left	leave	VERB
inlawrev-25507	310	6	to	to	ADP
inlawrev-25507	310	7	the	the	DET
inlawrev-25507	310	8	patent	patent	NOUN
inlawrev-25507	310	9	examiners	examiner	NOUN
inlawrev-25507	310	10	and	and	CCONJ
inlawrev-25507	310	11	administrative	administrative	ADJ
inlawrev-25507	310	12	judges	judge	NOUN
inlawrev-25507	310	13	at	at	ADP
inlawrev-25507	310	14	the	the	DET
inlawrev-25507	310	15	uspto	uspto	NOUN
inlawrev-25507	310	16	,	,	PUNCT
inlawrev-25507	310	17	the	the	DET
inlawrev-25507	310	18	patent	patent	NOUN
inlawrev-25507	310	19	trial	trial	NOUN
inlawrev-25507	310	20	and	and	CCONJ
inlawrev-25507	310	21	appeal	appeal	PROPN
inlawrev-25507	310	22	board	board	NOUN
inlawrev-25507	310	23	(	(	PUNCT
inlawrev-25507	310	24	the	the	DET
inlawrev-25507	310	25	“	"	PUNCT
inlawrev-25507	310	26	ptab	ptab	NOUN
inlawrev-25507	310	27	”	"	PUNCT
inlawrev-25507	310	28	)	)	PUNCT
inlawrev-25507	310	29	,	,	PUNCT
inlawrev-25507	310	30	and	and	CCONJ
inlawrev-25507	310	31	the	the	DET
inlawrev-25507	310	32	court	court	NOUN
inlawrev-25507	310	33	of	of	ADP
inlawrev-25507	310	34	appeals	appeal	NOUN
inlawrev-25507	310	35	for	for	ADP
inlawrev-25507	310	36	the	the	DET
inlawrev-25507	310	37	federal	federal	ADJ
inlawrev-25507	310	38	circuit	circuit	NOUN
inlawrev-25507	310	39	(	(	PUNCT
inlawrev-25507	310	40	the	the	DET
inlawrev-25507	310	41	“	"	PUNCT
inlawrev-25507	310	42	federal	federal	ADJ
inlawrev-25507	310	43	circuit”).116	circuit”).116	PROPN
inlawrev-25507	310	44	the	the	DET
inlawrev-25507	310	45	examiners	examiner	NOUN
inlawrev-25507	310	46	and	and	CCONJ
inlawrev-25507	310	47	administrative	administrative	ADJ
inlawrev-25507	310	48	judges	judge	NOUN
inlawrev-25507	310	49	have	have	AUX
inlawrev-25507	310	50	qualifications	qualification	NOUN
inlawrev-25507	310	51	to	to	PART
inlawrev-25507	310	52	examine	examine	VERB
inlawrev-25507	310	53	the	the	DET
inlawrev-25507	310	54	evergreen	evergreen	NOUN
inlawrev-25507	310	55	problem	problem	NOUN
inlawrev-25507	310	56	;	;	PUNCT
inlawrev-25507	310	57	this	this	PRON
inlawrev-25507	310	58	is	be	AUX
inlawrev-25507	310	59	because	because	SCONJ
inlawrev-25507	310	60	they	they	PRON
inlawrev-25507	310	61	carry	carry	VERB
inlawrev-25507	310	62	the	the	DET
inlawrev-25507	310	63	necessary	necessary	ADJ
inlawrev-25507	310	64	science	science	NOUN
inlawrev-25507	310	65	background	background	NOUN
inlawrev-25507	310	66	to	to	PART
inlawrev-25507	310	67	become	become	VERB
inlawrev-25507	310	68	examiners	examiner	NOUN
inlawrev-25507	310	69	and	and	CCONJ
inlawrev-25507	310	70	are	be	AUX
inlawrev-25507	310	71	highly	highly	ADV
inlawrev-25507	310	72	experienced	experienced	ADJ
inlawrev-25507	310	73	in	in	ADP
inlawrev-25507	310	74	the	the	DET
inlawrev-25507	310	75	area	area	NOUN
inlawrev-25507	310	76	of	of	ADP
inlawrev-25507	310	77	patent	patent	NOUN
inlawrev-25507	310	78	law.117	law.117	NOUN
inlawrev-25507	310	79	particularly	particularly	ADV
inlawrev-25507	310	80	,	,	PUNCT
inlawrev-25507	310	81	the	the	DET
inlawrev-25507	310	82	federal	federal	ADJ
inlawrev-25507	310	83	circuit	circuit	NOUN
inlawrev-25507	310	84	is	be	AUX
inlawrev-25507	310	85	a	a	DET
inlawrev-25507	310	86	specialized	specialized	ADJ
inlawrev-25507	310	87	court	court	NOUN
inlawrev-25507	310	88	that	that	PRON
inlawrev-25507	310	89	has	have	VERB
inlawrev-25507	310	90	exclusive	exclusive	ADJ
inlawrev-25507	310	91	jurisdiction	jurisdiction	NOUN
inlawrev-25507	310	92	for	for	ADP
inlawrev-25507	310	93	patent	patent	NOUN
inlawrev-25507	310	94	cases.118	cases.118	VERB
inlawrev-25507	310	95	currently	currently	ADV
inlawrev-25507	310	96	,	,	PUNCT
inlawrev-25507	310	97	the	the	DET
inlawrev-25507	310	98	federal	federal	ADJ
inlawrev-25507	310	99	circuit	circuit	NOUN
inlawrev-25507	310	100	is	be	AUX
inlawrev-25507	310	101	comprised	comprise	VERB
inlawrev-25507	310	102	of	of	ADP
inlawrev-25507	310	103	six	six	NUM
inlawrev-25507	310	104	judges	judge	NOUN
inlawrev-25507	310	105	that	that	PRON
inlawrev-25507	310	106	are	be	AUX
inlawrev-25507	310	107	former	former	ADJ
inlawrev-25507	310	108	patent	patent	NOUN
inlawrev-25507	310	109	attorneys	attorney	NOUN
inlawrev-25507	310	110	,	,	PUNCT
inlawrev-25507	310	111	at	at	ADP
inlawrev-25507	310	112	least	least	ADV
inlawrev-25507	310	113	two	two	NUM
inlawrev-25507	310	114	of	of	ADP
inlawrev-25507	310	115	whom	whom	PRON
inlawrev-25507	310	116	have	have	VERB
inlawrev-25507	310	117	degrees	degree	NOUN
inlawrev-25507	310	118	in	in	ADP
inlawrev-25507	310	119	chemistry.119	chemistry.119	PROPN
inlawrev-25507	310	120	both	both	CCONJ
inlawrev-25507	310	121	the	the	DET
inlawrev-25507	310	122	examiners	examiner	NOUN
inlawrev-25507	310	123	and	and	CCONJ
inlawrev-25507	310	124	the	the	DET
inlawrev-25507	310	125	federal	federal	ADJ
inlawrev-25507	310	126	circuit	circuit	NOUN
inlawrev-25507	310	127	have	have	VERB
inlawrev-25507	310	128	the	the	DET
inlawrev-25507	310	129	most	most	ADJ
inlawrev-25507	310	130	experience	experience	NOUN
inlawrev-25507	310	131	not	not	PART
inlawrev-25507	310	132	only	only	ADV
inlawrev-25507	310	133	with	with	ADP
inlawrev-25507	310	134	patent	patent	NOUN
inlawrev-25507	310	135	law	law	NOUN
inlawrev-25507	310	136	in	in	ADP
inlawrev-25507	310	137	general	general	ADJ
inlawrev-25507	310	138	,	,	PUNCT
inlawrev-25507	310	139	but	but	CCONJ
inlawrev-25507	310	140	also	also	ADV
inlawrev-25507	310	141	in	in	ADP
inlawrev-25507	310	142	terms	term	NOUN
inlawrev-25507	310	143	of	of	ADP
inlawrev-25507	310	144	obviousness	obviousness	NOUN
inlawrev-25507	310	145	and	and	CCONJ
inlawrev-25507	310	146	double	double	ADJ
inlawrev-25507	310	147	patenting	patenting	NOUN
inlawrev-25507	310	148	rejections.120	rejections.120	ADJ
inlawrev-25507	310	149	however	however	ADV
inlawrev-25507	310	150	,	,	PUNCT
inlawrev-25507	310	151	the	the	DET
inlawrev-25507	310	152	evergreening	evergreene	VERB
inlawrev-25507	310	153	issue	issue	NOUN
inlawrev-25507	310	154	should	should	AUX
inlawrev-25507	310	155	not	not	PART
inlawrev-25507	310	156	be	be	AUX
inlawrev-25507	310	157	left	leave	VERB
inlawrev-25507	310	158	to	to	ADP
inlawrev-25507	310	159	the	the	DET
inlawrev-25507	310	160	uspto	uspto	NOUN
inlawrev-25507	310	161	,	,	PUNCT
inlawrev-25507	310	162	the	the	DET
inlawrev-25507	310	163	ptab	ptab	NOUN
inlawrev-25507	310	164	,	,	PUNCT
inlawrev-25507	310	165	and	and	CCONJ
inlawrev-25507	310	166	the	the	DET
inlawrev-25507	310	167	federal	federal	ADJ
inlawrev-25507	310	168	circuit	circuit	NOUN
inlawrev-25507	310	169	without	without	ADP
inlawrev-25507	310	170	any	any	DET
inlawrev-25507	310	171	adjustments	adjustment	NOUN
inlawrev-25507	310	172	,	,	PUNCT
inlawrev-25507	310	173	as	as	SCONJ
inlawrev-25507	310	174	there	there	PRON
inlawrev-25507	310	175	have	have	AUX
inlawrev-25507	310	176	been	be	AUX
inlawrev-25507	310	177	many	many	ADJ
inlawrev-25507	310	178	114	114	NUM
inlawrev-25507	310	179	.	.	PUNCT
inlawrev-25507	311	1	i	i	PRON
inlawrev-25507	311	2	d.	d.	PROPN
inlawrev-25507	311	3	115	115	NUM
inlawrev-25507	311	4	.	.	PUNCT
inlawrev-25507	312	1	see	see	VERB
inlawrev-25507	312	2	i	i	PRON
inlawrev-25507	312	3	d.	d.	PROPN
inlawrev-25507	312	4	116	116	NUM
inlawrev-25507	312	5	.	.	PUNCT
inlawrev-25507	313	1	see	see	VERB
inlawrev-25507	313	2	giovanetti	giovanetti	NOUN
inlawrev-25507	313	3	et	et	PROPN
inlawrev-25507	313	4	al	al	PROPN
inlawrev-25507	313	5	.	.	PROPN
inlawrev-25507	313	6	,	,	PUNCT
inlawrev-25507	313	7	supra	supra	PROPN
inlawrev-25507	313	8	note	note	PROPN
inlawrev-25507	313	9	96	96	NUM
inlawrev-25507	313	10	(	(	PUNCT
inlawrev-25507	313	11	noting	note	VERB
inlawrev-25507	313	12	the	the	DET
inlawrev-25507	313	13	baseless	baseless	ADJ
inlawrev-25507	313	14	and	and	CCONJ
inlawrev-25507	313	15	inaccurate	inaccurate	ADJ
inlawrev-25507	313	16	criticisms	criticism	NOUN
inlawrev-25507	313	17	of	of	ADP
inlawrev-25507	313	18	the	the	DET
inlawrev-25507	313	19	patent	patent	NOUN
inlawrev-25507	313	20	system	system	NOUN
inlawrev-25507	313	21	in	in	ADP
inlawrev-25507	313	22	terms	term	NOUN
inlawrev-25507	313	23	of	of	ADP
inlawrev-25507	313	24	evergreening	evergreening	NOUN
inlawrev-25507	313	25	)	)	PUNCT
inlawrev-25507	313	26	;	;	PUNCT
inlawrev-25507	313	27	see	see	VERB
inlawrev-25507	313	28	also	also	ADV
inlawrev-25507	313	29	steven	steven	PROPN
inlawrev-25507	313	30	globerman	globerman	PROPN
inlawrev-25507	313	31	&	&	CCONJ
inlawrev-25507	313	32	kristina	kristina	PROPN
inlawrev-25507	313	33	m.	m.	PROPN
inlawrev-25507	313	34	lybecker	lybecker	PROPN
inlawrev-25507	313	35	,	,	PUNCT
inlawrev-25507	313	36	the	the	DET
inlawrev-25507	313	37	benefits	benefit	NOUN
inlawrev-25507	313	38	of	of	ADP
inlawrev-25507	313	39	incremental	incremental	ADJ
inlawrev-25507	313	40	innovation	innovation	NOUN
inlawrev-25507	313	41	:	:	PUNCT
inlawrev-25507	313	42	focus	focus	VERB
inlawrev-25507	313	43	on	on	ADP
inlawrev-25507	313	44	the	the	DET
inlawrev-25507	313	45	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	313	46	industry	industry	NOUN
inlawrev-25507	313	47	,	,	PUNCT
inlawrev-25507	313	48	fraser	fraser	PROPN
inlawrev-25507	313	49	inst	inst	PROPN
inlawrev-25507	313	50	.	.	PUNCT
inlawrev-25507	314	1	(	(	PUNCT
inlawrev-25507	314	2	june	june	PROPN
inlawrev-25507	314	3	2014	2014	NUM
inlawrev-25507	314	4	)	)	PUNCT
inlawrev-25507	314	5	,	,	PUNCT
inlawrev-25507	315	1	https://www.fraserinstitute.org/sites/default/files/benefits-of-incremental-innovation.pdf	https://www.fraserinstitute.org/sites/default/files/benefits-of-incremental-innovation.pdf	PROPN
inlawrev-25507	315	2	[	[	X
inlawrev-25507	315	3	https://perma.cc/7b23-9euh	https://perma.cc/7b23-9euh	PROPN
inlawrev-25507	315	4	]	]	X
inlawrev-25507	315	5	;	;	PUNCT
inlawrev-25507	315	6	kevin	kevin	PROPN
inlawrev-25507	315	7	madigan	madigan	PROPN
inlawrev-25507	315	8	&	&	CCONJ
inlawrev-25507	315	9	sean	sean	PROPN
inlawrev-25507	315	10	o’connor	o’connor	PROPN
inlawrev-25507	315	11	,	,	PUNCT
inlawrev-25507	315	12	“	"	PUNCT
inlawrev-25507	315	13	no	no	DET
inlawrev-25507	315	14	combination	combination	NOUN
inlawrev-25507	315	15	drug	drug	NOUN
inlawrev-25507	315	16	patents	patent	NOUN
inlawrev-25507	315	17	act	act	VERB
inlawrev-25507	315	18	”	"	PUNCT
inlawrev-25507	315	19	stalls	stall	NOUN
inlawrev-25507	315	20	,	,	PUNCT
inlawrev-25507	315	21	but	but	CCONJ
inlawrev-25507	315	22	threats	threat	NOUN
inlawrev-25507	315	23	to	to	ADP
inlawrev-25507	315	24	innovation	innovation	NOUN
inlawrev-25507	315	25	remain	remain	VERB
inlawrev-25507	315	26	,	,	PUNCT
inlawrev-25507	315	27	ctr	ctr	PROPN
inlawrev-25507	315	28	.	.	PROPN
inlawrev-25507	316	1	for	for	ADP
inlawrev-25507	316	2	protection	protection	PROPN
inlawrev-25507	316	3	intell	intell	PROPN
inlawrev-25507	316	4	.	.	PUNCT
inlawrev-25507	317	1	prop	prop	NOUN
inlawrev-25507	317	2	.	.	PUNCT
inlawrev-25507	318	1	(	(	PUNCT
inlawrev-25507	318	2	june	june	PROPN
inlawrev-25507	318	3	27	27	NUM
inlawrev-25507	318	4	,	,	PUNCT
inlawrev-25507	318	5	2019	2019	NUM
inlawrev-25507	318	6	)	)	PUNCT
inlawrev-25507	318	7	,	,	PUNCT
inlawrev-25507	318	8	https://cpip.gmu.edu/2019/06/27/no-combination-drug-patents-act-stalls-but-threats-toinnovation-remain/	https://cpip.gmu.edu/2019/06/27/no-combination-drug-patents-act-stalls-but-threats-toinnovation-remain/	NOUN
inlawrev-25507	319	1	[	[	X
inlawrev-25507	319	2	https://perma.cc/7m39-gcc7	https://perma.cc/7m39-gcc7	X
inlawrev-25507	319	3	]	]	X
inlawrev-25507	319	4	.	.	PUNCT
inlawrev-25507	320	1	117	117	NUM
inlawrev-25507	320	2	.	.	PUNCT
inlawrev-25507	320	3	patent	patent	NOUN
inlawrev-25507	320	4	examiner	examiner	NOUN
inlawrev-25507	320	5	:	:	PUNCT
inlawrev-25507	320	6	everything	everything	PRON
inlawrev-25507	320	7	you	you	PRON
inlawrev-25507	320	8	need	need	VERB
inlawrev-25507	320	9	to	to	PART
inlawrev-25507	320	10	know	know	VERB
inlawrev-25507	320	11	,	,	PUNCT
inlawrev-25507	320	12	upcouns	upcoun	NOUN
inlawrev-25507	320	13	.	.	PUNCT
inlawrev-25507	320	14	,	,	PUNCT
inlawrev-25507	320	15	https://www.upcounsel	https://www.upcounsel	PROPN
inlawrev-25507	320	16	.	.	PUNCT
inlawrev-25507	320	17	com	com	NOUN
inlawrev-25507	320	18	/	/	SYM
inlawrev-25507	320	19	patent	patent	NOUN
inlawrev-25507	320	20	-	-	PUNCT
inlawrev-25507	320	21	examiner	examiner	NOUN
inlawrev-25507	320	22	(	(	PUNCT
inlawrev-25507	320	23	last	last	ADV
inlawrev-25507	320	24	visited	visit	VERB
inlawrev-25507	320	25	oct	oct	PROPN
inlawrev-25507	320	26	.	.	PROPN
inlawrev-25507	320	27	14	14	NUM
inlawrev-25507	320	28	,	,	PUNCT
inlawrev-25507	320	29	2019	2019	NUM
inlawrev-25507	320	30	)	)	PUNCT
inlawrev-25507	321	1	[	[	X
inlawrev-25507	321	2	https://perma.cc/c46l-5ajh	https://perma.cc/c46l-5ajh	X
inlawrev-25507	321	3	]	]	X
inlawrev-25507	321	4	.	.	PUNCT
inlawrev-25507	322	1	118	118	NUM
inlawrev-25507	322	2	.	.	PUNCT
inlawrev-25507	322	3	court	court	NOUN
inlawrev-25507	322	4	jurisdiction	jurisdiction	NOUN
inlawrev-25507	322	5	,	,	PUNCT
inlawrev-25507	322	6	u.s	u.s	PROPN
inlawrev-25507	322	7	.	.	PROPN
inlawrev-25507	322	8	ct	ct	PROPN
inlawrev-25507	322	9	.	.	PUNCT
inlawrev-25507	322	10	appeals	appeal	NOUN
inlawrev-25507	322	11	for	for	ADP
inlawrev-25507	322	12	fed	fed	PROPN
inlawrev-25507	322	13	.	.	PUNCT
inlawrev-25507	323	1	cir	cir	PROPN
inlawrev-25507	323	2	.	.	PROPN
inlawrev-25507	323	3	,	,	PUNCT
inlawrev-25507	323	4	http://www.cafc.uscourts.gov/thecourt/court-jurisdiction	http://www.cafc.uscourts.gov/thecourt/court-jurisdiction	PROPN
inlawrev-25507	323	5	(	(	PUNCT
inlawrev-25507	323	6	last	last	ADV
inlawrev-25507	323	7	visited	visit	VERB
inlawrev-25507	323	8	oct	oct	PROPN
inlawrev-25507	323	9	.	.	PROPN
inlawrev-25507	323	10	16	16	NUM
inlawrev-25507	323	11	,	,	PUNCT
inlawrev-25507	323	12	2019	2019	NUM
inlawrev-25507	323	13	)	)	PUNCT
inlawrev-25507	324	1	[	[	X
inlawrev-25507	324	2	https://perma.cc/4epm-k2fe	https://perma.cc/4epm-k2fe	NOUN
inlawrev-25507	324	3	]	]	PUNCT
inlawrev-25507	324	4	.	.	PUNCT
inlawrev-25507	325	1	119	119	NUM
inlawrev-25507	325	2	.	.	PUNCT
inlawrev-25507	326	1	judges	judge	NOUN
inlawrev-25507	326	2	,	,	PUNCT
inlawrev-25507	326	3	u.s	u.s	PROPN
inlawrev-25507	326	4	.	.	PROPN
inlawrev-25507	326	5	ct	ct	PROPN
inlawrev-25507	326	6	.	.	PUNCT
inlawrev-25507	326	7	appeals	appeal	NOUN
inlawrev-25507	326	8	for	for	ADP
inlawrev-25507	326	9	fed	fed	PROPN
inlawrev-25507	326	10	.	.	PUNCT
inlawrev-25507	327	1	cir	cir	PROPN
inlawrev-25507	327	2	.	.	PROPN
inlawrev-25507	327	3	,	,	PUNCT
inlawrev-25507	327	4	http://www.cafc.uscourts.gov/judges/s-jayplager-circuit-judge.html	http://www.cafc.uscourts.gov/judges/s-jayplager-circuit-judge.html	PROPN
inlawrev-25507	327	5	(	(	PUNCT
inlawrev-25507	327	6	last	last	ADV
inlawrev-25507	327	7	visited	visit	VERB
inlawrev-25507	327	8	oct	oct	PROPN
inlawrev-25507	327	9	.	.	PROPN
inlawrev-25507	327	10	16	16	NUM
inlawrev-25507	327	11	,	,	PUNCT
inlawrev-25507	327	12	2019	2019	NUM
inlawrev-25507	327	13	)	)	PUNCT
inlawrev-25507	328	1	[	[	X
inlawrev-25507	328	2	https://perma.cc/htm5-6rqf	https://perma.cc/htm5-6rqf	X
inlawrev-25507	328	3	]	]	X
inlawrev-25507	328	4	(	(	PUNCT
inlawrev-25507	328	5	further	far	ADV
inlawrev-25507	328	6	noting	note	VERB
inlawrev-25507	328	7	a	a	DET
inlawrev-25507	328	8	few	few	ADJ
inlawrev-25507	328	9	judges	judge	NOUN
inlawrev-25507	328	10	that	that	PRON
inlawrev-25507	328	11	were	be	AUX
inlawrev-25507	328	12	not	not	PART
inlawrev-25507	328	13	patent	patent	NOUN
inlawrev-25507	328	14	attorneys	attorney	NOUN
inlawrev-25507	328	15	but	but	CCONJ
inlawrev-25507	328	16	were	be	AUX
inlawrev-25507	328	17	instrumental	instrumental	ADJ
inlawrev-25507	328	18	in	in	ADP
inlawrev-25507	328	19	patent	patent	NOUN
inlawrev-25507	328	20	treatises	treatise	NOUN
inlawrev-25507	328	21	,	,	PUNCT
inlawrev-25507	328	22	casebooks	casebook	NOUN
inlawrev-25507	328	23	,	,	PUNCT
inlawrev-25507	328	24	and	and	CCONJ
inlawrev-25507	328	25	seminars	seminar	NOUN
inlawrev-25507	328	26	)	)	PUNCT
inlawrev-25507	328	27	.	.	PUNCT
inlawrev-25507	329	1	120	120	NUM
inlawrev-25507	329	2	.	.	X
inlawrev-25507	329	3	35	35	NUM
inlawrev-25507	329	4	u.s.c	u.s.c	NOUN
inlawrev-25507	329	5	.	.	PUNCT
inlawrev-25507	330	1	§	§	PROPN
inlawrev-25507	330	2	103	103	NUM
inlawrev-25507	330	3	(	(	PUNCT
inlawrev-25507	330	4	1952	1952	NUM
inlawrev-25507	330	5	)	)	PUNCT
inlawrev-25507	330	6	;	;	PUNCT
inlawrev-25507	330	7	mpep	mpep	PROPN
inlawrev-25507	330	8	§	§	PROPN
inlawrev-25507	330	9	804	804	NUM
inlawrev-25507	330	10	(	(	PUNCT
inlawrev-25507	330	11	9th	9th	ADJ
inlawrev-25507	330	12	ed	ed	NOUN
inlawrev-25507	330	13	.	.	PUNCT
inlawrev-25507	331	1	rev	rev	PROPN
inlawrev-25507	331	2	.	.	PROPN
inlawrev-25507	331	3	10.2019	10.2019	NUM
inlawrev-25507	331	4	,	,	PUNCT
inlawrev-25507	331	5	june	june	PROPN
inlawrev-25507	331	6	2020	2020	NUM
inlawrev-25507	331	7	)	)	PUNCT
inlawrev-25507	331	8	.	.	PUNCT
inlawrev-25507	332	1	208	208	NUM
inlawrev-25507	332	2	indiana	indiana	PROPN
inlawrev-25507	332	3	law	law	NOUN
inlawrev-25507	332	4	review	review	NOUN
inlawrev-25507	332	5	[	[	X
inlawrev-25507	332	6	vol	vol	NOUN
inlawrev-25507	332	7	.	.	PUNCT
inlawrev-25507	333	1	54:195	54:195	NUM
inlawrev-25507	333	2	examples	example	NOUN
inlawrev-25507	333	3	of	of	ADP
inlawrev-25507	333	4	evergreening	evergreene	VERB
inlawrev-25507	333	5	that	that	PRON
inlawrev-25507	333	6	have	have	AUX
inlawrev-25507	333	7	escaped	escape	VERB
inlawrev-25507	333	8	the	the	DET
inlawrev-25507	333	9	uspto	uspto	NOUN
inlawrev-25507	333	10	and	and	CCONJ
inlawrev-25507	333	11	the	the	DET
inlawrev-25507	333	12	federal	federal	ADJ
inlawrev-25507	333	13	circuit.121	circuit.121	NOUN
inlawrev-25507	333	14	therefore	therefore	ADV
inlawrev-25507	333	15	,	,	PUNCT
inlawrev-25507	333	16	the	the	DET
inlawrev-25507	333	17	uspto	uspto	NOUN
inlawrev-25507	333	18	,	,	PUNCT
inlawrev-25507	333	19	the	the	DET
inlawrev-25507	333	20	ptab	ptab	NOUN
inlawrev-25507	333	21	,	,	PUNCT
inlawrev-25507	333	22	and	and	CCONJ
inlawrev-25507	333	23	the	the	DET
inlawrev-25507	333	24	federal	federal	ADJ
inlawrev-25507	333	25	circuit	circuit	NOUN
inlawrev-25507	333	26	should	should	AUX
inlawrev-25507	333	27	implement	implement	VERB
inlawrev-25507	333	28	a	a	DET
inlawrev-25507	333	29	balancing	balancing	NOUN
inlawrev-25507	333	30	test	test	NOUN
inlawrev-25507	333	31	that	that	SCONJ
inlawrev-25507	333	32	“	"	PUNCT
inlawrev-25507	333	33	delicately	delicately	ADJ
inlawrev-25507	333	34	balances	balance	NOUN
inlawrev-25507	333	35	innovation	innovation	NOUN
inlawrev-25507	333	36	and	and	CCONJ
inlawrev-25507	333	37	competition	competition	NOUN
inlawrev-25507	333	38	.	.	PUNCT
inlawrev-25507	334	1	”122	”122	PUNCT
inlawrev-25507	335	1	ideally	ideally	ADV
inlawrev-25507	335	2	,	,	PUNCT
inlawrev-25507	335	3	the	the	DET
inlawrev-25507	335	4	balancing	balancing	NOUN
inlawrev-25507	335	5	test	test	NOUN
inlawrev-25507	335	6	would	would	AUX
inlawrev-25507	335	7	include	include	VERB
inlawrev-25507	335	8	examining	examine	VERB
inlawrev-25507	335	9	the	the	DET
inlawrev-25507	335	10	following	follow	VERB
inlawrev-25507	335	11	factors	factor	NOUN
inlawrev-25507	335	12	:	:	PUNCT
inlawrev-25507	335	13	(	(	PUNCT
inlawrev-25507	335	14	1	1	X
inlawrev-25507	335	15	)	)	PUNCT
inlawrev-25507	335	16	the	the	DET
inlawrev-25507	335	17	number	number	NOUN
inlawrev-25507	335	18	of	of	ADP
inlawrev-25507	335	19	secondary	secondary	ADJ
inlawrev-25507	335	20	patents	patent	NOUN
inlawrev-25507	335	21	on	on	ADP
inlawrev-25507	335	22	the	the	DET
inlawrev-25507	335	23	drug123	drug123	PROPN
inlawrev-25507	335	24	;	;	PUNCT
inlawrev-25507	335	25	(	(	PUNCT
inlawrev-25507	335	26	2	2	X
inlawrev-25507	335	27	)	)	PUNCT
inlawrev-25507	335	28	whether	whether	SCONJ
inlawrev-25507	335	29	members	member	NOUN
inlawrev-25507	335	30	of	of	ADP
inlawrev-25507	335	31	the	the	DET
inlawrev-25507	335	32	patent	patent	NOUN
inlawrev-25507	335	33	family	family	NOUN
inlawrev-25507	335	34	have	have	AUX
inlawrev-25507	335	35	been	be	AUX
inlawrev-25507	335	36	challenged	challenge	VERB
inlawrev-25507	335	37	and	and	CCONJ
inlawrev-25507	335	38	invalidated	invalidate	VERB
inlawrev-25507	335	39	at	at	ADP
inlawrev-25507	335	40	the	the	DET
inlawrev-25507	335	41	uspto	uspto	NOUN
inlawrev-25507	335	42	,	,	PUNCT
inlawrev-25507	335	43	ptab	ptab	NOUN
inlawrev-25507	335	44	,	,	PUNCT
inlawrev-25507	335	45	or	or	CCONJ
inlawrev-25507	335	46	federal	federal	ADJ
inlawrev-25507	335	47	circuit	circuit	NOUN
inlawrev-25507	335	48	;	;	PUNCT
inlawrev-25507	335	49	(	(	PUNCT
inlawrev-25507	335	50	3	3	X
inlawrev-25507	335	51	)	)	PUNCT
inlawrev-25507	335	52	when	when	SCONJ
inlawrev-25507	335	53	the	the	DET
inlawrev-25507	335	54	bulk	bulk	NOUN
inlawrev-25507	335	55	of	of	ADP
inlawrev-25507	335	56	the	the	DET
inlawrev-25507	335	57	patents	patent	NOUN
inlawrev-25507	335	58	were	be	AUX
inlawrev-25507	335	59	filed	file	VERB
inlawrev-25507	335	60	in	in	ADP
inlawrev-25507	335	61	relation	relation	NOUN
inlawrev-25507	335	62	to	to	ADP
inlawrev-25507	335	63	the	the	DET
inlawrev-25507	335	64	approval	approval	NOUN
inlawrev-25507	335	65	date	date	NOUN
inlawrev-25507	335	66	for	for	ADP
inlawrev-25507	335	67	the	the	DET
inlawrev-25507	335	68	drug	drug	NOUN
inlawrev-25507	335	69	;	;	PUNCT
inlawrev-25507	335	70	(	(	PUNCT
inlawrev-25507	335	71	4	4	X
inlawrev-25507	335	72	)	)	PUNCT
inlawrev-25507	335	73	whether	whether	SCONJ
inlawrev-25507	335	74	the	the	DET
inlawrev-25507	335	75	patent	patent	NOUN
inlawrev-25507	335	76	owner	owner	NOUN
inlawrev-25507	335	77	is	be	AUX
inlawrev-25507	335	78	attempting	attempt	VERB
inlawrev-25507	335	79	to	to	PART
inlawrev-25507	335	80	protect	protect	VERB
inlawrev-25507	335	81	a	a	DET
inlawrev-25507	335	82	legacy	legacy	NOUN
inlawrev-25507	335	83	patent	patent	NOUN
inlawrev-25507	335	84	(	(	PUNCT
inlawrev-25507	335	85	i.e.	i.e.	X
inlawrev-25507	335	86	a	a	DET
inlawrev-25507	335	87	product	product	NOUN
inlawrev-25507	335	88	with	with	ADP
inlawrev-25507	335	89	approved	approve	VERB
inlawrev-25507	335	90	generics	generic	NOUN
inlawrev-25507	335	91	or	or	CCONJ
inlawrev-25507	335	92	biosimilars	biosimilar	NOUN
inlawrev-25507	335	93	on	on	ADP
inlawrev-25507	335	94	the	the	DET
inlawrev-25507	335	95	market	market	NOUN
inlawrev-25507	335	96	)	)	PUNCT
inlawrev-25507	335	97	;	;	PUNCT
inlawrev-25507	335	98	(	(	PUNCT
inlawrev-25507	335	99	5	5	X
inlawrev-25507	335	100	)	)	PUNCT
inlawrev-25507	335	101	the	the	DET
inlawrev-25507	335	102	innovation	innovation	NOUN
inlawrev-25507	335	103	between	between	ADP
inlawrev-25507	335	104	the	the	DET
inlawrev-25507	335	105	initial	initial	ADJ
inlawrev-25507	335	106	patent	patent	NOUN
inlawrev-25507	335	107	and	and	CCONJ
inlawrev-25507	335	108	secondary	secondary	ADJ
inlawrev-25507	335	109	patent124	patent124	NOUN
inlawrev-25507	335	110	;	;	PUNCT
inlawrev-25507	335	111	(	(	PUNCT
inlawrev-25507	335	112	6	6	X
inlawrev-25507	335	113	)	)	PUNCT
inlawrev-25507	335	114	the	the	DET
inlawrev-25507	335	115	amount	amount	NOUN
inlawrev-25507	335	116	of	of	ADP
inlawrev-25507	335	117	research	research	NOUN
inlawrev-25507	335	118	and	and	CCONJ
inlawrev-25507	335	119	development	development	NOUN
inlawrev-25507	335	120	initiated	initiate	VERB
inlawrev-25507	335	121	in	in	ADP
inlawrev-25507	335	122	order	order	NOUN
inlawrev-25507	335	123	to	to	PART
inlawrev-25507	335	124	find	find	VERB
inlawrev-25507	335	125	the	the	DET
inlawrev-25507	335	126	innovation125	innovation125	PROPN
inlawrev-25507	335	127	;	;	PUNCT
inlawrev-25507	335	128	(	(	PUNCT
inlawrev-25507	335	129	7	7	X
inlawrev-25507	335	130	)	)	PUNCT
inlawrev-25507	335	131	whether	whether	SCONJ
inlawrev-25507	335	132	the	the	DET
inlawrev-25507	335	133	patent	patent	NOUN
inlawrev-25507	335	134	relates	relate	VERB
inlawrev-25507	335	135	to	to	ADP
inlawrev-25507	335	136	a	a	DET
inlawrev-25507	335	137	new	new	ADJ
inlawrev-25507	335	138	and	and	CCONJ
inlawrev-25507	335	139	improved	improved	ADJ
inlawrev-25507	335	140	treatment	treatment	NOUN
inlawrev-25507	335	141	in	in	ADP
inlawrev-25507	335	142	the	the	DET
inlawrev-25507	335	143	disease	disease	NOUN
inlawrev-25507	335	144	area	area	NOUN
inlawrev-25507	335	145	or	or	CCONJ
inlawrev-25507	335	146	whether	whether	SCONJ
inlawrev-25507	335	147	it	it	PRON
inlawrev-25507	335	148	relates	relate	VERB
inlawrev-25507	335	149	to	to	ADP
inlawrev-25507	335	150	an	an	DET
inlawrev-25507	335	151	alternative	alternative	ADJ
inlawrev-25507	335	152	treatment	treatment	NOUN
inlawrev-25507	335	153	;	;	PUNCT
inlawrev-25507	335	154	(	(	PUNCT
inlawrev-25507	335	155	8)	8)	NUM
inlawrev-25507	335	156	the	the	DET
inlawrev-25507	335	157	number	number	NOUN
inlawrev-25507	335	158	of	of	ADP
inlawrev-25507	335	159	patents	patent	NOUN
inlawrev-25507	335	160	granted	grant	VERB
inlawrev-25507	335	161	in	in	ADP
inlawrev-25507	335	162	other	other	ADJ
inlawrev-25507	335	163	countries	country	NOUN
inlawrev-25507	335	164	in	in	ADP
inlawrev-25507	335	165	comparison	comparison	NOUN
inlawrev-25507	335	166	to	to	ADP
inlawrev-25507	335	167	the	the	DET
inlawrev-25507	335	168	expiration	expiration	NOUN
inlawrev-25507	335	169	date	date	NOUN
inlawrev-25507	335	170	in	in	ADP
inlawrev-25507	335	171	those	those	DET
inlawrev-25507	335	172	countries126	countries126	PROPN
inlawrev-25507	335	173	;	;	PUNCT
inlawrev-25507	335	174	(	(	PUNCT
inlawrev-25507	335	175	9	9	X
inlawrev-25507	335	176	)	)	PUNCT
inlawrev-25507	335	177	whether	whether	SCONJ
inlawrev-25507	335	178	the	the	DET
inlawrev-25507	335	179	secondary	secondary	ADJ
inlawrev-25507	335	180	patent	patent	NOUN
inlawrev-25507	335	181	was	be	AUX
inlawrev-25507	335	182	related	relate	VERB
inlawrev-25507	335	183	to	to	ADP
inlawrev-25507	335	184	innovation	innovation	NOUN
inlawrev-25507	335	185	that	that	SCONJ
inlawrev-25507	335	186	the	the	DET
inlawrev-25507	335	187	applicant	applicant	NOUN
inlawrev-25507	335	188	suppressed	suppress	VERB
inlawrev-25507	335	189	or	or	CCONJ
inlawrev-25507	335	190	concealed	conceal	VERB
inlawrev-25507	335	191	for	for	ADP
inlawrev-25507	335	192	a	a	DET
inlawrev-25507	335	193	significant	significant	ADJ
inlawrev-25507	335	194	period	period	NOUN
inlawrev-25507	335	195	of	of	ADP
inlawrev-25507	335	196	time	time	NOUN
inlawrev-25507	335	197	or	or	CCONJ
inlawrev-25507	335	198	whether	whether	SCONJ
inlawrev-25507	335	199	the	the	DET
inlawrev-25507	335	200	applicant	applicant	NOUN
inlawrev-25507	335	201	was	be	AUX
inlawrev-25507	335	202	not	not	PART
inlawrev-25507	335	203	reasonably	reasonably	ADV
inlawrev-25507	335	204	diligent	diligent	ADJ
inlawrev-25507	335	205	in	in	ADP
inlawrev-25507	335	206	filing	file	VERB
inlawrev-25507	335	207	the	the	DET
inlawrev-25507	335	208	patent	patent	NOUN
inlawrev-25507	335	209	application(s	application(s	NOUN
inlawrev-25507	335	210	)	)	PUNCT
inlawrev-25507	335	211	;	;	PUNCT
inlawrev-25507	335	212	(	(	PUNCT
inlawrev-25507	335	213	10	10	NUM
inlawrev-25507	335	214	)	)	PUNCT
inlawrev-25507	335	215	whether	whether	SCONJ
inlawrev-25507	335	216	the	the	DET
inlawrev-25507	335	217	patent	patent	NOUN
inlawrev-25507	335	218	was	be	AUX
inlawrev-25507	335	219	not	not	PART
inlawrev-25507	335	220	listed	list	VERB
inlawrev-25507	335	221	in	in	ADP
inlawrev-25507	335	222	the	the	DET
inlawrev-25507	335	223	orange	orange	NOUN
inlawrev-25507	335	224	book127	book127	PROPN
inlawrev-25507	335	225	;	;	PUNCT
inlawrev-25507	335	226	and	and	CCONJ
inlawrev-25507	335	227	(	(	PUNCT
inlawrev-25507	335	228	11	11	NUM
inlawrev-25507	335	229	)	)	PUNCT
inlawrev-25507	335	230	any	any	DET
inlawrev-25507	335	231	other	other	ADJ
inlawrev-25507	335	232	information	information	NOUN
inlawrev-25507	335	233	that	that	PRON
inlawrev-25507	335	234	may	may	AUX
inlawrev-25507	335	235	be	be	AUX
inlawrev-25507	335	236	relevant	relevant	ADJ
inlawrev-25507	335	237	.	.	PUNCT
inlawrev-25507	336	1	this	this	DET
inlawrev-25507	336	2	test	test	NOUN
inlawrev-25507	336	3	could	could	AUX
inlawrev-25507	336	4	be	be	AUX
inlawrev-25507	336	5	applied	apply	VERB
inlawrev-25507	336	6	when	when	SCONJ
inlawrev-25507	336	7	determining	determine	VERB
inlawrev-25507	336	8	whether	whether	SCONJ
inlawrev-25507	336	9	to	to	PART
inlawrev-25507	336	10	grant	grant	VERB
inlawrev-25507	336	11	a	a	DET
inlawrev-25507	336	12	patent	patent	NOUN
inlawrev-25507	336	13	during	during	ADP
inlawrev-25507	336	14	an	an	DET
inlawrev-25507	336	15	inter	inter	ADJ
inlawrev-25507	336	16	partes	parte	NOUN
inlawrev-25507	336	17	review	review	NOUN
inlawrev-25507	336	18	(	(	PUNCT
inlawrev-25507	336	19	“	"	PUNCT
inlawrev-25507	336	20	ipr	ipr	PROPN
inlawrev-25507	336	21	”	"	PUNCT
inlawrev-25507	336	22	)	)	PUNCT
inlawrev-25507	336	23	or	or	CCONJ
inlawrev-25507	336	24	post	post	ADJ
inlawrev-25507	336	25	-	-	ADJ
inlawrev-25507	336	26	grant	grant	ADJ
inlawrev-25507	336	27	review	review	NOUN
inlawrev-25507	336	28	(	(	PUNCT
inlawrev-25507	336	29	“	"	PUNCT
inlawrev-25507	336	30	pgr	pgr	NOUN
inlawrev-25507	336	31	”	"	PUNCT
inlawrev-25507	336	32	)	)	PUNCT
inlawrev-25507	336	33	validity	validity	NOUN
inlawrev-25507	336	34	proceeding	proceeding	NOUN
inlawrev-25507	336	35	or	or	CCONJ
inlawrev-25507	336	36	during	during	ADP
inlawrev-25507	336	37	hatch	hatch	NOUN
inlawrev-25507	336	38	-	-	PUNCT
inlawrev-25507	336	39	waxman	waxman	NOUN
inlawrev-25507	336	40	or	or	CCONJ
inlawrev-25507	336	41	bpcia	bpcia	NOUN
inlawrev-25507	336	42	litigation.128	litigation.128	NOUN
inlawrev-25507	336	43	additionally	additionally	ADV
inlawrev-25507	336	44	,	,	PUNCT
inlawrev-25507	336	45	because	because	SCONJ
inlawrev-25507	336	46	other	other	ADJ
inlawrev-25507	336	47	121	121	NUM
inlawrev-25507	336	48	.	.	PUNCT
inlawrev-25507	337	1	see	see	AUX
inlawrev-25507	337	2	overpatented	overpatente	VERB
inlawrev-25507	337	3	,	,	PUNCT
inlawrev-25507	337	4	overpriced	overprice	VERB
inlawrev-25507	337	5	:	:	PUNCT
inlawrev-25507	337	6	special	special	ADJ
inlawrev-25507	337	7	humira	humira	PROPN
inlawrev-25507	337	8	edition	edition	PROPN
inlawrev-25507	337	9	,	,	PUNCT
inlawrev-25507	337	10	supra	supra	PROPN
inlawrev-25507	337	11	note	note	NOUN
inlawrev-25507	337	12	2	2	NUM
inlawrev-25507	337	13	;	;	PUNCT
inlawrev-25507	337	14	overpatented	overpatente	VERB
inlawrev-25507	337	15	,	,	PUNCT
inlawrev-25507	337	16	overpriced	overprice	VERB
inlawrev-25507	337	17	special	special	ADJ
inlawrev-25507	337	18	edition	edition	NOUN
inlawrev-25507	337	19	:	:	PUNCT
inlawrev-25507	337	20	lantus	lantus	PROPN
inlawrev-25507	337	21	,	,	PUNCT
inlawrev-25507	337	22	supra	supra	NOUN
inlawrev-25507	337	23	note	note	NOUN
inlawrev-25507	337	24	9	9	NUM
inlawrev-25507	337	25	.	.	SYM
inlawrev-25507	337	26	122	122	NUM
inlawrev-25507	337	27	.	.	PUNCT
inlawrev-25507	338	1	robin	robin	PROPN
inlawrev-25507	338	2	feldman	feldman	PROPN
inlawrev-25507	338	3	,	,	PUNCT
inlawrev-25507	338	4	may	may	AUX
inlawrev-25507	338	5	your	your	PRON
inlawrev-25507	338	6	drug	drug	NOUN
inlawrev-25507	338	7	prices	price	NOUN
inlawrev-25507	338	8	be	be	AUX
inlawrev-25507	338	9	evergreen	evergreen	VERB
inlawrev-25507	338	10	,	,	PUNCT
inlawrev-25507	338	11	5	5	NUM
inlawrev-25507	338	12	j.l	j.l	PROPN
inlawrev-25507	338	13	.	.	PROPN
inlawrev-25507	338	14	&	&	CCONJ
inlawrev-25507	338	15	biosci	biosci	PROPN
inlawrev-25507	338	16	.	.	PUNCT
inlawrev-25507	339	1	590	590	NUM
inlawrev-25507	339	2	,	,	PUNCT
inlawrev-25507	339	3	639	639	NUM
inlawrev-25507	339	4	(	(	PUNCT
inlawrev-25507	339	5	2018	2018	NUM
inlawrev-25507	339	6	)	)	PUNCT
inlawrev-25507	339	7	,	,	PUNCT
inlawrev-25507	339	8	https://academic.oup.com/jlb/article/5/3/590/5232981	https://academic.oup.com/jlb/article/5/3/590/5232981	X
inlawrev-25507	339	9	[	[	X
inlawrev-25507	339	10	https://perma.cc/69yh-2sbv	https://perma.cc/69yh-2sbv	PROPN
inlawrev-25507	339	11	]	]	PUNCT
inlawrev-25507	339	12	.	.	PUNCT
inlawrev-25507	340	1	123	123	NUM
inlawrev-25507	340	2	.	.	PUNCT
inlawrev-25507	341	1	see	see	AUX
inlawrev-25507	341	2	overpatented	overpatente	VERB
inlawrev-25507	341	3	:	:	PUNCT
inlawrev-25507	341	4	(	(	PUNCT
inlawrev-25507	341	5	not	not	PART
inlawrev-25507	341	6	so	so	ADV
inlawrev-25507	341	7	)	)	PUNCT
inlawrev-25507	341	8	average	average	ADJ
inlawrev-25507	341	9	,	,	PUNCT
inlawrev-25507	341	10	supra	supra	PROPN
inlawrev-25507	341	11	note	note	NOUN
inlawrev-25507	341	12	16	16	NUM
inlawrev-25507	341	13	.	.	PUNCT
inlawrev-25507	341	14	124	124	NUM
inlawrev-25507	341	15	.	.	PUNCT
inlawrev-25507	342	1	sarah	sarah	PROPN
inlawrev-25507	342	2	jane	jane	PROPN
inlawrev-25507	342	3	tribble	tribble	PROPN
inlawrev-25507	342	4	,	,	PUNCT
inlawrev-25507	342	5	‘	'	PUNCT
inlawrev-25507	342	6	evergreening	evergreening	NOUN
inlawrev-25507	342	7	’	'	PUNCT
inlawrev-25507	342	8	and	and	CCONJ
inlawrev-25507	342	9	other	other	ADJ
inlawrev-25507	342	10	ways	way	NOUN
inlawrev-25507	342	11	pharma	pharma	PROPN
inlawrev-25507	342	12	companies	company	NOUN
inlawrev-25507	342	13	manipulate	manipulate	VERB
inlawrev-25507	342	14	patents	patent	NOUN
inlawrev-25507	342	15	,	,	PUNCT
inlawrev-25507	342	16	benefitspro	benefitspro	X
inlawrev-25507	342	17	(	(	PUNCT
inlawrev-25507	342	18	oct	oct	PROPN
inlawrev-25507	342	19	.	.	PROPN
inlawrev-25507	342	20	4	4	NUM
inlawrev-25507	342	21	,	,	PUNCT
inlawrev-25507	342	22	2018	2018	NUM
inlawrev-25507	342	23	,	,	PUNCT
inlawrev-25507	342	24	10:36	10:36	NUM
inlawrev-25507	342	25	am	am	NOUN
inlawrev-25507	342	26	)	)	PUNCT
inlawrev-25507	342	27	,	,	PUNCT
inlawrev-25507	342	28	https://www.benefitspro.com/2018/10/04/	https://www.benefitspro.com/2018/10/04/	PROPN
inlawrev-25507	342	29	evergreen	evergreen	PROPN
inlawrev-25507	342	30	in	in	ADP
inlawrev-25507	342	31	g	g	NOUN
inlawrev-25507	342	32	-	-	PUNCT
inlawrev-25507	342	33	an	an	DET
inlawrev-25507	342	34	d	d	PROPN
inlawrev-25507	342	35	-	-	PUNCT
inlawrev-25507	342	36	oth	oth	PROPN
inlawrev-25507	342	37	er	er	PROPN
inlawrev-25507	342	38	-	-	PUNCT
inlawrev-25507	342	39	w	w	NOUN
inlawrev-25507	342	40	ays	ays	ADJ
inlawrev-25507	342	41	-	-	PUNCT
inlawrev-25507	342	42	pharma	pharma	NOUN
inlawrev-25507	342	43	-	-	PUNCT
inlawrev-25507	342	44	com	com	NOUN
inlawrev-25507	342	45	pan	pan	NOUN
inlawrev-25507	342	46	ies	ies	PROPN
inlawrev-25507	342	47	-	-	PROPN
inlawrev-25507	342	48	m	m	PROPN
inlawrev-25507	342	49	an	an	DET
inlawrev-25507	342	50	ip/?slretu	ip/?slretu	NOUN
inlawrev-25507	342	51	rn	rn	NOUN
inlawrev-25507	342	52	=	=	NOUN
inlawrev-25507	342	53	2	2	NUM
inlawrev-25507	342	54	0	0	NUM
inlawrev-25507	342	55	1	1	NUM
inlawrev-25507	342	56	9	9	NUM
inlawrev-25507	342	57	0	0	NUM
inlawrev-25507	342	58	9	9	NUM
inlawrev-25507	342	59	1	1	NUM
inlawrev-25507	342	60	6	6	NUM
inlawrev-25507	342	61	1	1	NUM
inlawrev-25507	342	62	9	9	NUM
inlawrev-25507	342	63	0	0	NUM
inlawrev-25507	342	64	5	5	NUM
inlawrev-25507	342	65	2	2	NUM
inlawrev-25507	342	66	9	9	NUM
inlawrev-25507	342	67	[	[	X
inlawrev-25507	342	68	https://perma.cc/7nla-6upq	https://perma.cc/7nla-6upq	X
inlawrev-25507	342	69	]	]	X
inlawrev-25507	342	70	.	.	PUNCT
inlawrev-25507	343	1	125	125	NUM
inlawrev-25507	343	2	.	.	PUNCT
inlawrev-25507	343	3	see	see	VERB
inlawrev-25507	343	4	collier	collier	NOUN
inlawrev-25507	343	5	,	,	PUNCT
inlawrev-25507	343	6	supra	supra	PROPN
inlawrev-25507	343	7	note	note	NOUN
inlawrev-25507	343	8	26	26	NUM
inlawrev-25507	343	9	.	.	PUNCT
inlawrev-25507	343	10	126	126	NUM
inlawrev-25507	343	11	.	.	PUNCT
inlawrev-25507	344	1	overpatented	overpatente	VERB
inlawrev-25507	344	2	,	,	PUNCT
inlawrev-25507	344	3	overpriced	overprice	VERB
inlawrev-25507	344	4	:	:	PUNCT
inlawrev-25507	344	5	special	special	ADJ
inlawrev-25507	344	6	humira	humira	PROPN
inlawrev-25507	344	7	edition	edition	PROPN
inlawrev-25507	344	8	,	,	PUNCT
inlawrev-25507	344	9	supra	supra	PROPN
inlawrev-25507	344	10	note	note	NOUN
inlawrev-25507	344	11	2	2	NUM
inlawrev-25507	344	12	,	,	PUNCT
inlawrev-25507	344	13	at	at	ADP
inlawrev-25507	344	14	5	5	NUM
inlawrev-25507	344	15	.	.	PUNCT
inlawrev-25507	345	1	127	127	NUM
inlawrev-25507	345	2	.	.	PUNCT
inlawrev-25507	346	1	orange	orange	PROPN
inlawrev-25507	346	2	book	book	PROPN
inlawrev-25507	346	3	:	:	PUNCT
inlawrev-25507	346	4	approved	approve	VERB
inlawrev-25507	346	5	drug	drug	NOUN
inlawrev-25507	346	6	products	product	NOUN
inlawrev-25507	346	7	with	with	ADP
inlawrev-25507	346	8	therapeutic	therapeutic	ADJ
inlawrev-25507	346	9	equivalence	equivalence	NOUN
inlawrev-25507	346	10	evaluations	evaluation	NOUN
inlawrev-25507	346	11	,	,	PUNCT
inlawrev-25507	346	12	u.s	u.s	PROPN
inlawrev-25507	346	13	.	.	PROPN
inlawrev-25507	346	14	food	food	PROPN
inlawrev-25507	346	15	&	&	CCONJ
inlawrev-25507	346	16	drug	drug	PROPN
inlawrev-25507	346	17	admin	admin	PROPN
inlawrev-25507	346	18	.	.	PROPN
inlawrev-25507	346	19	,	,	PUNCT
inlawrev-25507	346	20	https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drugproducts-therapeutic-equivalence-evaluations-orange-book	https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drugproducts-therapeutic-equivalence-evaluations-orange-book	PROPN
inlawrev-25507	346	21	(	(	PUNCT
inlawrev-25507	346	22	last	last	ADJ
inlawrev-25507	346	23	updated	update	VERB
inlawrev-25507	346	24	sept	sept	PROPN
inlawrev-25507	346	25	.	.	PROPN
inlawrev-25507	346	26	11	11	NUM
inlawrev-25507	346	27	,	,	PUNCT
inlawrev-25507	346	28	2020	2020	NUM
inlawrev-25507	346	29	)	)	PUNCT
inlawrev-25507	347	1	[	[	X
inlawrev-25507	347	2	https://perma.cc/9yav-ayqu	https://perma.cc/9yav-ayqu	X
inlawrev-25507	347	3	]	]	X
inlawrev-25507	347	4	.	.	PUNCT
inlawrev-25507	348	1	128	128	NUM
inlawrev-25507	348	2	.	.	PUNCT
inlawrev-25507	349	1	for	for	ADP
inlawrev-25507	349	2	a	a	DET
inlawrev-25507	349	3	discussion	discussion	NOUN
inlawrev-25507	349	4	on	on	ADP
inlawrev-25507	349	5	ipr	ipr	PROPN
inlawrev-25507	349	6	and	and	CCONJ
inlawrev-25507	349	7	pgr	pgr	PROPN
inlawrev-25507	349	8	,	,	PUNCT
inlawrev-25507	349	9	see	see	VERB
inlawrev-25507	349	10	ryan	ryan	PROPN
inlawrev-25507	349	11	kenny	kenny	PROPN
inlawrev-25507	349	12	,	,	PUNCT
inlawrev-25507	349	13	which	which	DET
inlawrev-25507	349	14	invalidity	invalidity	NOUN
inlawrev-25507	349	15	avenue	avenue	NOUN
inlawrev-25507	349	16	to	to	PART
inlawrev-25507	349	17	take	take	VERB
inlawrev-25507	349	18	:	:	PUNCT
inlawrev-25507	349	19	inter	inter	ADJ
inlawrev-25507	349	20	partes	partes	PROPN
inlawrev-25507	349	21	review	review	NOUN
inlawrev-25507	349	22	verses	verses	ADP
inlawrev-25507	349	23	post	post	ADJ
inlawrev-25507	349	24	-	-	ADJ
inlawrev-25507	349	25	grant	grant	ADJ
inlawrev-25507	349	26	review	review	NOUN
inlawrev-25507	349	27	,	,	PUNCT
inlawrev-25507	349	28	ipwatchdog	ipwatchdog	PROPN
inlawrev-25507	349	29	(	(	PUNCT
inlawrev-25507	349	30	july	july	PROPN
inlawrev-25507	349	31	31	31	NUM
inlawrev-25507	349	32	,	,	PUNCT
inlawrev-25507	349	33	2018	2018	NUM
inlawrev-25507	349	34	)	)	PUNCT
inlawrev-25507	349	35	,	,	PUNCT
inlawrev-25507	349	36	https://www	https://www	PROPN
inlawrev-25507	349	37	.	.	PUNCT
inlawrev-25507	350	1	ipwatchdog.com/2018/07/31/which-invalidity-avenue-ipr-verses-post-grant-review/id=99460/	ipwatchdog.com/2018/07/31/which-invalidity-avenue-ipr-verses-post-grant-review/id=99460/	ADJ
inlawrev-25507	350	2	2021	2021	NUM
inlawrev-25507	350	3	]	]	PUNCT
inlawrev-25507	351	1	leaving	leave	VERB
inlawrev-25507	351	2	the	the	DET
inlawrev-25507	351	3	evergreening	evergreene	VERB
inlawrev-25507	351	4	problem	problem	NOUN
inlawrev-25507	351	5	to	to	ADP
inlawrev-25507	351	6	the	the	DET
inlawrev-25507	351	7	patent	patent	NOUN
inlawrev-25507	351	8	experts	expert	NOUN
inlawrev-25507	351	9	209	209	NUM
inlawrev-25507	351	10	federal	federal	ADJ
inlawrev-25507	351	11	courts	court	NOUN
inlawrev-25507	351	12	have	have	VERB
inlawrev-25507	351	13	jurisdiction	jurisdiction	NOUN
inlawrev-25507	351	14	to	to	PART
inlawrev-25507	351	15	hear	hear	VERB
inlawrev-25507	351	16	patent	patent	NOUN
inlawrev-25507	351	17	cases,129	cases,129	PROPN
inlawrev-25507	351	18	they	they	PRON
inlawrev-25507	351	19	are	be	AUX
inlawrev-25507	351	20	encouraged	encourage	VERB
inlawrev-25507	351	21	to	to	PART
inlawrev-25507	351	22	implement	implement	VERB
inlawrev-25507	351	23	the	the	DET
inlawrev-25507	351	24	test	test	NOUN
inlawrev-25507	351	25	as	as	ADV
inlawrev-25507	351	26	well	well	ADV
inlawrev-25507	351	27	.	.	PUNCT
inlawrev-25507	352	1	however	however	ADV
inlawrev-25507	352	2	,	,	PUNCT
inlawrev-25507	352	3	as	as	ADP
inlawrev-25507	352	4	with	with	ADP
inlawrev-25507	352	5	most	most	ADJ
inlawrev-25507	352	6	patent	patent	NOUN
inlawrev-25507	352	7	cases	case	NOUN
inlawrev-25507	352	8	,	,	PUNCT
inlawrev-25507	352	9	the	the	DET
inlawrev-25507	352	10	court	court	NOUN
inlawrev-25507	352	11	of	of	ADP
inlawrev-25507	352	12	appeals	appeal	NOUN
inlawrev-25507	352	13	for	for	ADP
inlawrev-25507	352	14	the	the	DET
inlawrev-25507	352	15	federal	federal	ADJ
inlawrev-25507	352	16	circuit	circuit	NOUN
inlawrev-25507	352	17	is	be	AUX
inlawrev-25507	352	18	usually	usually	ADV
inlawrev-25507	352	19	the	the	DET
inlawrev-25507	352	20	last	last	ADJ
inlawrev-25507	352	21	court	court	NOUN
inlawrev-25507	352	22	to	to	PART
inlawrev-25507	352	23	hear	hear	VERB
inlawrev-25507	352	24	a	a	DET
inlawrev-25507	352	25	case1	case1	NOUN
inlawrev-25507	352	26	3	3	NUM
inlawrev-25507	352	27	0	0	NUM
inlawrev-25507	352	28	;	;	PUNCT
inlawrev-25507	352	29	it	it	PRON
inlawrev-25507	352	30	is	be	AUX
inlawrev-25507	352	31	therefore	therefore	ADV
inlawrev-25507	352	32	crucial	crucial	ADJ
inlawrev-25507	352	33	that	that	SCONJ
inlawrev-25507	352	34	the	the	DET
inlawrev-25507	352	35	test	test	NOUN
inlawrev-25507	352	36	is	be	AUX
inlawrev-25507	352	37	implemented	implement	VERB
inlawrev-25507	352	38	there	there	ADV
inlawrev-25507	352	39	as	as	ADV
inlawrev-25507	352	40	well	well	ADV
inlawrev-25507	352	41	as	as	ADP
inlawrev-25507	352	42	at	at	ADP
inlawrev-25507	352	43	the	the	DET
inlawrev-25507	352	44	uspto	uspto	NOUN
inlawrev-25507	352	45	.	.	PUNCT
inlawrev-25507	353	1	b.	b.	PROPN
inlawrev-25507	353	2	explanation	explanation	NOUN
inlawrev-25507	353	3	of	of	ADP
inlawrev-25507	353	4	the	the	DET
inlawrev-25507	353	5	balancing	balancing	NOUN
inlawrev-25507	353	6	test	test	NOUN
inlawrev-25507	353	7	the	the	DET
inlawrev-25507	353	8	balancing	balancing	NOUN
inlawrev-25507	353	9	test	test	NOUN
inlawrev-25507	353	10	above	above	ADV
inlawrev-25507	353	11	contains	contain	VERB
inlawrev-25507	353	12	eleven	eleven	NUM
inlawrev-25507	353	13	relevant	relevant	ADJ
inlawrev-25507	353	14	factors	factor	NOUN
inlawrev-25507	353	15	that	that	PRON
inlawrev-25507	353	16	may	may	AUX
inlawrev-25507	353	17	help	help	VERB
inlawrev-25507	353	18	the	the	DET
inlawrev-25507	353	19	uspto	uspto	NOUN
inlawrev-25507	353	20	,	,	PUNCT
inlawrev-25507	353	21	the	the	DET
inlawrev-25507	353	22	ptab	ptab	NOUN
inlawrev-25507	353	23	,	,	PUNCT
inlawrev-25507	353	24	or	or	CCONJ
inlawrev-25507	353	25	the	the	DET
inlawrev-25507	353	26	federal	federal	ADJ
inlawrev-25507	353	27	circuit	circuit	NOUN
inlawrev-25507	353	28	determine	determine	VERB
inlawrev-25507	353	29	whether	whether	SCONJ
inlawrev-25507	353	30	or	or	CCONJ
inlawrev-25507	353	31	not	not	PART
inlawrev-25507	353	32	a	a	DET
inlawrev-25507	353	33	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	353	34	company	company	NOUN
inlawrev-25507	353	35	is	be	AUX
inlawrev-25507	353	36	attempting	attempt	VERB
inlawrev-25507	353	37	to	to	PART
inlawrev-25507	353	38	evergreen	evergreen	VERB
inlawrev-25507	353	39	on	on	ADP
inlawrev-25507	353	40	one	one	NUM
inlawrev-25507	353	41	of	of	ADP
inlawrev-25507	353	42	its	its	PRON
inlawrev-25507	353	43	products	product	NOUN
inlawrev-25507	353	44	.	.	PUNCT
inlawrev-25507	354	1	however	however	ADV
inlawrev-25507	354	2	,	,	PUNCT
inlawrev-25507	354	3	not	not	PART
inlawrev-25507	354	4	every	every	DET
inlawrev-25507	354	5	factor	factor	NOUN
inlawrev-25507	354	6	should	should	AUX
inlawrev-25507	354	7	be	be	AUX
inlawrev-25507	354	8	given	give	VERB
inlawrev-25507	354	9	equal	equal	ADJ
inlawrev-25507	354	10	weight	weight	NOUN
inlawrev-25507	354	11	;	;	PUNCT
inlawrev-25507	354	12	additionally	additionally	ADV
inlawrev-25507	354	13	,	,	PUNCT
inlawrev-25507	354	14	not	not	PART
inlawrev-25507	354	15	every	every	DET
inlawrev-25507	354	16	factor	factor	NOUN
inlawrev-25507	354	17	would	would	AUX
inlawrev-25507	354	18	need	need	VERB
inlawrev-25507	354	19	to	to	PART
inlawrev-25507	354	20	be	be	AUX
inlawrev-25507	354	21	found	find	VERB
inlawrev-25507	354	22	to	to	PART
inlawrev-25507	354	23	draw	draw	VERB
inlawrev-25507	354	24	the	the	DET
inlawrev-25507	354	25	conclusion	conclusion	NOUN
inlawrev-25507	354	26	of	of	ADP
inlawrev-25507	354	27	evergreening	evergreene	VERB
inlawrev-25507	354	28	.	.	PUNCT
inlawrev-25507	355	1	the	the	DET
inlawrev-25507	355	2	first	first	ADJ
inlawrev-25507	355	3	factor	factor	NOUN
inlawrev-25507	355	4	—	—	PUNCT
inlawrev-25507	355	5	the	the	DET
inlawrev-25507	355	6	number	number	NOUN
inlawrev-25507	355	7	of	of	ADP
inlawrev-25507	355	8	secondary	secondary	ADJ
inlawrev-25507	355	9	patents	patent	NOUN
inlawrev-25507	355	10	on	on	ADP
inlawrev-25507	355	11	a	a	DET
inlawrev-25507	355	12	drug	drug	NOUN
inlawrev-25507	355	13	—	—	PUNCT
inlawrev-25507	355	14	should	should	AUX
inlawrev-25507	355	15	be	be	AUX
inlawrev-25507	355	16	given	give	VERB
inlawrev-25507	355	17	substantial	substantial	ADJ
inlawrev-25507	355	18	weight	weight	NOUN
inlawrev-25507	355	19	,	,	PUNCT
inlawrev-25507	355	20	considering	consider	VERB
inlawrev-25507	355	21	the	the	DET
inlawrev-25507	355	22	issue	issue	NOUN
inlawrev-25507	355	23	of	of	ADP
inlawrev-25507	355	24	evergreening	evergreening	NOUN
inlawrev-25507	355	25	is	be	AUX
inlawrev-25507	355	26	the	the	DET
inlawrev-25507	355	27	abundance	abundance	NOUN
inlawrev-25507	355	28	of	of	ADP
inlawrev-25507	355	29	secondary	secondary	ADJ
inlawrev-25507	355	30	patents	patent	NOUN
inlawrev-25507	355	31	on	on	ADP
inlawrev-25507	355	32	slight	slight	ADJ
inlawrev-25507	355	33	modifications.131	modifications.131	VERB
inlawrev-25507	355	34	a	a	DET
inlawrev-25507	355	35	substantial	substantial	ADJ
inlawrev-25507	355	36	number	number	NOUN
inlawrev-25507	355	37	of	of	ADP
inlawrev-25507	355	38	secondary	secondary	ADJ
inlawrev-25507	355	39	patents	patent	NOUN
inlawrev-25507	355	40	could	could	AUX
inlawrev-25507	355	41	be	be	AUX
inlawrev-25507	355	42	a	a	DET
inlawrev-25507	355	43	clear	clear	ADJ
inlawrev-25507	355	44	indication	indication	NOUN
inlawrev-25507	355	45	of	of	ADP
inlawrev-25507	355	46	a	a	DET
inlawrev-25507	355	47	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	355	48	company	company	NOUN
inlawrev-25507	355	49	’s	’s	PART
inlawrev-25507	355	50	intent	intent	NOUN
inlawrev-25507	355	51	to	to	AUX
inlawrev-25507	355	52	evergreen.132	evergreen.132	VERB
inlawrev-25507	355	53	however	however	ADV
inlawrev-25507	355	54	,	,	PUNCT
inlawrev-25507	355	55	the	the	DET
inlawrev-25507	355	56	secondary	secondary	ADJ
inlawrev-25507	355	57	patents	patent	NOUN
inlawrev-25507	355	58	could	could	AUX
inlawrev-25507	355	59	be	be	AUX
inlawrev-25507	355	60	genuine	genuine	ADJ
inlawrev-25507	355	61	discoveries133	discoveries133	PROPN
inlawrev-25507	355	62	;	;	PUNCT
inlawrev-25507	355	63	therefore	therefore	ADV
inlawrev-25507	355	64	,	,	PUNCT
inlawrev-25507	355	65	factor	factor	NOUN
inlawrev-25507	355	66	one	one	PRON
inlawrev-25507	355	67	would	would	AUX
inlawrev-25507	355	68	likely	likely	ADV
inlawrev-25507	355	69	be	be	AUX
inlawrev-25507	355	70	examined	examine	VERB
inlawrev-25507	355	71	alongside	alongside	ADP
inlawrev-25507	355	72	factor	factor	NOUN
inlawrev-25507	355	73	five	five	NUM
inlawrev-25507	355	74	—	—	PUNCT
inlawrev-25507	355	75	the	the	DET
inlawrev-25507	355	76	innovation	innovation	NOUN
inlawrev-25507	355	77	between	between	ADP
inlawrev-25507	355	78	the	the	DET
inlawrev-25507	355	79	initial	initial	ADJ
inlawrev-25507	355	80	patent	patent	NOUN
inlawrev-25507	355	81	and	and	CCONJ
inlawrev-25507	355	82	the	the	DET
inlawrev-25507	355	83	secondary	secondary	ADJ
inlawrev-25507	355	84	patent	patent	NOUN
inlawrev-25507	355	85	.	.	PUNCT
inlawrev-25507	356	1	ideally	ideally	ADV
inlawrev-25507	356	2	,	,	PUNCT
inlawrev-25507	356	3	whichever	whichever	DET
inlawrev-25507	356	4	entity	entity	NOUN
inlawrev-25507	356	5	implements	implement	VERB
inlawrev-25507	356	6	the	the	DET
inlawrev-25507	356	7	balancing	balancing	NOUN
inlawrev-25507	356	8	test	test	NOUN
inlawrev-25507	356	9	would	would	AUX
inlawrev-25507	356	10	heavily	heavily	ADV
inlawrev-25507	356	11	rely	rely	VERB
inlawrev-25507	356	12	on	on	ADP
inlawrev-25507	356	13	not	not	PART
inlawrev-25507	356	14	only	only	ADV
inlawrev-25507	356	15	their	their	PRON
inlawrev-25507	356	16	own	own	ADJ
inlawrev-25507	356	17	expertise	expertise	NOUN
inlawrev-25507	356	18	with	with	ADP
inlawrev-25507	356	19	their	their	PRON
inlawrev-25507	356	20	patent	patent	NOUN
inlawrev-25507	356	21	and	and	CCONJ
inlawrev-25507	356	22	science	science	NOUN
inlawrev-25507	356	23	background,134	background,134	PROPN
inlawrev-25507	356	24	but	but	CCONJ
inlawrev-25507	356	25	also	also	ADV
inlawrev-25507	356	26	on	on	ADP
inlawrev-25507	356	27	that	that	PRON
inlawrev-25507	356	28	of	of	ADP
inlawrev-25507	356	29	other	other	ADJ
inlawrev-25507	356	30	scientists	scientist	NOUN
inlawrev-25507	356	31	and	and	CCONJ
inlawrev-25507	356	32	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	356	33	researchers	researcher	NOUN
inlawrev-25507	356	34	.	.	PUNCT
inlawrev-25507	357	1	the	the	DET
inlawrev-25507	357	2	purpose	purpose	NOUN
inlawrev-25507	357	3	of	of	ADP
inlawrev-25507	357	4	the	the	DET
inlawrev-25507	357	5	second	second	ADJ
inlawrev-25507	357	6	factor	factor	NOUN
inlawrev-25507	357	7	—	—	PUNCT
inlawrev-25507	357	8	whether	whether	SCONJ
inlawrev-25507	357	9	members	member	NOUN
inlawrev-25507	357	10	of	of	ADP
inlawrev-25507	357	11	the	the	DET
inlawrev-25507	357	12	patent	patent	NOUN
inlawrev-25507	357	13	family	family	NOUN
inlawrev-25507	358	1	[	[	X
inlawrev-25507	358	2	https://perma.cc/9d8r-7xz8	https://perma.cc/9d8r-7xz8	PROPN
inlawrev-25507	358	3	]	]	X
inlawrev-25507	358	4	.	.	PUNCT
inlawrev-25507	359	1	for	for	ADP
inlawrev-25507	359	2	a	a	DET
inlawrev-25507	359	3	discussion	discussion	NOUN
inlawrev-25507	359	4	on	on	ADP
inlawrev-25507	359	5	hatch	hatch	NOUN
inlawrev-25507	359	6	-	-	PUNCT
inlawrev-25507	359	7	waxman	waxman	NOUN
inlawrev-25507	359	8	and	and	CCONJ
inlawrev-25507	359	9	bpcia	bpcia	NOUN
inlawrev-25507	359	10	litigation	litigation	NOUN
inlawrev-25507	359	11	,	,	PUNCT
inlawrev-25507	359	12	see	see	VERB
inlawrev-25507	359	13	what	what	PRON
inlawrev-25507	359	14	are	be	AUX
inlawrev-25507	359	15	the	the	DET
inlawrev-25507	359	16	patent	patent	NOUN
inlawrev-25507	359	17	litigation	litigation	NOUN
inlawrev-25507	359	18	differences	difference	NOUN
inlawrev-25507	359	19	between	between	ADP
inlawrev-25507	359	20	the	the	DET
inlawrev-25507	359	21	bpcia	bpcia	NOUN
inlawrev-25507	359	22	and	and	CCONJ
inlawrev-25507	359	23	hatch	hatch	PROPN
inlawrev-25507	359	24	-	-	PUNCT
inlawrev-25507	359	25	waxman	waxman	PROPN
inlawrev-25507	359	26	act	act	PROPN
inlawrev-25507	359	27	?	?	PROPN
inlawrev-25507	359	28	,	,	PUNCT
inlawrev-25507	359	29	winston	winston	PROPN
inlawrev-25507	359	30	&	&	CCONJ
inlawrev-25507	359	31	strawn	strawn	PROPN
inlawrev-25507	359	32	llp	llp	PROPN
inlawrev-25507	359	33	,	,	PUNCT
inlawrev-25507	359	34	https://www.winston.com/en/legal-glossary/bpcia-hatch-waxmanact-differences.html	https://www.winston.com/en/legal-glossary/bpcia-hatch-waxmanact-differences.html	X
inlawrev-25507	359	35	(	(	PUNCT
inlawrev-25507	359	36	last	last	ADV
inlawrev-25507	359	37	visited	visit	VERB
inlawrev-25507	359	38	nov	nov	PROPN
inlawrev-25507	359	39	.	.	PROPN
inlawrev-25507	359	40	28	28	NUM
inlawrev-25507	359	41	,	,	PUNCT
inlawrev-25507	359	42	2019	2019	NUM
inlawrev-25507	359	43	)	)	PUNCT
inlawrev-25507	360	1	[	[	X
inlawrev-25507	360	2	https://perma.cc/vyr8-2cnh	https://perma.cc/vyr8-2cnh	X
inlawrev-25507	360	3	]	]	PUNCT
inlawrev-25507	360	4	.	.	PUNCT
inlawrev-25507	361	1	129	129	NUM
inlawrev-25507	361	2	.	.	PUNCT
inlawrev-25507	362	1	state	state	NOUN
inlawrev-25507	362	2	and	and	CCONJ
inlawrev-25507	362	3	federal	federal	ADJ
inlawrev-25507	362	4	court	court	NOUN
inlawrev-25507	362	5	adjudication	adjudication	NOUN
inlawrev-25507	362	6	of	of	ADP
inlawrev-25507	362	7	federal	federal	ADJ
inlawrev-25507	362	8	patent	patent	NOUN
inlawrev-25507	362	9	issues	issue	NOUN
inlawrev-25507	362	10	,	,	PUNCT
inlawrev-25507	362	11	brinks	brinks	PROPN
inlawrev-25507	362	12	gilson	gilson	PROPN
inlawrev-25507	362	13	&	&	CCONJ
inlawrev-25507	362	14	lione	lione	PROPN
inlawrev-25507	362	15	,	,	PUNCT
inlawrev-25507	362	16	https://www.brinksgilson.com/state-federal-court-adjudication-federal-patent-issues	https://www.brinksgilson.com/state-federal-court-adjudication-federal-patent-issues	PROPN
inlawrev-25507	362	17	(	(	PUNCT
inlawrev-25507	362	18	last	last	ADV
inlawrev-25507	362	19	visited	visit	VERB
inlawrev-25507	362	20	nov	nov	PROPN
inlawrev-25507	362	21	.	.	PROPN
inlawrev-25507	362	22	29	29	NUM
inlawrev-25507	362	23	,	,	PUNCT
inlawrev-25507	362	24	2019	2019	NUM
inlawrev-25507	362	25	)	)	PUNCT
inlawrev-25507	363	1	[	[	X
inlawrev-25507	363	2	https://perma.cc/r4h9-c963	https://perma.cc/r4h9-c963	X
inlawrev-25507	363	3	]	]	PUNCT
inlawrev-25507	363	4	.	.	PUNCT
inlawrev-25507	364	1	130	130	NUM
inlawrev-25507	364	2	.	.	PUNCT
inlawrev-25507	365	1	i	i	PRON
inlawrev-25507	365	2	d.	d.	PROPN
inlawrev-25507	365	3	131	131	NUM
inlawrev-25507	365	4	.	.	PUNCT
inlawrev-25507	366	1	collier	collier	PROPN
inlawrev-25507	366	2	,	,	PUNCT
inlawrev-25507	366	3	supra	supra	PROPN
inlawrev-25507	366	4	note	note	PROPN
inlawrev-25507	366	5	26	26	NUM
inlawrev-25507	366	6	,	,	PUNCT
inlawrev-25507	366	7	at	at	ADP
inlawrev-25507	366	8	e385	e385	PROPN
inlawrev-25507	366	9	.	.	PUNCT
inlawrev-25507	367	1	132	132	NUM
inlawrev-25507	367	2	.	.	PUNCT
inlawrev-25507	368	1	see	see	VERB
inlawrev-25507	368	2	erik	erik	PROPN
inlawrev-25507	368	3	komendant	komendant	PROPN
inlawrev-25507	368	4	,	,	PUNCT
inlawrev-25507	368	5	anti	anti	ADJ
inlawrev-25507	368	6	-	-	ADJ
inlawrev-25507	368	7	competitive	competitive	ADJ
inlawrev-25507	368	8	evergreening	evergreening	NOUN
inlawrev-25507	368	9	delays	delay	NOUN
inlawrev-25507	368	10	patient	patient	ADJ
inlawrev-25507	368	11	access	access	NOUN
inlawrev-25507	368	12	to	to	ADP
inlawrev-25507	368	13	more	more	ADJ
inlawrev-25507	368	14	affordable	affordable	ADJ
inlawrev-25507	368	15	generics	generic	NOUN
inlawrev-25507	368	16	and	and	CCONJ
inlawrev-25507	368	17	biosimilars	biosimilar	NOUN
inlawrev-25507	368	18	,	,	PUNCT
inlawrev-25507	368	19	ass’n	ass’n	NOUN
inlawrev-25507	368	20	for	for	ADP
inlawrev-25507	368	21	accessible	accessible	ADJ
inlawrev-25507	368	22	meds	med	NOUN
inlawrev-25507	368	23	.	.	PUNCT
inlawrev-25507	369	1	,	,	PUNCT
inlawrev-25507	369	2	https://accessiblemeds.org/	https://accessiblemeds.org/	ADJ
inlawrev-25507	369	3	resources	resource	NOUN
inlawrev-25507	369	4	/	/	SYM
inlawrev-25507	369	5	blog	blog	NOUN
inlawrev-25507	369	6	/	/	SYM
inlawrev-25507	369	7	anti	anti	ADJ
inlawrev-25507	369	8	-	-	ADJ
inlawrev-25507	369	9	competitive	competitive	ADJ
inlawrev-25507	369	10	-	-	PUNCT
inlawrev-25507	369	11	evergreening	evergreene	VERB
inlawrev-25507	369	12	-	-	PUNCT
inlawrev-25507	369	13	delays	delay	NOUN
inlawrev-25507	369	14	-	-	PUNCT
inlawrev-25507	369	15	patient	patient	NOUN
inlawrev-25507	369	16	-	-	PUNCT
inlawrev-25507	369	17	access	access	NOUN
inlawrev-25507	369	18	-	-	PUNCT
inlawrev-25507	369	19	more	more	ADJ
inlawrev-25507	369	20	-	-	PUNCT
inlawrev-25507	369	21	affordable	affordable	ADJ
inlawrev-25507	369	22	-	-	PUNCT
inlawrev-25507	369	23	generics	generic	NOUN
inlawrev-25507	369	24	(	(	PUNCT
inlawrev-25507	369	25	last	last	ADV
inlawrev-25507	369	26	visited	visit	VERB
inlawrev-25507	369	27	jan	jan	PROPN
inlawrev-25507	369	28	.	.	PROPN
inlawrev-25507	369	29	18	18	NUM
inlawrev-25507	369	30	,	,	PUNCT
inlawrev-25507	369	31	2020	2020	NUM
inlawrev-25507	369	32	)	)	PUNCT
inlawrev-25507	370	1	[	[	X
inlawrev-25507	370	2	https://perma.cc/5ysz-v6pr	https://perma.cc/5ysz-v6pr	X
inlawrev-25507	370	3	]	]	X
inlawrev-25507	370	4	(	(	PUNCT
inlawrev-25507	370	5	discussing	discuss	VERB
inlawrev-25507	370	6	abbvie	abbvie	PROPN
inlawrev-25507	370	7	’s	’s	PART
inlawrev-25507	370	8	strategy	strategy	NOUN
inlawrev-25507	370	9	of	of	ADP
inlawrev-25507	370	10	filing	file	VERB
inlawrev-25507	370	11	more	more	ADJ
inlawrev-25507	370	12	than	than	ADP
inlawrev-25507	370	13	100	100	NUM
inlawrev-25507	370	14	late	late	ADJ
inlawrev-25507	370	15	-	-	PUNCT
inlawrev-25507	370	16	stage	stage	NOUN
inlawrev-25507	370	17	patents	patent	NOUN
inlawrev-25507	370	18	to	to	PART
inlawrev-25507	370	19	protect	protect	VERB
inlawrev-25507	370	20	its	its	PRON
inlawrev-25507	370	21	annual	annual	ADJ
inlawrev-25507	370	22	revenues	revenue	NOUN
inlawrev-25507	370	23	of	of	ADP
inlawrev-25507	370	24	more	more	ADJ
inlawrev-25507	370	25	than	than	ADP
inlawrev-25507	370	26	$	$	SYM
inlawrev-25507	370	27	16	16	NUM
inlawrev-25507	370	28	billion	billion	NUM
inlawrev-25507	370	29	)	)	PUNCT
inlawrev-25507	370	30	.	.	PUNCT
inlawrev-25507	371	1	133	133	NUM
inlawrev-25507	371	2	.	.	PUNCT
inlawrev-25507	372	1	see	see	VERB
inlawrev-25507	372	2	holman	holman	PROPN
inlawrev-25507	372	3	,	,	PUNCT
inlawrev-25507	372	4	supra	supra	PROPN
inlawrev-25507	372	5	note	note	PROPN
inlawrev-25507	372	6	38	38	NUM
inlawrev-25507	372	7	(	(	PUNCT
inlawrev-25507	372	8	discussing	discuss	VERB
inlawrev-25507	372	9	how	how	SCONJ
inlawrev-25507	372	10	secondary	secondary	ADJ
inlawrev-25507	372	11	patents	patent	NOUN
inlawrev-25507	372	12	can	can	AUX
inlawrev-25507	372	13	be	be	AUX
inlawrev-25507	372	14	protecting	protect	VERB
inlawrev-25507	372	15	followon	followon	VERB
inlawrev-25507	372	16	innovation	innovation	NOUN
inlawrev-25507	372	17	that	that	PRON
inlawrev-25507	372	18	can	can	AUX
inlawrev-25507	372	19	play	play	VERB
inlawrev-25507	372	20	a	a	DET
inlawrev-25507	372	21	critical	critical	ADJ
inlawrev-25507	372	22	role	role	NOUN
inlawrev-25507	372	23	in	in	ADP
inlawrev-25507	372	24	transforming	transform	VERB
inlawrev-25507	372	25	a	a	DET
inlawrev-25507	372	26	drug	drug	NOUN
inlawrev-25507	372	27	to	to	ADP
inlawrev-25507	372	28	a	a	DET
inlawrev-25507	372	29	more	more	ADV
inlawrev-25507	372	30	effective	effective	ADJ
inlawrev-25507	372	31	and	and	CCONJ
inlawrev-25507	372	32	safe	safe	ADJ
inlawrev-25507	372	33	treatment	treatment	NOUN
inlawrev-25507	372	34	)	)	PUNCT
inlawrev-25507	372	35	.	.	PUNCT
inlawrev-25507	373	1	134	134	NUM
inlawrev-25507	373	2	.	.	PUNCT
inlawrev-25507	374	1	see	see	VERB
inlawrev-25507	374	2	patent	patent	NOUN
inlawrev-25507	374	3	examiner	examiner	NOUN
inlawrev-25507	374	4	:	:	PUNCT
inlawrev-25507	374	5	everything	everything	PRON
inlawrev-25507	374	6	you	you	PRON
inlawrev-25507	374	7	need	need	VERB
inlawrev-25507	374	8	to	to	PART
inlawrev-25507	374	9	know	know	VERB
inlawrev-25507	374	10	,	,	PUNCT
inlawrev-25507	374	11	supra	supra	PROPN
inlawrev-25507	374	12	note	note	NOUN
inlawrev-25507	374	13	117	117	NUM
inlawrev-25507	374	14	(	(	PUNCT
inlawrev-25507	374	15	discussing	discuss	VERB
inlawrev-25507	374	16	a	a	DET
inlawrev-25507	374	17	degree	degree	NOUN
inlawrev-25507	374	18	in	in	ADP
inlawrev-25507	374	19	the	the	DET
inlawrev-25507	374	20	relevant	relevant	ADJ
inlawrev-25507	374	21	science	science	NOUN
inlawrev-25507	374	22	is	be	AUX
inlawrev-25507	374	23	necessary	necessary	ADJ
inlawrev-25507	374	24	to	to	PART
inlawrev-25507	374	25	be	be	AUX
inlawrev-25507	374	26	a	a	DET
inlawrev-25507	374	27	patent	patent	NOUN
inlawrev-25507	374	28	examiner	examiner	NOUN
inlawrev-25507	374	29	in	in	ADP
inlawrev-25507	374	30	a	a	DET
inlawrev-25507	374	31	particular	particular	ADJ
inlawrev-25507	374	32	field	field	NOUN
inlawrev-25507	374	33	)	)	PUNCT
inlawrev-25507	374	34	;	;	PUNCT
inlawrev-25507	374	35	see	see	VERB
inlawrev-25507	374	36	also	also	ADV
inlawrev-25507	374	37	judges	judge	NOUN
inlawrev-25507	374	38	,	,	PUNCT
inlawrev-25507	374	39	supra	supra	PROPN
inlawrev-25507	374	40	note	note	PROPN
inlawrev-25507	374	41	119	119	NUM
inlawrev-25507	374	42	(	(	PUNCT
inlawrev-25507	374	43	discussing	discuss	VERB
inlawrev-25507	374	44	that	that	SCONJ
inlawrev-25507	374	45	many	many	ADJ
inlawrev-25507	374	46	judges	judge	NOUN
inlawrev-25507	374	47	on	on	ADP
inlawrev-25507	374	48	the	the	DET
inlawrev-25507	374	49	federal	federal	ADJ
inlawrev-25507	374	50	circuit	circuit	NOUN
inlawrev-25507	374	51	have	have	VERB
inlawrev-25507	374	52	a	a	DET
inlawrev-25507	374	53	science	science	NOUN
inlawrev-25507	374	54	background	background	NOUN
inlawrev-25507	374	55	,	,	PUNCT
inlawrev-25507	374	56	and	and	CCONJ
inlawrev-25507	374	57	further	far	ADV
inlawrev-25507	374	58	noting	note	VERB
inlawrev-25507	374	59	a	a	DET
inlawrev-25507	374	60	few	few	ADJ
inlawrev-25507	374	61	judges	judge	NOUN
inlawrev-25507	374	62	that	that	PRON
inlawrev-25507	374	63	have	have	AUX
inlawrev-25507	374	64	contributed	contribute	VERB
inlawrev-25507	374	65	to	to	ADP
inlawrev-25507	374	66	patent	patent	NOUN
inlawrev-25507	374	67	treatises	treatise	NOUN
inlawrev-25507	374	68	,	,	PUNCT
inlawrev-25507	374	69	casebooks	casebook	NOUN
inlawrev-25507	374	70	,	,	PUNCT
inlawrev-25507	374	71	and	and	CCONJ
inlawrev-25507	374	72	seminars	seminar	NOUN
inlawrev-25507	374	73	)	)	PUNCT
inlawrev-25507	374	74	.	.	PUNCT
inlawrev-25507	375	1	210	210	NUM
inlawrev-25507	375	2	indiana	indiana	PROPN
inlawrev-25507	375	3	law	law	PROPN
inlawrev-25507	375	4	review	review	NOUN
inlawrev-25507	375	5	[	[	X
inlawrev-25507	375	6	vol	vol	NOUN
inlawrev-25507	375	7	.	.	PUNCT
inlawrev-25507	375	8	54:195	54:195	NUM
inlawrev-25507	375	9	have	have	AUX
inlawrev-25507	375	10	been	be	AUX
inlawrev-25507	375	11	challenged	challenge	VERB
inlawrev-25507	375	12	and	and	CCONJ
inlawrev-25507	375	13	invalidated	invalidate	VERB
inlawrev-25507	375	14	at	at	ADP
inlawrev-25507	375	15	the	the	DET
inlawrev-25507	375	16	uspto	uspto	NOUN
inlawrev-25507	375	17	,	,	PUNCT
inlawrev-25507	375	18	the	the	DET
inlawrev-25507	375	19	ptab	ptab	NOUN
inlawrev-25507	375	20	,	,	PUNCT
inlawrev-25507	375	21	or	or	CCONJ
inlawrev-25507	375	22	at	at	ADP
inlawrev-25507	375	23	the	the	DET
inlawrev-25507	375	24	federal	federal	ADJ
inlawrev-25507	375	25	circuit	circuit	NOUN
inlawrev-25507	375	26	—	—	PUNCT
inlawrev-25507	375	27	could	could	AUX
inlawrev-25507	375	28	be	be	AUX
inlawrev-25507	375	29	a	a	DET
inlawrev-25507	375	30	sign	sign	NOUN
inlawrev-25507	375	31	to	to	ADP
inlawrev-25507	375	32	the	the	DET
inlawrev-25507	375	33	examining	examine	VERB
inlawrev-25507	375	34	entity	entity	NOUN
inlawrev-25507	375	35	that	that	SCONJ
inlawrev-25507	375	36	evergreening	evergreening	NOUN
inlawrev-25507	375	37	is	be	AUX
inlawrev-25507	375	38	taking	take	VERB
inlawrev-25507	375	39	place	place	NOUN
inlawrev-25507	375	40	if	if	SCONJ
inlawrev-25507	375	41	multiple	multiple	ADJ
inlawrev-25507	375	42	members	member	NOUN
inlawrev-25507	375	43	of	of	ADP
inlawrev-25507	375	44	the	the	DET
inlawrev-25507	375	45	patent	patent	NOUN
inlawrev-25507	375	46	family	family	NOUN
inlawrev-25507	375	47	were	be	AUX
inlawrev-25507	375	48	invalidated	invalidated	ADJ
inlawrev-25507	375	49	.	.	PUNCT
inlawrev-25507	376	1	on	on	ADP
inlawrev-25507	376	2	the	the	DET
inlawrev-25507	376	3	other	other	ADJ
inlawrev-25507	376	4	hand	hand	NOUN
inlawrev-25507	376	5	,	,	PUNCT
inlawrev-25507	376	6	if	if	SCONJ
inlawrev-25507	376	7	members	member	NOUN
inlawrev-25507	376	8	of	of	ADP
inlawrev-25507	376	9	the	the	DET
inlawrev-25507	376	10	family	family	NOUN
inlawrev-25507	376	11	had	have	AUX
inlawrev-25507	376	12	been	be	AUX
inlawrev-25507	376	13	challenged	challenge	VERB
inlawrev-25507	376	14	previously	previously	ADV
inlawrev-25507	376	15	and	and	CCONJ
inlawrev-25507	376	16	were	be	AUX
inlawrev-25507	376	17	found	find	VERB
inlawrev-25507	376	18	valid	valid	ADJ
inlawrev-25507	376	19	for	for	ADP
inlawrev-25507	376	20	true	true	ADJ
inlawrev-25507	376	21	innovation	innovation	NOUN
inlawrev-25507	376	22	,	,	PUNCT
inlawrev-25507	376	23	this	this	PRON
inlawrev-25507	376	24	could	could	AUX
inlawrev-25507	376	25	be	be	AUX
inlawrev-25507	376	26	a	a	DET
inlawrev-25507	376	27	signal	signal	NOUN
inlawrev-25507	376	28	that	that	SCONJ
inlawrev-25507	376	29	evergreening	evergreening	NOUN
inlawrev-25507	376	30	is	be	AUX
inlawrev-25507	376	31	absent	absent	ADJ
inlawrev-25507	376	32	.	.	PUNCT
inlawrev-25507	377	1	however	however	ADV
inlawrev-25507	377	2	,	,	PUNCT
inlawrev-25507	377	3	when	when	SCONJ
inlawrev-25507	377	4	looking	look	VERB
inlawrev-25507	377	5	to	to	ADP
inlawrev-25507	377	6	invalidated	invalidated	ADJ
inlawrev-25507	377	7	family	family	NOUN
inlawrev-25507	377	8	members	member	NOUN
inlawrev-25507	377	9	,	,	PUNCT
inlawrev-25507	377	10	it	it	PRON
inlawrev-25507	377	11	would	would	AUX
inlawrev-25507	377	12	be	be	AUX
inlawrev-25507	377	13	important	important	ADJ
inlawrev-25507	377	14	that	that	SCONJ
inlawrev-25507	377	15	the	the	DET
inlawrev-25507	377	16	uspto	uspto	NOUN
inlawrev-25507	377	17	,	,	PUNCT
inlawrev-25507	377	18	the	the	DET
inlawrev-25507	377	19	ptab	ptab	NOUN
inlawrev-25507	377	20	,	,	PUNCT
inlawrev-25507	377	21	and	and	CCONJ
inlawrev-25507	377	22	the	the	DET
inlawrev-25507	377	23	federal	federal	ADJ
inlawrev-25507	377	24	circuit	circuit	NOUN
inlawrev-25507	377	25	give	give	VERB
inlawrev-25507	377	26	weight	weight	NOUN
inlawrev-25507	377	27	to	to	ADP
inlawrev-25507	377	28	why	why	SCONJ
inlawrev-25507	377	29	the	the	DET
inlawrev-25507	377	30	members	member	NOUN
inlawrev-25507	377	31	were	be	AUX
inlawrev-25507	377	32	held	hold	VERB
inlawrev-25507	377	33	invalid	invalid	ADJ
inlawrev-25507	377	34	,	,	PUNCT
inlawrev-25507	377	35	as	as	SCONJ
inlawrev-25507	377	36	it	it	PRON
inlawrev-25507	377	37	could	could	AUX
inlawrev-25507	377	38	be	be	AUX
inlawrev-25507	377	39	invalidated	invalidated	ADJ
inlawrev-25507	377	40	for	for	ADP
inlawrev-25507	377	41	reasons	reason	NOUN
inlawrev-25507	377	42	other	other	ADJ
inlawrev-25507	377	43	than	than	ADP
inlawrev-25507	377	44	lack	lack	NOUN
inlawrev-25507	377	45	of	of	ADP
inlawrev-25507	377	46	novelty	novelty	NOUN
inlawrev-25507	377	47	or	or	CCONJ
inlawrev-25507	377	48	obviousness.135	obviousness.135	NOUN
inlawrev-25507	377	49	as	as	SCONJ
inlawrev-25507	377	50	the	the	DET
inlawrev-25507	377	51	humira	humira	PROPN
inlawrev-25507	377	52	®	®	NOUN
inlawrev-25507	377	53	facts	fact	NOUN
inlawrev-25507	377	54	demonstrated,136	demonstrated,136	VERB
inlawrev-25507	377	55	the	the	DET
inlawrev-25507	377	56	third	third	ADJ
inlawrev-25507	377	57	factor	factor	NOUN
inlawrev-25507	377	58	—	—	PUNCT
inlawrev-25507	377	59	when	when	SCONJ
inlawrev-25507	377	60	the	the	DET
inlawrev-25507	377	61	bulk	bulk	NOUN
inlawrev-25507	377	62	of	of	ADP
inlawrev-25507	377	63	the	the	DET
inlawrev-25507	377	64	patents	patent	NOUN
inlawrev-25507	377	65	were	be	AUX
inlawrev-25507	377	66	filed	file	VERB
inlawrev-25507	377	67	in	in	ADP
inlawrev-25507	377	68	relation	relation	NOUN
inlawrev-25507	377	69	to	to	ADP
inlawrev-25507	377	70	the	the	DET
inlawrev-25507	377	71	approval	approval	NOUN
inlawrev-25507	377	72	date	date	NOUN
inlawrev-25507	377	73	for	for	ADP
inlawrev-25507	377	74	the	the	DET
inlawrev-25507	377	75	drug	drug	NOUN
inlawrev-25507	377	76	—	—	PUNCT
inlawrev-25507	377	77	can	can	AUX
inlawrev-25507	377	78	be	be	AUX
inlawrev-25507	377	79	evidence	evidence	NOUN
inlawrev-25507	377	80	of	of	ADP
inlawrev-25507	377	81	evergreening	evergreening	NOUN
inlawrev-25507	377	82	;	;	PUNCT
inlawrev-25507	377	83	a	a	DET
inlawrev-25507	377	84	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	377	85	company	company	NOUN
inlawrev-25507	377	86	that	that	PRON
inlawrev-25507	377	87	files	file	VERB
inlawrev-25507	377	88	a	a	DET
inlawrev-25507	377	89	multitude	multitude	NOUN
inlawrev-25507	377	90	of	of	ADP
inlawrev-25507	377	91	secondary	secondary	ADJ
inlawrev-25507	377	92	patents	patent	NOUN
inlawrev-25507	377	93	at	at	ADP
inlawrev-25507	377	94	the	the	DET
inlawrev-25507	377	95	end	end	NOUN
inlawrev-25507	377	96	of	of	ADP
inlawrev-25507	377	97	the	the	DET
inlawrev-25507	377	98	life	life	NOUN
inlawrev-25507	377	99	of	of	ADP
inlawrev-25507	377	100	the	the	DET
inlawrev-25507	377	101	compound	compound	NOUN
inlawrev-25507	377	102	patent	patent	NOUN
inlawrev-25507	377	103	and	and	CCONJ
inlawrev-25507	377	104	not	not	PART
inlawrev-25507	377	105	throughout	throughout	ADP
inlawrev-25507	377	106	the	the	DET
inlawrev-25507	377	107	life	life	NOUN
inlawrev-25507	377	108	of	of	ADP
inlawrev-25507	377	109	the	the	DET
inlawrev-25507	377	110	drug	drug	NOUN
inlawrev-25507	377	111	can	can	AUX
inlawrev-25507	377	112	indicate	indicate	VERB
inlawrev-25507	377	113	that	that	SCONJ
inlawrev-25507	377	114	the	the	DET
inlawrev-25507	377	115	company	company	NOUN
inlawrev-25507	377	116	was	be	AUX
inlawrev-25507	377	117	not	not	PART
inlawrev-25507	377	118	focused	focus	VERB
inlawrev-25507	377	119	on	on	ADP
inlawrev-25507	377	120	innovation	innovation	NOUN
inlawrev-25507	377	121	,	,	PUNCT
inlawrev-25507	377	122	but	but	CCONJ
inlawrev-25507	377	123	instead	instead	ADV
inlawrev-25507	377	124	on	on	ADP
inlawrev-25507	377	125	holding	hold	VERB
inlawrev-25507	377	126	its	its	PRON
inlawrev-25507	377	127	exclusivity	exclusivity	NOUN
inlawrev-25507	377	128	on	on	ADP
inlawrev-25507	377	129	the	the	DET
inlawrev-25507	377	130	drug.137	drug.137	NOUN
inlawrev-25507	377	131	however	however	ADV
inlawrev-25507	377	132	,	,	PUNCT
inlawrev-25507	377	133	the	the	DET
inlawrev-25507	377	134	inspecting	inspect	VERB
inlawrev-25507	377	135	authority	authority	NOUN
inlawrev-25507	377	136	should	should	AUX
inlawrev-25507	377	137	be	be	AUX
inlawrev-25507	377	138	mindful	mindful	ADJ
inlawrev-25507	377	139	that	that	SCONJ
inlawrev-25507	377	140	innovations	innovation	NOUN
inlawrev-25507	377	141	can	can	AUX
inlawrev-25507	377	142	be	be	AUX
inlawrev-25507	377	143	very	very	ADV
inlawrev-25507	377	144	time	time	NOUN
inlawrev-25507	377	145	-	-	PUNCT
inlawrev-25507	377	146	consuming138	consuming138	PROPN
inlawrev-25507	377	147	;	;	PUNCT
inlawrev-25507	377	148	therefore	therefore	ADV
inlawrev-25507	377	149	,	,	PUNCT
inlawrev-25507	377	150	the	the	DET
inlawrev-25507	377	151	authority	authority	NOUN
inlawrev-25507	377	152	should	should	AUX
inlawrev-25507	377	153	compare	compare	VERB
inlawrev-25507	377	154	the	the	DET
inlawrev-25507	377	155	timeline	timeline	NOUN
inlawrev-25507	377	156	of	of	ADP
inlawrev-25507	377	157	the	the	DET
inlawrev-25507	377	158	applications	application	NOUN
inlawrev-25507	377	159	filed	file	VERB
inlawrev-25507	377	160	to	to	ADP
inlawrev-25507	377	161	the	the	DET
inlawrev-25507	377	162	time	time	NOUN
inlawrev-25507	377	163	the	the	DET
inlawrev-25507	377	164	research	research	NOUN
inlawrev-25507	377	165	was	be	AUX
inlawrev-25507	377	166	started	start	VERB
inlawrev-25507	377	167	and	and	CCONJ
inlawrev-25507	377	168	the	the	DET
inlawrev-25507	377	169	innovations	innovation	NOUN
inlawrev-25507	377	170	were	be	AUX
inlawrev-25507	377	171	recognized	recognize	VERB
inlawrev-25507	377	172	.	.	PUNCT
inlawrev-25507	378	1	additionally	additionally	ADV
inlawrev-25507	378	2	,	,	PUNCT
inlawrev-25507	378	3	the	the	DET
inlawrev-25507	378	4	sixth	sixth	ADJ
inlawrev-25507	378	5	factor	factor	NOUN
inlawrev-25507	378	6	—	—	PUNCT
inlawrev-25507	378	7	the	the	DET
inlawrev-25507	378	8	amount	amount	NOUN
inlawrev-25507	378	9	of	of	ADP
inlawrev-25507	378	10	research	research	NOUN
inlawrev-25507	378	11	and	and	CCONJ
inlawrev-25507	378	12	development	development	NOUN
inlawrev-25507	378	13	initiated	initiate	VERB
inlawrev-25507	378	14	in	in	ADP
inlawrev-25507	378	15	order	order	NOUN
inlawrev-25507	378	16	to	to	PART
inlawrev-25507	378	17	find	find	VERB
inlawrev-25507	378	18	the	the	DET
inlawrev-25507	378	19	drug	drug	NOUN
inlawrev-25507	378	20	—	—	PUNCT
inlawrev-25507	378	21	could	could	AUX
inlawrev-25507	378	22	be	be	AUX
inlawrev-25507	378	23	examined	examine	VERB
inlawrev-25507	378	24	along	along	ADP
inlawrev-25507	378	25	with	with	ADP
inlawrev-25507	378	26	the	the	DET
inlawrev-25507	378	27	third	third	ADJ
inlawrev-25507	378	28	,	,	PUNCT
inlawrev-25507	378	29	as	as	SCONJ
inlawrev-25507	378	30	a	a	DET
inlawrev-25507	378	31	minimal	minimal	ADJ
inlawrev-25507	378	32	adjustment	adjustment	NOUN
inlawrev-25507	378	33	is	be	AUX
inlawrev-25507	378	34	not	not	PART
inlawrev-25507	378	35	likely	likely	ADJ
inlawrev-25507	378	36	to	to	PART
inlawrev-25507	378	37	yield	yield	VERB
inlawrev-25507	378	38	from	from	ADP
inlawrev-25507	378	39	a	a	DET
inlawrev-25507	378	40	large	large	ADJ
inlawrev-25507	378	41	amount	amount	NOUN
inlawrev-25507	378	42	of	of	ADP
inlawrev-25507	378	43	research	research	NOUN
inlawrev-25507	378	44	and	and	CCONJ
inlawrev-25507	378	45	development	development	NOUN
inlawrev-25507	378	46	.	.	PUNCT
inlawrev-25507	379	1	further	far	ADV
inlawrev-25507	379	2	,	,	PUNCT
inlawrev-25507	379	3	the	the	DET
inlawrev-25507	379	4	examining	examining	NOUN
inlawrev-25507	379	5	authority	authority	NOUN
inlawrev-25507	379	6	should	should	AUX
inlawrev-25507	379	7	give	give	VERB
inlawrev-25507	379	8	heavy	heavy	ADJ
inlawrev-25507	379	9	weight	weight	NOUN
inlawrev-25507	379	10	to	to	ADP
inlawrev-25507	379	11	the	the	DET
inlawrev-25507	379	12	ninth	ninth	ADJ
inlawrev-25507	379	13	factor	factor	NOUN
inlawrev-25507	379	14	—	—	PUNCT
inlawrev-25507	379	15	whether	whether	SCONJ
inlawrev-25507	379	16	the	the	DET
inlawrev-25507	379	17	secondary	secondary	ADJ
inlawrev-25507	379	18	patent	patent	NOUN
inlawrev-25507	379	19	was	be	AUX
inlawrev-25507	379	20	related	relate	VERB
inlawrev-25507	379	21	to	to	ADP
inlawrev-25507	379	22	innovation	innovation	NOUN
inlawrev-25507	379	23	that	that	SCONJ
inlawrev-25507	379	24	the	the	DET
inlawrev-25507	379	25	applicant	applicant	NOUN
inlawrev-25507	379	26	suppressed	suppress	VERB
inlawrev-25507	379	27	or	or	CCONJ
inlawrev-25507	379	28	concealed	conceal	VERB
inlawrev-25507	379	29	for	for	ADP
inlawrev-25507	379	30	a	a	DET
inlawrev-25507	379	31	significant	significant	ADJ
inlawrev-25507	379	32	period	period	NOUN
inlawrev-25507	379	33	of	of	ADP
inlawrev-25507	379	34	time	time	NOUN
inlawrev-25507	379	35	or	or	CCONJ
inlawrev-25507	379	36	whether	whether	SCONJ
inlawrev-25507	379	37	the	the	DET
inlawrev-25507	379	38	applicant	applicant	NOUN
inlawrev-25507	379	39	was	be	AUX
inlawrev-25507	379	40	not	not	PART
inlawrev-25507	379	41	reasonably	reasonably	ADV
inlawrev-25507	379	42	diligent	diligent	ADJ
inlawrev-25507	379	43	in	in	ADP
inlawrev-25507	379	44	filing	file	VERB
inlawrev-25507	379	45	the	the	DET
inlawrev-25507	379	46	patent	patent	NOUN
inlawrev-25507	379	47	application(s	application(s	NOUN
inlawrev-25507	379	48	)	)	PUNCT
inlawrev-25507	379	49	.	.	PUNCT
inlawrev-25507	380	1	this	this	DET
inlawrev-25507	380	2	factor	factor	NOUN
inlawrev-25507	380	3	can	can	AUX
inlawrev-25507	380	4	be	be	AUX
inlawrev-25507	380	5	determinative	determinative	ADJ
inlawrev-25507	380	6	of	of	ADP
inlawrev-25507	380	7	whether	whether	SCONJ
inlawrev-25507	380	8	or	or	CCONJ
inlawrev-25507	380	9	not	not	PART
inlawrev-25507	380	10	a	a	DET
inlawrev-25507	380	11	company	company	NOUN
inlawrev-25507	380	12	is	be	AUX
inlawrev-25507	380	13	evergreening	evergreene	VERB
inlawrev-25507	380	14	;	;	PUNCT
inlawrev-25507	380	15	a	a	DET
inlawrev-25507	380	16	delay	delay	NOUN
inlawrev-25507	380	17	in	in	ADP
inlawrev-25507	380	18	the	the	DET
inlawrev-25507	380	19	application	application	NOUN
inlawrev-25507	380	20	process	process	NOUN
inlawrev-25507	380	21	is	be	AUX
inlawrev-25507	380	22	likely	likely	ADJ
inlawrev-25507	380	23	due	due	ADP
inlawrev-25507	380	24	to	to	ADP
inlawrev-25507	380	25	a	a	DET
inlawrev-25507	380	26	company	company	NOUN
inlawrev-25507	380	27	wanting	want	VERB
inlawrev-25507	380	28	to	to	PART
inlawrev-25507	380	29	file	file	VERB
inlawrev-25507	380	30	its	its	PRON
inlawrev-25507	380	31	application	application	NOUN
inlawrev-25507	380	32	later	later	ADV
inlawrev-25507	380	33	during	during	ADP
inlawrev-25507	380	34	the	the	DET
inlawrev-25507	380	35	life	life	NOUN
inlawrev-25507	380	36	of	of	ADP
inlawrev-25507	380	37	the	the	DET
inlawrev-25507	380	38	compound	compound	NOUN
inlawrev-25507	380	39	patent	patent	NOUN
inlawrev-25507	380	40	in	in	ADP
inlawrev-25507	380	41	order	order	NOUN
inlawrev-25507	380	42	to	to	PART
inlawrev-25507	380	43	extend	extend	VERB
inlawrev-25507	380	44	exclusivity	exclusivity	NOUN
inlawrev-25507	380	45	.	.	PUNCT
inlawrev-25507	381	1	however	however	ADV
inlawrev-25507	381	2	,	,	PUNCT
inlawrev-25507	381	3	the	the	DET
inlawrev-25507	381	4	examining	examining	NOUN
inlawrev-25507	381	5	authority	authority	NOUN
inlawrev-25507	381	6	should	should	AUX
inlawrev-25507	381	7	consider	consider	VERB
inlawrev-25507	381	8	whether	whether	SCONJ
inlawrev-25507	381	9	there	there	PRON
inlawrev-25507	381	10	were	be	VERB
inlawrev-25507	381	11	other	other	ADJ
inlawrev-25507	381	12	reasons	reason	NOUN
inlawrev-25507	381	13	as	as	ADP
inlawrev-25507	381	14	to	to	ADP
inlawrev-25507	381	15	135	135	NUM
inlawrev-25507	381	16	.	.	PUNCT
inlawrev-25507	382	1	what	what	PRON
inlawrev-25507	382	2	are	be	AUX
inlawrev-25507	382	3	the	the	DET
inlawrev-25507	382	4	grounds	ground	NOUN
inlawrev-25507	382	5	for	for	ADP
inlawrev-25507	382	6	patent	patent	NOUN
inlawrev-25507	382	7	invalidity	invalidity	NOUN
inlawrev-25507	382	8	,	,	PUNCT
inlawrev-25507	382	9	trademarks	trademark	NOUN
inlawrev-25507	382	10	&	&	CCONJ
inlawrev-25507	382	11	pats	pat	NOUN
inlawrev-25507	382	12	.	.	PUNCT
inlawrev-25507	383	1	(	(	PUNCT
inlawrev-25507	383	2	feb	feb	PROPN
inlawrev-25507	383	3	.	.	PROPN
inlawrev-25507	383	4	26	26	NUM
inlawrev-25507	383	5	,	,	PUNCT
inlawrev-25507	383	6	2018	2018	NUM
inlawrev-25507	383	7	)	)	PUNCT
inlawrev-25507	383	8	,	,	PUNCT
inlawrev-25507	383	9	h	h	NOUN
inlawrev-25507	383	10	ttp	ttp	PROPN
inlawrev-25507	383	11	:/	:/	PUNCT
inlawrev-25507	383	12	/	/	SYM
inlawrev-25507	383	13	t	t	PROPN
inlawrev-25507	383	14	r	r	NOUN
inlawrev-25507	383	15	a	a	PROPN
inlawrev-25507	384	1	d	d	X
inlawrev-25507	384	2	e	e	NOUN
inlawrev-25507	384	3	m	m	NOUN
inlawrev-25507	385	1	a	a	DET
inlawrev-25507	385	2	r	r	NOUN
inlawrev-25507	385	3	k	k	PROPN
inlawrev-25507	385	4	s	s	X
inlawrev-25507	385	5	p	p	X
inlawrev-25507	385	6	a	a	PRON
inlawrev-25507	385	7	t	t	NOUN
inlawrev-25507	385	8	e	e	NOUN
inlawrev-25507	385	9	n	n	ADP
inlawrev-25507	385	10	t	t	PROPN
inlawrev-25507	385	11	s	s	X
inlawrev-25507	385	12	la	la	NOUN
inlawrev-25507	385	13	w	w	NOUN
inlawrev-25507	385	14	ye	ye	NOUN
inlawrev-25507	385	15	r	r	NOUN
inlawrev-25507	385	16	.	.	PUNCT
inlawrev-25507	386	1	c	c	NOUN
inlawrev-25507	387	1	o	o	NOUN
inlawrev-25507	387	2	m	m	VERB
inlawrev-25507	387	3	/	/	SYM
inlawrev-25507	387	4	w	w	PROPN
inlawrev-25507	387	5	h	h	PROPN
inlawrev-25507	387	6	a	a	DET
inlawrev-25507	387	7	t	t	NOUN
inlawrev-25507	387	8	-a	-a	PUNCT
inlawrev-25507	387	9	r	r	NOUN
inlawrev-25507	387	10	e	e	NOUN
inlawrev-25507	388	1	-t	-t	PUNCT
inlawrev-25507	388	2	h	h	NOUN
inlawrev-25507	388	3	e	e	NOUN
inlawrev-25507	388	4	-g	-g	PUNCT
inlawrev-25507	388	5	r	r	NOUN
inlawrev-25507	388	6	o	o	X
inlawrev-25507	388	7	u	u	NOUN
inlawrev-25507	388	8	n	n	PROPN
inlawrev-25507	388	9	d	d	NOUN
inlawrev-25507	388	10	s	s	PROPN
inlawrev-25507	389	1	-f	-f	NUM
inlawrev-25507	389	2	o	o	NOUN
inlawrev-25507	389	3	r	r	NOUN
inlawrev-25507	390	1	-p	-p	NOUN
inlawrev-25507	390	2	a	a	DET
inlawrev-25507	390	3	t	t	X
inlawrev-25507	390	4	e	e	NOUN
inlawrev-25507	390	5	n	n	PROPN
inlawrev-25507	390	6	t	t	PROPN
inlawrev-25507	390	7	-in	-in	NUM
inlawrev-25507	390	8	v	v	ADP
inlawrev-25507	390	9	a	a	DET
inlawrev-25507	390	10	lid	lid	NOUN
inlawrev-25507	390	11	ity/	ity/	NOUN
inlawrev-25507	391	1	[	[	X
inlawrev-25507	391	2	https://perma.cc/l6xk-aulk	https://perma.cc/l6xk-aulk	X
inlawrev-25507	391	3	]	]	X
inlawrev-25507	391	4	.	.	PUNCT
inlawrev-25507	392	1	136	136	NUM
inlawrev-25507	392	2	.	.	PUNCT
inlawrev-25507	393	1	cynthia	cynthia	PROPN
inlawrev-25507	393	2	koons	koons	PROPN
inlawrev-25507	393	3	,	,	PUNCT
inlawrev-25507	393	4	this	this	DET
inlawrev-25507	393	5	shield	shield	NOUN
inlawrev-25507	393	6	of	of	ADP
inlawrev-25507	393	7	patents	patent	NOUN
inlawrev-25507	393	8	protects	protect	VERB
inlawrev-25507	393	9	the	the	DET
inlawrev-25507	393	10	world	world	NOUN
inlawrev-25507	393	11	’s	’s	PART
inlawrev-25507	393	12	best	well	ADV
inlawrev-25507	393	13	-	-	PUNCT
inlawrev-25507	393	14	selling	sell	VERB
inlawrev-25507	393	15	drug	drug	NOUN
inlawrev-25507	393	16	,	,	PUNCT
inlawrev-25507	393	17	bloomberg	bloomberg	PROPN
inlawrev-25507	393	18	businesswk	businesswk	NOUN
inlawrev-25507	393	19	.	.	PUNCT
inlawrev-25507	394	1	(	(	PUNCT
inlawrev-25507	394	2	sept	sept	AUX
inlawrev-25507	394	3	.	.	PROPN
inlawrev-25507	394	4	7	7	NUM
inlawrev-25507	394	5	,	,	PUNCT
inlawrev-25507	394	6	2017	2017	NUM
inlawrev-25507	394	7	,	,	PUNCT
inlawrev-25507	394	8	6:00	6:00	NUM
inlawrev-25507	394	9	am	am	NOUN
inlawrev-25507	394	10	)	)	PUNCT
inlawrev-25507	394	11	,	,	PUNCT
inlawrev-25507	394	12	https://www.bloomberg.com/news/articles/	https://www.bloomberg.com/news/articles/	PROPN
inlawrev-25507	394	13	2017	2017	NUM
inlawrev-25507	394	14	-	-	SYM
inlawrev-25507	394	15	09	09	NUM
inlawrev-25507	394	16	-	-	PUNCT
inlawrev-25507	394	17	07	07	NUM
inlawrev-25507	394	18	/	/	SYM
inlawrev-25507	394	19	this	this	DET
inlawrev-25507	394	20	-	-	PUNCT
inlawrev-25507	394	21	shield	shield	NOUN
inlawrev-25507	394	22	-	-	PUNCT
inlawrev-25507	394	23	of	of	ADP
inlawrev-25507	394	24	-	-	PUNCT
inlawrev-25507	394	25	patents	patent	NOUN
inlawrev-25507	394	26	-	-	PUNCT
inlawrev-25507	394	27	protects	protect	NOUN
inlawrev-25507	394	28	-	-	PUNCT
inlawrev-25507	394	29	the	the	DET
inlawrev-25507	394	30	-	-	PUNCT
inlawrev-25507	394	31	world	world	NOUN
inlawrev-25507	394	32	-	-	PUNCT
inlawrev-25507	394	33	s	s	NOUN
inlawrev-25507	394	34	-	-	PUNCT
inlawrev-25507	394	35	best	well	ADV
inlawrev-25507	394	36	-	-	PUNCT
inlawrev-25507	394	37	selling	selling	NOUN
inlawrev-25507	394	38	-	-	PUNCT
inlawrev-25507	394	39	drug	drug	NOUN
inlawrev-25507	394	40	[	[	X
inlawrev-25507	394	41	https://perma.cc/9sv9lgch	https://perma.cc/9sv9lgch	X
inlawrev-25507	394	42	]	]	X
inlawrev-25507	394	43	(	(	PUNCT
inlawrev-25507	394	44	noting	note	VERB
inlawrev-25507	394	45	that	that	SCONJ
inlawrev-25507	394	46	many	many	ADJ
inlawrev-25507	394	47	of	of	ADP
inlawrev-25507	394	48	the	the	DET
inlawrev-25507	394	49	secondary	secondary	ADJ
inlawrev-25507	394	50	patents	patent	NOUN
inlawrev-25507	394	51	on	on	ADP
inlawrev-25507	394	52	humira	humira	PROPN
inlawrev-25507	394	53	®	®	PROPN
inlawrev-25507	394	54	were	be	AUX
inlawrev-25507	394	55	issued	issue	VERB
inlawrev-25507	394	56	as	as	ADP
inlawrev-25507	394	57	the	the	DET
inlawrev-25507	394	58	expiration	expiration	NOUN
inlawrev-25507	394	59	date	date	NOUN
inlawrev-25507	394	60	of	of	ADP
inlawrev-25507	394	61	the	the	DET
inlawrev-25507	394	62	compound	compound	NOUN
inlawrev-25507	394	63	patent	patent	NOUN
inlawrev-25507	394	64	grew	grow	VERB
inlawrev-25507	394	65	closer	close	ADV
inlawrev-25507	394	66	)	)	PUNCT
inlawrev-25507	394	67	.	.	PUNCT
inlawrev-25507	395	1	137	137	NUM
inlawrev-25507	395	2	.	.	PUNCT
inlawrev-25507	396	1	see	see	AUX
inlawrev-25507	396	2	overpatented	overpatente	VERB
inlawrev-25507	396	3	,	,	PUNCT
inlawrev-25507	396	4	overpriced	overprice	VERB
inlawrev-25507	396	5	:	:	PUNCT
inlawrev-25507	396	6	special	special	ADJ
inlawrev-25507	396	7	humira	humira	PROPN
inlawrev-25507	396	8	edition	edition	PROPN
inlawrev-25507	396	9	,	,	PUNCT
inlawrev-25507	396	10	supra	supra	PROPN
inlawrev-25507	396	11	note	note	NOUN
inlawrev-25507	396	12	2	2	NUM
inlawrev-25507	396	13	,	,	PUNCT
inlawrev-25507	396	14	at	at	ADP
inlawrev-25507	396	15	2	2	NUM
inlawrev-25507	396	16	(	(	PUNCT
inlawrev-25507	396	17	noting	note	VERB
inlawrev-25507	396	18	that	that	SCONJ
inlawrev-25507	396	19	“	"	PUNCT
inlawrev-25507	396	20	89	89	NUM
inlawrev-25507	396	21	%	%	NOUN
inlawrev-25507	396	22	of	of	ADP
inlawrev-25507	396	23	the	the	DET
inlawrev-25507	396	24	total	total	ADJ
inlawrev-25507	396	25	patent	patent	NOUN
inlawrev-25507	396	26	applications	application	NOUN
inlawrev-25507	396	27	on	on	ADP
inlawrev-25507	396	28	humira	humira	PROPN
inlawrev-25507	396	29	in	in	ADP
inlawrev-25507	396	30	the	the	DET
inlawrev-25507	396	31	u.s	u.s	PROPN
inlawrev-25507	396	32	.	.	PROPN
inlawrev-25507	396	33	were	be	AUX
inlawrev-25507	396	34	filed	file	VERB
inlawrev-25507	396	35	after	after	SCONJ
inlawrev-25507	396	36	the	the	DET
inlawrev-25507	396	37	drug	drug	NOUN
inlawrev-25507	396	38	was	be	AUX
inlawrev-25507	396	39	first	first	ADV
inlawrev-25507	396	40	approved	approve	VERB
inlawrev-25507	396	41	and	and	CCONJ
inlawrev-25507	396	42	on	on	ADP
inlawrev-25507	396	43	the	the	DET
inlawrev-25507	396	44	market	market	NOUN
inlawrev-25507	396	45	”	"	PUNCT
inlawrev-25507	396	46	)	)	PUNCT
inlawrev-25507	396	47	.	.	PUNCT
inlawrev-25507	397	1	138	138	NUM
inlawrev-25507	397	2	.	.	PUNCT
inlawrev-25507	398	1	see	see	VERB
inlawrev-25507	398	2	emily	emily	PROPN
inlawrev-25507	398	3	saadi	saadi	PROPN
inlawrev-25507	398	4	&	&	CCONJ
inlawrev-25507	398	5	greg	greg	PROPN
inlawrev-25507	398	6	white	white	PROPN
inlawrev-25507	398	7	,	,	PUNCT
inlawrev-25507	398	8	rewarding	rewarding	ADJ
inlawrev-25507	398	9	innovation	innovation	NOUN
inlawrev-25507	398	10	in	in	ADP
inlawrev-25507	398	11	drug	drug	NOUN
inlawrev-25507	398	12	development	development	NOUN
inlawrev-25507	398	13	,	,	PUNCT
inlawrev-25507	398	14	7(7	7(7	NUM
inlawrev-25507	398	15	)	)	PUNCT
inlawrev-25507	398	16	am	be	AUX
inlawrev-25507	398	17	.	.	PUNCT
inlawrev-25507	399	1	healt	healt	PROPN
inlawrev-25507	399	2	h	h	PROPN
inlawrev-25507	399	3	&	&	CCONJ
inlawrev-25507	399	4	drug	drug	PROPN
inlawrev-25507	399	5	benefits	benefit	NOUN
inlawrev-25507	399	6	373	373	NUM
inlawrev-25507	399	7	,	,	PUNCT
inlawrev-25507	399	8	373	373	NUM
inlawrev-25507	399	9	(	(	PUNCT
inlawrev-25507	399	10	2014	2014	NUM
inlawrev-25507	399	11	)	)	PUNCT
inlawrev-25507	399	12	,	,	PUNCT
inlawrev-25507	399	13	https://www.ncbi.nlm.nih.gov/pmc/articles/	https://www.ncbi.nlm.nih.gov/pmc/articles/	PROPN
inlawrev-25507	399	14	pmc4268767/	pmc4268767/	PROPN
inlawrev-25507	399	15	[	[	X
inlawrev-25507	399	16	https://perma.cc/q9ul-df98	https://perma.cc/q9ul-df98	X
inlawrev-25507	399	17	]	]	X
inlawrev-25507	399	18	(	(	PUNCT
inlawrev-25507	399	19	discussing	discuss	VERB
inlawrev-25507	399	20	how	how	SCONJ
inlawrev-25507	399	21	the	the	DET
inlawrev-25507	399	22	entire	entire	ADJ
inlawrev-25507	399	23	cycle	cycle	NOUN
inlawrev-25507	399	24	from	from	ADP
inlawrev-25507	399	25	initial	initial	ADJ
inlawrev-25507	399	26	research	research	NOUN
inlawrev-25507	399	27	and	and	CCONJ
inlawrev-25507	399	28	development	development	NOUN
inlawrev-25507	399	29	to	to	ADP
inlawrev-25507	399	30	a	a	DET
inlawrev-25507	399	31	drug	drug	NOUN
inlawrev-25507	399	32	’s	’s	PART
inlawrev-25507	399	33	regulatory	regulatory	ADJ
inlawrev-25507	399	34	approval	approval	NOUN
inlawrev-25507	399	35	can	can	AUX
inlawrev-25507	399	36	take	take	VERB
inlawrev-25507	399	37	between	between	ADP
inlawrev-25507	399	38	ten	ten	NUM
inlawrev-25507	399	39	and	and	CCONJ
inlawrev-25507	399	40	fifteen	fifteen	NUM
inlawrev-25507	399	41	years	year	NOUN
inlawrev-25507	399	42	)	)	PUNCT
inlawrev-25507	399	43	.	.	PUNCT
inlawrev-25507	400	1	2021	2021	NUM
inlawrev-25507	400	2	]	]	PUNCT
inlawrev-25507	401	1	leaving	leave	VERB
inlawrev-25507	401	2	the	the	DET
inlawrev-25507	401	3	evergreening	evergreene	VERB
inlawrev-25507	401	4	problem	problem	NOUN
inlawrev-25507	401	5	to	to	ADP
inlawrev-25507	401	6	the	the	DET
inlawrev-25507	401	7	patent	patent	NOUN
inlawrev-25507	401	8	experts	expert	NOUN
inlawrev-25507	401	9	211	211	NUM
inlawrev-25507	401	10	why	why	SCONJ
inlawrev-25507	401	11	the	the	DET
inlawrev-25507	401	12	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	401	13	company	company	NOUN
inlawrev-25507	401	14	decided	decide	VERB
inlawrev-25507	401	15	to	to	PART
inlawrev-25507	401	16	delay	delay	VERB
inlawrev-25507	401	17	the	the	DET
inlawrev-25507	401	18	application	application	NOUN
inlawrev-25507	401	19	process.139	process.139	ADP
inlawrev-25507	401	20	the	the	DET
inlawrev-25507	401	21	fourth	fourth	ADJ
inlawrev-25507	401	22	factor	factor	NOUN
inlawrev-25507	401	23	—	—	PUNCT
inlawrev-25507	401	24	whether	whether	SCONJ
inlawrev-25507	401	25	the	the	DET
inlawrev-25507	401	26	patent	patent	NOUN
inlawrev-25507	401	27	owner	owner	NOUN
inlawrev-25507	401	28	is	be	AUX
inlawrev-25507	401	29	attempting	attempt	VERB
inlawrev-25507	401	30	to	to	PART
inlawrev-25507	401	31	protect	protect	VERB
inlawrev-25507	401	32	a	a	DET
inlawrev-25507	401	33	legacy	legacy	NOUN
inlawrev-25507	401	34	patent	patent	NOUN
inlawrev-25507	401	35	—	—	PUNCT
inlawrev-25507	401	36	should	should	AUX
inlawrev-25507	401	37	be	be	AUX
inlawrev-25507	401	38	given	give	VERB
inlawrev-25507	401	39	substantial	substantial	ADJ
inlawrev-25507	401	40	weight	weight	NOUN
inlawrev-25507	401	41	by	by	ADP
inlawrev-25507	401	42	the	the	DET
inlawrev-25507	401	43	examining	examine	VERB
inlawrev-25507	401	44	entity	entity	NOUN
inlawrev-25507	401	45	.	.	PUNCT
inlawrev-25507	402	1	under	under	ADP
inlawrev-25507	402	2	the	the	DET
inlawrev-25507	402	3	bpcia	bpcia	NOUN
inlawrev-25507	402	4	,	,	PUNCT
inlawrev-25507	402	5	a	a	DET
inlawrev-25507	402	6	biosimilar	biosimilar	PROPN
inlawrev-25507	402	7	applicant	applicant	NOUN
inlawrev-25507	402	8	is	be	AUX
inlawrev-25507	402	9	expected	expect	VERB
inlawrev-25507	402	10	to	to	PART
inlawrev-25507	402	11	provide	provide	VERB
inlawrev-25507	402	12	the	the	DET
inlawrev-25507	402	13	innovation	innovation	NOUN
inlawrev-25507	402	14	company	company	NOUN
inlawrev-25507	402	15	with	with	ADP
inlawrev-25507	402	16	a	a	DET
inlawrev-25507	402	17	copy	copy	NOUN
inlawrev-25507	402	18	of	of	ADP
inlawrev-25507	402	19	its	its	PRON
inlawrev-25507	402	20	abbreviated	abbreviate	VERB
inlawrev-25507	402	21	biologics	biologic	NOUN
inlawrev-25507	402	22	license	license	NOUN
inlawrev-25507	402	23	application	application	NOUN
inlawrev-25507	402	24	(	(	PUNCT
inlawrev-25507	402	25	“	"	PUNCT
inlawrev-25507	402	26	abla”).140	abla”).140	DET
inlawrev-25507	402	27	the	the	DET
inlawrev-25507	402	28	purpose	purpose	NOUN
inlawrev-25507	402	29	of	of	ADP
inlawrev-25507	402	30	the	the	DET
inlawrev-25507	402	31	abla	abla	NOUN
inlawrev-25507	402	32	is	be	AUX
inlawrev-25507	402	33	for	for	SCONJ
inlawrev-25507	402	34	the	the	DET
inlawrev-25507	402	35	biosimilar	biosimilar	PROPN
inlawrev-25507	402	36	applicant	applicant	NOUN
inlawrev-25507	402	37	to	to	PART
inlawrev-25507	402	38	show	show	VERB
inlawrev-25507	402	39	that	that	SCONJ
inlawrev-25507	402	40	the	the	DET
inlawrev-25507	402	41	product	product	NOUN
inlawrev-25507	402	42	is	be	AUX
inlawrev-25507	402	43	“	"	PUNCT
inlawrev-25507	402	44	highly	highly	ADV
inlawrev-25507	402	45	similar	similar	ADJ
inlawrev-25507	402	46	”	"	PUNCT
inlawrev-25507	402	47	to	to	ADP
inlawrev-25507	402	48	the	the	DET
inlawrev-25507	402	49	branded	brand	VERB
inlawrev-25507	402	50	drug	drug	NOUN
inlawrev-25507	402	51	and	and	CCONJ
inlawrev-25507	402	52	that	that	SCONJ
inlawrev-25507	402	53	there	there	PRON
inlawrev-25507	402	54	are	be	VERB
inlawrev-25507	402	55	no	no	DET
inlawrev-25507	402	56	existing	exist	VERB
inlawrev-25507	402	57	“	"	PUNCT
inlawrev-25507	402	58	meaningful	meaningful	ADJ
inlawrev-25507	402	59	differences	difference	NOUN
inlawrev-25507	402	60	between	between	ADP
inlawrev-25507	402	61	the	the	DET
inlawrev-25507	402	62	biological	biological	ADJ
inlawrev-25507	402	63	product	product	NOUN
inlawrev-25507	402	64	and	and	CCONJ
inlawrev-25507	402	65	the	the	DET
inlawrev-25507	402	66	reference	reference	NOUN
inlawrev-25507	402	67	product	product	NOUN
inlawrev-25507	402	68	in	in	ADP
inlawrev-25507	402	69	terms	term	NOUN
inlawrev-25507	402	70	of	of	ADP
inlawrev-25507	402	71	safety	safety	NOUN
inlawrev-25507	402	72	,	,	PUNCT
inlawrev-25507	402	73	purity	purity	NOUN
inlawrev-25507	402	74	and	and	CCONJ
inlawrev-25507	402	75	potency	potency	NOUN
inlawrev-25507	402	76	.	.	PUNCT
inlawrev-25507	403	1	”141	”141	NOUN
inlawrev-25507	403	2	the	the	DET
inlawrev-25507	403	3	innovator	innovator	NOUN
inlawrev-25507	403	4	company	company	NOUN
inlawrev-25507	403	5	can	can	AUX
inlawrev-25507	403	6	then	then	ADV
inlawrev-25507	403	7	use	use	VERB
inlawrev-25507	403	8	the	the	DET
inlawrev-25507	403	9	confidential	confidential	ADJ
inlawrev-25507	403	10	disclosure	disclosure	NOUN
inlawrev-25507	403	11	provided	provide	VERB
inlawrev-25507	403	12	by	by	ADP
inlawrev-25507	403	13	the	the	DET
inlawrev-25507	403	14	generic	generic	ADJ
inlawrev-25507	403	15	company	company	NOUN
inlawrev-25507	403	16	to	to	PART
inlawrev-25507	403	17	determine	determine	VERB
inlawrev-25507	403	18	which	which	DET
inlawrev-25507	403	19	patents	patent	NOUN
inlawrev-25507	403	20	it	it	PRON
inlawrev-25507	403	21	may	may	AUX
inlawrev-25507	403	22	assert	assert	VERB
inlawrev-25507	403	23	to	to	PART
inlawrev-25507	403	24	block	block	VERB
inlawrev-25507	403	25	the	the	DET
inlawrev-25507	403	26	biosimilar	biosimilar	NOUN
inlawrev-25507	403	27	applicant.142	applicant.142	PRON
inlawrev-25507	403	28	if	if	SCONJ
inlawrev-25507	403	29	there	there	PRON
inlawrev-25507	403	30	are	be	VERB
inlawrev-25507	403	31	approved	approve	VERB
inlawrev-25507	403	32	biosimilars	biosimilar	NOUN
inlawrev-25507	403	33	,	,	PUNCT
inlawrev-25507	403	34	the	the	DET
inlawrev-25507	403	35	secondary	secondary	ADJ
inlawrev-25507	403	36	patents	patent	NOUN
inlawrev-25507	403	37	a	a	DET
inlawrev-25507	403	38	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	403	39	company	company	NOUN
inlawrev-25507	403	40	is	be	AUX
inlawrev-25507	403	41	granted	grant	VERB
inlawrev-25507	403	42	are	be	AUX
inlawrev-25507	403	43	likely	likely	ADJ
inlawrev-25507	403	44	to	to	PART
inlawrev-25507	403	45	impede	impede	VERB
inlawrev-25507	403	46	biosimilar	biosimilar	ADJ
inlawrev-25507	403	47	launches	launch	NOUN
inlawrev-25507	403	48	.	.	PUNCT
inlawrev-25507	404	1	therefore	therefore	ADV
inlawrev-25507	404	2	,	,	PUNCT
inlawrev-25507	404	3	factors	factor	NOUN
inlawrev-25507	404	4	indicating	indicate	VERB
inlawrev-25507	404	5	an	an	DET
inlawrev-25507	404	6	innovator	innovator	NOUN
inlawrev-25507	404	7	company	company	NOUN
inlawrev-25507	404	8	is	be	AUX
inlawrev-25507	404	9	attempting	attempt	VERB
inlawrev-25507	404	10	to	to	PART
inlawrev-25507	404	11	protect	protect	VERB
inlawrev-25507	404	12	its	its	PRON
inlawrev-25507	404	13	legacy	legacy	NOUN
inlawrev-25507	404	14	patent	patent	NOUN
inlawrev-25507	404	15	by	by	ADP
inlawrev-25507	404	16	keeping	keep	VERB
inlawrev-25507	404	17	the	the	DET
inlawrev-25507	404	18	biosimilar	biosimilar	ADJ
inlawrev-25507	404	19	products	product	NOUN
inlawrev-25507	404	20	at	at	ADP
inlawrev-25507	404	21	bay	bay	NOUN
inlawrev-25507	404	22	,	,	PUNCT
inlawrev-25507	404	23	including	include	VERB
inlawrev-25507	404	24	the	the	DET
inlawrev-25507	404	25	timing	timing	NOUN
inlawrev-25507	404	26	of	of	ADP
inlawrev-25507	404	27	the	the	DET
inlawrev-25507	404	28	filing	filing	NOUN
inlawrev-25507	404	29	of	of	ADP
inlawrev-25507	404	30	the	the	DET
inlawrev-25507	404	31	secondary	secondary	ADJ
inlawrev-25507	404	32	patents	patent	NOUN
inlawrev-25507	404	33	,	,	PUNCT
inlawrev-25507	404	34	can	can	AUX
inlawrev-25507	404	35	be	be	AUX
inlawrev-25507	404	36	evidence	evidence	NOUN
inlawrev-25507	404	37	of	of	ADP
inlawrev-25507	404	38	the	the	DET
inlawrev-25507	404	39	intent	intent	NOUN
inlawrev-25507	404	40	to	to	PART
inlawrev-25507	404	41	evergreen	evergreen	VERB
inlawrev-25507	404	42	.	.	PUNCT
inlawrev-25507	405	1	the	the	DET
inlawrev-25507	405	2	fifth	fifth	ADJ
inlawrev-25507	405	3	factor	factor	NOUN
inlawrev-25507	405	4	—	—	PUNCT
inlawrev-25507	405	5	the	the	DET
inlawrev-25507	405	6	innovation	innovation	NOUN
inlawrev-25507	405	7	between	between	ADP
inlawrev-25507	405	8	the	the	DET
inlawrev-25507	405	9	initial	initial	ADJ
inlawrev-25507	405	10	patent	patent	NOUN
inlawrev-25507	405	11	and	and	CCONJ
inlawrev-25507	405	12	secondary	secondary	ADJ
inlawrev-25507	405	13	patent	patent	NOUN
inlawrev-25507	405	14	—	—	PUNCT
inlawrev-25507	405	15	should	should	AUX
inlawrev-25507	405	16	also	also	ADV
inlawrev-25507	405	17	be	be	AUX
inlawrev-25507	405	18	heavily	heavily	ADV
inlawrev-25507	405	19	considered	consider	VERB
inlawrev-25507	405	20	;	;	PUNCT
inlawrev-25507	405	21	however	however	ADV
inlawrev-25507	405	22	,	,	PUNCT
inlawrev-25507	405	23	the	the	DET
inlawrev-25507	405	24	examining	examining	NOUN
inlawrev-25507	405	25	authority	authority	NOUN
inlawrev-25507	405	26	should	should	AUX
inlawrev-25507	405	27	be	be	AUX
inlawrev-25507	405	28	sure	sure	ADJ
inlawrev-25507	405	29	to	to	PART
inlawrev-25507	405	30	include	include	VERB
inlawrev-25507	405	31	experts	expert	NOUN
inlawrev-25507	405	32	and	and	CCONJ
inlawrev-25507	405	33	scientists	scientist	NOUN
inlawrev-25507	405	34	in	in	ADP
inlawrev-25507	405	35	the	the	DET
inlawrev-25507	405	36	determination	determination	NOUN
inlawrev-25507	405	37	of	of	ADP
inlawrev-25507	405	38	whether	whether	SCONJ
inlawrev-25507	405	39	or	or	CCONJ
inlawrev-25507	405	40	not	not	PART
inlawrev-25507	405	41	there	there	PRON
inlawrev-25507	405	42	was	be	VERB
inlawrev-25507	405	43	substantial	substantial	ADJ
inlawrev-25507	405	44	innovation	innovation	NOUN
inlawrev-25507	405	45	.	.	PUNCT
inlawrev-25507	406	1	as	as	SCONJ
inlawrev-25507	406	2	noted	note	VERB
inlawrev-25507	406	3	by	by	ADP
inlawrev-25507	406	4	a	a	DET
inlawrev-25507	406	5	number	number	NOUN
inlawrev-25507	406	6	of	of	ADP
inlawrev-25507	406	7	patent	patent	NOUN
inlawrev-25507	406	8	experts	expert	NOUN
inlawrev-25507	406	9	,	,	PUNCT
inlawrev-25507	406	10	there	there	PRON
inlawrev-25507	406	11	is	be	VERB
inlawrev-25507	406	12	a	a	DET
inlawrev-25507	406	13	flawed	flawed	ADJ
inlawrev-25507	406	14	premise	premise	NOUN
inlawrev-25507	406	15	that	that	SCONJ
inlawrev-25507	406	16	follow	follow	VERB
inlawrev-25507	406	17	-	-	PUNCT
inlawrev-25507	406	18	on	on	ADP
inlawrev-25507	406	19	innovation	innovation	NOUN
inlawrev-25507	406	20	is	be	AUX
inlawrev-25507	406	21	of	of	ADP
inlawrev-25507	406	22	little	little	ADJ
inlawrev-25507	406	23	value	value	NOUN
inlawrev-25507	406	24	and	and	CCONJ
inlawrev-25507	406	25	is	be	AUX
inlawrev-25507	406	26	less	less	ADV
inlawrev-25507	406	27	deserving	deserving	ADJ
inlawrev-25507	406	28	than	than	ADP
inlawrev-25507	406	29	the	the	DET
inlawrev-25507	406	30	innovation	innovation	NOUN
inlawrev-25507	406	31	that	that	PRON
inlawrev-25507	406	32	resulted	result	VERB
inlawrev-25507	406	33	in	in	ADP
inlawrev-25507	406	34	the	the	DET
inlawrev-25507	406	35	primary	primary	ADJ
inlawrev-25507	406	36	patent.143	patent.143	NOUN
inlawrev-25507	406	37	on	on	ADP
inlawrev-25507	406	38	the	the	DET
inlawrev-25507	406	39	contrary	contrary	NOUN
inlawrev-25507	406	40	,	,	PUNCT
inlawrev-25507	406	41	the	the	DET
inlawrev-25507	406	42	innovation	innovation	NOUN
inlawrev-25507	406	43	that	that	PRON
inlawrev-25507	406	44	leads	lead	VERB
inlawrev-25507	406	45	to	to	ADP
inlawrev-25507	406	46	the	the	DET
inlawrev-25507	406	47	secondary	secondary	ADJ
inlawrev-25507	406	48	patent	patent	NOUN
inlawrev-25507	406	49	can	can	AUX
inlawrev-25507	406	50	be	be	AUX
inlawrev-25507	406	51	more	more	ADV
inlawrev-25507	406	52	beneficial	beneficial	ADJ
inlawrev-25507	406	53	to	to	ADP
inlawrev-25507	406	54	society	society	NOUN
inlawrev-25507	406	55	than	than	ADP
inlawrev-25507	406	56	the	the	DET
inlawrev-25507	406	57	innovation	innovation	NOUN
inlawrev-25507	406	58	that	that	PRON
inlawrev-25507	406	59	led	lead	VERB
inlawrev-25507	406	60	to	to	ADP
inlawrev-25507	406	61	the	the	DET
inlawrev-25507	406	62	first.144	first.144	NOUN
inlawrev-25507	406	63	however	however	ADV
inlawrev-25507	406	64	,	,	PUNCT
inlawrev-25507	406	65	innovator	innovator	NOUN
inlawrev-25507	406	66	companies	company	NOUN
inlawrev-25507	406	67	do	do	AUX
inlawrev-25507	406	68	have	have	VERB
inlawrev-25507	406	69	the	the	DET
inlawrev-25507	406	70	ability	ability	NOUN
inlawrev-25507	406	71	to	to	PART
inlawrev-25507	406	72	make	make	VERB
inlawrev-25507	406	73	small	small	ADJ
inlawrev-25507	406	74	changes	change	NOUN
inlawrev-25507	406	75	to	to	ADP
inlawrev-25507	406	76	the	the	DET
inlawrev-25507	406	77	branded	brand	VERB
inlawrev-25507	406	78	drug	drug	NOUN
inlawrev-25507	406	79	—	—	PUNCT
inlawrev-25507	406	80	including	include	VERB
inlawrev-25507	406	81	changes	change	NOUN
inlawrev-25507	406	82	to	to	ADP
inlawrev-25507	406	83	the	the	DET
inlawrev-25507	406	84	mode	mode	NOUN
inlawrev-25507	406	85	of	of	ADP
inlawrev-25507	406	86	administration	administration	NOUN
inlawrev-25507	406	87	,	,	PUNCT
inlawrev-25507	406	88	new	new	ADJ
inlawrev-25507	406	89	dosages	dosage	NOUN
inlawrev-25507	406	90	,	,	PUNCT
inlawrev-25507	406	91	or	or	CCONJ
inlawrev-25507	406	92	even	even	ADV
inlawrev-25507	406	93	a	a	DET
inlawrev-25507	406	94	change	change	NOUN
inlawrev-25507	406	95	in	in	ADP
inlawrev-25507	406	96	color	color	NOUN
inlawrev-25507	406	97	to	to	ADP
inlawrev-25507	406	98	the	the	DET
inlawrev-25507	406	99	drug	drug	NOUN
inlawrev-25507	406	100	itself	itself	PRON
inlawrev-25507	406	101	—	—	PUNCT
inlawrev-25507	406	102	in	in	ADP
inlawrev-25507	406	103	order	order	NOUN
inlawrev-25507	406	104	to	to	PART
inlawrev-25507	406	105	obtain	obtain	VERB
inlawrev-25507	406	106	the	the	DET
inlawrev-25507	406	107	secondary	secondary	ADJ
inlawrev-25507	406	108	patent.145	patent.145	NOUN
inlawrev-25507	406	109	though	though	ADV
inlawrev-25507	406	110	,	,	PUNCT
inlawrev-25507	406	111	based	base	VERB
inlawrev-25507	406	112	on	on	ADP
inlawrev-25507	406	113	the	the	DET
inlawrev-25507	406	114	patentability	patentability	NOUN
inlawrev-25507	406	115	standards	standard	NOUN
inlawrev-25507	406	116	enforced	enforce	VERB
inlawrev-25507	406	117	at	at	ADP
inlawrev-25507	406	118	the	the	DET
inlawrev-25507	406	119	uspto,146	uspto,146	PROPN
inlawrev-25507	406	120	any	any	DET
inlawrev-25507	406	121	139	139	NUM
inlawrev-25507	406	122	.	.	PUNCT
inlawrev-25507	407	1	see	see	VERB
inlawrev-25507	407	2	michael	michael	PROPN
inlawrev-25507	407	3	henry	henry	PROPN
inlawrev-25507	407	4	,	,	PUNCT
inlawrev-25507	407	5	how	how	SCONJ
inlawrev-25507	407	6	to	to	PART
inlawrev-25507	407	7	slow	slow	VERB
inlawrev-25507	407	8	down	down	ADP
inlawrev-25507	407	9	patent	patent	NOUN
inlawrev-25507	407	10	prosecution	prosecution	NOUN
inlawrev-25507	407	11	with	with	ADP
inlawrev-25507	407	12	the	the	DET
inlawrev-25507	407	13	uspto	uspto	NOUN
inlawrev-25507	407	14	,	,	PUNCT
inlawrev-25507	407	15	henry	henry	PROPN
inlawrev-25507	407	16	pat	pat	PROPN
inlawrev-25507	407	17	.	.	PROPN
inlawrev-25507	407	18	l.	l.	PROPN
inlawrev-25507	407	19	firm	firm	PROPN
inlawrev-25507	407	20	(	(	PUNCT
inlawrev-25507	407	21	may	may	PROPN
inlawrev-25507	407	22	10	10	NUM
inlawrev-25507	407	23	,	,	PUNCT
inlawrev-25507	407	24	2018	2018	NUM
inlawrev-25507	407	25	)	)	PUNCT
inlawrev-25507	407	26	,	,	PUNCT
inlawrev-25507	407	27	https://www.henrypatentfirm.com/blog/slow-down-patent-prosecution	https://www.henrypatentfirm.com/blog/slow-down-patent-prosecution	X
inlawrev-25507	408	1	[	[	X
inlawrev-25507	408	2	https://perma.cc/4hhj-h49c	https://perma.cc/4hhj-h49c	X
inlawrev-25507	408	3	]	]	X
inlawrev-25507	408	4	(	(	PUNCT
inlawrev-25507	408	5	discussing	discuss	VERB
inlawrev-25507	408	6	reasons	reason	NOUN
inlawrev-25507	408	7	to	to	PART
inlawrev-25507	408	8	delay	delay	VERB
inlawrev-25507	408	9	the	the	DET
inlawrev-25507	408	10	patent	patent	NOUN
inlawrev-25507	408	11	prosecution	prosecution	NOUN
inlawrev-25507	408	12	process	process	NOUN
inlawrev-25507	408	13	)	)	PUNCT
inlawrev-25507	408	14	.	.	PUNCT
inlawrev-25507	409	1	140	140	NUM
inlawrev-25507	409	2	.	.	PUNCT
inlawrev-25507	409	3	claire	claire	PROPN
inlawrev-25507	409	4	laporte	laporte	PROPN
inlawrev-25507	409	5	,	,	PUNCT
inlawrev-25507	409	6	manufacturers	manufacturer	NOUN
inlawrev-25507	409	7	of	of	ADP
inlawrev-25507	409	8	biosimilar	biosimilar	ADJ
inlawrev-25507	409	9	drugs	drug	NOUN
inlawrev-25507	409	10	sit	sit	VERB
inlawrev-25507	409	11	out	out	ADP
inlawrev-25507	409	12	the	the	DET
inlawrev-25507	409	13	‘	'	PUNCT
inlawrev-25507	409	14	patent	patent	NOUN
inlawrev-25507	409	15	dance	dance	NOUN
inlawrev-25507	409	16	’	'	PUNCT
inlawrev-25507	409	17	,	,	PUNCT
inlawrev-25507	409	18	health	health	NOUN
inlawrev-25507	409	19	aff	aff	PROPN
inlawrev-25507	409	20	.	.	PUNCT
inlawrev-25507	410	1	(	(	PUNCT
inlawrev-25507	410	2	mar	mar	PROPN
inlawrev-25507	410	3	.	.	PROPN
inlawrev-25507	410	4	10	10	NUM
inlawrev-25507	410	5	,	,	PUNCT
inlawrev-25507	410	6	2017	2017	NUM
inlawrev-25507	410	7	)	)	PUNCT
inlawrev-25507	410	8	,	,	PUNCT
inlawrev-25507	410	9	https://www.healthaffairs.org/do/10.1377/hblog20170310.059143/full/	https://www.healthaffairs.org/do/10.1377/hblog20170310.059143/full/	X
inlawrev-25507	411	1	[	[	X
inlawrev-25507	411	2	https://perma.cc/q3du-lrkl	https://perma.cc/q3du-lrkl	NOUN
inlawrev-25507	411	3	]	]	X
inlawrev-25507	411	4	.	.	PUNCT
inlawrev-25507	412	1	141	141	NUM
inlawrev-25507	412	2	.	.	PUNCT
inlawrev-25507	413	1	i	i	PRON
inlawrev-25507	413	2	d.	d.	PROPN
inlawrev-25507	413	3	142	142	NUM
inlawrev-25507	413	4	.	.	PUNCT
inlawrev-25507	414	1	i	i	PRON
inlawrev-25507	414	2	d.	d.	PROPN
inlawrev-25507	414	3	143	143	NUM
inlawrev-25507	414	4	.	.	PUNCT
inlawrev-25507	415	1	holman	holman	PROPN
inlawrev-25507	415	2	,	,	PUNCT
inlawrev-25507	415	3	supra	supra	PROPN
inlawrev-25507	415	4	note	note	PROPN
inlawrev-25507	415	5	38	38	NUM
inlawrev-25507	415	6	.	.	PUNCT
inlawrev-25507	416	1	144	144	NUM
inlawrev-25507	416	2	.	.	PUNCT
inlawrev-25507	416	3	see	see	VERB
inlawrev-25507	416	4	i	i	PRON
inlawrev-25507	416	5	d.	d.	PROPN
inlawrev-25507	416	6	(	(	PUNCT
inlawrev-25507	416	7	discussing	discuss	VERB
inlawrev-25507	416	8	how	how	SCONJ
inlawrev-25507	416	9	azt	azt	PROPN
inlawrev-25507	416	10	was	be	AUX
inlawrev-25507	416	11	initially	initially	ADV
inlawrev-25507	416	12	a	a	DET
inlawrev-25507	416	13	failed	fail	VERB
inlawrev-25507	416	14	cancer	cancer	NOUN
inlawrev-25507	416	15	drug	drug	NOUN
inlawrev-25507	416	16	until	until	SCONJ
inlawrev-25507	416	17	its	its	PRON
inlawrev-25507	416	18	application	application	NOUN
inlawrev-25507	416	19	to	to	ADP
inlawrev-25507	416	20	the	the	DET
inlawrev-25507	416	21	fight	fight	NOUN
inlawrev-25507	416	22	against	against	ADP
inlawrev-25507	416	23	aids	aid	NOUN
inlawrev-25507	416	24	was	be	AUX
inlawrev-25507	416	25	discovered	discover	VERB
inlawrev-25507	416	26	)	)	PUNCT
inlawrev-25507	416	27	.	.	PUNCT
inlawrev-25507	417	1	145	145	NUM
inlawrev-25507	417	2	.	.	PUNCT
inlawrev-25507	418	1	allie	allie	PROPN
inlawrev-25507	418	2	nawrat	nawrat	PROPN
inlawrev-25507	418	3	,	,	PUNCT
inlawrev-25507	418	4	from	from	ADP
inlawrev-25507	418	5	evergreening	evergreene	VERB
inlawrev-25507	418	6	to	to	ADP
inlawrev-25507	418	7	thicketing	thickete	VERB
inlawrev-25507	418	8	:	:	PUNCT
inlawrev-25507	418	9	exploring	explore	VERB
inlawrev-25507	418	10	manipulation	manipulation	NOUN
inlawrev-25507	418	11	of	of	ADP
inlawrev-25507	418	12	the	the	DET
inlawrev-25507	418	13	pharma	pharma	PROPN
inlawrev-25507	418	14	patent	patent	NOUN
inlawrev-25507	418	15	system	system	NOUN
inlawrev-25507	418	16	,	,	PUNCT
inlawrev-25507	418	17	pharma	pharma	PROPN
inlawrev-25507	418	18	tech	tech	NOUN
inlawrev-25507	418	19	.	.	PUNCT
inlawrev-25507	419	1	focus	focus	NOUN
inlawrev-25507	419	2	,	,	PUNCT
inlawrev-25507	419	3	https://pharma.nridigital.com/pharma_nov19/from	https://pharma.nridigital.com/pharma_nov19/from	NOUN
inlawrev-25507	419	4	_	_	NOUN
inlawrev-25507	419	5	evergreening_to_thicketing_exploring_manipulation_of_the_pharma_patent_sys	evergreening_to_thicketing_exploring_manipulation_of_the_pharma_patent_sy	NOUN
inlawrev-25507	419	6	#	#	NOUN
inlawrev-25507	419	7	(	(	PUNCT
inlawrev-25507	419	8	last	last	ADV
inlawrev-25507	419	9	visited	visit	VERB
inlawrev-25507	419	10	jan	jan	PROPN
inlawrev-25507	419	11	.	.	PROPN
inlawrev-25507	419	12	24	24	NUM
inlawrev-25507	419	13	,	,	PUNCT
inlawrev-25507	419	14	2020	2020	NUM
inlawrev-25507	419	15	)	)	PUNCT
inlawrev-25507	420	1	[	[	X
inlawrev-25507	420	2	https://perma.cc/l5dg-klgs	https://perma.cc/l5dg-klgs	NOUN
inlawrev-25507	420	3	]	]	X
inlawrev-25507	420	4	.	.	PUNCT
inlawrev-25507	421	1	146	146	NUM
inlawrev-25507	421	2	.	.	PUNCT
inlawrev-25507	422	1	see	see	VERB
inlawrev-25507	422	2	mpep	mpep	PROPN
inlawrev-25507	422	3	§	§	PROPN
inlawrev-25507	422	4	1504	1504	NUM
inlawrev-25507	422	5	(	(	PUNCT
inlawrev-25507	422	6	9th	9th	ADJ
inlawrev-25507	422	7	ed	ed	NOUN
inlawrev-25507	422	8	.	.	PUNCT
inlawrev-25507	423	1	rev	rev	PROPN
inlawrev-25507	423	2	.	.	PROPN
inlawrev-25507	423	3	10.2019	10.2019	NUM
inlawrev-25507	423	4	,	,	PUNCT
inlawrev-25507	423	5	june	june	PROPN
inlawrev-25507	423	6	2020	2020	NUM
inlawrev-25507	423	7	)	)	PUNCT
inlawrev-25507	424	1	(	(	PUNCT
inlawrev-25507	424	2	discussing	discuss	VERB
inlawrev-25507	424	3	the	the	DET
inlawrev-25507	424	4	standards	standard	NOUN
inlawrev-25507	424	5	of	of	ADP
inlawrev-25507	424	6	novelty	novelty	NOUN
inlawrev-25507	424	7	212	212	NUM
inlawrev-25507	424	8	indiana	indiana	NOUN
inlawrev-25507	424	9	law	law	PROPN
inlawrev-25507	424	10	review	review	NOUN
inlawrev-25507	424	11	[	[	X
inlawrev-25507	424	12	vol	vol	NOUN
inlawrev-25507	424	13	.	.	PUNCT
inlawrev-25507	425	1	54:195	54:195	NUM
inlawrev-25507	425	2	innovation	innovation	NOUN
inlawrev-25507	425	3	that	that	PRON
inlawrev-25507	425	4	is	be	AUX
inlawrev-25507	425	5	minimal	minimal	ADJ
inlawrev-25507	425	6	is	be	AUX
inlawrev-25507	425	7	unlikely	unlikely	ADJ
inlawrev-25507	425	8	to	to	PART
inlawrev-25507	425	9	be	be	AUX
inlawrev-25507	425	10	granted	grant	VERB
inlawrev-25507	425	11	.	.	PUNCT
inlawrev-25507	426	1	on	on	ADP
inlawrev-25507	426	2	the	the	DET
inlawrev-25507	426	3	other	other	ADJ
inlawrev-25507	426	4	hand	hand	NOUN
inlawrev-25507	426	5	,	,	PUNCT
inlawrev-25507	426	6	the	the	DET
inlawrev-25507	426	7	possibility	possibility	NOUN
inlawrev-25507	426	8	of	of	ADP
inlawrev-25507	426	9	patentability	patentability	NOUN
inlawrev-25507	426	10	still	still	ADV
inlawrev-25507	426	11	exists	exist	VERB
inlawrev-25507	426	12	;	;	PUNCT
inlawrev-25507	426	13	therefore	therefore	ADV
inlawrev-25507	426	14	,	,	PUNCT
inlawrev-25507	426	15	scientists	scientist	NOUN
inlawrev-25507	426	16	and	and	CCONJ
inlawrev-25507	426	17	experts	expert	NOUN
inlawrev-25507	426	18	should	should	AUX
inlawrev-25507	426	19	be	be	AUX
inlawrev-25507	426	20	used	use	VERB
inlawrev-25507	426	21	to	to	PART
inlawrev-25507	426	22	determine	determine	VERB
inlawrev-25507	426	23	if	if	SCONJ
inlawrev-25507	426	24	there	there	PRON
inlawrev-25507	426	25	is	be	VERB
inlawrev-25507	426	26	genuine	genuine	ADJ
inlawrev-25507	426	27	innovation	innovation	NOUN
inlawrev-25507	426	28	.	.	PUNCT
inlawrev-25507	427	1	next	next	ADV
inlawrev-25507	427	2	,	,	PUNCT
inlawrev-25507	427	3	the	the	DET
inlawrev-25507	427	4	seventh	seventh	ADJ
inlawrev-25507	427	5	factor	factor	NOUN
inlawrev-25507	427	6	—	—	PUNCT
inlawrev-25507	427	7	whether	whether	SCONJ
inlawrev-25507	427	8	the	the	DET
inlawrev-25507	427	9	patent	patent	NOUN
inlawrev-25507	427	10	relates	relate	VERB
inlawrev-25507	427	11	to	to	ADP
inlawrev-25507	427	12	a	a	DET
inlawrev-25507	427	13	new	new	ADJ
inlawrev-25507	427	14	and	and	CCONJ
inlawrev-25507	427	15	improved	improved	ADJ
inlawrev-25507	427	16	treatment	treatment	NOUN
inlawrev-25507	427	17	in	in	ADP
inlawrev-25507	427	18	the	the	DET
inlawrev-25507	427	19	disease	disease	NOUN
inlawrev-25507	427	20	area	area	NOUN
inlawrev-25507	427	21	or	or	CCONJ
inlawrev-25507	427	22	whether	whether	SCONJ
inlawrev-25507	427	23	it	it	PRON
inlawrev-25507	427	24	relates	relate	VERB
inlawrev-25507	427	25	to	to	ADP
inlawrev-25507	427	26	an	an	DET
inlawrev-25507	427	27	alternative	alternative	ADJ
inlawrev-25507	427	28	treatment	treatment	NOUN
inlawrev-25507	427	29	—	—	PUNCT
inlawrev-25507	427	30	should	should	AUX
inlawrev-25507	427	31	be	be	AUX
inlawrev-25507	427	32	given	give	VERB
inlawrev-25507	427	33	weight	weight	NOUN
inlawrev-25507	427	34	,	,	PUNCT
inlawrev-25507	427	35	but	but	CCONJ
inlawrev-25507	427	36	it	it	PRON
inlawrev-25507	427	37	is	be	AUX
inlawrev-25507	427	38	important	important	ADJ
inlawrev-25507	427	39	to	to	PART
inlawrev-25507	427	40	consider	consider	VERB
inlawrev-25507	427	41	this	this	DET
inlawrev-25507	427	42	factor	factor	NOUN
inlawrev-25507	427	43	in	in	ADP
inlawrev-25507	427	44	light	light	NOUN
inlawrev-25507	427	45	of	of	ADP
inlawrev-25507	427	46	not	not	PART
inlawrev-25507	427	47	only	only	ADV
inlawrev-25507	427	48	the	the	DET
inlawrev-25507	427	49	disease	disease	NOUN
inlawrev-25507	427	50	or	or	CCONJ
inlawrev-25507	427	51	condition	condition	NOUN
inlawrev-25507	427	52	being	be	AUX
inlawrev-25507	427	53	treated	treat	VERB
inlawrev-25507	427	54	,	,	PUNCT
inlawrev-25507	427	55	but	but	CCONJ
inlawrev-25507	427	56	also	also	ADV
inlawrev-25507	427	57	the	the	DET
inlawrev-25507	427	58	treatment	treatment	NOUN
inlawrev-25507	427	59	already	already	ADV
inlawrev-25507	427	60	in	in	ADP
inlawrev-25507	427	61	existence	existence	NOUN
inlawrev-25507	427	62	.	.	PUNCT
inlawrev-25507	428	1	for	for	ADP
inlawrev-25507	428	2	example	example	NOUN
inlawrev-25507	428	3	,	,	PUNCT
inlawrev-25507	428	4	if	if	SCONJ
inlawrev-25507	428	5	the	the	DET
inlawrev-25507	428	6	drug	drug	NOUN
inlawrev-25507	428	7	is	be	AUX
inlawrev-25507	428	8	deemed	deem	VERB
inlawrev-25507	428	9	ineffective	ineffective	ADJ
inlawrev-25507	428	10	for	for	ADP
inlawrev-25507	428	11	the	the	DET
inlawrev-25507	428	12	disease	disease	NOUN
inlawrev-25507	428	13	it	it	PRON
inlawrev-25507	428	14	was	be	AUX
inlawrev-25507	428	15	originally	originally	ADV
inlawrev-25507	428	16	in	in	ADP
inlawrev-25507	428	17	pursuance	pursuance	NOUN
inlawrev-25507	428	18	of	of	ADP
inlawrev-25507	428	19	,	,	PUNCT
inlawrev-25507	428	20	but	but	CCONJ
inlawrev-25507	428	21	is	be	AUX
inlawrev-25507	428	22	discovered	discover	VERB
inlawrev-25507	428	23	to	to	PART
inlawrev-25507	428	24	be	be	AUX
inlawrev-25507	428	25	effective	effective	ADJ
inlawrev-25507	428	26	against	against	ADP
inlawrev-25507	428	27	another	another	DET
inlawrev-25507	428	28	disease	disease	NOUN
inlawrev-25507	428	29	,	,	PUNCT
inlawrev-25507	428	30	this	this	PRON
inlawrev-25507	428	31	could	could	AUX
inlawrev-25507	428	32	be	be	AUX
inlawrev-25507	428	33	an	an	DET
inlawrev-25507	428	34	indication	indication	NOUN
inlawrev-25507	428	35	of	of	ADP
inlawrev-25507	428	36	true	true	ADJ
inlawrev-25507	428	37	innovation	innovation	NOUN
inlawrev-25507	428	38	.	.	PUNCT
inlawrev-25507	429	1	however	however	ADV
inlawrev-25507	429	2	,	,	PUNCT
inlawrev-25507	429	3	if	if	SCONJ
inlawrev-25507	429	4	the	the	DET
inlawrev-25507	429	5	claimed	claim	VERB
inlawrev-25507	429	6	innovation	innovation	NOUN
inlawrev-25507	429	7	seems	seem	VERB
inlawrev-25507	429	8	to	to	PART
inlawrev-25507	429	9	be	be	AUX
inlawrev-25507	429	10	minor	minor	ADJ
inlawrev-25507	429	11	,	,	PUNCT
inlawrev-25507	429	12	such	such	ADJ
inlawrev-25507	429	13	as	as	ADP
inlawrev-25507	429	14	requiring	require	VERB
inlawrev-25507	429	15	a	a	DET
inlawrev-25507	429	16	patient	patient	NOUN
inlawrev-25507	429	17	to	to	PART
inlawrev-25507	429	18	take	take	VERB
inlawrev-25507	429	19	three	three	NUM
inlawrev-25507	429	20	pills	pill	NOUN
inlawrev-25507	429	21	a	a	DET
inlawrev-25507	429	22	day	day	NOUN
inlawrev-25507	429	23	instead	instead	ADV
inlawrev-25507	429	24	of	of	ADP
inlawrev-25507	429	25	four	four	NUM
inlawrev-25507	429	26	,	,	PUNCT
inlawrev-25507	429	27	this	this	PRON
inlawrev-25507	429	28	may	may	AUX
inlawrev-25507	429	29	be	be	AUX
inlawrev-25507	429	30	an	an	DET
inlawrev-25507	429	31	indication	indication	NOUN
inlawrev-25507	429	32	of	of	ADP
inlawrev-25507	429	33	evergreening	evergreene	VERB
inlawrev-25507	429	34	.	.	PUNCT
inlawrev-25507	430	1	because	because	SCONJ
inlawrev-25507	430	2	the	the	DET
inlawrev-25507	430	3	facts	fact	NOUN
inlawrev-25507	430	4	of	of	ADP
inlawrev-25507	430	5	each	each	DET
inlawrev-25507	430	6	case	case	NOUN
inlawrev-25507	430	7	will	will	AUX
inlawrev-25507	430	8	vary	vary	VERB
inlawrev-25507	430	9	depending	depend	VERB
inlawrev-25507	430	10	on	on	ADP
inlawrev-25507	430	11	the	the	DET
inlawrev-25507	430	12	drug	drug	NOUN
inlawrev-25507	430	13	and	and	CCONJ
inlawrev-25507	430	14	the	the	DET
inlawrev-25507	430	15	claimed	claim	VERB
inlawrev-25507	430	16	innovation	innovation	NOUN
inlawrev-25507	430	17	,	,	PUNCT
inlawrev-25507	430	18	the	the	DET
inlawrev-25507	430	19	examining	examining	NOUN
inlawrev-25507	430	20	authority	authority	NOUN
inlawrev-25507	430	21	should	should	AUX
inlawrev-25507	430	22	recognize	recognize	VERB
inlawrev-25507	430	23	what	what	PRON
inlawrev-25507	430	24	seems	seem	VERB
inlawrev-25507	430	25	like	like	ADP
inlawrev-25507	430	26	a	a	DET
inlawrev-25507	430	27	minor	minor	ADJ
inlawrev-25507	430	28	improvement	improvement	NOUN
inlawrev-25507	430	29	in	in	ADP
inlawrev-25507	430	30	one	one	NUM
inlawrev-25507	430	31	case	case	NOUN
inlawrev-25507	430	32	could	could	AUX
inlawrev-25507	430	33	be	be	AUX
inlawrev-25507	430	34	the	the	DET
inlawrev-25507	430	35	result	result	NOUN
inlawrev-25507	430	36	of	of	ADP
inlawrev-25507	430	37	genuine	genuine	ADJ
inlawrev-25507	430	38	innovation	innovation	NOUN
inlawrev-25507	430	39	in	in	ADP
inlawrev-25507	430	40	another	another	PRON
inlawrev-25507	430	41	.	.	PUNCT
inlawrev-25507	431	1	the	the	DET
inlawrev-25507	431	2	eighth	eighth	ADJ
inlawrev-25507	431	3	factor	factor	NOUN
inlawrev-25507	431	4	—	—	PUNCT
inlawrev-25507	431	5	the	the	DET
inlawrev-25507	431	6	number	number	NOUN
inlawrev-25507	431	7	of	of	ADP
inlawrev-25507	431	8	patents	patent	NOUN
inlawrev-25507	431	9	granted	grant	VERB
inlawrev-25507	431	10	in	in	ADP
inlawrev-25507	431	11	other	other	ADJ
inlawrev-25507	431	12	countries	country	NOUN
inlawrev-25507	431	13	in	in	ADP
inlawrev-25507	431	14	comparison	comparison	NOUN
inlawrev-25507	431	15	to	to	ADP
inlawrev-25507	431	16	the	the	DET
inlawrev-25507	431	17	expiration	expiration	NOUN
inlawrev-25507	431	18	date	date	NOUN
inlawrev-25507	431	19	in	in	ADP
inlawrev-25507	431	20	those	those	DET
inlawrev-25507	431	21	countries	country	NOUN
inlawrev-25507	431	22	—	—	PUNCT
inlawrev-25507	431	23	should	should	AUX
inlawrev-25507	431	24	be	be	AUX
inlawrev-25507	431	25	considered	consider	VERB
inlawrev-25507	431	26	but	but	CCONJ
inlawrev-25507	431	27	should	should	AUX
inlawrev-25507	431	28	not	not	PART
inlawrev-25507	431	29	be	be	AUX
inlawrev-25507	431	30	determinative	determinative	ADJ
inlawrev-25507	431	31	of	of	ADP
inlawrev-25507	431	32	a	a	DET
inlawrev-25507	431	33	conclusion	conclusion	NOUN
inlawrev-25507	431	34	of	of	ADP
inlawrev-25507	431	35	evergreening	evergreene	VERB
inlawrev-25507	431	36	on	on	ADP
inlawrev-25507	431	37	its	its	PRON
inlawrev-25507	431	38	own	own	ADJ
inlawrev-25507	431	39	.	.	PUNCT
inlawrev-25507	432	1	this	this	DET
inlawrev-25507	432	2	factor	factor	NOUN
inlawrev-25507	432	3	could	could	AUX
inlawrev-25507	432	4	be	be	AUX
inlawrev-25507	432	5	indicative	indicative	ADJ
inlawrev-25507	432	6	of	of	ADP
inlawrev-25507	432	7	evergreening	evergreene	VERB
inlawrev-25507	432	8	because	because	SCONJ
inlawrev-25507	432	9	a	a	DET
inlawrev-25507	432	10	blockbuster	blockbuster	ADJ
inlawrev-25507	432	11	drug	drug	NOUN
inlawrev-25507	432	12	in	in	ADP
inlawrev-25507	432	13	one	one	NUM
inlawrev-25507	432	14	country	country	NOUN
inlawrev-25507	432	15	is	be	AUX
inlawrev-25507	432	16	likely	likely	ADJ
inlawrev-25507	432	17	to	to	PART
inlawrev-25507	432	18	be	be	AUX
inlawrev-25507	432	19	a	a	DET
inlawrev-25507	432	20	blockbuster	blockbuster	ADJ
inlawrev-25507	432	21	drug	drug	NOUN
inlawrev-25507	432	22	in	in	ADP
inlawrev-25507	432	23	many	many	ADJ
inlawrev-25507	432	24	countries.147	countries.147	NOUN
inlawrev-25507	432	25	however	however	ADV
inlawrev-25507	432	26	,	,	PUNCT
inlawrev-25507	432	27	because	because	SCONJ
inlawrev-25507	432	28	different	different	ADJ
inlawrev-25507	432	29	countries	country	NOUN
inlawrev-25507	432	30	regulate	regulate	VERB
inlawrev-25507	432	31	the	the	DET
inlawrev-25507	432	32	patenting	patenting	NOUN
inlawrev-25507	432	33	process	process	NOUN
inlawrev-25507	432	34	differently	differently	ADV
inlawrev-25507	432	35	for	for	ADP
inlawrev-25507	432	36	the	the	DET
inlawrev-25507	432	37	prevention	prevention	NOUN
inlawrev-25507	432	38	of	of	ADP
inlawrev-25507	432	39	evergreening,14	evergreening,14	ADV
inlawrev-25507	432	40	8	8	NUM
inlawrev-25507	432	41	a	a	DET
inlawrev-25507	432	42	large	large	ADJ
inlawrev-25507	432	43	number	number	NOUN
inlawrev-25507	432	44	of	of	ADP
inlawrev-25507	432	45	patents	patent	NOUN
inlawrev-25507	432	46	in	in	ADP
inlawrev-25507	432	47	other	other	ADJ
inlawrev-25507	432	48	countries	country	NOUN
inlawrev-25507	432	49	in	in	ADP
inlawrev-25507	432	50	comparison	comparison	NOUN
inlawrev-25507	432	51	to	to	ADP
inlawrev-25507	432	52	their	their	PRON
inlawrev-25507	432	53	expiration	expiration	NOUN
inlawrev-25507	432	54	date	date	NOUN
inlawrev-25507	432	55	should	should	AUX
inlawrev-25507	432	56	not	not	PART
inlawrev-25507	432	57	necessarily	necessarily	ADV
inlawrev-25507	432	58	cause	cause	VERB
inlawrev-25507	432	59	the	the	DET
inlawrev-25507	432	60	examining	examine	VERB
inlawrev-25507	432	61	entity	entity	NOUN
inlawrev-25507	432	62	to	to	PART
inlawrev-25507	432	63	find	find	VERB
inlawrev-25507	432	64	a	a	DET
inlawrev-25507	432	65	result	result	NOUN
inlawrev-25507	432	66	of	of	ADP
inlawrev-25507	432	67	evergreening	evergreene	VERB
inlawrev-25507	432	68	.	.	PUNCT
inlawrev-25507	433	1	on	on	ADP
inlawrev-25507	433	2	the	the	DET
inlawrev-25507	433	3	other	other	ADJ
inlawrev-25507	433	4	hand	hand	NOUN
inlawrev-25507	433	5	,	,	PUNCT
inlawrev-25507	433	6	the	the	DET
inlawrev-25507	433	7	examining	examine	VERB
inlawrev-25507	433	8	entity	entity	NOUN
inlawrev-25507	433	9	should	should	AUX
inlawrev-25507	433	10	take	take	VERB
inlawrev-25507	433	11	notice	notice	NOUN
inlawrev-25507	433	12	of	of	ADP
inlawrev-25507	433	13	the	the	DET
inlawrev-25507	433	14	innovator	innovator	NOUN
inlawrev-25507	433	15	company	company	NOUN
inlawrev-25507	433	16	’s	’s	PART
inlawrev-25507	433	17	efforts	effort	NOUN
inlawrev-25507	433	18	of	of	ADP
inlawrev-25507	433	19	applying	apply	VERB
inlawrev-25507	433	20	for	for	ADP
inlawrev-25507	433	21	secondary	secondary	ADJ
inlawrev-25507	433	22	patents	patent	NOUN
inlawrev-25507	433	23	later	later	ADV
inlawrev-25507	433	24	in	in	ADP
inlawrev-25507	433	25	the	the	DET
inlawrev-25507	433	26	life	life	NOUN
inlawrev-25507	433	27	of	of	ADP
inlawrev-25507	433	28	the	the	DET
inlawrev-25507	433	29	compound	compound	NOUN
inlawrev-25507	433	30	patent	patent	NOUN
inlawrev-25507	433	31	in	in	ADP
inlawrev-25507	433	32	other	other	ADJ
inlawrev-25507	433	33	countries	country	NOUN
inlawrev-25507	433	34	as	as	SCONJ
inlawrev-25507	433	35	it	it	PRON
inlawrev-25507	433	36	would	would	AUX
inlawrev-25507	433	37	in	in	ADP
inlawrev-25507	433	38	the	the	DET
inlawrev-25507	433	39	united	united	PROPN
inlawrev-25507	433	40	states	states	PROPN
inlawrev-25507	433	41	(	(	PUNCT
inlawrev-25507	433	42	see	see	VERB
inlawrev-25507	433	43	factor	factor	NOUN
inlawrev-25507	433	44	three	three	NUM
inlawrev-25507	433	45	above	above	ADP
inlawrev-25507	433	46	)	)	PUNCT
inlawrev-25507	433	47	;	;	PUNCT
inlawrev-25507	433	48	the	the	DET
inlawrev-25507	433	49	display	display	NOUN
inlawrev-25507	433	50	of	of	ADP
inlawrev-25507	433	51	secondary	secondary	ADJ
inlawrev-25507	433	52	patents	patent	NOUN
inlawrev-25507	433	53	only	only	ADV
inlawrev-25507	433	54	later	later	ADV
inlawrev-25507	433	55	in	in	ADP
inlawrev-25507	433	56	the	the	DET
inlawrev-25507	433	57	compound	compound	NOUN
inlawrev-25507	433	58	patent	patent	NOUN
inlawrev-25507	433	59	’s	’s	PART
inlawrev-25507	433	60	life	life	NOUN
inlawrev-25507	433	61	,	,	PUNCT
inlawrev-25507	433	62	and	and	CCONJ
inlawrev-25507	433	63	not	not	PART
inlawrev-25507	433	64	throughout	throughout	ADV
inlawrev-25507	433	65	,	,	PUNCT
inlawrev-25507	433	66	could	could	AUX
inlawrev-25507	433	67	be	be	AUX
inlawrev-25507	433	68	a	a	DET
inlawrev-25507	433	69	signal	signal	NOUN
inlawrev-25507	433	70	that	that	SCONJ
inlawrev-25507	433	71	the	the	DET
inlawrev-25507	433	72	innovator	innovator	NOUN
inlawrev-25507	433	73	was	be	AUX
inlawrev-25507	433	74	intending	intend	VERB
inlawrev-25507	433	75	to	to	PART
inlawrev-25507	433	76	evergreen	evergreen	VERB
inlawrev-25507	433	77	in	in	ADP
inlawrev-25507	433	78	another	another	DET
inlawrev-25507	433	79	country	country	NOUN
inlawrev-25507	433	80	.	.	PUNCT
inlawrev-25507	434	1	with	with	ADP
inlawrev-25507	434	2	regard	regard	NOUN
inlawrev-25507	434	3	to	to	ADP
inlawrev-25507	434	4	the	the	DET
inlawrev-25507	434	5	tenth	tenth	ADJ
inlawrev-25507	434	6	factor	factor	NOUN
inlawrev-25507	434	7	,	,	PUNCT
inlawrev-25507	434	8	once	once	ADV
inlawrev-25507	434	9	approved	approve	VERB
inlawrev-25507	434	10	,	,	PUNCT
inlawrev-25507	434	11	every	every	DET
inlawrev-25507	434	12	drug	drug	NOUN
inlawrev-25507	434	13	is	be	AUX
inlawrev-25507	434	14	to	to	PART
inlawrev-25507	434	15	be	be	AUX
inlawrev-25507	434	16	listed	list	VERB
inlawrev-25507	434	17	in	in	ADP
inlawrev-25507	434	18	the	the	DET
inlawrev-25507	434	19	orange	orange	PROPN
inlawrev-25507	434	20	book	book	NOUN
inlawrev-25507	434	21	in	in	ADP
inlawrev-25507	434	22	order	order	NOUN
inlawrev-25507	434	23	to	to	PART
inlawrev-25507	434	24	serve	serve	VERB
inlawrev-25507	434	25	as	as	ADP
inlawrev-25507	434	26	a	a	DET
inlawrev-25507	434	27	reference	reference	NOUN
inlawrev-25507	434	28	for	for	ADP
inlawrev-25507	434	29	generic	generic	ADJ
inlawrev-25507	434	30	companies	company	NOUN
inlawrev-25507	434	31	who	who	PRON
inlawrev-25507	434	32	want	want	VERB
inlawrev-25507	434	33	to	to	PART
inlawrev-25507	434	34	launch	launch	VERB
inlawrev-25507	434	35	their	their	PRON
inlawrev-25507	434	36	generic	generic	ADJ
inlawrev-25507	434	37	products	product	NOUN
inlawrev-25507	434	38	at	at	ADP
inlawrev-25507	434	39	the	the	DET
inlawrev-25507	434	40	end	end	NOUN
inlawrev-25507	434	41	of	of	ADP
inlawrev-25507	434	42	the	the	DET
inlawrev-25507	434	43	patent	patent	NOUN
inlawrev-25507	435	1	term.149	term.149	DET
inlawrev-25507	435	2	additional	additional	ADJ
inlawrev-25507	435	3	patents	patent	NOUN
inlawrev-25507	435	4	and	and	CCONJ
inlawrev-25507	435	5	non	non	ADJ
inlawrev-25507	435	6	-	-	NOUN
inlawrev-25507	435	7	obviousness	obviousness	ADJ
inlawrev-25507	435	8	)	)	PUNCT
inlawrev-25507	435	9	.	.	PUNCT
inlawrev-25507	436	1	147	147	NUM
inlawrev-25507	436	2	.	.	PUNCT
inlawrev-25507	437	1	see	see	VERB
inlawrev-25507	437	2	world	world	PROPN
inlawrev-25507	437	3	health	health	PROPN
inlawrev-25507	437	4	organization	organization	PROPN
inlawrev-25507	437	5	model	model	NOUN
inlawrev-25507	437	6	list	list	NOUN
inlawrev-25507	437	7	of	of	ADP
inlawrev-25507	437	8	essential	essential	ADJ
inlawrev-25507	437	9	medicines	medicine	NOUN
inlawrev-25507	437	10	,	,	PUNCT
inlawrev-25507	437	11	21st	21st	ADJ
inlawrev-25507	437	12	list	list	NOUN
inlawrev-25507	437	13	,	,	PUNCT
inlawrev-25507	437	14	world	world	NOUN
inlawrev-25507	437	15	health	health	NOUN
inlawrev-25507	437	16	org	org	PROPN
inlawrev-25507	437	17	.	.	PUNCT
inlawrev-25507	438	1	(	(	PUNCT
inlawrev-25507	438	2	2019	2019	NUM
inlawrev-25507	438	3	)	)	PUNCT
inlawrev-25507	438	4	,	,	PUNCT
inlawrev-25507	438	5	https://apps.who.int/iris/bitstream/handle/10665/325771/whomvp-emp-iau-2019.06-eng.pdf?ua=1	https://apps.who.int/iris/bitstream/handle/10665/325771/whomvp-emp-iau-2019.06-eng.pdf?ua=1	PROPN
inlawrev-25507	439	1	[	[	X
inlawrev-25507	439	2	https://perma.cc/emt4-qjqj	https://perma.cc/emt4-qjqj	PROPN
inlawrev-25507	439	3	]	]	PUNCT
inlawrev-25507	439	4	(	(	PUNCT
inlawrev-25507	439	5	discussing	discuss	VERB
inlawrev-25507	439	6	essential	essential	ADJ
inlawrev-25507	439	7	medicines	medicine	NOUN
inlawrev-25507	439	8	of	of	ADP
inlawrev-25507	439	9	the	the	DET
inlawrev-25507	439	10	world	world	NOUN
inlawrev-25507	439	11	)	)	PUNCT
inlawrev-25507	439	12	.	.	PUNCT
inlawrev-25507	440	1	148	148	NUM
inlawrev-25507	440	2	.	.	PUNCT
inlawrev-25507	441	1	see	see	VERB
inlawrev-25507	441	2	arun	arun	PROPN
inlawrev-25507	441	3	kumar	kumar	PROPN
inlawrev-25507	441	4	&	&	CCONJ
inlawrev-25507	441	5	arun	arun	PROPN
inlawrev-25507	441	6	nanda	nanda	PROPN
inlawrev-25507	441	7	,	,	PUNCT
inlawrev-25507	441	8	ever	ever	ADV
inlawrev-25507	441	9	-	-	PUNCT
inlawrev-25507	441	10	greening	greening	NOUN
inlawrev-25507	441	11	in	in	ADP
inlawrev-25507	441	12	pharmaceuticals	pharmaceutical	NOUN
inlawrev-25507	441	13	:	:	PUNCT
inlawrev-25507	441	14	strategies	strategy	NOUN
inlawrev-25507	441	15	,	,	PUNCT
inlawrev-25507	441	16	consequences	consequence	NOUN
inlawrev-25507	441	17	and	and	CCONJ
inlawrev-25507	441	18	provisions	provision	NOUN
inlawrev-25507	441	19	in	in	ADP
inlawrev-25507	441	20	the	the	DET
inlawrev-25507	441	21	usa	usa	PROPN
inlawrev-25507	441	22	,	,	PUNCT
inlawrev-25507	441	23	eu	eu	PROPN
inlawrev-25507	441	24	,	,	PUNCT
inlawrev-25507	441	25	india	india	PROPN
inlawrev-25507	441	26	and	and	CCONJ
inlawrev-25507	441	27	other	other	ADJ
inlawrev-25507	441	28	countries	country	NOUN
inlawrev-25507	441	29	,	,	PUNCT
inlawrev-25507	441	30	6	6	NUM
inlawrev-25507	441	31	pharm	pharm	NOUN
inlawrev-25507	441	32	.	.	PUNCT
inlawrev-25507	442	1	reg	reg	PROPN
inlawrev-25507	442	2	.	.	PUNCT
inlawrev-25507	443	1	aff	aff	PROPN
inlawrev-25507	443	2	.	.	PUNCT
inlawrev-25507	443	3	:	:	PUNCT
inlawrev-25507	444	1	open	open	ADJ
inlawrev-25507	444	2	access	access	NOUN
inlawrev-25507	444	3	(	(	PUNCT
inlawrev-25507	444	4	apr	apr	PROPN
inlawrev-25507	444	5	.	.	PROPN
inlawrev-25507	444	6	18	18	NUM
inlawrev-25507	444	7	,	,	PUNCT
inlawrev-25507	444	8	2017	2017	NUM
inlawrev-25507	444	9	)	)	PUNCT
inlawrev-25507	444	10	,	,	PUNCT
inlawrev-25507	444	11	https://www.hilarispublisher.com/open-access/evergreening-inpharmaceuticals-strategies-consequences-and-provisions-for-prevention-in-usa-eu-india-and-othercountries-2167-7689-1000185.pdf	https://www.hilarispublisher.com/open-access/evergreening-inpharmaceuticals-strategies-consequences-and-provisions-for-prevention-in-usa-eu-india-and-othercountries-2167-7689-1000185.pdf	PUNCT
inlawrev-25507	445	1	[	[	X
inlawrev-25507	445	2	https://perma.cc/ce4h-m3be	https://perma.cc/ce4h-m3be	X
inlawrev-25507	445	3	]	]	X
inlawrev-25507	445	4	.	.	PUNCT
inlawrev-25507	446	1	149	149	NUM
inlawrev-25507	446	2	.	.	PUNCT
inlawrev-25507	447	1	i	i	PRON
inlawrev-25507	447	2	d.	d.	PROPN
inlawrev-25507	447	3	;	;	PUNCT
inlawrev-25507	447	4	orange	orange	PROPN
inlawrev-25507	447	5	book	book	PROPN
inlawrev-25507	447	6	:	:	PUNCT
inlawrev-25507	447	7	approved	approve	VERB
inlawrev-25507	447	8	drug	drug	NOUN
inlawrev-25507	447	9	products	product	NOUN
inlawrev-25507	447	10	with	with	ADP
inlawrev-25507	447	11	therapeutic	therapeutic	ADJ
inlawrev-25507	447	12	equivalence	equivalence	NOUN
inlawrev-25507	447	13	evaluations	evaluation	NOUN
inlawrev-25507	447	14	,	,	PUNCT
inlawrev-25507	447	15	supra	supra	PROPN
inlawrev-25507	447	16	note	note	VERB
inlawrev-25507	447	17	127	127	NUM
inlawrev-25507	447	18	(	(	PUNCT
inlawrev-25507	447	19	discussing	discuss	VERB
inlawrev-25507	447	20	how	how	SCONJ
inlawrev-25507	447	21	the	the	DET
inlawrev-25507	447	22	purpose	purpose	NOUN
inlawrev-25507	447	23	of	of	ADP
inlawrev-25507	447	24	the	the	DET
inlawrev-25507	447	25	orange	orange	PROPN
inlawrev-25507	447	26	book	book	NOUN
inlawrev-25507	447	27	is	be	AUX
inlawrev-25507	447	28	to	to	PART
inlawrev-25507	447	29	identify	identify	VERB
inlawrev-25507	447	30	drug	drug	NOUN
inlawrev-25507	447	31	products	product	NOUN
inlawrev-25507	447	32	approved	approve	VERB
inlawrev-25507	447	33	on	on	ADP
inlawrev-25507	447	34	the	the	DET
inlawrev-25507	447	35	basis	basis	NOUN
inlawrev-25507	447	36	of	of	ADP
inlawrev-25507	447	37	safety	safety	NOUN
inlawrev-25507	447	38	and	and	CCONJ
inlawrev-25507	447	39	effectiveness	effectiveness	NOUN
inlawrev-25507	447	40	by	by	ADP
inlawrev-25507	447	41	the	the	DET
inlawrev-25507	447	42	fda	fda	PROPN
inlawrev-25507	447	43	as	as	ADV
inlawrev-25507	447	44	well	well	ADV
inlawrev-25507	447	45	as	as	ADP
inlawrev-25507	447	46	identify	identify	VERB
inlawrev-25507	447	47	related	related	ADJ
inlawrev-25507	447	48	patent	patent	NOUN
inlawrev-25507	447	49	and	and	CCONJ
inlawrev-25507	447	50	2021	2021	NUM
inlawrev-25507	447	51	]	]	PUNCT
inlawrev-25507	447	52	leaving	leave	VERB
inlawrev-25507	447	53	the	the	DET
inlawrev-25507	447	54	evergreening	evergreene	VERB
inlawrev-25507	447	55	problem	problem	NOUN
inlawrev-25507	447	56	to	to	ADP
inlawrev-25507	447	57	the	the	DET
inlawrev-25507	447	58	patent	patent	NOUN
inlawrev-25507	447	59	experts	expert	NOUN
inlawrev-25507	447	60	213	213	NUM
inlawrev-25507	447	61	that	that	PRON
inlawrev-25507	447	62	are	be	AUX
inlawrev-25507	447	63	tied	tie	VERB
inlawrev-25507	447	64	to	to	ADP
inlawrev-25507	447	65	the	the	DET
inlawrev-25507	447	66	primary	primary	ADJ
inlawrev-25507	447	67	patent	patent	NOUN
inlawrev-25507	447	68	,	,	PUNCT
inlawrev-25507	447	69	including	include	VERB
inlawrev-25507	447	70	secondary	secondary	ADJ
inlawrev-25507	447	71	patents	patent	NOUN
inlawrev-25507	447	72	,	,	PUNCT
inlawrev-25507	447	73	should	should	AUX
inlawrev-25507	447	74	be	be	AUX
inlawrev-25507	447	75	listed	list	VERB
inlawrev-25507	447	76	as	as	ADP
inlawrev-25507	447	77	well.150	well.150	PROPN
inlawrev-25507	447	78	in	in	ADP
inlawrev-25507	447	79	order	order	NOUN
inlawrev-25507	447	80	for	for	ADP
inlawrev-25507	447	81	a	a	DET
inlawrev-25507	447	82	generic	generic	ADJ
inlawrev-25507	447	83	drug	drug	NOUN
inlawrev-25507	447	84	to	to	PART
inlawrev-25507	447	85	get	get	AUX
inlawrev-25507	447	86	approved	approve	VERB
inlawrev-25507	447	87	,	,	PUNCT
inlawrev-25507	447	88	it	it	PRON
inlawrev-25507	447	89	must	must	AUX
inlawrev-25507	447	90	file	file	VERB
inlawrev-25507	447	91	an	an	DET
inlawrev-25507	447	92	abbreviated	abbreviate	VERB
inlawrev-25507	447	93	new	new	ADJ
inlawrev-25507	447	94	drug	drug	NOUN
inlawrev-25507	447	95	application	application	NOUN
inlawrev-25507	447	96	(	(	PUNCT
inlawrev-25507	447	97	“	"	PUNCT
inlawrev-25507	447	98	anda	anda	PROPN
inlawrev-25507	447	99	”	"	PUNCT
inlawrev-25507	447	100	)	)	PUNCT
inlawrev-25507	447	101	and	and	CCONJ
inlawrev-25507	447	102	must	must	AUX
inlawrev-25507	447	103	certify	certify	VERB
inlawrev-25507	447	104	one	one	NUM
inlawrev-25507	447	105	of	of	ADP
inlawrev-25507	447	106	the	the	DET
inlawrev-25507	447	107	following	following	NOUN
inlawrev-25507	447	108	:	:	PUNCT
inlawrev-25507	447	109	(	(	PUNCT
inlawrev-25507	447	110	1	1	X
inlawrev-25507	447	111	)	)	PUNCT
inlawrev-25507	447	112	“	"	PUNCT
inlawrev-25507	447	113	[	[	X
inlawrev-25507	447	114	t]he	t]he	ADJ
inlawrev-25507	447	115	drug	drug	NOUN
inlawrev-25507	447	116	is	be	AUX
inlawrev-25507	447	117	not	not	PART
inlawrev-25507	447	118	patented	patent	VERB
inlawrev-25507	447	119	”	"	PUNCT
inlawrev-25507	447	120	;	;	PUNCT
inlawrev-25507	447	121	(	(	PUNCT
inlawrev-25507	447	122	2	2	X
inlawrev-25507	447	123	)	)	PUNCT
inlawrev-25507	447	124	“	"	PUNCT
inlawrev-25507	447	125	[	[	X
inlawrev-25507	447	126	t]he	t]he	ADV
inlawrev-25507	447	127	drug	drug	NOUN
inlawrev-25507	447	128	patent	patent	NOUN
inlawrev-25507	447	129	has	have	AUX
inlawrev-25507	447	130	already	already	ADV
inlawrev-25507	447	131	expired	expire	VERB
inlawrev-25507	447	132	”	"	PUNCT
inlawrev-25507	447	133	;	;	PUNCT
inlawrev-25507	447	134	(	(	PUNCT
inlawrev-25507	447	135	3	3	X
inlawrev-25507	447	136	)	)	PUNCT
inlawrev-25507	447	137	“	"	PUNCT
inlawrev-25507	447	138	[	[	X
inlawrev-25507	447	139	t]he	t]he	ADV
inlawrev-25507	447	140	generic	generic	ADJ
inlawrev-25507	447	141	will	will	AUX
inlawrev-25507	447	142	enter	enter	VERB
inlawrev-25507	447	143	the	the	DET
inlawrev-25507	447	144	market	market	NOUN
inlawrev-25507	447	145	only	only	ADV
inlawrev-25507	447	146	when	when	SCONJ
inlawrev-25507	447	147	the	the	DET
inlawrev-25507	447	148	patent	patent	NOUN
inlawrev-25507	447	149	has	have	AUX
inlawrev-25507	447	150	expired	expire	VERB
inlawrev-25507	447	151	”	"	PUNCT
inlawrev-25507	447	152	;	;	PUNCT
inlawrev-25507	447	153	or	or	CCONJ
inlawrev-25507	447	154	(	(	PUNCT
inlawrev-25507	447	155	4	4	NUM
inlawrev-25507	447	156	)	)	PUNCT
inlawrev-25507	447	157	“	"	PUNCT
inlawrev-25507	447	158	[	[	X
inlawrev-25507	447	159	t]he	t]he	X
inlawrev-25507	447	160	patent	patent	NOUN
inlawrev-25507	447	161	is	be	AUX
inlawrev-25507	447	162	invalid	invalid	ADJ
inlawrev-25507	447	163	or	or	CCONJ
inlawrev-25507	447	164	will	will	AUX
inlawrev-25507	447	165	not	not	PART
inlawrev-25507	447	166	be	be	AUX
inlawrev-25507	447	167	infringed	infringe	VERB
inlawrev-25507	447	168	by	by	ADP
inlawrev-25507	447	169	the	the	DET
inlawrev-25507	447	170	generic	generic	NOUN
inlawrev-25507	447	171	.	.	PUNCT
inlawrev-25507	447	172	”151	”151	PUNCT
inlawrev-25507	448	1	additionally	additionally	ADV
inlawrev-25507	448	2	,	,	PUNCT
inlawrev-25507	448	3	the	the	DET
inlawrev-25507	448	4	generic	generic	ADJ
inlawrev-25507	448	5	company	company	NOUN
inlawrev-25507	448	6	must	must	AUX
inlawrev-25507	448	7	show	show	VERB
inlawrev-25507	448	8	that	that	SCONJ
inlawrev-25507	448	9	its	its	PRON
inlawrev-25507	448	10	version	version	NOUN
inlawrev-25507	448	11	is	be	AUX
inlawrev-25507	448	12	comparable	comparable	ADJ
inlawrev-25507	448	13	to	to	ADP
inlawrev-25507	448	14	the	the	DET
inlawrev-25507	448	15	innovator	innovator	NOUN
inlawrev-25507	448	16	drug	drug	NOUN
inlawrev-25507	448	17	in	in	ADP
inlawrev-25507	448	18	bio	bio	PROPN
inlawrev-25507	448	19	-	-	NOUN
inlawrev-25507	448	20	equivalence.152	equivalence.152	PROPN
inlawrev-25507	448	21	however	however	ADV
inlawrev-25507	448	22	,	,	PUNCT
inlawrev-25507	448	23	an	an	DET
inlawrev-25507	448	24	innovator	innovator	NOUN
inlawrev-25507	448	25	can	can	AUX
inlawrev-25507	448	26	work	work	VERB
inlawrev-25507	448	27	to	to	ADP
inlawrev-25507	448	28	de	de	NOUN
inlawrev-25507	448	29	-	-	NOUN
inlawrev-25507	448	30	list	list	VERB
inlawrev-25507	448	31	its	its	PRON
inlawrev-25507	448	32	drug	drug	NOUN
inlawrev-25507	448	33	in	in	ADP
inlawrev-25507	448	34	order	order	NOUN
inlawrev-25507	448	35	to	to	PART
inlawrev-25507	448	36	significantly	significantly	ADV
inlawrev-25507	448	37	delay	delay	VERB
inlawrev-25507	448	38	the	the	DET
inlawrev-25507	448	39	entry	entry	NOUN
inlawrev-25507	448	40	of	of	ADP
inlawrev-25507	448	41	generics.153	generics.153	PROPN
inlawrev-25507	448	42	additionally	additionally	ADV
inlawrev-25507	448	43	,	,	PUNCT
inlawrev-25507	448	44	under	under	ADP
inlawrev-25507	448	45	the	the	DET
inlawrev-25507	448	46	hatchwaxman	hatchwaxman	NOUN
inlawrev-25507	448	47	amendments,154	amendments,154	PROPN
inlawrev-25507	448	48	manufacturing	manufacture	VERB
inlawrev-25507	448	49	patents	patent	NOUN
inlawrev-25507	448	50	are	be	AUX
inlawrev-25507	448	51	not	not	PART
inlawrev-25507	448	52	allowed	allow	VERB
inlawrev-25507	448	53	to	to	PART
inlawrev-25507	448	54	be	be	AUX
inlawrev-25507	448	55	listed	list	VERB
inlawrev-25507	448	56	.	.	PUNCT
inlawrev-25507	449	1	therefore	therefore	ADV
inlawrev-25507	449	2	,	,	PUNCT
inlawrev-25507	449	3	if	if	SCONJ
inlawrev-25507	449	4	a	a	DET
inlawrev-25507	449	5	secondary	secondary	ADJ
inlawrev-25507	449	6	patent	patent	NOUN
inlawrev-25507	449	7	is	be	AUX
inlawrev-25507	449	8	not	not	PART
inlawrev-25507	449	9	listed	list	VERB
inlawrev-25507	449	10	,	,	PUNCT
inlawrev-25507	449	11	it	it	PRON
inlawrev-25507	449	12	is	be	AUX
inlawrev-25507	449	13	conclusively	conclusively	ADV
inlawrev-25507	449	14	either	either	CCONJ
inlawrev-25507	449	15	a	a	DET
inlawrev-25507	449	16	manufacturing	manufacture	VERB
inlawrev-25507	449	17	patent	patent	NOUN
inlawrev-25507	449	18	or	or	CCONJ
inlawrev-25507	449	19	a	a	DET
inlawrev-25507	449	20	patent	patent	NOUN
inlawrev-25507	449	21	that	that	SCONJ
inlawrev-25507	449	22	the	the	DET
inlawrev-25507	449	23	innovator	innovator	NOUN
inlawrev-25507	449	24	company	company	NOUN
inlawrev-25507	449	25	decided	decide	VERB
inlawrev-25507	449	26	not	not	PART
inlawrev-25507	449	27	to	to	PART
inlawrev-25507	449	28	list	list	VERB
inlawrev-25507	449	29	in	in	ADP
inlawrev-25507	449	30	the	the	DET
inlawrev-25507	449	31	orange	orange	NOUN
inlawrev-25507	449	32	book.155	book.155	ADP
inlawrev-25507	449	33	the	the	DET
inlawrev-25507	449	34	strategy	strategy	NOUN
inlawrev-25507	449	35	to	to	PART
inlawrev-25507	449	36	obtain	obtain	VERB
inlawrev-25507	449	37	secondary	secondary	ADJ
inlawrev-25507	449	38	patents	patent	NOUN
inlawrev-25507	449	39	on	on	ADP
inlawrev-25507	449	40	manufacturing	manufacture	VERB
inlawrev-25507	449	41	patents	patent	NOUN
inlawrev-25507	449	42	can	can	AUX
inlawrev-25507	449	43	delay	delay	VERB
inlawrev-25507	449	44	the	the	DET
inlawrev-25507	449	45	release	release	NOUN
inlawrev-25507	449	46	of	of	ADP
inlawrev-25507	449	47	the	the	DET
inlawrev-25507	449	48	generic	generic	ADJ
inlawrev-25507	449	49	products	product	NOUN
inlawrev-25507	449	50	,	,	PUNCT
inlawrev-25507	449	51	and	and	CCONJ
inlawrev-25507	449	52	therefore	therefore	ADV
inlawrev-25507	449	53	should	should	AUX
inlawrev-25507	449	54	be	be	AUX
inlawrev-25507	449	55	scrutinized	scrutinize	VERB
inlawrev-25507	449	56	.	.	PUNCT
inlawrev-25507	450	1	the	the	DET
inlawrev-25507	450	2	final	final	ADJ
inlawrev-25507	450	3	factor	factor	NOUN
inlawrev-25507	450	4	—	—	PUNCT
inlawrev-25507	450	5	any	any	DET
inlawrev-25507	450	6	other	other	ADJ
inlawrev-25507	450	7	information	information	NOUN
inlawrev-25507	450	8	that	that	PRON
inlawrev-25507	450	9	may	may	AUX
inlawrev-25507	450	10	be	be	AUX
inlawrev-25507	450	11	relevant	relevant	ADJ
inlawrev-25507	450	12	—	—	PUNCT
inlawrev-25507	450	13	is	be	AUX
inlawrev-25507	450	14	necessary	necessary	ADJ
inlawrev-25507	450	15	considering	consider	VERB
inlawrev-25507	450	16	that	that	SCONJ
inlawrev-25507	450	17	evergreening	evergreening	NOUN
inlawrev-25507	450	18	is	be	AUX
inlawrev-25507	450	19	an	an	DET
inlawrev-25507	450	20	evolving	evolve	VERB
inlawrev-25507	450	21	problem	problem	NOUN
inlawrev-25507	450	22	in	in	ADP
inlawrev-25507	450	23	the	the	DET
inlawrev-25507	450	24	united	united	PROPN
inlawrev-25507	450	25	states	states	PROPN
inlawrev-25507	450	26	,	,	PUNCT
inlawrev-25507	450	27	and	and	CCONJ
inlawrev-25507	450	28	it	it	PRON
inlawrev-25507	450	29	is	be	AUX
inlawrev-25507	450	30	expected	expect	VERB
inlawrev-25507	450	31	that	that	SCONJ
inlawrev-25507	450	32	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	450	33	companies	company	NOUN
inlawrev-25507	450	34	will	will	AUX
inlawrev-25507	450	35	continue	continue	VERB
inlawrev-25507	450	36	to	to	PART
inlawrev-25507	450	37	search	search	VERB
inlawrev-25507	450	38	for	for	ADP
inlawrev-25507	450	39	technicalities	technicality	NOUN
inlawrev-25507	450	40	in	in	ADP
inlawrev-25507	450	41	the	the	DET
inlawrev-25507	450	42	patent	patent	NOUN
inlawrev-25507	450	43	system	system	NOUN
inlawrev-25507	450	44	in	in	ADP
inlawrev-25507	450	45	order	order	NOUN
inlawrev-25507	450	46	to	to	PART
inlawrev-25507	450	47	extend	extend	VERB
inlawrev-25507	450	48	the	the	DET
inlawrev-25507	450	49	exclusivity	exclusivity	NOUN
inlawrev-25507	450	50	on	on	ADP
inlawrev-25507	450	51	a	a	DET
inlawrev-25507	450	52	blockbuster	blockbuster	ADJ
inlawrev-25507	450	53	drug	drug	NOUN
inlawrev-25507	450	54	.	.	PUNCT
inlawrev-25507	451	1	it	it	PRON
inlawrev-25507	451	2	is	be	AUX
inlawrev-25507	451	3	also	also	ADV
inlawrev-25507	451	4	possible	possible	ADJ
inlawrev-25507	451	5	that	that	SCONJ
inlawrev-25507	451	6	there	there	PRON
inlawrev-25507	451	7	will	will	AUX
inlawrev-25507	451	8	be	be	AUX
inlawrev-25507	451	9	evidence	evidence	NOUN
inlawrev-25507	451	10	unearthed	unearth	VERB
inlawrev-25507	451	11	during	during	ADP
inlawrev-25507	451	12	discovery	discovery	NOUN
inlawrev-25507	451	13	or	or	CCONJ
inlawrev-25507	451	14	after	after	ADP
inlawrev-25507	451	15	the	the	DET
inlawrev-25507	451	16	uspto	uspto	PROPN
inlawrev-25507	451	17	requests	request	VERB
inlawrev-25507	451	18	additional	additional	ADJ
inlawrev-25507	451	19	information	information	NOUN
inlawrev-25507	451	20	that	that	PRON
inlawrev-25507	451	21	may	may	AUX
inlawrev-25507	451	22	prove	prove	VERB
inlawrev-25507	451	23	evergreening	evergreene	VERB
inlawrev-25507	451	24	and	and	CCONJ
inlawrev-25507	451	25	is	be	AUX
inlawrev-25507	451	26	not	not	PART
inlawrev-25507	451	27	one	one	NUM
inlawrev-25507	451	28	of	of	ADP
inlawrev-25507	451	29	the	the	DET
inlawrev-25507	451	30	factors	factor	NOUN
inlawrev-25507	451	31	described	describe	VERB
inlawrev-25507	451	32	above	above	ADV
inlawrev-25507	451	33	.	.	PUNCT
inlawrev-25507	452	1	therefore	therefore	ADV
inlawrev-25507	452	2	,	,	PUNCT
inlawrev-25507	452	3	the	the	DET
inlawrev-25507	452	4	examining	examine	VERB
inlawrev-25507	452	5	entity	entity	NOUN
inlawrev-25507	452	6	could	could	AUX
inlawrev-25507	452	7	consider	consider	VERB
inlawrev-25507	452	8	including	include	VERB
inlawrev-25507	452	9	additional	additional	ADJ
inlawrev-25507	452	10	factors	factor	NOUN
inlawrev-25507	452	11	it	it	PRON
inlawrev-25507	452	12	believes	believe	VERB
inlawrev-25507	452	13	to	to	PART
inlawrev-25507	452	14	be	be	AUX
inlawrev-25507	452	15	necessary	necessary	ADJ
inlawrev-25507	452	16	in	in	ADP
inlawrev-25507	452	17	the	the	DET
inlawrev-25507	452	18	determination	determination	NOUN
inlawrev-25507	452	19	of	of	ADP
inlawrev-25507	452	20	whether	whether	SCONJ
inlawrev-25507	452	21	or	or	CCONJ
inlawrev-25507	452	22	not	not	PART
inlawrev-25507	452	23	evergreening	evergreene	VERB
inlawrev-25507	452	24	exists	exist	NOUN
inlawrev-25507	452	25	in	in	ADP
inlawrev-25507	452	26	a	a	DET
inlawrev-25507	452	27	particular	particular	ADJ
inlawrev-25507	452	28	case	case	NOUN
inlawrev-25507	452	29	.	.	PUNCT
inlawrev-25507	453	1	c.	c.	NOUN
inlawrev-25507	453	2	application	application	NOUN
inlawrev-25507	453	3	of	of	ADP
inlawrev-25507	453	4	the	the	DET
inlawrev-25507	453	5	balancing	balancing	NOUN
inlawrev-25507	453	6	test	test	NOUN
inlawrev-25507	453	7	to	to	ADP
inlawrev-25507	453	8	the	the	DET
inlawrev-25507	453	9	best	well	ADV
inlawrev-25507	453	10	-	-	PUNCT
inlawrev-25507	453	11	known	know	VERB
inlawrev-25507	453	12	example	example	NOUN
inlawrev-25507	453	13	of	of	ADP
inlawrev-25507	453	14	evergreening	evergreene	VERB
inlawrev-25507	453	15	the	the	DET
inlawrev-25507	453	16	balancing	balance	VERB
inlawrev-25507	453	17	test	test	NOUN
inlawrev-25507	453	18	can	can	AUX
inlawrev-25507	453	19	be	be	AUX
inlawrev-25507	453	20	applied	apply	VERB
inlawrev-25507	453	21	to	to	ADP
inlawrev-25507	453	22	abbvie	abbvie	PROPN
inlawrev-25507	453	23	’s	’s	PART
inlawrev-25507	453	24	patent	patent	NOUN
inlawrev-25507	453	25	strategy	strategy	NOUN
inlawrev-25507	453	26	on	on	ADP
inlawrev-25507	453	27	its	its	PRON
inlawrev-25507	453	28	blockbuster	blockbuster	ADJ
inlawrev-25507	453	29	drug	drug	NOUN
inlawrev-25507	453	30	humira	humira	PROPN
inlawrev-25507	453	31	®	®	PROPN
inlawrev-25507	453	32	,	,	PUNCT
inlawrev-25507	453	33	as	as	SCONJ
inlawrev-25507	453	34	it	it	PRON
inlawrev-25507	453	35	is	be	AUX
inlawrev-25507	453	36	conceivably	conceivably	ADV
inlawrev-25507	453	37	the	the	DET
inlawrev-25507	453	38	best	good	ADJ
inlawrev-25507	453	39	example	example	NOUN
inlawrev-25507	453	40	of	of	ADP
inlawrev-25507	453	41	evergreening	evergreene	VERB
inlawrev-25507	453	42	.	.	PUNCT
inlawrev-25507	454	1	however	however	ADV
inlawrev-25507	454	2	,	,	PUNCT
inlawrev-25507	454	3	not	not	PART
inlawrev-25507	454	4	all	all	DET
inlawrev-25507	454	5	factors	factor	NOUN
inlawrev-25507	454	6	will	will	AUX
inlawrev-25507	454	7	be	be	AUX
inlawrev-25507	454	8	considered	consider	VERB
inlawrev-25507	454	9	,	,	PUNCT
inlawrev-25507	454	10	as	as	SCONJ
inlawrev-25507	454	11	some	some	PRON
inlawrev-25507	454	12	of	of	ADP
inlawrev-25507	454	13	the	the	DET
inlawrev-25507	454	14	factors	factor	NOUN
inlawrev-25507	454	15	listed	list	VERB
inlawrev-25507	454	16	above	above	ADV
inlawrev-25507	454	17	would	would	AUX
inlawrev-25507	454	18	be	be	AUX
inlawrev-25507	454	19	scrutinized	scrutinize	VERB
inlawrev-25507	454	20	only	only	ADV
inlawrev-25507	454	21	after	after	ADP
inlawrev-25507	454	22	(	(	PUNCT
inlawrev-25507	454	23	1	1	X
inlawrev-25507	454	24	)	)	PUNCT
inlawrev-25507	454	25	a	a	DET
inlawrev-25507	454	26	competitor	competitor	NOUN
inlawrev-25507	454	27	completed	complete	VERB
inlawrev-25507	454	28	discovery	discovery	NOUN
inlawrev-25507	454	29	,	,	PUNCT
inlawrev-25507	454	30	or	or	CCONJ
inlawrev-25507	454	31	(	(	PUNCT
inlawrev-25507	454	32	2	2	X
inlawrev-25507	454	33	)	)	PUNCT
inlawrev-25507	454	34	the	the	DET
inlawrev-25507	454	35	exclusivity	exclusivity	NOUN
inlawrev-25507	454	36	information	information	NOUN
inlawrev-25507	454	37	)	)	PUNCT
inlawrev-25507	454	38	.	.	PUNCT
inlawrev-25507	455	1	150	150	NUM
inlawrev-25507	455	2	.	.	PUNCT
inlawrev-25507	456	1	kumar	kumar	PROPN
inlawrev-25507	456	2	&	&	CCONJ
inlawrev-25507	456	3	nanda	nanda	PROPN
inlawrev-25507	456	4	,	,	PUNCT
inlawrev-25507	456	5	supra	supra	PROPN
inlawrev-25507	456	6	note	note	NOUN
inlawrev-25507	456	7	148	148	NUM
inlawrev-25507	456	8	,	,	PUNCT
inlawrev-25507	456	9	at	at	ADP
inlawrev-25507	456	10	2	2	NUM
inlawrev-25507	456	11	.	.	NOUN
inlawrev-25507	456	12	151	151	NUM
inlawrev-25507	456	13	.	.	PUNCT
inlawrev-25507	457	1	i	i	PRON
inlawrev-25507	457	2	d.	d.	PROPN
inlawrev-25507	457	3	152	152	NUM
inlawrev-25507	457	4	.	.	PUNCT
inlawrev-25507	458	1	i	i	PRON
inlawrev-25507	458	2	d.	d.	PROPN
inlawrev-25507	458	3	at	at	ADP
inlawrev-25507	458	4	3	3	NUM
inlawrev-25507	458	5	.	.	NOUN
inlawrev-25507	458	6	153	153	NUM
inlawrev-25507	458	7	.	.	PUNCT
inlawrev-25507	459	1	i	i	PRON
inlawrev-25507	459	2	d.	d.	PROPN
inlawrev-25507	459	3	154	154	NUM
inlawrev-25507	459	4	.	.	PUNCT
inlawrev-25507	460	1	for	for	ADP
inlawrev-25507	460	2	an	an	DET
inlawrev-25507	460	3	overview	overview	NOUN
inlawrev-25507	460	4	of	of	ADP
inlawrev-25507	460	5	the	the	DET
inlawrev-25507	460	6	hatch	hatch	NOUN
inlawrev-25507	460	7	-	-	PUNCT
inlawrev-25507	460	8	waxman	waxman	NOUN
inlawrev-25507	460	9	amendments	amendment	NOUN
inlawrev-25507	460	10	,	,	PUNCT
inlawrev-25507	460	11	see	see	VERB
inlawrev-25507	460	12	hatch	hatch	NOUN
inlawrev-25507	460	13	-	-	PUNCT
inlawrev-25507	460	14	waxman	waxman	NOUN
inlawrev-25507	460	15	letters	letter	NOUN
inlawrev-25507	460	16	,	,	PUNCT
inlawrev-25507	460	17	u.s	u.s	PROPN
inlawrev-25507	460	18	.	.	PROPN
inlawrev-25507	460	19	food	food	PROPN
inlawrev-25507	460	20	&	&	CCONJ
inlawrev-25507	460	21	drug	drug	PROPN
inlawrev-25507	460	22	admin	admin	PROPN
inlawrev-25507	460	23	.	.	PROPN
inlawrev-25507	460	24	,	,	PUNCT
inlawrev-25507	460	25	https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/hatchwaxman-letters	https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/hatchwaxman-letter	NOUN
inlawrev-25507	460	26	(	(	PUNCT
inlawrev-25507	460	27	last	last	ADJ
inlawrev-25507	460	28	modified	modify	VERB
inlawrev-25507	460	29	july	july	PROPN
inlawrev-25507	460	30	19	19	NUM
inlawrev-25507	460	31	,	,	PUNCT
inlawrev-25507	460	32	2018	2018	NUM
inlawrev-25507	460	33	)	)	PUNCT
inlawrev-25507	461	1	[	[	X
inlawrev-25507	461	2	https://perma.cc/7hnm-nha3	https://perma.cc/7hnm-nha3	NOUN
inlawrev-25507	461	3	]	]	PUNCT
inlawrev-25507	461	4	.	.	PUNCT
inlawrev-25507	462	1	155	155	NUM
inlawrev-25507	462	2	.	.	PUNCT
inlawrev-25507	463	1	for	for	ADP
inlawrev-25507	463	2	a	a	DET
inlawrev-25507	463	3	discussion	discussion	NOUN
inlawrev-25507	463	4	on	on	ADP
inlawrev-25507	463	5	which	which	PRON
inlawrev-25507	463	6	patents	patent	NOUN
inlawrev-25507	463	7	can	can	AUX
inlawrev-25507	463	8	be	be	AUX
inlawrev-25507	463	9	listed	list	VERB
inlawrev-25507	463	10	in	in	ADP
inlawrev-25507	463	11	the	the	DET
inlawrev-25507	463	12	orange	orange	PROPN
inlawrev-25507	463	13	book	book	NOUN
inlawrev-25507	463	14	,	,	PUNCT
inlawrev-25507	463	15	see	see	VERB
inlawrev-25507	463	16	orange	orange	NOUN
inlawrev-25507	463	17	book	book	PROPN
inlawrev-25507	463	18	listed	list	VERB
inlawrev-25507	463	19	patents	patent	NOUN
inlawrev-25507	463	20	:	:	PUNCT
inlawrev-25507	463	21	everything	everything	PRON
inlawrev-25507	463	22	you	you	PRON
inlawrev-25507	463	23	need	need	VERB
inlawrev-25507	463	24	to	to	PART
inlawrev-25507	463	25	know	know	VERB
inlawrev-25507	463	26	,	,	PUNCT
inlawrev-25507	463	27	upcouns	upcoun	NOUN
inlawrev-25507	463	28	.	.	PUNCT
inlawrev-25507	463	29	,	,	PUNCT
inlawrev-25507	463	30	https://www.upcounsel.com/orangebook-listed-patents	https://www.upcounsel.com/orangebook-listed-patents	PROPN
inlawrev-25507	463	31	(	(	PUNCT
inlawrev-25507	463	32	last	last	ADV
inlawrev-25507	463	33	visited	visit	VERB
inlawrev-25507	463	34	jan	jan	PROPN
inlawrev-25507	463	35	.	.	PROPN
inlawrev-25507	463	36	26	26	NUM
inlawrev-25507	463	37	,	,	PUNCT
inlawrev-25507	463	38	2020	2020	NUM
inlawrev-25507	463	39	)	)	PUNCT
inlawrev-25507	464	1	[	[	X
inlawrev-25507	464	2	https://perma.cc/kqz5-ypp2	https://perma.cc/kqz5-ypp2	X
inlawrev-25507	464	3	]	]	X
inlawrev-25507	464	4	.	.	PUNCT
inlawrev-25507	465	1	214	214	NUM
inlawrev-25507	465	2	indiana	indiana	PROPN
inlawrev-25507	465	3	law	law	PROPN
inlawrev-25507	465	4	review	review	NOUN
inlawrev-25507	466	1	[	[	X
inlawrev-25507	466	2	vol	vol	NOUN
inlawrev-25507	466	3	.	.	PUNCT
inlawrev-25507	466	4	54:195	54:195	NUM
inlawrev-25507	466	5	uspto	uspto	NOUN
inlawrev-25507	466	6	requested	request	VERB
inlawrev-25507	466	7	additional	additional	ADJ
inlawrev-25507	466	8	information	information	NOUN
inlawrev-25507	466	9	regarding	regard	VERB
inlawrev-25507	466	10	certain	certain	ADJ
inlawrev-25507	466	11	factors	factor	NOUN
inlawrev-25507	466	12	;	;	PUNCT
inlawrev-25507	466	13	and	and	CCONJ
inlawrev-25507	466	14	not	not	PART
inlawrev-25507	466	15	all	all	PRON
inlawrev-25507	466	16	of	of	ADP
inlawrev-25507	466	17	the	the	DET
inlawrev-25507	466	18	information	information	NOUN
inlawrev-25507	466	19	that	that	PRON
inlawrev-25507	466	20	would	would	AUX
inlawrev-25507	466	21	be	be	AUX
inlawrev-25507	466	22	found	find	VERB
inlawrev-25507	466	23	during	during	ADP
inlawrev-25507	466	24	such	such	ADJ
inlawrev-25507	466	25	discovery	discovery	NOUN
inlawrev-25507	466	26	or	or	CCONJ
inlawrev-25507	466	27	request	request	NOUN
inlawrev-25507	466	28	from	from	ADP
inlawrev-25507	466	29	the	the	DET
inlawrev-25507	466	30	uspto	uspto	NOUN
inlawrev-25507	466	31	is	be	AUX
inlawrev-25507	466	32	available	available	ADJ
inlawrev-25507	466	33	now	now	ADV
inlawrev-25507	466	34	.	.	PUNCT
inlawrev-25507	467	1	in	in	ADP
inlawrev-25507	467	2	examining	examine	VERB
inlawrev-25507	467	3	the	the	DET
inlawrev-25507	467	4	first	first	ADJ
inlawrev-25507	467	5	factor	factor	NOUN
inlawrev-25507	467	6	(	(	PUNCT
inlawrev-25507	467	7	the	the	DET
inlawrev-25507	467	8	number	number	NOUN
inlawrev-25507	467	9	of	of	ADP
inlawrev-25507	467	10	secondary	secondary	ADJ
inlawrev-25507	467	11	patents	patent	NOUN
inlawrev-25507	467	12	on	on	ADP
inlawrev-25507	467	13	a	a	DET
inlawrev-25507	467	14	drug	drug	NOUN
inlawrev-25507	467	15	)	)	PUNCT
inlawrev-25507	467	16	,	,	PUNCT
inlawrev-25507	467	17	there	there	PRON
inlawrev-25507	467	18	are	be	VERB
inlawrev-25507	467	19	247	247	NUM
inlawrev-25507	467	20	secondary	secondary	ADJ
inlawrev-25507	467	21	patents	patent	NOUN
inlawrev-25507	467	22	on	on	ADP
inlawrev-25507	467	23	humira	humira	PROPN
inlawrev-25507	467	24	®	®	PROPN
inlawrev-25507	467	25	in	in	ADP
inlawrev-25507	467	26	the	the	DET
inlawrev-25507	467	27	united	united	PROPN
inlawrev-25507	467	28	states	states	PROPN
inlawrev-25507	467	29	alone.156	alone.156	PROPN
inlawrev-25507	467	30	eightynine	eightynine	NOUN
inlawrev-25507	467	31	percent	percent	NOUN
inlawrev-25507	467	32	of	of	ADP
inlawrev-25507	467	33	the	the	DET
inlawrev-25507	467	34	applications	application	NOUN
inlawrev-25507	467	35	were	be	AUX
inlawrev-25507	467	36	filed	file	VERB
inlawrev-25507	467	37	after	after	SCONJ
inlawrev-25507	467	38	humira	humira	PROPN
inlawrev-25507	467	39	®	®	PROPN
inlawrev-25507	467	40	was	be	AUX
inlawrev-25507	467	41	on	on	ADP
inlawrev-25507	467	42	the	the	DET
inlawrev-25507	467	43	market	market	NOUN
inlawrev-25507	467	44	in	in	ADP
inlawrev-25507	467	45	2002.157	2002.157	NUM
inlawrev-25507	467	46	abbvie	abbvie	NOUN
inlawrev-25507	467	47	filed	file	VERB
inlawrev-25507	467	48	the	the	DET
inlawrev-25507	467	49	primary	primary	ADJ
inlawrev-25507	467	50	patent	patent	NOUN
inlawrev-25507	467	51	for	for	ADP
inlawrev-25507	467	52	humira	humira	PROPN
inlawrev-25507	467	53	®	®	NOUN
inlawrev-25507	467	54	in	in	ADP
inlawrev-25507	467	55	1994	1994	NUM
inlawrev-25507	467	56	,	,	PUNCT
inlawrev-25507	467	57	so	so	ADV
inlawrev-25507	467	58	abbvie	abbvie	PROPN
inlawrev-25507	467	59	’s	’s	PART
inlawrev-25507	467	60	exclusivity	exclusivity	NOUN
inlawrev-25507	467	61	for	for	ADP
inlawrev-25507	467	62	this	this	DET
inlawrev-25507	467	63	drug	drug	NOUN
inlawrev-25507	467	64	should	should	AUX
inlawrev-25507	467	65	have	have	AUX
inlawrev-25507	467	66	expired	expire	VERB
inlawrev-25507	467	67	in	in	ADP
inlawrev-25507	467	68	2014158	2014158	NUM
inlawrev-25507	467	69	;	;	PUNCT
inlawrev-25507	467	70	however	however	ADV
inlawrev-25507	467	71	,	,	PUNCT
inlawrev-25507	467	72	if	if	SCONJ
inlawrev-25507	467	73	its	its	PRON
inlawrev-25507	467	74	secondary	secondary	ADJ
inlawrev-25507	467	75	patents	patent	NOUN
inlawrev-25507	467	76	are	be	AUX
inlawrev-25507	467	77	enforced	enforce	VERB
inlawrev-25507	467	78	,	,	PUNCT
inlawrev-25507	467	79	its	its	PRON
inlawrev-25507	467	80	exclusivity	exclusivity	NOUN
inlawrev-25507	467	81	could	could	AUX
inlawrev-25507	467	82	be	be	AUX
inlawrev-25507	467	83	protected	protect	VERB
inlawrev-25507	467	84	until	until	ADP
inlawrev-25507	467	85	2037.159	2037.159	PROPN
inlawrev-25507	467	86	in	in	ADP
inlawrev-25507	467	87	relation	relation	NOUN
inlawrev-25507	467	88	to	to	ADP
inlawrev-25507	467	89	the	the	DET
inlawrev-25507	467	90	third	third	ADJ
inlawrev-25507	467	91	factor	factor	NOUN
inlawrev-25507	467	92	(	(	PUNCT
inlawrev-25507	467	93	when	when	SCONJ
inlawrev-25507	467	94	the	the	DET
inlawrev-25507	467	95	bulk	bulk	NOUN
inlawrev-25507	467	96	of	of	ADP
inlawrev-25507	467	97	the	the	DET
inlawrev-25507	467	98	patents	patent	NOUN
inlawrev-25507	467	99	were	be	AUX
inlawrev-25507	467	100	filed	file	VERB
inlawrev-25507	467	101	in	in	ADP
inlawrev-25507	467	102	relation	relation	NOUN
inlawrev-25507	467	103	to	to	ADP
inlawrev-25507	467	104	the	the	DET
inlawrev-25507	467	105	approval	approval	NOUN
inlawrev-25507	467	106	date	date	NOUN
inlawrev-25507	467	107	for	for	ADP
inlawrev-25507	467	108	the	the	DET
inlawrev-25507	467	109	drug	drug	NOUN
inlawrev-25507	467	110	)	)	PUNCT
inlawrev-25507	467	111	,	,	PUNCT
inlawrev-25507	467	112	forty	forty	NUM
inlawrev-25507	467	113	-	-	PUNCT
inlawrev-25507	467	114	nine	nine	NUM
inlawrev-25507	467	115	percent	percent	NOUN
inlawrev-25507	467	116	of	of	ADP
inlawrev-25507	467	117	all	all	DET
inlawrev-25507	467	118	applications	application	NOUN
inlawrev-25507	467	119	were	be	AUX
inlawrev-25507	467	120	filed	file	VERB
inlawrev-25507	467	121	after	after	SCONJ
inlawrev-25507	467	122	the	the	DET
inlawrev-25507	467	123	first	first	ADJ
inlawrev-25507	467	124	patent	patent	NOUN
inlawrev-25507	467	125	expired	expire	VERB
inlawrev-25507	467	126	in	in	ADP
inlawrev-25507	467	127	2014.160	2014.160	NUM
inlawrev-25507	467	128	these	these	DET
inlawrev-25507	467	129	facts	fact	NOUN
inlawrev-25507	467	130	make	make	VERB
inlawrev-25507	467	131	it	it	PRON
inlawrev-25507	467	132	clear	clear	ADJ
inlawrev-25507	467	133	that	that	SCONJ
inlawrev-25507	467	134	,	,	PUNCT
inlawrev-25507	467	135	with	with	ADP
inlawrev-25507	467	136	regard	regard	NOUN
inlawrev-25507	467	137	to	to	ADP
inlawrev-25507	467	138	the	the	DET
inlawrev-25507	467	139	first	first	ADJ
inlawrev-25507	467	140	factor	factor	NOUN
inlawrev-25507	467	141	,	,	PUNCT
inlawrev-25507	467	142	abbvie	abbvie	PROPN
inlawrev-25507	467	143	was	be	AUX
inlawrev-25507	467	144	likely	likely	ADV
inlawrev-25507	467	145	attempting	attempt	VERB
inlawrev-25507	467	146	to	to	PART
inlawrev-25507	467	147	evergreen	evergreen	VERB
inlawrev-25507	467	148	.	.	PUNCT
inlawrev-25507	468	1	similarly	similarly	ADV
inlawrev-25507	468	2	,	,	PUNCT
inlawrev-25507	468	3	considering	consider	VERB
inlawrev-25507	468	4	the	the	DET
inlawrev-25507	468	5	eighth	eighth	ADJ
inlawrev-25507	468	6	factor	factor	NOUN
inlawrev-25507	468	7	(	(	PUNCT
inlawrev-25507	468	8	the	the	DET
inlawrev-25507	468	9	number	number	NOUN
inlawrev-25507	468	10	of	of	ADP
inlawrev-25507	468	11	patents	patent	NOUN
inlawrev-25507	468	12	granted	grant	VERB
inlawrev-25507	468	13	in	in	ADP
inlawrev-25507	468	14	other	other	ADJ
inlawrev-25507	468	15	countries	country	NOUN
inlawrev-25507	468	16	in	in	ADP
inlawrev-25507	468	17	comparison	comparison	NOUN
inlawrev-25507	468	18	to	to	ADP
inlawrev-25507	468	19	the	the	DET
inlawrev-25507	468	20	expiration	expiration	NOUN
inlawrev-25507	468	21	date	date	NOUN
inlawrev-25507	468	22	in	in	ADP
inlawrev-25507	468	23	those	those	DET
inlawrev-25507	468	24	countries	country	NOUN
inlawrev-25507	468	25	)	)	PUNCT
inlawrev-25507	468	26	,	,	PUNCT
inlawrev-25507	468	27	abbvie	abbvie	PROPN
inlawrev-25507	468	28	has	have	AUX
inlawrev-25507	468	29	filed	file	VERB
inlawrev-25507	468	30	an	an	DET
inlawrev-25507	468	31	additional	additional	ADJ
inlawrev-25507	468	32	seventy	seventy	NUM
inlawrev-25507	468	33	-	-	PUNCT
inlawrev-25507	468	34	six	six	NUM
inlawrev-25507	468	35	patent	patent	NOUN
inlawrev-25507	468	36	applications	application	NOUN
inlawrev-25507	468	37	in	in	ADP
inlawrev-25507	468	38	europe	europe	PROPN
inlawrev-25507	468	39	after	after	SCONJ
inlawrev-25507	468	40	its	its	PRON
inlawrev-25507	468	41	primary	primary	NOUN
inlawrev-25507	468	42	patent.161	patent.161	ADJ
inlawrev-25507	468	43	however	however	ADV
inlawrev-25507	468	44	,	,	PUNCT
inlawrev-25507	468	45	secondary	secondary	ADJ
inlawrev-25507	468	46	patents	patent	NOUN
inlawrev-25507	468	47	filed	file	VERB
inlawrev-25507	468	48	after	after	ADP
inlawrev-25507	468	49	2002	2002	NUM
inlawrev-25507	468	50	that	that	PRON
inlawrev-25507	468	51	would	would	AUX
inlawrev-25507	468	52	have	have	VERB
inlawrev-25507	468	53	significantly	significantly	ADV
inlawrev-25507	468	54	extended	extend	VERB
inlawrev-25507	468	55	abbvie	abbvie	PROPN
inlawrev-25507	468	56	’s	’s	PART
inlawrev-25507	468	57	exclusivity	exclusivity	NOUN
inlawrev-25507	468	58	in	in	ADP
inlawrev-25507	468	59	the	the	DET
inlawrev-25507	468	60	market	market	NOUN
inlawrev-25507	468	61	were	be	AUX
inlawrev-25507	468	62	either	either	ADV
inlawrev-25507	468	63	withdrawn	withdraw	VERB
inlawrev-25507	468	64	,	,	PUNCT
inlawrev-25507	468	65	refused	refuse	VERB
inlawrev-25507	468	66	,	,	PUNCT
inlawrev-25507	468	67	or	or	CCONJ
inlawrev-25507	468	68	revoked	revoke	VERB
inlawrev-25507	468	69	after	after	SCONJ
inlawrev-25507	468	70	patent	patent	NOUN
inlawrev-25507	468	71	challenges.162	challenges.162	PROPN
inlawrev-25507	468	72	the	the	DET
inlawrev-25507	468	73	reluctance	reluctance	NOUN
inlawrev-25507	468	74	of	of	ADP
inlawrev-25507	468	75	the	the	DET
inlawrev-25507	468	76	european	european	PROPN
inlawrev-25507	468	77	patent	patent	NOUN
inlawrev-25507	468	78	office	office	NOUN
inlawrev-25507	468	79	is	be	AUX
inlawrev-25507	468	80	an	an	DET
inlawrev-25507	468	81	indication	indication	NOUN
inlawrev-25507	468	82	of	of	ADP
inlawrev-25507	468	83	the	the	DET
inlawrev-25507	468	84	office	office	NOUN
inlawrev-25507	468	85	’s	’s	PART
inlawrev-25507	468	86	awareness	awareness	NOUN
inlawrev-25507	468	87	of	of	ADP
inlawrev-25507	468	88	abbvie	abbvie	PROPN
inlawrev-25507	468	89	’s	’s	PART
inlawrev-25507	468	90	intentions	intention	NOUN
inlawrev-25507	468	91	.	.	PUNCT
inlawrev-25507	469	1	abbvie	abbvie	PROPN
inlawrev-25507	469	2	likewise	likewise	ADV
inlawrev-25507	469	3	filed	file	VERB
inlawrev-25507	469	4	sixty	sixty	NUM
inlawrev-25507	469	5	-	-	PUNCT
inlawrev-25507	469	6	three	three	NUM
inlawrev-25507	469	7	additional	additional	ADJ
inlawrev-25507	469	8	patents	patent	NOUN
inlawrev-25507	469	9	in	in	ADP
inlawrev-25507	469	10	japan163	japan163	PROPN
inlawrev-25507	469	11	;	;	PUNCT
inlawrev-25507	469	12	while	while	SCONJ
inlawrev-25507	469	13	japan	japan	PROPN
inlawrev-25507	469	14	’s	’s	PART
inlawrev-25507	469	15	reaction	reaction	NOUN
inlawrev-25507	469	16	to	to	ADP
inlawrev-25507	469	17	the	the	DET
inlawrev-25507	469	18	abundant	abundant	ADJ
inlawrev-25507	469	19	filings	filing	NOUN
inlawrev-25507	469	20	is	be	AUX
inlawrev-25507	469	21	not	not	PART
inlawrev-25507	469	22	readily	readily	ADV
inlawrev-25507	469	23	apparent	apparent	ADJ
inlawrev-25507	469	24	,	,	PUNCT
inlawrev-25507	469	25	it	it	PRON
inlawrev-25507	469	26	is	be	AUX
inlawrev-25507	469	27	known	know	VERB
inlawrev-25507	469	28	that	that	SCONJ
inlawrev-25507	469	29	the	the	DET
inlawrev-25507	469	30	original	original	ADJ
inlawrev-25507	469	31	expiration	expiration	NOUN
inlawrev-25507	469	32	of	of	ADP
inlawrev-25507	469	33	the	the	DET
inlawrev-25507	469	34	primary	primary	ADJ
inlawrev-25507	469	35	patent	patent	NOUN
inlawrev-25507	469	36	was	be	AUX
inlawrev-25507	469	37	supposed	suppose	VERB
inlawrev-25507	469	38	to	to	PART
inlawrev-25507	469	39	be	be	AUX
inlawrev-25507	469	40	in	in	ADP
inlawrev-25507	469	41	2017	2017	NUM
inlawrev-25507	469	42	but	but	CCONJ
inlawrev-25507	469	43	has	have	AUX
inlawrev-25507	469	44	been	be	AUX
inlawrev-25507	469	45	extended	extend	VERB
inlawrev-25507	469	46	to	to	ADP
inlawrev-25507	469	47	august	august	PROPN
inlawrev-25507	469	48	of	of	ADP
inlawrev-25507	469	49	2021.164	2021.164	NUM
inlawrev-25507	469	50	when	when	SCONJ
inlawrev-25507	469	51	applying	apply	VERB
inlawrev-25507	469	52	the	the	DET
inlawrev-25507	469	53	second	second	ADJ
inlawrev-25507	469	54	factor	factor	NOUN
inlawrev-25507	469	55	(	(	PUNCT
inlawrev-25507	469	56	whether	whether	SCONJ
inlawrev-25507	469	57	members	member	NOUN
inlawrev-25507	469	58	of	of	ADP
inlawrev-25507	469	59	the	the	DET
inlawrev-25507	469	60	patent	patent	NOUN
inlawrev-25507	469	61	family	family	NOUN
inlawrev-25507	469	62	have	have	AUX
inlawrev-25507	469	63	been	be	AUX
inlawrev-25507	469	64	challenged	challenge	VERB
inlawrev-25507	469	65	and	and	CCONJ
inlawrev-25507	469	66	invalidated	invalidate	VERB
inlawrev-25507	469	67	by	by	ADP
inlawrev-25507	469	68	the	the	DET
inlawrev-25507	469	69	uspto	uspto	NOUN
inlawrev-25507	469	70	,	,	PUNCT
inlawrev-25507	469	71	ptab	ptab	NOUN
inlawrev-25507	469	72	,	,	PUNCT
inlawrev-25507	469	73	or	or	CCONJ
inlawrev-25507	469	74	federal	federal	ADJ
inlawrev-25507	469	75	circuit	circuit	NOUN
inlawrev-25507	469	76	)	)	PUNCT
inlawrev-25507	469	77	to	to	PART
inlawrev-25507	469	78	humira	humira	PROPN
inlawrev-25507	469	79	®	®	PROPN
inlawrev-25507	469	80	,	,	PUNCT
inlawrev-25507	469	81	it	it	PRON
inlawrev-25507	469	82	is	be	AUX
inlawrev-25507	469	83	crucial	crucial	ADJ
inlawrev-25507	469	84	not	not	PART
inlawrev-25507	469	85	only	only	ADV
inlawrev-25507	469	86	to	to	PART
inlawrev-25507	469	87	look	look	VERB
inlawrev-25507	469	88	at	at	ADP
inlawrev-25507	469	89	the	the	DET
inlawrev-25507	469	90	number	number	NOUN
inlawrev-25507	469	91	of	of	ADP
inlawrev-25507	469	92	patents	patent	NOUN
inlawrev-25507	469	93	that	that	PRON
inlawrev-25507	469	94	have	have	AUX
inlawrev-25507	469	95	been	be	AUX
inlawrev-25507	469	96	invalidated	invalidate	VERB
inlawrev-25507	469	97	,	,	PUNCT
inlawrev-25507	469	98	but	but	CCONJ
inlawrev-25507	469	99	to	to	PART
inlawrev-25507	469	100	also	also	ADV
inlawrev-25507	469	101	consider	consider	VERB
inlawrev-25507	469	102	any	any	DET
inlawrev-25507	469	103	reasoning	reasoning	NOUN
inlawrev-25507	469	104	as	as	ADP
inlawrev-25507	469	105	to	to	ADP
inlawrev-25507	469	106	why	why	SCONJ
inlawrev-25507	469	107	all	all	PRON
inlawrev-25507	469	108	were	be	AUX
inlawrev-25507	469	109	not	not	PART
inlawrev-25507	469	110	challenged	challenge	VERB
inlawrev-25507	469	111	.	.	PUNCT
inlawrev-25507	470	1	on	on	ADP
inlawrev-25507	470	2	june	june	PROPN
inlawrev-25507	470	3	9	9	NUM
inlawrev-25507	470	4	,	,	PUNCT
inlawrev-25507	470	5	2017	2017	NUM
inlawrev-25507	470	6	,	,	PUNCT
inlawrev-25507	470	7	the	the	DET
inlawrev-25507	470	8	ptab	ptab	NOUN
inlawrev-25507	470	9	found	find	VERB
inlawrev-25507	470	10	three	three	NUM
inlawrev-25507	470	11	of	of	ADP
inlawrev-25507	470	12	the	the	DET
inlawrev-25507	470	13	humira	humira	PROPN
inlawrev-25507	470	14	®	®	NOUN
inlawrev-25507	470	15	patents	patent	NOUN
inlawrev-25507	470	16	invalid	invalid	ADJ
inlawrev-25507	470	17	based	base	VERB
inlawrev-25507	470	18	on	on	ADP
inlawrev-25507	470	19	a	a	DET
inlawrev-25507	470	20	finding	finding	NOUN
inlawrev-25507	470	21	of	of	ADP
inlawrev-25507	470	22	obviousness.165	obviousness.165	NOUN
inlawrev-25507	470	23	on	on	ADP
inlawrev-25507	470	24	july	july	PROPN
inlawrev-25507	470	25	6	6	NUM
inlawrev-25507	470	26	,	,	PUNCT
inlawrev-25507	470	27	2017	2017	NUM
inlawrev-25507	470	28	,	,	PUNCT
inlawrev-25507	470	29	the	the	DET
inlawrev-25507	470	30	ptab	ptab	NOUN
inlawrev-25507	470	31	found	find	VERB
inlawrev-25507	470	32	one	one	NUM
inlawrev-25507	470	33	additional	additional	ADJ
inlawrev-25507	470	34	156	156	NUM
inlawrev-25507	470	35	.	.	PUNCT
inlawrev-25507	471	1	overpatented	overpatente	VERB
inlawrev-25507	471	2	,	,	PUNCT
inlawrev-25507	471	3	overpriced	overprice	VERB
inlawrev-25507	471	4	:	:	PUNCT
inlawrev-25507	471	5	special	special	ADJ
inlawrev-25507	471	6	humira	humira	PROPN
inlawrev-25507	471	7	edition	edition	PROPN
inlawrev-25507	471	8	,	,	PUNCT
inlawrev-25507	471	9	supra	supra	PROPN
inlawrev-25507	471	10	note	note	NOUN
inlawrev-25507	471	11	2	2	NUM
inlawrev-25507	471	12	,	,	PUNCT
inlawrev-25507	471	13	at	at	ADP
inlawrev-25507	471	14	2	2	NUM
inlawrev-25507	471	15	.	.	NUM
inlawrev-25507	471	16	157	157	NUM
inlawrev-25507	471	17	.	.	PUNCT
inlawrev-25507	472	1	i	i	PRON
inlawrev-25507	472	2	d.	d.	PROPN
inlawrev-25507	472	3	158	158	NUM
inlawrev-25507	472	4	.	.	PUNCT
inlawrev-25507	473	1	i	i	PRON
inlawrev-25507	473	2	d.	d.	PROPN
inlawrev-25507	473	3	at	at	ADP
inlawrev-25507	473	4	4	4	NUM
inlawrev-25507	473	5	.	.	NOUN
inlawrev-25507	473	6	159	159	NUM
inlawrev-25507	473	7	.	.	PUNCT
inlawrev-25507	474	1	i	i	PRON
inlawrev-25507	474	2	d.	d.	PROPN
inlawrev-25507	474	3	160	160	NUM
inlawrev-25507	474	4	.	.	PUNCT
inlawrev-25507	475	1	i	i	PRON
inlawrev-25507	475	2	d.	d.	PROPN
inlawrev-25507	475	3	161	161	NUM
inlawrev-25507	475	4	.	.	PUNCT
inlawrev-25507	476	1	i	i	PRON
inlawrev-25507	476	2	d.	d.	PROPN
inlawrev-25507	476	3	at	at	ADP
inlawrev-25507	476	4	5	5	NUM
inlawrev-25507	476	5	.	.	PUNCT
inlawrev-25507	476	6	162	162	NUM
inlawrev-25507	476	7	.	.	PUNCT
inlawrev-25507	477	1	i	i	PRON
inlawrev-25507	477	2	d.	d.	PROPN
inlawrev-25507	477	3	163	163	NUM
inlawrev-25507	477	4	.	.	PUNCT
inlawrev-25507	478	1	i	i	PRON
inlawrev-25507	478	2	d.	d.	PROPN
inlawrev-25507	478	3	164	164	NUM
inlawrev-25507	478	4	.	.	PUNCT
inlawrev-25507	479	1	see	see	VERB
inlawrev-25507	479	2	william	william	PROPN
inlawrev-25507	479	3	han	han	PROPN
inlawrev-25507	479	4	,	,	PUNCT
inlawrev-25507	479	5	the	the	DET
inlawrev-25507	479	6	benefits	benefit	NOUN
inlawrev-25507	479	7	of	of	ADP
inlawrev-25507	479	8	japanese	japanese	ADJ
inlawrev-25507	479	9	patent	patent	NOUN
inlawrev-25507	479	10	law	law	NOUN
inlawrev-25507	479	11	system	system	NOUN
inlawrev-25507	479	12	over	over	ADP
inlawrev-25507	479	13	those	those	PRON
inlawrev-25507	479	14	of	of	ADP
inlawrev-25507	479	15	the	the	DET
inlawrev-25507	479	16	us	us	PROPN
inlawrev-25507	479	17	in	in	ADP
inlawrev-25507	479	18	the	the	DET
inlawrev-25507	479	19	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	479	20	area	area	NOUN
inlawrev-25507	479	21	,	,	PUNCT
inlawrev-25507	479	22	japan	japan	PROPN
inlawrev-25507	479	23	pat	pat	PROPN
inlawrev-25507	479	24	.	.	PROPN
inlawrev-25507	479	25	att’ys	att’ys	PROPN
inlawrev-25507	479	26	ass’n	ass’n	PROPN
inlawrev-25507	479	27	7	7	NUM
inlawrev-25507	479	28	,	,	PUNCT
inlawrev-25507	479	29	https://www.jpaa.or.jp/discoveripjapan/pdf/	https://www.jpaa.or.jp/discoveripjapan/pdf/	NOUN
inlawrev-25507	479	30	plenary_session.pdf	plenary_session.pdf	NOUN
inlawrev-25507	479	31	(	(	PUNCT
inlawrev-25507	479	32	last	last	ADV
inlawrev-25507	479	33	visited	visit	VERB
inlawrev-25507	479	34	mar	mar	PROPN
inlawrev-25507	479	35	.	.	PROPN
inlawrev-25507	479	36	11	11	NUM
inlawrev-25507	479	37	,	,	PUNCT
inlawrev-25507	479	38	2020	2020	NUM
inlawrev-25507	479	39	)	)	PUNCT
inlawrev-25507	480	1	[	[	X
inlawrev-25507	480	2	https://perma.cc/6rlv-a9qy	https://perma.cc/6rlv-a9qy	X
inlawrev-25507	480	3	]	]	X
inlawrev-25507	480	4	.	.	PUNCT
inlawrev-25507	481	1	165	165	NUM
inlawrev-25507	481	2	.	.	PUNCT
inlawrev-25507	481	3	christopher	christopher	PROPN
inlawrev-25507	481	4	j.	j.	PROPN
inlawrev-25507	481	5	betti	betti	PROPN
inlawrev-25507	481	6	&	&	CCONJ
inlawrev-25507	481	7	maria	maria	PROPN
inlawrev-25507	481	8	e.	e.	PROPN
inlawrev-25507	481	9	doukas	doukas	PROPN
inlawrev-25507	481	10	,	,	PUNCT
inlawrev-25507	481	11	humira	humira	PROPN
inlawrev-25507	481	12	patents	patent	NOUN
inlawrev-25507	481	13	invalidated	invalidate	VERB
inlawrev-25507	481	14	in	in	ADP
inlawrev-25507	481	15	inter	inter	ADJ
inlawrev-25507	481	16	partes	parte	NOUN
inlawrev-25507	481	17	reviews	review	NOUN
inlawrev-25507	481	18	,	,	PUNCT
inlawrev-25507	481	19	morgan	morgan	PROPN
inlawrev-25507	481	20	lewis	lewis	PROPN
inlawrev-25507	481	21	(	(	PUNCT
inlawrev-25507	481	22	june	june	PROPN
inlawrev-25507	481	23	14	14	NUM
inlawrev-25507	481	24	,	,	PUNCT
inlawrev-25507	481	25	2017	2017	NUM
inlawrev-25507	481	26	)	)	PUNCT
inlawrev-25507	481	27	,	,	PUNCT
inlawrev-25507	481	28	https://www.morganlewis.com/pubs/humira-patentsinvalidated-in-inter-partes-reviews	https://www.morganlewis.com/pubs/humira-patentsinvalidated-in-inter-partes-review	NOUN
inlawrev-25507	481	29	[	[	X
inlawrev-25507	481	30	https://perma.cc/5cdw-nl6x	https://perma.cc/5cdw-nl6x	X
inlawrev-25507	481	31	]	]	X
inlawrev-25507	481	32	.	.	PUNCT
inlawrev-25507	482	1	2021	2021	NUM
inlawrev-25507	482	2	]	]	PUNCT
inlawrev-25507	483	1	leaving	leave	VERB
inlawrev-25507	483	2	the	the	DET
inlawrev-25507	483	3	evergreening	evergreene	VERB
inlawrev-25507	483	4	problem	problem	NOUN
inlawrev-25507	483	5	to	to	ADP
inlawrev-25507	483	6	the	the	DET
inlawrev-25507	483	7	patent	patent	NOUN
inlawrev-25507	483	8	experts	expert	NOUN
inlawrev-25507	483	9	215	215	NUM
inlawrev-25507	483	10	patent	patent	NOUN
inlawrev-25507	483	11	invalid	invalid	ADJ
inlawrev-25507	483	12	on	on	ADP
inlawrev-25507	483	13	another	another	DET
inlawrev-25507	483	14	finding	finding	NOUN
inlawrev-25507	483	15	of	of	ADP
inlawrev-25507	483	16	obviousness.166	obviousness.166	NOUN
inlawrev-25507	483	17	more	more	ADV
inlawrev-25507	483	18	recently	recently	ADV
inlawrev-25507	483	19	,	,	PUNCT
inlawrev-25507	483	20	on	on	ADP
inlawrev-25507	483	21	january	january	PROPN
inlawrev-25507	483	22	7	7	NUM
inlawrev-25507	483	23	,	,	PUNCT
inlawrev-25507	483	24	2020	2020	NUM
inlawrev-25507	483	25	,	,	PUNCT
inlawrev-25507	483	26	the	the	DET
inlawrev-25507	483	27	federal	federal	ADJ
inlawrev-25507	483	28	circuit	circuit	NOUN
inlawrev-25507	483	29	found	find	VERB
inlawrev-25507	483	30	three	three	NUM
inlawrev-25507	483	31	humira	humira	PROPN
inlawrev-25507	483	32	®	®	NOUN
inlawrev-25507	483	33	patents	patent	NOUN
inlawrev-25507	483	34	invalid	invalid	ADJ
inlawrev-25507	483	35	based	base	VERB
inlawrev-25507	483	36	on	on	ADP
inlawrev-25507	483	37	obviousness.167	obviousness.167	ADV
inlawrev-25507	483	38	as	as	ADP
inlawrev-25507	483	39	of	of	ADP
inlawrev-25507	483	40	may	may	PROPN
inlawrev-25507	483	41	2017	2017	NUM
inlawrev-25507	483	42	,	,	PUNCT
inlawrev-25507	483	43	it	it	PRON
inlawrev-25507	483	44	had	have	AUX
inlawrev-25507	483	45	been	be	AUX
inlawrev-25507	483	46	estimated	estimate	VERB
inlawrev-25507	483	47	that	that	SCONJ
inlawrev-25507	483	48	only	only	ADV
inlawrev-25507	483	49	fourteen	fourteen	NUM
inlawrev-25507	483	50	of	of	ADP
inlawrev-25507	483	51	abbvie	abbvie	PROPN
inlawrev-25507	483	52	’s	’s	PART
inlawrev-25507	483	53	patents	patent	NOUN
inlawrev-25507	483	54	had	have	AUX
inlawrev-25507	483	55	been	be	AUX
inlawrev-25507	483	56	challenged.168	challenged.168	NOUN
inlawrev-25507	483	57	considering	consider	VERB
inlawrev-25507	483	58	the	the	DET
inlawrev-25507	483	59	premeditated	premeditate	VERB
inlawrev-25507	483	60	patent	patent	NOUN
inlawrev-25507	483	61	strategy	strategy	NOUN
inlawrev-25507	483	62	employed	employ	VERB
inlawrev-25507	483	63	by	by	ADP
inlawrev-25507	483	64	abbvie	abbvie	PROPN
inlawrev-25507	483	65	,	,	PUNCT
inlawrev-25507	483	66	it	it	PRON
inlawrev-25507	483	67	may	may	AUX
inlawrev-25507	483	68	come	come	VERB
inlawrev-25507	483	69	as	as	ADP
inlawrev-25507	483	70	a	a	DET
inlawrev-25507	483	71	surprise	surprise	NOUN
inlawrev-25507	483	72	,	,	PUNCT
inlawrev-25507	483	73	or	or	CCONJ
inlawrev-25507	483	74	even	even	ADV
inlawrev-25507	483	75	as	as	ADP
inlawrev-25507	483	76	an	an	DET
inlawrev-25507	483	77	indication	indication	NOUN
inlawrev-25507	483	78	of	of	ADP
inlawrev-25507	483	79	nonevergreening	nonevergreene	VERB
inlawrev-25507	483	80	,	,	PUNCT
inlawrev-25507	483	81	that	that	SCONJ
inlawrev-25507	483	82	so	so	ADV
inlawrev-25507	483	83	few	few	ADJ
inlawrev-25507	483	84	of	of	ADP
inlawrev-25507	483	85	the	the	DET
inlawrev-25507	483	86	246	246	NUM
inlawrev-25507	483	87	secondary	secondary	ADJ
inlawrev-25507	483	88	patents	patent	NOUN
inlawrev-25507	483	89	have	have	AUX
inlawrev-25507	483	90	been	be	AUX
inlawrev-25507	483	91	invalidated	invalidate	VERB
inlawrev-25507	483	92	.	.	PUNCT
inlawrev-25507	484	1	however	however	ADV
inlawrev-25507	484	2	,	,	PUNCT
inlawrev-25507	484	3	when	when	SCONJ
inlawrev-25507	484	4	the	the	DET
inlawrev-25507	484	5	median	median	ADJ
inlawrev-25507	484	6	cost	cost	NOUN
inlawrev-25507	484	7	of	of	ADP
inlawrev-25507	484	8	a	a	DET
inlawrev-25507	484	9	patent	patent	NOUN
inlawrev-25507	484	10	litigation	litigation	NOUN
inlawrev-25507	484	11	case	case	NOUN
inlawrev-25507	484	12	is	be	AUX
inlawrev-25507	484	13	over	over	ADV
inlawrev-25507	484	14	three	three	NUM
inlawrev-25507	484	15	million	million	NUM
inlawrev-25507	484	16	dollars	dollar	NOUN
inlawrev-25507	484	17	alone,169	alone,169	PROPN
inlawrev-25507	485	1	it	it	PRON
inlawrev-25507	485	2	is	be	AUX
inlawrev-25507	485	3	unlikely	unlikely	ADJ
inlawrev-25507	485	4	that	that	SCONJ
inlawrev-25507	485	5	generic	generic	ADJ
inlawrev-25507	485	6	companies	company	NOUN
inlawrev-25507	485	7	are	be	AUX
inlawrev-25507	485	8	willing	willing	ADJ
inlawrev-25507	485	9	to	to	PART
inlawrev-25507	485	10	spend	spend	VERB
inlawrev-25507	485	11	that	that	DET
inlawrev-25507	485	12	much	much	ADJ
inlawrev-25507	485	13	to	to	PART
inlawrev-25507	485	14	invalidate	invalidate	VERB
inlawrev-25507	485	15	such	such	ADJ
inlawrev-25507	485	16	patents	patent	NOUN
inlawrev-25507	485	17	.	.	PUNCT
inlawrev-25507	486	1	as	as	ADP
inlawrev-25507	486	2	such	such	ADJ
inlawrev-25507	486	3	,	,	PUNCT
inlawrev-25507	486	4	the	the	DET
inlawrev-25507	486	5	invalidated	invalidated	ADJ
inlawrev-25507	486	6	cases	case	NOUN
inlawrev-25507	486	7	themselves	themselves	PRON
inlawrev-25507	486	8	should	should	AUX
inlawrev-25507	486	9	hold	hold	VERB
inlawrev-25507	486	10	heavy	heavy	ADJ
inlawrev-25507	486	11	weight	weight	NOUN
inlawrev-25507	486	12	;	;	PUNCT
inlawrev-25507	486	13	however	however	ADV
inlawrev-25507	486	14	,	,	PUNCT
inlawrev-25507	486	15	the	the	DET
inlawrev-25507	486	16	number	number	NOUN
inlawrev-25507	486	17	of	of	ADP
inlawrev-25507	486	18	unchallenged	unchallenged	ADJ
inlawrev-25507	486	19	cases	case	NOUN
inlawrev-25507	486	20	should	should	AUX
inlawrev-25507	486	21	not	not	PART
inlawrev-25507	486	22	.	.	PUNCT
inlawrev-25507	487	1	given	give	VERB
inlawrev-25507	487	2	the	the	DET
inlawrev-25507	487	3	available	available	ADJ
inlawrev-25507	487	4	patent	patent	NOUN
inlawrev-25507	487	5	history	history	NOUN
inlawrev-25507	487	6	and	and	CCONJ
inlawrev-25507	487	7	the	the	DET
inlawrev-25507	487	8	known	known	ADJ
inlawrev-25507	487	9	generics	generic	NOUN
inlawrev-25507	487	10	that	that	PRON
inlawrev-25507	487	11	are	be	AUX
inlawrev-25507	487	12	ready	ready	ADJ
inlawrev-25507	487	13	for	for	ADP
inlawrev-25507	487	14	launch	launch	NOUN
inlawrev-25507	487	15	,	,	PUNCT
inlawrev-25507	487	16	it	it	PRON
inlawrev-25507	487	17	would	would	AUX
inlawrev-25507	487	18	be	be	AUX
inlawrev-25507	487	19	easy	easy	ADJ
inlawrev-25507	487	20	for	for	SCONJ
inlawrev-25507	487	21	the	the	DET
inlawrev-25507	487	22	uspto	uspto	NOUN
inlawrev-25507	487	23	,	,	PUNCT
inlawrev-25507	487	24	ptab	ptab	NOUN
inlawrev-25507	487	25	,	,	PUNCT
inlawrev-25507	487	26	or	or	CCONJ
inlawrev-25507	487	27	federal	federal	ADJ
inlawrev-25507	487	28	circuit	circuit	NOUN
inlawrev-25507	487	29	to	to	PART
inlawrev-25507	487	30	find	find	VERB
inlawrev-25507	487	31	factor	factor	NOUN
inlawrev-25507	487	32	four	four	NUM
inlawrev-25507	487	33	in	in	ADP
inlawrev-25507	487	34	favor	favor	NOUN
inlawrev-25507	487	35	of	of	ADP
inlawrev-25507	487	36	evergreening	evergreene	VERB
inlawrev-25507	487	37	.	.	PUNCT
inlawrev-25507	488	1	there	there	PRON
inlawrev-25507	488	2	are	be	VERB
inlawrev-25507	488	3	multiple	multiple	ADJ
inlawrev-25507	488	4	generic	generic	ADJ
inlawrev-25507	488	5	drugs	drug	NOUN
inlawrev-25507	488	6	available	available	ADJ
inlawrev-25507	488	7	that	that	PRON
inlawrev-25507	488	8	are	be	AUX
inlawrev-25507	488	9	ready	ready	ADJ
inlawrev-25507	488	10	for	for	ADP
inlawrev-25507	488	11	launch	launch	NOUN
inlawrev-25507	488	12	,	,	PUNCT
inlawrev-25507	488	13	including	include	VERB
inlawrev-25507	488	14	hyrimoz,170	hyrimoz,170	INTJ
inlawrev-25507	488	15	amjevita,171	amjevita,171	INTJ
inlawrev-25507	489	1	and	and	CCONJ
inlawrev-25507	489	2	hadlima.172	hadlima.172	NOUN
inlawrev-25507	489	3	in	in	ADP
inlawrev-25507	489	4	actuality	actuality	NOUN
inlawrev-25507	489	5	,	,	PUNCT
inlawrev-25507	489	6	at	at	ADV
inlawrev-25507	489	7	least	least	ADJ
inlawrev-25507	489	8	five	five	NUM
inlawrev-25507	489	9	different	different	ADJ
inlawrev-25507	489	10	generics	generic	NOUN
inlawrev-25507	489	11	that	that	PRON
inlawrev-25507	489	12	could	could	AUX
inlawrev-25507	489	13	be	be	AUX
inlawrev-25507	489	14	launched	launch	VERB
inlawrev-25507	489	15	now	now	ADV
inlawrev-25507	489	16	might	might	AUX
inlawrev-25507	489	17	make	make	VERB
inlawrev-25507	489	18	the	the	DET
inlawrev-25507	489	19	medicine	medicine	NOUN
inlawrev-25507	489	20	more	more	ADV
inlawrev-25507	489	21	affordable	affordable	ADJ
inlawrev-25507	489	22	for	for	ADP
inlawrev-25507	489	23	consumers.173	consumers.173	PROPN
inlawrev-25507	489	24	however	however	ADV
inlawrev-25507	489	25	,	,	PUNCT
inlawrev-25507	489	26	the	the	DET
inlawrev-25507	489	27	120	120	NUM
inlawrev-25507	489	28	patents	patent	NOUN
inlawrev-25507	489	29	filed	file	VERB
inlawrev-25507	489	30	after	after	SCONJ
inlawrev-25507	489	31	the	the	DET
inlawrev-25507	489	32	primary	primary	ADJ
inlawrev-25507	489	33	patent	patent	NOUN
inlawrev-25507	489	34	expired	expire	VERB
inlawrev-25507	489	35	could	could	AUX
inlawrev-25507	489	36	theoretically	theoretically	ADV
inlawrev-25507	489	37	protect	protect	VERB
inlawrev-25507	489	38	abbvie	abbvie	PROPN
inlawrev-25507	489	39	’s	’s	PART
inlawrev-25507	489	40	exclusivity	exclusivity	NOUN
inlawrev-25507	489	41	until	until	ADP
inlawrev-25507	489	42	2037.174	2037.174	PROPN
inlawrev-25507	489	43	therefore	therefore	ADV
inlawrev-25507	489	44	,	,	PUNCT
inlawrev-25507	489	45	the	the	DET
inlawrev-25507	489	46	examination	examination	NOUN
inlawrev-25507	489	47	of	of	ADP
inlawrev-25507	489	48	this	this	DET
inlawrev-25507	489	49	factor	factor	NOUN
inlawrev-25507	489	50	would	would	AUX
inlawrev-25507	489	51	likely	likely	ADV
inlawrev-25507	489	52	lead	lead	VERB
inlawrev-25507	489	53	the	the	DET
inlawrev-25507	489	54	examining	examine	VERB
inlawrev-25507	489	55	entity	entity	NOUN
inlawrev-25507	489	56	to	to	PART
inlawrev-25507	489	57	believe	believe	VERB
inlawrev-25507	489	58	abbvie	abbvie	PROPN
inlawrev-25507	489	59	was	be	AUX
inlawrev-25507	489	60	evergreening	evergreene	VERB
inlawrev-25507	489	61	.	.	PUNCT
inlawrev-25507	490	1	the	the	DET
inlawrev-25507	490	2	fifth	fifth	ADJ
inlawrev-25507	490	3	factor	factor	NOUN
inlawrev-25507	490	4	,	,	PUNCT
inlawrev-25507	490	5	too	too	ADV
inlawrev-25507	490	6	,	,	PUNCT
inlawrev-25507	490	7	would	would	AUX
inlawrev-25507	490	8	likely	likely	ADV
inlawrev-25507	490	9	weigh	weigh	VERB
inlawrev-25507	490	10	in	in	ADP
inlawrev-25507	490	11	favor	favor	NOUN
inlawrev-25507	490	12	of	of	ADP
inlawrev-25507	490	13	a	a	DET
inlawrev-25507	490	14	finding	finding	NOUN
inlawrev-25507	490	15	of	of	ADP
inlawrev-25507	490	16	evergreening	evergreene	VERB
inlawrev-25507	490	17	.	.	PUNCT
inlawrev-25507	491	1	abbvie	abbvie	PROPN
inlawrev-25507	491	2	’s	’s	PART
inlawrev-25507	491	3	admitted	admit	VERB
inlawrev-25507	491	4	patent	patent	NOUN
inlawrev-25507	491	5	portfolio	portfolio	NOUN
inlawrev-25507	491	6	tends	tend	VERB
inlawrev-25507	491	7	to	to	PART
inlawrev-25507	491	8	protect	protect	VERB
inlawrev-25507	491	9	every	every	DET
inlawrev-25507	491	10	aspect	aspect	NOUN
inlawrev-25507	491	11	of	of	ADP
inlawrev-25507	491	12	the	the	DET
inlawrev-25507	491	13	drug	drug	NOUN
inlawrev-25507	491	14	’s	’s	PART
inlawrev-25507	491	15	life	life	NOUN
inlawrev-25507	491	16	,	,	PUNCT
inlawrev-25507	491	17	from	from	ADP
inlawrev-25507	491	18	its	its	PRON
inlawrev-25507	491	19	origins	origin	NOUN
inlawrev-25507	491	20	to	to	ADP
inlawrev-25507	491	21	the	the	DET
inlawrev-25507	491	22	diseases	disease	NOUN
inlawrev-25507	491	23	it	it	PRON
inlawrev-25507	491	24	’s	’s	AUX
inlawrev-25507	491	25	approved	approve	VERB
inlawrev-25507	491	26	for,175	for,175	NUM
inlawrev-25507	491	27	which	which	PRON
inlawrev-25507	491	28	,	,	PUNCT
inlawrev-25507	491	29	in	in	ADP
inlawrev-25507	491	30	general	general	ADJ
inlawrev-25507	491	31	,	,	PUNCT
inlawrev-25507	491	32	is	be	AUX
inlawrev-25507	491	33	not	not	PART
inlawrev-25507	491	34	considered	consider	VERB
inlawrev-25507	491	35	unfair	unfair	ADJ
inlawrev-25507	491	36	.	.	PUNCT
inlawrev-25507	492	1	however	however	ADV
inlawrev-25507	492	2	,	,	PUNCT
inlawrev-25507	492	3	many	many	ADJ
inlawrev-25507	492	4	of	of	ADP
inlawrev-25507	492	5	the	the	DET
inlawrev-25507	492	6	secondary	secondary	ADJ
inlawrev-25507	492	7	patents	patent	NOUN
inlawrev-25507	492	8	on	on	ADP
inlawrev-25507	492	9	humira	humira	PROPN
inlawrev-25507	492	10	®	®	PROPN
inlawrev-25507	492	11	were	be	AUX
inlawrev-25507	492	12	166	166	NUM
inlawrev-25507	492	13	.	.	PUNCT
inlawrev-25507	493	1	jan	jan	PROPN
inlawrev-25507	493	2	wolfe	wolfe	PROPN
inlawrev-25507	493	3	,	,	PUNCT
inlawrev-25507	493	4	ptab	ptab	VERB
inlawrev-25507	493	5	sides	side	NOUN
inlawrev-25507	493	6	with	with	ADP
inlawrev-25507	493	7	boehringer	boehringer	NOUN
inlawrev-25507	493	8	in	in	ADP
inlawrev-25507	493	9	challenge	challenge	NOUN
inlawrev-25507	493	10	to	to	ADP
inlawrev-25507	493	11	humira	humira	PROPN
inlawrev-25507	493	12	patent	patent	PROPN
inlawrev-25507	493	13	,	,	PUNCT
inlawrev-25507	493	14	reuters	reuters	PROPN
inlawrev-25507	493	15	(	(	PUNCT
inlawrev-25507	493	16	july	july	PROPN
inlawrev-25507	493	17	7	7	NUM
inlawrev-25507	493	18	,	,	PUNCT
inlawrev-25507	493	19	2017	2017	NUM
inlawrev-25507	493	20	)	)	PUNCT
inlawrev-25507	493	21	,	,	PUNCT
inlawrev-25507	494	1	https://www.reuters.com/article/ip-patent-boehringer/ptab-sides-with-boehringer-inchallenge-to-humira-patent-idusl1n1jy1u8	https://www.reuters.com/article/ip-patent-boehringer/ptab-sides-with-boehringer-inchallenge-to-humira-patent-idusl1n1jy1u8	CCONJ
inlawrev-25507	495	1	[	[	X
inlawrev-25507	495	2	https://perma.cc/7n5n-qk5f	https://perma.cc/7n5n-qk5f	X
inlawrev-25507	495	3	]	]	PUNCT
inlawrev-25507	495	4	.	.	PUNCT
inlawrev-25507	496	1	167	167	NUM
inlawrev-25507	496	2	.	.	PUNCT
inlawrev-25507	496	3	jan	jan	PROPN
inlawrev-25507	496	4	wolfe	wolfe	PROPN
inlawrev-25507	496	5	,	,	PUNCT
inlawrev-25507	496	6	in	in	ADP
inlawrev-25507	496	7	brief	brief	ADJ
inlawrev-25507	496	8	:	:	PUNCT
inlawrev-25507	496	9	appeals	appeal	NOUN
inlawrev-25507	496	10	court	court	NOUN
inlawrev-25507	496	11	chips	chip	NOUN
inlawrev-25507	496	12	away	away	ADV
inlawrev-25507	496	13	at	at	ADP
inlawrev-25507	496	14	abbvie	abbvie	PROPN
inlawrev-25507	496	15	’s	’s	PART
inlawrev-25507	496	16	humira	humira	PROPN
inlawrev-25507	496	17	patent	patent	PROPN
inlawrev-25507	496	18	fortress	fortress	NOUN
inlawrev-25507	496	19	,	,	PUNCT
inlawrev-25507	496	20	reuters	reuters	PROPN
inlawrev-25507	496	21	(	(	PUNCT
inlawrev-25507	496	22	jan	jan	PROPN
inlawrev-25507	496	23	.	.	PROPN
inlawrev-25507	496	24	7	7	NUM
inlawrev-25507	496	25	,	,	PUNCT
inlawrev-25507	496	26	2020	2020	NUM
inlawrev-25507	496	27	)	)	PUNCT
inlawrev-25507	496	28	,	,	PUNCT
inlawrev-25507	496	29	https://www.reuters.com/article/ip-patent-humira-idusl1n29d008	https://www.reuters.com/article/ip-patent-humira-idusl1n29d008	VERB
inlawrev-25507	496	30	[	[	X
inlawrev-25507	496	31	https://perma.cc/u9rb-5nzq	https://perma.cc/u9rb-5nzq	PROPN
inlawrev-25507	496	32	]	]	PUNCT
inlawrev-25507	496	33	.	.	PUNCT
inlawrev-25507	497	1	168	168	NUM
inlawrev-25507	497	2	.	.	PUNCT
inlawrev-25507	498	1	peter	peter	PROPN
inlawrev-25507	498	2	norman	norman	PROPN
inlawrev-25507	498	3	,	,	PUNCT
inlawrev-25507	498	4	humira	humira	PROPN
inlawrev-25507	498	5	®	®	PROPN
inlawrev-25507	498	6	:	:	PUNCT
inlawrev-25507	498	7	recent	recent	ADJ
inlawrev-25507	498	8	developments	development	NOUN
inlawrev-25507	498	9	,	,	PUNCT
inlawrev-25507	498	10	future	future	ADJ
inlawrev-25507	498	11	sci	sci	PROPN
inlawrev-25507	498	12	.	.	PUNCT
inlawrev-25507	499	1	(	(	PUNCT
inlawrev-25507	499	2	may	may	PROPN
inlawrev-25507	499	3	9	9	NUM
inlawrev-25507	499	4	,	,	PUNCT
inlawrev-25507	499	5	2017	2017	NUM
inlawrev-25507	499	6	)	)	PUNCT
inlawrev-25507	499	7	,	,	PUNCT
inlawrev-25507	499	8	https://www.future-science.com/doi/full/10.4155/ppa-2017-0012	https://www.future-science.com/doi/full/10.4155/ppa-2017-0012	PROPN
inlawrev-25507	500	1	[	[	X
inlawrev-25507	500	2	https://perma.cc/6mdh-c3hm	https://perma.cc/6mdh-c3hm	X
inlawrev-25507	500	3	]	]	X
inlawrev-25507	500	4	.	.	PUNCT
inlawrev-25507	501	1	169	169	NUM
inlawrev-25507	501	2	.	.	PUNCT
inlawrev-25507	502	1	nayak	nayak	PROPN
inlawrev-25507	502	2	,	,	PUNCT
inlawrev-25507	502	3	supra	supra	PROPN
inlawrev-25507	502	4	note	note	NOUN
inlawrev-25507	502	5	54	54	NUM
inlawrev-25507	502	6	.	.	NUM
inlawrev-25507	502	7	170	170	NUM
inlawrev-25507	502	8	.	.	PUNCT
inlawrev-25507	503	1	alex	alex	PROPN
inlawrev-25507	503	2	keown	keown	PROPN
inlawrev-25507	503	3	,	,	PUNCT
inlawrev-25507	503	4	fda	fda	PROPN
inlawrev-25507	503	5	approves	approve	VERB
inlawrev-25507	503	6	humira	humira	PROPN
inlawrev-25507	503	7	biosimilar	biosimilar	PROPN
inlawrev-25507	503	8	that	that	PRON
inlawrev-25507	503	9	wo	will	AUX
inlawrev-25507	503	10	n’t	not	PART
inlawrev-25507	503	11	be	be	AUX
inlawrev-25507	503	12	available	available	ADJ
inlawrev-25507	503	13	until	until	ADP
inlawrev-25507	503	14	2023	2023	NUM
inlawrev-25507	503	15	,	,	PUNCT
inlawrev-25507	503	16	biospace	biospace	NOUN
inlawrev-25507	503	17	(	(	PUNCT
inlawrev-25507	503	18	nov	nov	PROPN
inlawrev-25507	503	19	.	.	PROPN
inlawrev-25507	503	20	1	1	NUM
inlawrev-25507	503	21	,	,	PUNCT
inlawrev-25507	503	22	2018	2018	NUM
inlawrev-25507	503	23	)	)	PUNCT
inlawrev-25507	503	24	,	,	PUNCT
inlawrev-25507	504	1	https://www.biospace.com/article/fda-approves-humira-biosimilar-thatwon-t-be-available-until-2023/	https://www.biospace.com/article/fda-approves-humira-biosimilar-thatwon-t-be-available-until-2023/	PROPN
inlawrev-25507	504	2	[	[	X
inlawrev-25507	504	3	https://perma.cc/2ejj-hz5h	https://perma.cc/2ejj-hz5h	X
inlawrev-25507	504	4	]	]	X
inlawrev-25507	504	5	.	.	PUNCT
inlawrev-25507	505	1	171	171	NUM
inlawrev-25507	505	2	.	.	PUNCT
inlawrev-25507	506	1	roni	roni	PROPN
inlawrev-25507	506	2	shye	shye	PROPN
inlawrev-25507	506	3	,	,	PUNCT
inlawrev-25507	506	4	new	new	ADJ
inlawrev-25507	506	5	biosimilar	biosimilar	NOUN
inlawrev-25507	506	6	approved	approve	VERB
inlawrev-25507	506	7	for	for	ADP
inlawrev-25507	506	8	humira	humira	PROPN
inlawrev-25507	506	9	,	,	PUNCT
inlawrev-25507	506	10	goodrx	goodrx	NOUN
inlawrev-25507	506	11	(	(	PUNCT
inlawrev-25507	506	12	sept	sept	PROPN
inlawrev-25507	506	13	.	.	PROPN
inlawrev-25507	506	14	28	28	NUM
inlawrev-25507	506	15	,	,	PUNCT
inlawrev-25507	506	16	2016	2016	NUM
inlawrev-25507	506	17	)	)	PUNCT
inlawrev-25507	506	18	,	,	PUNCT
inlawrev-25507	506	19	https://	https://	PROPN
inlawrev-25507	506	20	www.goodrx.com/blog/new-biosimilar-approved-for-humira/	www.goodrx.com/blog/new-biosimilar-approved-for-humira/	PROPN
inlawrev-25507	506	21	[	[	X
inlawrev-25507	506	22	https://perma.cc/4sj5-mfvm	https://perma.cc/4sj5-mfvm	X
inlawrev-25507	506	23	]	]	PUNCT
inlawrev-25507	506	24	.	.	PUNCT
inlawrev-25507	507	1	172	172	NUM
inlawrev-25507	507	2	.	.	PUNCT
inlawrev-25507	508	1	fda	fda	PROPN
inlawrev-25507	508	2	approves	approve	VERB
inlawrev-25507	508	3	adalimumab	adalimumab	NOUN
inlawrev-25507	508	4	biosimilar	biosimilar	PROPN
inlawrev-25507	508	5	hadlima	hadlima	PROPN
inlawrev-25507	508	6	,	,	PUNCT
inlawrev-25507	508	7	generics	generics	PROPN
inlawrev-25507	508	8	&	&	CCONJ
inlawrev-25507	508	9	biosimilars	biosimilars	PROPN
inlawrev-25507	508	10	initiative	initiative	PROPN
inlawrev-25507	508	11	(	(	PUNCT
inlawrev-25507	508	12	aug	aug	PROPN
inlawrev-25507	508	13	.	.	PROPN
inlawrev-25507	508	14	16	16	NUM
inlawrev-25507	508	15	,	,	PUNCT
inlawrev-25507	508	16	2019	2019	NUM
inlawrev-25507	508	17	)	)	PUNCT
inlawrev-25507	508	18	,	,	PUNCT
inlawrev-25507	508	19	http://www.gabionline.net/biosimilars/news/fda-approves-adalimumabbiosimilar-hadlima	http://www.gabionline.net/biosimilars/news/fda-approves-adalimumabbiosimilar-hadlima	PROPN
inlawrev-25507	509	1	[	[	X
inlawrev-25507	509	2	https://perma.cc/hjq6-ns2j	https://perma.cc/hjq6-ns2j	X
inlawrev-25507	509	3	]	]	X
inlawrev-25507	509	4	.	.	PUNCT
inlawrev-25507	510	1	173	173	NUM
inlawrev-25507	510	2	.	.	PUNCT
inlawrev-25507	510	3	rowland	rowland	PROPN
inlawrev-25507	510	4	,	,	PUNCT
inlawrev-25507	510	5	supra	supra	PROPN
inlawrev-25507	510	6	note	note	PROPN
inlawrev-25507	510	7	57	57	NUM
inlawrev-25507	510	8	.	.	NOUN
inlawrev-25507	510	9	174	174	NUM
inlawrev-25507	510	10	.	.	PUNCT
inlawrev-25507	511	1	overpatented	overpatente	VERB
inlawrev-25507	511	2	,	,	PUNCT
inlawrev-25507	511	3	overpriced	overprice	VERB
inlawrev-25507	511	4	:	:	PUNCT
inlawrev-25507	511	5	special	special	ADJ
inlawrev-25507	511	6	humira	humira	PROPN
inlawrev-25507	511	7	edition	edition	PROPN
inlawrev-25507	511	8	,	,	PUNCT
inlawrev-25507	511	9	supra	supra	PROPN
inlawrev-25507	511	10	note	note	NOUN
inlawrev-25507	511	11	2	2	NUM
inlawrev-25507	511	12	,	,	PUNCT
inlawrev-25507	511	13	at	at	ADP
inlawrev-25507	511	14	4	4	NUM
inlawrev-25507	511	15	.	.	NUM
inlawrev-25507	511	16	175	175	NUM
inlawrev-25507	511	17	.	.	PUNCT
inlawrev-25507	512	1	koons	koon	NOUN
inlawrev-25507	512	2	,	,	PUNCT
inlawrev-25507	512	3	supra	supra	PROPN
inlawrev-25507	512	4	note	note	NOUN
inlawrev-25507	512	5	136	136	NUM
inlawrev-25507	512	6	.	.	PUNCT
inlawrev-25507	513	1	216	216	NUM
inlawrev-25507	513	2	indiana	indiana	PROPN
inlawrev-25507	513	3	law	law	NOUN
inlawrev-25507	513	4	review	review	NOUN
inlawrev-25507	513	5	[	[	X
inlawrev-25507	513	6	vol	vol	NOUN
inlawrev-25507	513	7	.	.	PUNCT
inlawrev-25507	514	1	54:195	54:195	NUM
inlawrev-25507	514	2	granted	grant	VERB
inlawrev-25507	514	3	based	base	VERB
inlawrev-25507	514	4	on	on	ADP
inlawrev-25507	514	5	changing	change	VERB
inlawrev-25507	514	6	the	the	DET
inlawrev-25507	514	7	drug	drug	NOUN
inlawrev-25507	514	8	in	in	ADP
inlawrev-25507	514	9	superficial	superficial	ADJ
inlawrev-25507	514	10	,	,	PUNCT
inlawrev-25507	514	11	non	non	ADJ
inlawrev-25507	514	12	-	-	ADJ
inlawrev-25507	514	13	innovative	innovative	ADJ
inlawrev-25507	514	14	ways.176	ways.176	NOUN
inlawrev-25507	514	15	additionally	additionally	ADV
inlawrev-25507	514	16	,	,	PUNCT
inlawrev-25507	514	17	regarding	regard	VERB
inlawrev-25507	514	18	the	the	DET
inlawrev-25507	514	19	sixth	sixth	ADJ
inlawrev-25507	514	20	factor	factor	NOUN
inlawrev-25507	514	21	(	(	PUNCT
inlawrev-25507	514	22	the	the	DET
inlawrev-25507	514	23	amount	amount	NOUN
inlawrev-25507	514	24	of	of	ADP
inlawrev-25507	514	25	research	research	NOUN
inlawrev-25507	514	26	and	and	CCONJ
inlawrev-25507	514	27	development	development	NOUN
inlawrev-25507	514	28	initiated	initiate	VERB
inlawrev-25507	514	29	to	to	PART
inlawrev-25507	514	30	find	find	VERB
inlawrev-25507	514	31	the	the	DET
inlawrev-25507	514	32	innovation	innovation	NOUN
inlawrev-25507	514	33	)	)	PUNCT
inlawrev-25507	514	34	,	,	PUNCT
inlawrev-25507	514	35	an	an	DET
inlawrev-25507	514	36	examining	examining	NOUN
inlawrev-25507	514	37	authority	authority	NOUN
inlawrev-25507	514	38	would	would	AUX
inlawrev-25507	514	39	more	more	ADV
inlawrev-25507	514	40	than	than	ADP
inlawrev-25507	514	41	likely	likely	ADV
inlawrev-25507	514	42	find	find	VERB
inlawrev-25507	514	43	in	in	ADP
inlawrev-25507	514	44	favor	favor	NOUN
inlawrev-25507	514	45	of	of	ADP
inlawrev-25507	514	46	evergreening	evergreene	VERB
inlawrev-25507	514	47	.	.	PUNCT
inlawrev-25507	515	1	humira	humira	PROPN
inlawrev-25507	515	2	®	®	PROPN
inlawrev-25507	515	3	,	,	PUNCT
inlawrev-25507	515	4	as	as	SCONJ
inlawrev-25507	515	5	opposed	oppose	VERB
inlawrev-25507	515	6	to	to	ADP
inlawrev-25507	515	7	other	other	ADJ
inlawrev-25507	515	8	drugs	drug	NOUN
inlawrev-25507	515	9	made	make	VERB
inlawrev-25507	515	10	through	through	ADP
inlawrev-25507	515	11	chemical	chemical	ADJ
inlawrev-25507	515	12	synthesis	synthesis	NOUN
inlawrev-25507	515	13	,	,	PUNCT
inlawrev-25507	515	14	is	be	AUX
inlawrev-25507	515	15	typically	typically	ADV
inlawrev-25507	515	16	made	make	VERB
inlawrev-25507	515	17	in	in	ADP
inlawrev-25507	515	18	living	live	VERB
inlawrev-25507	515	19	cells.177	cells.177	PRON
inlawrev-25507	515	20	this	this	DET
inlawrev-25507	515	21	process	process	NOUN
inlawrev-25507	515	22	involves	involve	VERB
inlawrev-25507	515	23	more	more	ADJ
inlawrev-25507	515	24	steps	step	NOUN
inlawrev-25507	515	25	and	and	CCONJ
inlawrev-25507	515	26	more	more	ADJ
inlawrev-25507	515	27	complexity	complexity	NOUN
inlawrev-25507	515	28	,	,	PUNCT
inlawrev-25507	515	29	which	which	PRON
inlawrev-25507	515	30	allows	allow	VERB
inlawrev-25507	515	31	abbvie	abbvie	NOUN
inlawrev-25507	515	32	to	to	PART
inlawrev-25507	515	33	file	file	VERB
inlawrev-25507	515	34	more	more	ADJ
inlawrev-25507	515	35	applications.178	applications.178	PROPN
inlawrev-25507	515	36	abbvie	abbvie	PROPN
inlawrev-25507	515	37	’s	’s	PART
inlawrev-25507	515	38	patents	patent	NOUN
inlawrev-25507	515	39	on	on	ADP
inlawrev-25507	515	40	humira	humira	PROPN
inlawrev-25507	515	41	®	®	NOUN
inlawrev-25507	515	42	contain	contain	VERB
inlawrev-25507	515	43	such	such	ADJ
inlawrev-25507	515	44	slight	slight	ADJ
inlawrev-25507	515	45	improvements	improvement	NOUN
inlawrev-25507	515	46	that	that	SCONJ
inlawrev-25507	515	47	the	the	DET
inlawrev-25507	515	48	company	company	NOUN
inlawrev-25507	515	49	has	have	AUX
inlawrev-25507	515	50	been	be	AUX
inlawrev-25507	515	51	accused	accuse	VERB
inlawrev-25507	515	52	of	of	ADP
inlawrev-25507	515	53	wrongful	wrongful	ADJ
inlawrev-25507	515	54	use	use	NOUN
inlawrev-25507	515	55	of	of	ADP
inlawrev-25507	515	56	the	the	DET
inlawrev-25507	515	57	patent	patent	NOUN
inlawrev-25507	515	58	system	system	NOUN
inlawrev-25507	515	59	to	to	PART
inlawrev-25507	515	60	delay	delay	VERB
inlawrev-25507	515	61	competition.179	competition.179	PRON
inlawrev-25507	515	62	not	not	PART
inlawrev-25507	515	63	only	only	ADV
inlawrev-25507	515	64	does	do	AUX
inlawrev-25507	515	65	abbvie	abbvie	NOUN
inlawrev-25507	515	66	have	have	VERB
inlawrev-25507	515	67	a	a	DET
inlawrev-25507	515	68	large	large	ADJ
inlawrev-25507	515	69	number	number	NOUN
inlawrev-25507	515	70	of	of	ADP
inlawrev-25507	515	71	patents	patent	NOUN
inlawrev-25507	515	72	protecting	protect	VERB
inlawrev-25507	515	73	humira	humira	PROPN
inlawrev-25507	515	74	®	®	NOUN
inlawrev-25507	515	75	,	,	PUNCT
inlawrev-25507	515	76	but	but	CCONJ
inlawrev-25507	515	77	some	some	DET
inlawrev-25507	515	78	generic	generic	ADJ
inlawrev-25507	515	79	companies	company	NOUN
inlawrev-25507	515	80	claim	claim	VERB
inlawrev-25507	515	81	that	that	SCONJ
inlawrev-25507	515	82	many	many	ADJ
inlawrev-25507	515	83	of	of	ADP
inlawrev-25507	515	84	the	the	DET
inlawrev-25507	515	85	patents	patent	NOUN
inlawrev-25507	515	86	cover	cover	VERB
inlawrev-25507	515	87	the	the	DET
inlawrev-25507	515	88	same	same	ADJ
inlawrev-25507	515	89	alteration.180	alteration.180	NOUN
inlawrev-25507	515	90	more	more	ADV
inlawrev-25507	515	91	specifically	specifically	ADV
inlawrev-25507	515	92	,	,	PUNCT
inlawrev-25507	515	93	boehringer	boehringer	PROPN
inlawrev-25507	515	94	ingelheim	ingelheim	PROPN
inlawrev-25507	515	95	claims	claim	VERB
inlawrev-25507	515	96	that	that	SCONJ
inlawrev-25507	515	97	the	the	DET
inlawrev-25507	515	98	original	original	ADJ
inlawrev-25507	515	99	patent	patent	NOUN
inlawrev-25507	515	100	not	not	PART
inlawrev-25507	515	101	only	only	ADV
inlawrev-25507	515	102	covered	cover	VERB
inlawrev-25507	515	103	the	the	DET
inlawrev-25507	515	104	protein	protein	NOUN
inlawrev-25507	515	105	itself	itself	PRON
inlawrev-25507	515	106	,	,	PUNCT
inlawrev-25507	515	107	but	but	CCONJ
inlawrev-25507	515	108	also	also	ADV
inlawrev-25507	515	109	included	include	VERB
inlawrev-25507	515	110	formulations	formulation	NOUN
inlawrev-25507	515	111	and	and	CCONJ
inlawrev-25507	515	112	methods	method	NOUN
inlawrev-25507	515	113	of	of	ADP
inlawrev-25507	515	114	making	make	VERB
inlawrev-25507	515	115	and	and	CCONJ
inlawrev-25507	515	116	using	use	VERB
inlawrev-25507	515	117	it.181	it.181	PROPN
inlawrev-25507	515	118	boehringer	boehringer	NOUN
inlawrev-25507	515	119	alleges	allege	VERB
inlawrev-25507	515	120	that	that	SCONJ
inlawrev-25507	515	121	abbvie	abbvie	PROPN
inlawrev-25507	515	122	“	"	PUNCT
inlawrev-25507	515	123	engaged	engage	VERB
inlawrev-25507	515	124	in	in	ADP
inlawrev-25507	515	125	a	a	DET
inlawrev-25507	515	126	pattern	pattern	NOUN
inlawrev-25507	515	127	of	of	ADP
inlawrev-25507	515	128	pursuing	pursue	VERB
inlawrev-25507	515	129	numerous	numerous	ADJ
inlawrev-25507	515	130	overlapping	overlapping	NOUN
inlawrev-25507	515	131	and	and	CCONJ
inlawrev-25507	515	132	non	non	ADJ
inlawrev-25507	515	133	-	-	ADJ
inlawrev-25507	515	134	inventive	inventive	ADJ
inlawrev-25507	515	135	patents	patent	NOUN
inlawrev-25507	515	136	for	for	ADP
inlawrev-25507	515	137	the	the	DET
inlawrev-25507	515	138	purpose	purpose	NOUN
inlawrev-25507	515	139	of	of	ADP
inlawrev-25507	515	140	developing	develop	VERB
inlawrev-25507	515	141	a	a	DET
inlawrev-25507	515	142	‘	'	PUNCT
inlawrev-25507	515	143	patent	patent	NOUN
inlawrev-25507	515	144	thicket	thicket	NOUN
inlawrev-25507	515	145	.	.	PUNCT
inlawrev-25507	516	1	’”182	’”182	PROPN
inlawrev-25507	516	2	finally	finally	ADV
inlawrev-25507	516	3	,	,	PUNCT
inlawrev-25507	516	4	boehringer	boehringer	PROPN
inlawrev-25507	516	5	claims	claim	VERB
inlawrev-25507	516	6	that	that	SCONJ
inlawrev-25507	516	7	many	many	ADJ
inlawrev-25507	516	8	of	of	ADP
inlawrev-25507	516	9	the	the	DET
inlawrev-25507	516	10	patents	patent	NOUN
inlawrev-25507	516	11	share	share	VERB
inlawrev-25507	516	12	the	the	DET
inlawrev-25507	516	13	same	same	ADJ
inlawrev-25507	516	14	disclosure	disclosure	NOUN
inlawrev-25507	516	15	and	and	CCONJ
inlawrev-25507	516	16	cover	cover	VERB
inlawrev-25507	516	17	the	the	DET
inlawrev-25507	516	18	same	same	ADJ
inlawrev-25507	516	19	inventions.183	inventions.183	NOUN
inlawrev-25507	516	20	given	give	VERB
inlawrev-25507	516	21	the	the	DET
inlawrev-25507	516	22	fact	fact	NOUN
inlawrev-25507	516	23	that	that	SCONJ
inlawrev-25507	516	24	a	a	DET
inlawrev-25507	516	25	drug	drug	NOUN
inlawrev-25507	516	26	covered	cover	VERB
inlawrev-25507	516	27	by	by	ADP
inlawrev-25507	516	28	twenty	twenty	NUM
inlawrev-25507	516	29	patents	patent	NOUN
inlawrev-25507	516	30	in	in	ADP
inlawrev-25507	516	31	the	the	DET
inlawrev-25507	516	32	orange	orange	PROPN
inlawrev-25507	516	33	book	book	NOUN
inlawrev-25507	516	34	is	be	AUX
inlawrev-25507	516	35	generally	generally	ADV
inlawrev-25507	516	36	considered	consider	VERB
inlawrev-25507	516	37	excessive,184	excessive,184	NOUN
inlawrev-25507	516	38	it	it	PRON
inlawrev-25507	516	39	is	be	AUX
inlawrev-25507	516	40	not	not	PART
inlawrev-25507	516	41	likely	likely	ADJ
inlawrev-25507	516	42	that	that	SCONJ
inlawrev-25507	516	43	boehringer	boehringer	NOUN
inlawrev-25507	516	44	’s	’s	PART
inlawrev-25507	516	45	claims	claim	NOUN
inlawrev-25507	516	46	are	be	AUX
inlawrev-25507	516	47	unfounded	unfounded	ADJ
inlawrev-25507	516	48	.	.	PUNCT
inlawrev-25507	517	1	additionally	additionally	ADV
inlawrev-25507	517	2	,	,	PUNCT
inlawrev-25507	517	3	this	this	DET
inlawrev-25507	517	4	evidence	evidence	NOUN
inlawrev-25507	517	5	can	can	AUX
inlawrev-25507	517	6	support	support	VERB
inlawrev-25507	517	7	a	a	DET
inlawrev-25507	517	8	finding	finding	NOUN
inlawrev-25507	517	9	for	for	ADP
inlawrev-25507	517	10	evergreening	evergreene	VERB
inlawrev-25507	517	11	in	in	ADP
inlawrev-25507	517	12	terms	term	NOUN
inlawrev-25507	517	13	of	of	ADP
inlawrev-25507	517	14	the	the	DET
inlawrev-25507	517	15	seventh	seventh	ADJ
inlawrev-25507	517	16	factor	factor	NOUN
inlawrev-25507	517	17	(	(	PUNCT
inlawrev-25507	517	18	whether	whether	SCONJ
inlawrev-25507	517	19	the	the	DET
inlawrev-25507	517	20	patent	patent	NOUN
inlawrev-25507	517	21	relates	relate	VERB
inlawrev-25507	517	22	to	to	ADP
inlawrev-25507	517	23	a	a	DET
inlawrev-25507	517	24	new	new	ADJ
inlawrev-25507	517	25	and	and	CCONJ
inlawrev-25507	517	26	improved	improved	ADJ
inlawrev-25507	517	27	treatment	treatment	NOUN
inlawrev-25507	517	28	in	in	ADP
inlawrev-25507	517	29	a	a	DET
inlawrev-25507	517	30	disease	disease	NOUN
inlawrev-25507	517	31	area	area	NOUN
inlawrev-25507	517	32	or	or	CCONJ
inlawrev-25507	517	33	whether	whether	SCONJ
inlawrev-25507	517	34	it	it	PRON
inlawrev-25507	517	35	relates	relate	VERB
inlawrev-25507	517	36	to	to	ADP
inlawrev-25507	517	37	an	an	DET
inlawrev-25507	517	38	alternative	alternative	ADJ
inlawrev-25507	517	39	treatment	treatment	NOUN
inlawrev-25507	517	40	)	)	PUNCT
inlawrev-25507	517	41	.	.	PUNCT
inlawrev-25507	518	1	humira	humira	PROPN
inlawrev-25507	518	2	®	®	PROPN
inlawrev-25507	518	3	is	be	AUX
inlawrev-25507	518	4	“	"	PUNCT
inlawrev-25507	518	5	a	a	DET
inlawrev-25507	518	6	fully	fully	ADV
inlawrev-25507	518	7	human	human	ADJ
inlawrev-25507	518	8	monoclonal	monoclonal	NOUN
inlawrev-25507	518	9	antibody	antibody	NOUN
inlawrev-25507	518	10	that	that	PRON
inlawrev-25507	518	11	binds	bind	VERB
inlawrev-25507	518	12	to	to	ADP
inlawrev-25507	518	13	tumor	tumor	NOUN
inlawrev-25507	518	14	necrosis	necrosis	NOUN
inlawrev-25507	518	15	factor	factor	NOUN
inlawrev-25507	518	16	-	-	PUNCT
inlawrev-25507	518	17	alpha	alpha	NOUN
inlawrev-25507	518	18	”	"	PUNCT
inlawrev-25507	518	19	(	(	PUNCT
inlawrev-25507	518	20	“	"	PUNCT
inlawrev-25507	518	21	tnf	tnf	PROPN
inlawrev-25507	518	22	-	-	PUNCT
inlawrev-25507	518	23	á	á	PROPN
inlawrev-25507	518	24	”	"	PUNCT
inlawrev-25507	518	25	)	)	PUNCT
inlawrev-25507	518	26	,	,	PUNCT
inlawrev-25507	518	27	a	a	DET
inlawrev-25507	518	28	signaling	signal	VERB
inlawrev-25507	518	29	protein	protein	NOUN
inlawrev-25507	518	30	involved	involve	VERB
inlawrev-25507	518	31	in	in	ADP
inlawrev-25507	518	32	inflammation.185	inflammation.185	PRON
inlawrev-25507	518	33	therefore	therefore	ADV
inlawrev-25507	518	34	,	,	PUNCT
inlawrev-25507	518	35	humira	humira	PROPN
inlawrev-25507	518	36	®	®	NOUN
inlawrev-25507	518	37	reduces	reduce	VERB
inlawrev-25507	518	38	the	the	DET
inlawrev-25507	518	39	inflammatory	inflammatory	ADJ
inlawrev-25507	518	40	response	response	NOUN
inlawrev-25507	518	41	of	of	ADP
inlawrev-25507	518	42	autoimmune	autoimmune	NOUN
inlawrev-25507	518	43	diseases.186	diseases.186	PROPN
inlawrev-25507	518	44	looking	look	VERB
inlawrev-25507	518	45	to	to	ADP
inlawrev-25507	518	46	the	the	DET
inlawrev-25507	518	47	claims	claim	NOUN
inlawrev-25507	518	48	of	of	ADP
inlawrev-25507	518	49	the	the	DET
inlawrev-25507	518	50	various	various	ADJ
inlawrev-25507	518	51	humira	humira	PROPN
inlawrev-25507	518	52	®	®	NOUN
inlawrev-25507	518	53	patents,187	patents,187	PROPN
inlawrev-25507	518	54	an	an	DET
inlawrev-25507	518	55	examining	examining	NOUN
inlawrev-25507	518	56	authority	authority	NOUN
inlawrev-25507	518	57	would	would	AUX
inlawrev-25507	518	58	probably	probably	ADV
inlawrev-25507	518	59	find	find	VERB
inlawrev-25507	518	60	that	that	SCONJ
inlawrev-25507	518	61	past	past	ADP
inlawrev-25507	518	62	the	the	DET
inlawrev-25507	518	63	initial	initial	ADJ
inlawrev-25507	518	64	discovery	discovery	NOUN
inlawrev-25507	518	65	of	of	ADP
inlawrev-25507	518	66	humira	humira	PROPN
inlawrev-25507	518	67	®	®	PROPN
inlawrev-25507	518	68	,	,	PUNCT
inlawrev-25507	518	69	not	not	PART
inlawrev-25507	518	70	much	much	ADJ
inlawrev-25507	518	71	innovation	innovation	NOUN
inlawrev-25507	518	72	continued	continue	VERB
inlawrev-25507	518	73	176	176	NUM
inlawrev-25507	518	74	.	.	PUNCT
inlawrev-25507	519	1	joe	joe	PROPN
inlawrev-25507	519	2	cahill	cahill	PROPN
inlawrev-25507	519	3	,	,	PUNCT
inlawrev-25507	519	4	humira	humira	PROPN
inlawrev-25507	519	5	patent	patent	NOUN
inlawrev-25507	519	6	strategy	strategy	NOUN
inlawrev-25507	519	7	makes	make	VERB
inlawrev-25507	519	8	the	the	DET
inlawrev-25507	519	9	case	case	NOUN
inlawrev-25507	519	10	for	for	ADP
inlawrev-25507	519	11	reform	reform	NOUN
inlawrev-25507	519	12	,	,	PUNCT
inlawrev-25507	520	1	crain	crain	NOUN
inlawrev-25507	520	2	’s	’s	PART
inlawrev-25507	520	3	chi	chi	PROPN
inlawrev-25507	520	4	.	.	PUNCT
inlawrev-25507	520	5	bus	bus	NOUN
inlawrev-25507	520	6	.	.	PUNCT
inlawrev-25507	521	1	(	(	PUNCT
inlawrev-25507	521	2	may	may	AUX
inlawrev-25507	521	3	15	15	NUM
inlawrev-25507	521	4	,	,	PUNCT
inlawrev-25507	521	5	2019	2019	NUM
inlawrev-25507	521	6	)	)	PUNCT
inlawrev-25507	521	7	,	,	PUNCT
inlawrev-25507	521	8	https://www.chicagobusiness.com/joe-cahill-business/humira-patent-strategy-makescase-reform	https://www.chicagobusiness.com/joe-cahill-business/humira-patent-strategy-makescase-reform	NOUN
inlawrev-25507	521	9	[	[	X
inlawrev-25507	521	10	https://perma.cc/yp98-kbk3	https://perma.cc/yp98-kbk3	X
inlawrev-25507	521	11	]	]	PUNCT
inlawrev-25507	521	12	.	.	PUNCT
inlawrev-25507	522	1	177	177	NUM
inlawrev-25507	522	2	.	.	PUNCT
inlawrev-25507	523	1	koons	koon	NOUN
inlawrev-25507	523	2	,	,	PUNCT
inlawrev-25507	523	3	supra	supra	PROPN
inlawrev-25507	523	4	note	note	NOUN
inlawrev-25507	523	5	136	136	NUM
inlawrev-25507	523	6	.	.	PUNCT
inlawrev-25507	523	7	178	178	NUM
inlawrev-25507	523	8	.	.	PUNCT
inlawrev-25507	524	1	i	i	PRON
inlawrev-25507	524	2	d.	d.	PROPN
inlawrev-25507	524	3	179	179	NUM
inlawrev-25507	524	4	.	.	PUNCT
inlawrev-25507	525	1	zachary	zachary	PROPN
inlawrev-25507	525	2	silbersher	silbersher	ADV
inlawrev-25507	525	3	,	,	PUNCT
inlawrev-25507	525	4	did	do	AUX
inlawrev-25507	525	5	abbvie	abbvie	NOUN
inlawrev-25507	525	6	create	create	VERB
inlawrev-25507	525	7	a	a	DET
inlawrev-25507	525	8	wrongful	wrongful	ADJ
inlawrev-25507	525	9	“	"	PUNCT
inlawrev-25507	525	10	patent	patent	NOUN
inlawrev-25507	525	11	thicket	thicket	NOUN
inlawrev-25507	525	12	”	"	PUNCT
inlawrev-25507	525	13	around	around	ADP
inlawrev-25507	525	14	humira	humira	PROPN
inlawrev-25507	525	15	®	®	PROPN
inlawrev-25507	525	16	?	?	PROPN
inlawrev-25507	525	17	,	,	PUNCT
inlawrev-25507	525	18	markman	markman	NOUN
inlawrev-25507	525	19	advisors	advisor	NOUN
inlawrev-25507	525	20	(	(	PUNCT
inlawrev-25507	525	21	aug	aug	PROPN
inlawrev-25507	525	22	.	.	PROPN
inlawrev-25507	525	23	27	27	NUM
inlawrev-25507	525	24	,	,	PUNCT
inlawrev-25507	525	25	2018	2018	NUM
inlawrev-25507	525	26	)	)	PUNCT
inlawrev-25507	525	27	,	,	PUNCT
inlawrev-25507	525	28	https://www.markmanadvisors.com/blog/2018/8/27/didabbvie-create-a-wrongful-patent-thicket-around-humira	https://www.markmanadvisors.com/blog/2018/8/27/didabbvie-create-a-wrongful-patent-thicket-around-humira	PROPN
inlawrev-25507	526	1	[	[	X
inlawrev-25507	526	2	https://perma.cc/jfc7-ux8q	https://perma.cc/jfc7-ux8q	X
inlawrev-25507	526	3	]	]	PUNCT
inlawrev-25507	526	4	.	.	PUNCT
inlawrev-25507	527	1	180	180	NUM
inlawrev-25507	527	2	.	.	PUNCT
inlawrev-25507	528	1	i	i	PRON
inlawrev-25507	528	2	d.	d.	PROPN
inlawrev-25507	528	3	181	181	NUM
inlawrev-25507	528	4	.	.	PUNCT
inlawrev-25507	529	1	i	i	PRON
inlawrev-25507	529	2	d.	d.	PROPN
inlawrev-25507	529	3	182	182	NUM
inlawrev-25507	529	4	.	.	PUNCT
inlawrev-25507	530	1	i	i	PRON
inlawrev-25507	530	2	d.	d.	PROPN
inlawrev-25507	530	3	183	183	NUM
inlawrev-25507	530	4	.	.	PUNCT
inlawrev-25507	531	1	i	i	PRON
inlawrev-25507	531	2	d.	d.	PROPN
inlawrev-25507	531	3	184	184	NUM
inlawrev-25507	531	4	.	.	PUNCT
inlawrev-25507	532	1	i	i	PRON
inlawrev-25507	532	2	d.	d.	PROPN
inlawrev-25507	532	3	185	185	NUM
inlawrev-25507	532	4	.	.	PUNCT
inlawrev-25507	533	1	paul	paul	PROPN
inlawrev-25507	533	2	moradian	moradian	PROPN
inlawrev-25507	533	3	,	,	PUNCT
inlawrev-25507	533	4	abbvie	abbvie	PROPN
inlawrev-25507	533	5	’s	’s	PROPN
inlawrev-25507	533	6	humira	humira	PROPN
inlawrev-25507	533	7	patent	patent	PROPN
inlawrev-25507	533	8	portfolio	portfolio	NOUN
inlawrev-25507	533	9	,	,	PUNCT
inlawrev-25507	533	10	biopharmapat	biopharmapat	PROPN
inlawrev-25507	533	11	.	.	PUNCT
inlawrev-25507	534	1	(	(	PUNCT
inlawrev-25507	534	2	sept	sept	PROPN
inlawrev-25507	534	3	.	.	PROPN
inlawrev-25507	534	4	29	29	NUM
inlawrev-25507	534	5	,	,	PUNCT
inlawrev-25507	534	6	2016	2016	NUM
inlawrev-25507	534	7	,	,	PUNCT
inlawrev-25507	534	8	3:21	3:21	NUM
inlawrev-25507	534	9	pm	pm	NOUN
inlawrev-25507	534	10	)	)	PUNCT
inlawrev-25507	534	11	,	,	PUNCT
inlawrev-25507	534	12	http://biopharmapatent.blogspot.com/2016/09/abbvies-humira-patent-portfolio.html	http://biopharmapatent.blogspot.com/2016/09/abbvies-humira-patent-portfolio.html	VERB
inlawrev-25507	535	1	[	[	X
inlawrev-25507	535	2	https://	https://	PROPN
inlawrev-25507	535	3	perma.cc/a66y-ee2r	perma.cc/a66y-ee2r	VERB
inlawrev-25507	535	4	]	]	PUNCT
inlawrev-25507	535	5	.	.	PUNCT
inlawrev-25507	536	1	186	186	NUM
inlawrev-25507	536	2	.	.	PUNCT
inlawrev-25507	537	1	i	i	PRON
inlawrev-25507	537	2	d.	d.	PROPN
inlawrev-25507	537	3	187	187	NUM
inlawrev-25507	537	4	.	.	PUNCT
inlawrev-25507	538	1	i	i	PRON
inlawrev-25507	538	2	d.	d.	PROPN
inlawrev-25507	538	3	2021	2021	NUM
inlawrev-25507	538	4	]	]	PUNCT
inlawrev-25507	539	1	leaving	leave	VERB
inlawrev-25507	539	2	the	the	DET
inlawrev-25507	539	3	evergreening	evergreene	VERB
inlawrev-25507	539	4	problem	problem	NOUN
inlawrev-25507	539	5	to	to	ADP
inlawrev-25507	539	6	the	the	DET
inlawrev-25507	539	7	patent	patent	NOUN
inlawrev-25507	539	8	experts	expert	NOUN
inlawrev-25507	539	9	217	217	NUM
inlawrev-25507	539	10	based	base	VERB
inlawrev-25507	539	11	on	on	ADP
inlawrev-25507	539	12	the	the	DET
inlawrev-25507	539	13	seemingly	seemingly	ADV
inlawrev-25507	539	14	slight	slight	ADJ
inlawrev-25507	539	15	changes	change	NOUN
inlawrev-25507	539	16	described	describe	VERB
inlawrev-25507	539	17	.	.	PUNCT
inlawrev-25507	540	1	although	although	SCONJ
inlawrev-25507	540	2	multiple	multiple	ADJ
inlawrev-25507	540	3	patents	patent	NOUN
inlawrev-25507	540	4	describe	describe	VERB
inlawrev-25507	540	5	different	different	ADJ
inlawrev-25507	540	6	diseases	disease	NOUN
inlawrev-25507	540	7	to	to	PART
inlawrev-25507	540	8	be	be	AUX
inlawrev-25507	540	9	treated	treat	VERB
inlawrev-25507	540	10	,	,	PUNCT
inlawrev-25507	540	11	and	and	CCONJ
inlawrev-25507	540	12	in	in	ADP
inlawrev-25507	540	13	general	general	ADJ
inlawrev-25507	540	14	treatments	treatment	NOUN
inlawrev-25507	540	15	for	for	ADP
inlawrev-25507	540	16	different	different	ADJ
inlawrev-25507	540	17	diseases	disease	NOUN
inlawrev-25507	540	18	should	should	AUX
inlawrev-25507	540	19	weigh	weigh	VERB
inlawrev-25507	540	20	against	against	ADP
inlawrev-25507	540	21	a	a	DET
inlawrev-25507	540	22	finding	finding	NOUN
inlawrev-25507	540	23	of	of	ADP
inlawrev-25507	540	24	evergreening	evergreening	NOUN
inlawrev-25507	540	25	,	,	PUNCT
inlawrev-25507	540	26	an	an	DET
inlawrev-25507	540	27	examining	examining	NOUN
inlawrev-25507	540	28	authority	authority	NOUN
inlawrev-25507	540	29	would	would	AUX
inlawrev-25507	540	30	likely	likely	ADV
inlawrev-25507	540	31	find	find	VERB
inlawrev-25507	540	32	the	the	DET
inlawrev-25507	540	33	opposite	opposite	NOUN
inlawrev-25507	540	34	here	here	ADV
inlawrev-25507	540	35	;	;	PUNCT
inlawrev-25507	540	36	the	the	DET
inlawrev-25507	540	37	inhibition	inhibition	NOUN
inlawrev-25507	540	38	of	of	ADP
inlawrev-25507	540	39	tnf	tnf	PROPN
inlawrev-25507	540	40	-	-	PUNCT
inlawrev-25507	540	41	á	á	PROPN
inlawrev-25507	540	42	would	would	AUX
inlawrev-25507	540	43	be	be	AUX
inlawrev-25507	540	44	expected	expect	VERB
inlawrev-25507	540	45	by	by	ADP
inlawrev-25507	540	46	one	one	NUM
inlawrev-25507	540	47	having	have	VERB
inlawrev-25507	540	48	ordinary	ordinary	ADJ
inlawrev-25507	540	49	skill	skill	NOUN
inlawrev-25507	540	50	in	in	ADP
inlawrev-25507	540	51	the	the	DET
inlawrev-25507	540	52	art	art	NOUN
inlawrev-25507	540	53	to	to	PART
inlawrev-25507	540	54	treat	treat	VERB
inlawrev-25507	540	55	autoimmune	autoimmune	ADJ
inlawrev-25507	540	56	diseases	disease	NOUN
inlawrev-25507	540	57	,	,	PUNCT
inlawrev-25507	540	58	as	as	SCONJ
inlawrev-25507	540	59	many	many	ADJ
inlawrev-25507	540	60	of	of	ADP
inlawrev-25507	540	61	these	these	DET
inlawrev-25507	540	62	diseases	disease	NOUN
inlawrev-25507	540	63	are	be	AUX
inlawrev-25507	540	64	exacerbated	exacerbate	VERB
inlawrev-25507	540	65	by	by	ADP
inlawrev-25507	540	66	signaling	signal	VERB
inlawrev-25507	540	67	proteins	protein	NOUN
inlawrev-25507	540	68	like	like	ADP
inlawrev-25507	540	69	tnf	tnf	PROPN
inlawrev-25507	540	70	-	-	PUNCT
inlawrev-25507	540	71	á.188	á.188	NUM
inlawrev-25507	540	72	this	this	PRON
inlawrev-25507	540	73	is	be	AUX
inlawrev-25507	540	74	not	not	PART
inlawrev-25507	540	75	the	the	DET
inlawrev-25507	540	76	same	same	ADJ
inlawrev-25507	540	77	as	as	ADP
inlawrev-25507	540	78	finding	find	VERB
inlawrev-25507	540	79	vital	vital	ADJ
inlawrev-25507	540	80	uses	use	NOUN
inlawrev-25507	540	81	for	for	ADP
inlawrev-25507	540	82	previously	previously	ADV
inlawrev-25507	540	83	failed	fail	VERB
inlawrev-25507	540	84	drugs	drug	NOUN
inlawrev-25507	540	85	after	after	ADP
inlawrev-25507	540	86	further	further	ADJ
inlawrev-25507	540	87	research	research	NOUN
inlawrev-25507	540	88	and	and	CCONJ
inlawrev-25507	540	89	development.189	development.189	PRON
inlawrev-25507	540	90	the	the	DET
inlawrev-25507	540	91	examination	examination	NOUN
inlawrev-25507	540	92	of	of	ADP
inlawrev-25507	540	93	the	the	DET
inlawrev-25507	540	94	ninth	ninth	ADJ
inlawrev-25507	540	95	factor	factor	NOUN
inlawrev-25507	540	96	would	would	AUX
inlawrev-25507	540	97	depend	depend	VERB
inlawrev-25507	540	98	heavily	heavily	ADV
inlawrev-25507	540	99	on	on	ADP
inlawrev-25507	540	100	information	information	NOUN
inlawrev-25507	540	101	requested	request	VERB
inlawrev-25507	540	102	by	by	ADP
inlawrev-25507	540	103	the	the	DET
inlawrev-25507	540	104	examining	examine	VERB
inlawrev-25507	540	105	entity	entity	NOUN
inlawrev-25507	540	106	or	or	CCONJ
inlawrev-25507	540	107	information	information	NOUN
inlawrev-25507	540	108	that	that	PRON
inlawrev-25507	540	109	is	be	AUX
inlawrev-25507	540	110	revealed	reveal	VERB
inlawrev-25507	540	111	during	during	ADP
inlawrev-25507	540	112	discovery	discovery	NOUN
inlawrev-25507	540	113	.	.	PUNCT
inlawrev-25507	541	1	based	base	VERB
inlawrev-25507	541	2	on	on	ADP
inlawrev-25507	541	3	the	the	DET
inlawrev-25507	541	4	current	current	ADJ
inlawrev-25507	541	5	information	information	NOUN
inlawrev-25507	541	6	available	available	ADJ
inlawrev-25507	541	7	,	,	PUNCT
inlawrev-25507	541	8	it	it	PRON
inlawrev-25507	541	9	is	be	AUX
inlawrev-25507	541	10	not	not	PART
inlawrev-25507	541	11	clear	clear	ADJ
inlawrev-25507	541	12	whether	whether	SCONJ
inlawrev-25507	541	13	there	there	PRON
inlawrev-25507	541	14	was	be	VERB
inlawrev-25507	541	15	calculated	calculate	VERB
inlawrev-25507	541	16	suppression	suppression	NOUN
inlawrev-25507	541	17	or	or	CCONJ
inlawrev-25507	541	18	concealment	concealment	NOUN
inlawrev-25507	541	19	for	for	ADP
inlawrev-25507	541	20	a	a	DET
inlawrev-25507	541	21	significant	significant	ADJ
inlawrev-25507	541	22	period	period	NOUN
inlawrev-25507	541	23	of	of	ADP
inlawrev-25507	541	24	time	time	NOUN
inlawrev-25507	541	25	.	.	PUNCT
inlawrev-25507	542	1	however	however	ADV
inlawrev-25507	542	2	,	,	PUNCT
inlawrev-25507	542	3	it	it	PRON
inlawrev-25507	542	4	does	do	AUX
inlawrev-25507	542	5	seem	seem	VERB
inlawrev-25507	542	6	that	that	DET
inlawrev-25507	542	7	abbvie	abbvie	PROPN
inlawrev-25507	542	8	was	be	AUX
inlawrev-25507	542	9	not	not	PART
inlawrev-25507	542	10	diligent	diligent	ADJ
inlawrev-25507	542	11	in	in	ADP
inlawrev-25507	542	12	filing	file	VERB
inlawrev-25507	542	13	patent	patent	NOUN
inlawrev-25507	542	14	applications	application	NOUN
inlawrev-25507	542	15	.	.	PUNCT
inlawrev-25507	543	1	out	out	ADP
inlawrev-25507	543	2	of	of	ADP
inlawrev-25507	543	3	the	the	DET
inlawrev-25507	543	4	246	246	NUM
inlawrev-25507	543	5	secondary	secondary	ADJ
inlawrev-25507	543	6	patents	patent	NOUN
inlawrev-25507	543	7	,	,	PUNCT
inlawrev-25507	543	8	only	only	ADV
inlawrev-25507	543	9	twenty	twenty	NUM
inlawrev-25507	543	10	-	-	PUNCT
inlawrev-25507	543	11	seven	seven	NUM
inlawrev-25507	543	12	patents	patent	NOUN
inlawrev-25507	543	13	were	be	AUX
inlawrev-25507	543	14	filed	file	VERB
inlawrev-25507	543	15	by	by	ADP
inlawrev-25507	543	16	the	the	DET
inlawrev-25507	543	17	launch	launch	NOUN
inlawrev-25507	543	18	of	of	ADP
inlawrev-25507	543	19	the	the	DET
inlawrev-25507	543	20	drug	drug	NOUN
inlawrev-25507	543	21	in	in	ADP
inlawrev-25507	543	22	2002.190	2002.190	NUM
inlawrev-25507	543	23	additionally	additionally	ADV
inlawrev-25507	543	24	,	,	PUNCT
inlawrev-25507	543	25	not	not	PART
inlawrev-25507	543	26	only	only	ADV
inlawrev-25507	543	27	were	be	AUX
inlawrev-25507	543	28	forty	forty	NUM
inlawrev-25507	543	29	-	-	PUNCT
inlawrev-25507	543	30	nine	nine	NUM
inlawrev-25507	543	31	percent	percent	NOUN
inlawrev-25507	543	32	of	of	ADP
inlawrev-25507	543	33	the	the	DET
inlawrev-25507	543	34	applications	application	NOUN
inlawrev-25507	543	35	filed	file	VERB
inlawrev-25507	543	36	after	after	SCONJ
inlawrev-25507	543	37	the	the	DET
inlawrev-25507	543	38	first	first	ADJ
inlawrev-25507	543	39	patent	patent	NOUN
inlawrev-25507	543	40	expired	expire	VERB
inlawrev-25507	543	41	in	in	ADP
inlawrev-25507	543	42	2014,191	2014,191	NUM
inlawrev-25507	543	43	but	but	CCONJ
inlawrev-25507	543	44	also	also	ADV
inlawrev-25507	543	45	an	an	DET
inlawrev-25507	543	46	examination	examination	NOUN
inlawrev-25507	543	47	of	of	ADP
inlawrev-25507	543	48	the	the	DET
inlawrev-25507	543	49	claims	claim	NOUN
inlawrev-25507	543	50	of	of	ADP
inlawrev-25507	543	51	these	these	DET
inlawrev-25507	543	52	later	later	ADV
inlawrev-25507	543	53	-	-	PUNCT
inlawrev-25507	543	54	filed	file	VERB
inlawrev-25507	543	55	applications	application	NOUN
inlawrev-25507	543	56	does	do	AUX
inlawrev-25507	543	57	not	not	PART
inlawrev-25507	543	58	display	display	VERB
inlawrev-25507	543	59	any	any	DET
inlawrev-25507	543	60	ground	ground	NOUN
inlawrev-25507	543	61	-	-	PUNCT
inlawrev-25507	543	62	breaking	break	VERB
inlawrev-25507	543	63	innovation	innovation	NOUN
inlawrev-25507	543	64	that	that	PRON
inlawrev-25507	543	65	was	be	AUX
inlawrev-25507	543	66	not	not	PART
inlawrev-25507	543	67	disclosed	disclose	VERB
inlawrev-25507	543	68	during	during	ADP
inlawrev-25507	543	69	the	the	DET
inlawrev-25507	543	70	early	early	ADJ
inlawrev-25507	543	71	years	year	NOUN
inlawrev-25507	543	72	of	of	ADP
inlawrev-25507	543	73	the	the	DET
inlawrev-25507	543	74	primary	primary	ADJ
inlawrev-25507	543	75	patent	patent	NOUN
inlawrev-25507	543	76	’s	’s	PART
inlawrev-25507	543	77	life.192	life.192	NOUN
inlawrev-25507	543	78	therefore	therefore	ADV
inlawrev-25507	543	79	,	,	PUNCT
inlawrev-25507	543	80	it	it	PRON
inlawrev-25507	543	81	is	be	AUX
inlawrev-25507	543	82	likely	likely	ADJ
inlawrev-25507	543	83	that	that	SCONJ
inlawrev-25507	543	84	the	the	DET
inlawrev-25507	543	85	examining	examining	NOUN
inlawrev-25507	543	86	authority	authority	NOUN
inlawrev-25507	543	87	would	would	AUX
inlawrev-25507	543	88	find	find	VERB
inlawrev-25507	543	89	abbvie	abbvie	NOUN
inlawrev-25507	543	90	to	to	PART
inlawrev-25507	543	91	be	be	AUX
inlawrev-25507	543	92	evergreening	evergreene	VERB
inlawrev-25507	543	93	when	when	SCONJ
inlawrev-25507	543	94	examining	examine	VERB
inlawrev-25507	543	95	this	this	DET
inlawrev-25507	543	96	factor	factor	NOUN
inlawrev-25507	543	97	.	.	PUNCT
inlawrev-25507	544	1	d.	d.	PROPN
inlawrev-25507	544	2	proposed	propose	VERB
inlawrev-25507	544	3	bill	bill	NOUN
inlawrev-25507	544	4	to	to	PART
inlawrev-25507	544	5	assist	assist	VERB
inlawrev-25507	544	6	the	the	DET
inlawrev-25507	544	7	uspto	uspto	NOUN
inlawrev-25507	544	8	and	and	CCONJ
inlawrev-25507	544	9	federal	federal	ADJ
inlawrev-25507	544	10	circuit	circuit	NOUN
inlawrev-25507	544	11	separately	separately	ADV
inlawrev-25507	544	12	,	,	PUNCT
inlawrev-25507	544	13	if	if	SCONJ
inlawrev-25507	544	14	congress	congress	PROPN
inlawrev-25507	544	15	is	be	AUX
inlawrev-25507	544	16	pressured	pressure	VERB
inlawrev-25507	544	17	to	to	PART
inlawrev-25507	544	18	enact	enact	VERB
inlawrev-25507	544	19	legislation	legislation	NOUN
inlawrev-25507	544	20	addressing	address	VERB
inlawrev-25507	544	21	the	the	DET
inlawrev-25507	544	22	evergreening	evergreene	VERB
inlawrev-25507	544	23	issue	issue	NOUN
inlawrev-25507	544	24	,	,	PUNCT
inlawrev-25507	544	25	they	they	PRON
inlawrev-25507	544	26	may	may	AUX
inlawrev-25507	544	27	be	be	AUX
inlawrev-25507	544	28	able	able	ADJ
inlawrev-25507	544	29	to	to	PART
inlawrev-25507	544	30	do	do	VERB
inlawrev-25507	544	31	so	so	ADV
inlawrev-25507	544	32	without	without	ADP
inlawrev-25507	544	33	supplementing	supplement	VERB
inlawrev-25507	544	34	their	their	PRON
inlawrev-25507	544	35	own	own	ADJ
inlawrev-25507	544	36	novice	novice	NOUN
inlawrev-25507	544	37	ideas	idea	NOUN
inlawrev-25507	544	38	for	for	ADP
inlawrev-25507	544	39	that	that	PRON
inlawrev-25507	544	40	of	of	ADP
inlawrev-25507	544	41	the	the	DET
inlawrev-25507	544	42	uspto	uspto	NOUN
inlawrev-25507	544	43	and	and	CCONJ
inlawrev-25507	544	44	the	the	DET
inlawrev-25507	544	45	federal	federal	ADJ
inlawrev-25507	544	46	circuit	circuit	NOUN
inlawrev-25507	544	47	or	or	CCONJ
inlawrev-25507	544	48	by	by	ADP
inlawrev-25507	544	49	changing	change	VERB
inlawrev-25507	544	50	established	establish	VERB
inlawrev-25507	544	51	procedures	procedure	NOUN
inlawrev-25507	544	52	in	in	ADP
inlawrev-25507	544	53	the	the	DET
inlawrev-25507	544	54	uspto	uspto	NOUN
inlawrev-25507	544	55	.	.	PUNCT
inlawrev-25507	545	1	the	the	DET
inlawrev-25507	545	2	legislature	legislature	NOUN
inlawrev-25507	545	3	can	can	AUX
inlawrev-25507	545	4	enact	enact	VERB
inlawrev-25507	545	5	a	a	DET
inlawrev-25507	545	6	statute	statute	NOUN
inlawrev-25507	545	7	that	that	SCONJ
inlawrev-25507	545	8	if	if	SCONJ
inlawrev-25507	545	9	one	one	NUM
inlawrev-25507	545	10	patent	patent	NOUN
inlawrev-25507	545	11	in	in	ADP
inlawrev-25507	545	12	the	the	DET
inlawrev-25507	545	13	family	family	NOUN
inlawrev-25507	545	14	is	be	AUX
inlawrev-25507	545	15	found	find	VERB
inlawrev-25507	545	16	to	to	PART
inlawrev-25507	545	17	be	be	AUX
inlawrev-25507	545	18	double	double	ADJ
inlawrev-25507	545	19	patenting	patenting	NOUN
inlawrev-25507	545	20	and	and	CCONJ
inlawrev-25507	545	21	is	be	AUX
inlawrev-25507	545	22	found	find	VERB
inlawrev-25507	545	23	by	by	ADP
inlawrev-25507	545	24	the	the	DET
inlawrev-25507	545	25	uspto	uspto	NOUN
inlawrev-25507	545	26	,	,	PUNCT
inlawrev-25507	545	27	the	the	DET
inlawrev-25507	545	28	ptab	ptab	NOUN
inlawrev-25507	545	29	,	,	PUNCT
inlawrev-25507	545	30	or	or	CCONJ
inlawrev-25507	545	31	the	the	DET
inlawrev-25507	545	32	federal	federal	ADJ
inlawrev-25507	545	33	circuit	circuit	NOUN
inlawrev-25507	545	34	to	to	PART
inlawrev-25507	545	35	be	be	AUX
inlawrev-25507	545	36	the	the	DET
inlawrev-25507	545	37	innovator	innovator	NOUN
inlawrev-25507	545	38	’s	’s	PART
inlawrev-25507	545	39	attempt	attempt	NOUN
inlawrev-25507	545	40	to	to	PART
inlawrev-25507	545	41	evergreen	evergreen	VERB
inlawrev-25507	545	42	,	,	PUNCT
inlawrev-25507	545	43	then	then	ADV
inlawrev-25507	545	44	the	the	DET
inlawrev-25507	545	45	reference	reference	NOUN
inlawrev-25507	545	46	patent	patent	NOUN
inlawrev-25507	545	47	is	be	AUX
inlawrev-25507	545	48	also	also	ADV
inlawrev-25507	545	49	unenforceable	unenforceable	ADJ
inlawrev-25507	545	50	for	for	ADP
inlawrev-25507	545	51	double	double	ADJ
inlawrev-25507	545	52	patenting.193	patenting.193	NOUN
inlawrev-25507	545	53	this	this	DET
inlawrev-25507	545	54	law	law	NOUN
inlawrev-25507	545	55	would	would	AUX
inlawrev-25507	545	56	discourage	discourage	VERB
inlawrev-25507	545	57	innovators	innovator	NOUN
inlawrev-25507	545	58	from	from	ADP
inlawrev-25507	545	59	evergreening	evergreene	VERB
inlawrev-25507	545	60	because	because	SCONJ
inlawrev-25507	545	61	applying	apply	VERB
inlawrev-25507	545	62	for	for	ADP
inlawrev-25507	545	63	non	non	ADJ
inlawrev-25507	545	64	-	-	ADJ
inlawrev-25507	545	65	innovative	innovative	ADJ
inlawrev-25507	545	66	secondary	secondary	ADJ
inlawrev-25507	545	67	patents	patent	NOUN
inlawrev-25507	545	68	would	would	AUX
inlawrev-25507	545	69	put	put	VERB
inlawrev-25507	545	70	the	the	DET
inlawrev-25507	545	71	active	active	ADJ
inlawrev-25507	545	72	drug	drug	NOUN
inlawrev-25507	545	73	patent	patent	NOUN
inlawrev-25507	545	74	at	at	ADP
inlawrev-25507	545	75	risk	risk	NOUN
inlawrev-25507	545	76	.	.	PUNCT
inlawrev-25507	546	1	on	on	ADP
inlawrev-25507	546	2	the	the	DET
inlawrev-25507	546	3	other	other	ADJ
inlawrev-25507	546	4	hand	hand	NOUN
inlawrev-25507	546	5	,	,	PUNCT
inlawrev-25507	546	6	if	if	SCONJ
inlawrev-25507	546	7	the	the	DET
inlawrev-25507	546	8	innovators	innovator	NOUN
inlawrev-25507	546	9	are	be	AUX
inlawrev-25507	546	10	confident	confident	ADJ
inlawrev-25507	546	11	that	that	SCONJ
inlawrev-25507	546	12	the	the	DET
inlawrev-25507	546	13	new	new	ADJ
inlawrev-25507	546	14	patent	patent	NOUN
inlawrev-25507	546	15	application	application	NOUN
inlawrev-25507	546	16	covers	cover	VERB
inlawrev-25507	546	17	188	188	NUM
inlawrev-25507	546	18	.	.	PUNCT
inlawrev-25507	547	1	k.	k.	PROPN
inlawrev-25507	547	2	chatzantoni	chatzantoni	PROPN
inlawrev-25507	547	3	&	&	CCONJ
inlawrev-25507	547	4	a.	a.	PROPN
inlawrev-25507	547	5	mouzaki	mouzaki	PROPN
inlawrev-25507	547	6	,	,	PUNCT
inlawrev-25507	547	7	anti	anti	ADJ
inlawrev-25507	547	8	-	-	ADJ
inlawrev-25507	547	9	tnf	tnf	ADJ
inlawrev-25507	547	10	-	-	PUNCT
inlawrev-25507	547	11	alpha	alpha	NOUN
inlawrev-25507	547	12	antibody	antibody	NOUN
inlawrev-25507	547	13	therapies	therapy	NOUN
inlawrev-25507	547	14	in	in	ADP
inlawrev-25507	547	15	autoimmune	autoimmune	ADJ
inlawrev-25507	547	16	diseases	disease	NOUN
inlawrev-25507	547	17	,	,	PUNCT
inlawrev-25507	547	18	pubmed	pubmed	PROPN
inlawrev-25507	547	19	(	(	PUNCT
inlawrev-25507	547	20	2006	2006	NUM
inlawrev-25507	547	21	)	)	PUNCT
inlawrev-25507	547	22	,	,	PUNCT
inlawrev-25507	547	23	https://www.ncbi.nlm.nih.gov/pubmed/17017952	https://www.ncbi.nlm.nih.gov/pubmed/17017952	X
inlawrev-25507	548	1	[	[	X
inlawrev-25507	548	2	https://perma.cc/	https://perma.cc/	VERB
inlawrev-25507	548	3	k9p3	k9p3	NOUN
inlawrev-25507	548	4	-	-	NOUN
inlawrev-25507	548	5	4y2e	4y2e	NOUN
inlawrev-25507	548	6	]	]	X
inlawrev-25507	548	7	.	.	PUNCT
inlawrev-25507	549	1	189	189	NUM
inlawrev-25507	549	2	.	.	PUNCT
inlawrev-25507	550	1	see	see	PROPN
inlawrev-25507	550	2	holman	holman	PROPN
inlawrev-25507	550	3	,	,	PUNCT
inlawrev-25507	550	4	supra	supra	PROPN
inlawrev-25507	550	5	note	note	PROPN
inlawrev-25507	550	6	38	38	NUM
inlawrev-25507	550	7	.	.	PUNCT
inlawrev-25507	551	1	190	190	NUM
inlawrev-25507	551	2	.	.	PUNCT
inlawrev-25507	552	1	alex	alex	PROPN
inlawrev-25507	552	2	berezow	berezow	PROPN
inlawrev-25507	552	3	,	,	PUNCT
inlawrev-25507	552	4	how	how	SCONJ
inlawrev-25507	552	5	big	big	ADJ
inlawrev-25507	552	6	pharma	pharma	NOUN
inlawrev-25507	552	7	uses	use	VERB
inlawrev-25507	552	8	logically	logically	ADV
inlawrev-25507	552	9	impossible	impossible	ADJ
inlawrev-25507	552	10	patents	patent	NOUN
inlawrev-25507	552	11	to	to	PART
inlawrev-25507	552	12	block	block	VERB
inlawrev-25507	552	13	innovation	innovation	NOUN
inlawrev-25507	552	14	,	,	PUNCT
inlawrev-25507	552	15	am	be	AUX
inlawrev-25507	552	16	.	.	PUNCT
inlawrev-25507	553	1	council	council	PROPN
inlawrev-25507	553	2	on	on	ADP
inlawrev-25507	553	3	sci	sci	PROPN
inlawrev-25507	553	4	.	.	PROPN
inlawrev-25507	553	5	&	&	CCONJ
inlawrev-25507	553	6	health	health	PROPN
inlawrev-25507	553	7	(	(	PUNCT
inlawrev-25507	553	8	aug	aug	PROPN
inlawrev-25507	553	9	.	.	PROPN
inlawrev-25507	553	10	7	7	NUM
inlawrev-25507	553	11	,	,	PUNCT
inlawrev-25507	553	12	2019	2019	NUM
inlawrev-25507	553	13	)	)	PUNCT
inlawrev-25507	553	14	,	,	PUNCT
inlawrev-25507	553	15	https://www.acsh.org/news/2019/08/07/how-bigpharma-uses-logically-impossible-patents-block-innovation-14207	https://www.acsh.org/news/2019/08/07/how-bigpharma-uses-logically-impossible-patents-block-innovation-14207	VERB
inlawrev-25507	554	1	[	[	X
inlawrev-25507	554	2	https://perma.cc/ara9-kzje	https://perma.cc/ara9-kzje	X
inlawrev-25507	554	3	]	]	PUNCT
inlawrev-25507	554	4	.	.	PUNCT
inlawrev-25507	555	1	191	191	NUM
inlawrev-25507	555	2	.	.	PUNCT
inlawrev-25507	555	3	overpatented	overpatente	VERB
inlawrev-25507	555	4	,	,	PUNCT
inlawrev-25507	555	5	overpriced	overprice	VERB
inlawrev-25507	555	6	:	:	PUNCT
inlawrev-25507	555	7	special	special	ADJ
inlawrev-25507	555	8	humira	humira	PROPN
inlawrev-25507	555	9	edition	edition	PROPN
inlawrev-25507	555	10	,	,	PUNCT
inlawrev-25507	555	11	supra	supra	PROPN
inlawrev-25507	555	12	note	note	NOUN
inlawrev-25507	555	13	2	2	NUM
inlawrev-25507	555	14	,	,	PUNCT
inlawrev-25507	555	15	at	at	ADP
inlawrev-25507	555	16	4	4	NUM
inlawrev-25507	555	17	.	.	NOUN
inlawrev-25507	555	18	192	192	NUM
inlawrev-25507	555	19	.	.	PUNCT
inlawrev-25507	556	1	to	to	PART
inlawrev-25507	556	2	view	view	VERB
inlawrev-25507	556	3	the	the	DET
inlawrev-25507	556	4	claims	claim	NOUN
inlawrev-25507	556	5	of	of	ADP
inlawrev-25507	556	6	the	the	DET
inlawrev-25507	556	7	humira	humira	PROPN
inlawrev-25507	556	8	®	®	PROPN
inlawrev-25507	556	9	patents	patent	NOUN
inlawrev-25507	556	10	,	,	PUNCT
inlawrev-25507	556	11	see	see	VERB
inlawrev-25507	556	12	moradian	moradian	ADJ
inlawrev-25507	556	13	,	,	PUNCT
inlawrev-25507	556	14	supra	supra	ADJ
inlawrev-25507	556	15	note	note	NOUN
inlawrev-25507	556	16	185	185	NUM
inlawrev-25507	556	17	.	.	PUNCT
inlawrev-25507	557	1	193	193	NUM
inlawrev-25507	557	2	.	.	PUNCT
inlawrev-25507	558	1	see	see	VERB
inlawrev-25507	558	2	mpep	mpep	PROPN
inlawrev-25507	558	3	§	§	PROPN
inlawrev-25507	558	4	1504.06	1504.06	NUM
inlawrev-25507	558	5	(	(	PUNCT
inlawrev-25507	558	6	9th	9th	ADJ
inlawrev-25507	558	7	ed	ed	NOUN
inlawrev-25507	558	8	.	.	PUNCT
inlawrev-25507	559	1	rev	rev	PROPN
inlawrev-25507	559	2	.	.	PROPN
inlawrev-25507	559	3	10.2019	10.2019	NUM
inlawrev-25507	559	4	,	,	PUNCT
inlawrev-25507	559	5	june	june	PROPN
inlawrev-25507	559	6	2020	2020	NUM
inlawrev-25507	559	7	)	)	PUNCT
inlawrev-25507	560	1	(	(	PUNCT
inlawrev-25507	560	2	discussing	discuss	VERB
inlawrev-25507	560	3	current	current	ADJ
inlawrev-25507	560	4	practices	practice	NOUN
inlawrev-25507	560	5	in	in	ADP
inlawrev-25507	560	6	terms	term	NOUN
inlawrev-25507	560	7	of	of	ADP
inlawrev-25507	560	8	double	double	ADJ
inlawrev-25507	560	9	patenting	patenting	NOUN
inlawrev-25507	560	10	rejections	rejection	NOUN
inlawrev-25507	560	11	)	)	PUNCT
inlawrev-25507	560	12	.	.	PUNCT
inlawrev-25507	561	1	218	218	NUM
inlawrev-25507	561	2	indiana	indiana	PROPN
inlawrev-25507	561	3	law	law	PROPN
inlawrev-25507	561	4	review	review	NOUN
inlawrev-25507	562	1	[	[	X
inlawrev-25507	562	2	vol	vol	NOUN
inlawrev-25507	562	3	.	.	PUNCT
inlawrev-25507	563	1	54:195	54:195	NUM
inlawrev-25507	563	2	meaningful	meaningful	ADJ
inlawrev-25507	563	3	innovation	innovation	NOUN
inlawrev-25507	563	4	,	,	PUNCT
inlawrev-25507	563	5	they	they	PRON
inlawrev-25507	563	6	are	be	AUX
inlawrev-25507	563	7	likely	likely	ADJ
inlawrev-25507	563	8	to	to	PART
inlawrev-25507	563	9	seek	seek	VERB
inlawrev-25507	563	10	protection	protection	NOUN
inlawrev-25507	563	11	for	for	ADP
inlawrev-25507	563	12	it	it	PRON
inlawrev-25507	563	13	.	.	PUNCT
inlawrev-25507	564	1	ideally	ideally	ADV
inlawrev-25507	564	2	,	,	PUNCT
inlawrev-25507	564	3	since	since	SCONJ
inlawrev-25507	564	4	double	double	ADJ
inlawrev-25507	564	5	patenting	patenting	NOUN
inlawrev-25507	564	6	rejections	rejection	NOUN
inlawrev-25507	564	7	are	be	AUX
inlawrev-25507	564	8	not	not	PART
inlawrev-25507	564	9	unusual	unusual	ADJ
inlawrev-25507	564	10	,	,	PUNCT
inlawrev-25507	564	11	the	the	DET
inlawrev-25507	564	12	uspto	uspto	NOUN
inlawrev-25507	564	13	would	would	AUX
inlawrev-25507	564	14	take	take	VERB
inlawrev-25507	564	15	into	into	ADP
inlawrev-25507	564	16	consideration	consideration	NOUN
inlawrev-25507	564	17	not	not	PART
inlawrev-25507	564	18	only	only	ADV
inlawrev-25507	564	19	the	the	DET
inlawrev-25507	564	20	rejection	rejection	NOUN
inlawrev-25507	564	21	but	but	CCONJ
inlawrev-25507	564	22	also	also	ADV
inlawrev-25507	564	23	the	the	DET
inlawrev-25507	564	24	balancing	balance	VERB
inlawrev-25507	564	25	test	test	NOUN
inlawrev-25507	564	26	above.194	above.194	PROPN
inlawrev-25507	564	27	e.	e.	PROPN
inlawrev-25507	564	28	effect	effect	NOUN
inlawrev-25507	564	29	of	of	ADP
inlawrev-25507	564	30	the	the	DET
inlawrev-25507	564	31	proposed	propose	VERB
inlawrev-25507	564	32	bill	bill	NOUN
inlawrev-25507	564	33	on	on	ADP
inlawrev-25507	564	34	evergreening	evergreene	VERB
inlawrev-25507	564	35	ploys	ploy	NOUN
inlawrev-25507	564	36	similar	similar	ADJ
inlawrev-25507	564	37	to	to	ADP
inlawrev-25507	564	38	humira	humira	PROPN
inlawrev-25507	564	39	®	®	VERB
inlawrev-25507	564	40	the	the	DET
inlawrev-25507	564	41	primary	primary	ADJ
inlawrev-25507	564	42	consequence	consequence	NOUN
inlawrev-25507	564	43	of	of	ADP
inlawrev-25507	564	44	enacting	enact	VERB
inlawrev-25507	564	45	the	the	DET
inlawrev-25507	564	46	proposed	propose	VERB
inlawrev-25507	564	47	bill	bill	NOUN
inlawrev-25507	564	48	in	in	ADP
inlawrev-25507	564	49	addition	addition	NOUN
inlawrev-25507	564	50	to	to	ADP
inlawrev-25507	564	51	the	the	DET
inlawrev-25507	564	52	balancing	balancing	NOUN
inlawrev-25507	564	53	test	test	NOUN
inlawrev-25507	564	54	is	be	AUX
inlawrev-25507	564	55	that	that	SCONJ
inlawrev-25507	564	56	innovator	innovator	NOUN
inlawrev-25507	564	57	companies	company	NOUN
inlawrev-25507	564	58	will	will	AUX
inlawrev-25507	564	59	not	not	PART
inlawrev-25507	564	60	risk	risk	VERB
inlawrev-25507	564	61	the	the	DET
inlawrev-25507	564	62	loss	loss	NOUN
inlawrev-25507	564	63	of	of	ADP
inlawrev-25507	564	64	the	the	DET
inlawrev-25507	564	65	primary	primary	ADJ
inlawrev-25507	564	66	patent	patent	NOUN
inlawrev-25507	564	67	in	in	ADP
inlawrev-25507	564	68	order	order	NOUN
inlawrev-25507	564	69	to	to	PART
inlawrev-25507	564	70	potentially	potentially	ADV
inlawrev-25507	564	71	extend	extend	VERB
inlawrev-25507	564	72	its	its	PRON
inlawrev-25507	564	73	twenty	twenty	NUM
inlawrev-25507	564	74	-	-	PUNCT
inlawrev-25507	564	75	year	year	NOUN
inlawrev-25507	564	76	exclusivity	exclusivity	NOUN
inlawrev-25507	564	77	.	.	PUNCT
inlawrev-25507	565	1	additionally	additionally	ADV
inlawrev-25507	565	2	,	,	PUNCT
inlawrev-25507	565	3	the	the	DET
inlawrev-25507	565	4	bill	bill	NOUN
inlawrev-25507	565	5	would	would	AUX
inlawrev-25507	565	6	prevent	prevent	VERB
inlawrev-25507	565	7	the	the	DET
inlawrev-25507	565	8	loss	loss	NOUN
inlawrev-25507	565	9	of	of	ADP
inlawrev-25507	565	10	the	the	DET
inlawrev-25507	565	11	uspto	uspto	NOUN
inlawrev-25507	565	12	,	,	PUNCT
inlawrev-25507	565	13	the	the	DET
inlawrev-25507	565	14	ptab	ptab	NOUN
inlawrev-25507	565	15	,	,	PUNCT
inlawrev-25507	565	16	and	and	CCONJ
inlawrev-25507	565	17	the	the	DET
inlawrev-25507	565	18	federal	federal	ADJ
inlawrev-25507	565	19	circuit	circuit	PROPN
inlawrev-25507	565	20	’s	’s	PART
inlawrev-25507	565	21	influence	influence	NOUN
inlawrev-25507	565	22	over	over	ADP
inlawrev-25507	565	23	pharmaceutical	pharmaceutical	NOUN
inlawrev-25507	565	24	patent	patent	NOUN
inlawrev-25507	565	25	law	law	NOUN
inlawrev-25507	565	26	into	into	ADP
inlawrev-25507	565	27	the	the	DET
inlawrev-25507	565	28	hands	hand	NOUN
inlawrev-25507	565	29	of	of	ADP
inlawrev-25507	565	30	the	the	DET
inlawrev-25507	565	31	legislature	legislature	NOUN
inlawrev-25507	565	32	while	while	SCONJ
inlawrev-25507	565	33	still	still	ADV
inlawrev-25507	565	34	allowing	allow	VERB
inlawrev-25507	565	35	the	the	DET
inlawrev-25507	565	36	legislature	legislature	NOUN
inlawrev-25507	565	37	to	to	PART
inlawrev-25507	565	38	act	act	VERB
inlawrev-25507	565	39	in	in	ADP
inlawrev-25507	565	40	the	the	DET
inlawrev-25507	565	41	prevention	prevention	NOUN
inlawrev-25507	565	42	of	of	ADP
inlawrev-25507	565	43	evergreening	evergreene	VERB
inlawrev-25507	565	44	to	to	PART
inlawrev-25507	565	45	decrease	decrease	VERB
inlawrev-25507	565	46	drug	drug	NOUN
inlawrev-25507	565	47	prices	price	NOUN
inlawrev-25507	565	48	.	.	PUNCT
inlawrev-25507	566	1	moreover	moreover	ADV
inlawrev-25507	566	2	,	,	PUNCT
inlawrev-25507	566	3	if	if	SCONJ
inlawrev-25507	566	4	innovator	innovator	NOUN
inlawrev-25507	566	5	companies	company	NOUN
inlawrev-25507	566	6	continue	continue	VERB
inlawrev-25507	566	7	to	to	PART
inlawrev-25507	566	8	evergreen	evergreen	VERB
inlawrev-25507	566	9	,	,	PUNCT
inlawrev-25507	566	10	less	less	ADJ
inlawrev-25507	566	11	generic	generic	ADJ
inlawrev-25507	566	12	companies	company	NOUN
inlawrev-25507	566	13	will	will	AUX
inlawrev-25507	566	14	be	be	AUX
inlawrev-25507	566	15	hesitant	hesitant	ADJ
inlawrev-25507	566	16	to	to	PART
inlawrev-25507	566	17	litigate	litigate	VERB
inlawrev-25507	566	18	due	due	ADP
inlawrev-25507	566	19	to	to	ADP
inlawrev-25507	566	20	an	an	DET
inlawrev-25507	566	21	abundance	abundance	NOUN
inlawrev-25507	566	22	of	of	ADP
inlawrev-25507	566	23	patents	patent	NOUN
inlawrev-25507	566	24	—	—	PUNCT
inlawrev-25507	566	25	an	an	DET
inlawrev-25507	566	26	issue	issue	NOUN
inlawrev-25507	566	27	that	that	PRON
inlawrev-25507	566	28	exists	exist	VERB
inlawrev-25507	566	29	with	with	ADP
inlawrev-25507	566	30	the	the	DET
inlawrev-25507	566	31	current	current	ADJ
inlawrev-25507	566	32	humira	humira	PROPN
inlawrev-25507	566	33	®	®	NOUN
inlawrev-25507	566	34	patent	patent	NOUN
inlawrev-25507	566	35	landscape	landscape	NOUN
inlawrev-25507	566	36	.	.	PUNCT
inlawrev-25507	567	1	what	what	PRON
inlawrev-25507	567	2	is	be	AUX
inlawrev-25507	567	3	now	now	ADV
inlawrev-25507	567	4	an	an	DET
inlawrev-25507	567	5	impossible	impossible	ADJ
inlawrev-25507	567	6	feat	feat	NOUN
inlawrev-25507	567	7	would	would	AUX
inlawrev-25507	567	8	become	become	VERB
inlawrev-25507	567	9	possible	possible	ADJ
inlawrev-25507	567	10	for	for	ADP
inlawrev-25507	567	11	generic	generic	ADJ
inlawrev-25507	567	12	companies	company	NOUN
inlawrev-25507	567	13	if	if	SCONJ
inlawrev-25507	567	14	the	the	DET
inlawrev-25507	567	15	knock	knock	NOUN
inlawrev-25507	567	16	-	-	PUNCT
inlawrev-25507	567	17	down	down	NOUN
inlawrev-25507	567	18	of	of	ADP
inlawrev-25507	567	19	one	one	NUM
inlawrev-25507	567	20	patent	patent	NOUN
inlawrev-25507	567	21	could	could	AUX
inlawrev-25507	567	22	become	become	VERB
inlawrev-25507	567	23	the	the	DET
inlawrev-25507	567	24	knock	knock	NOUN
inlawrev-25507	567	25	-	-	PUNCT
inlawrev-25507	567	26	down	down	NOUN
inlawrev-25507	567	27	of	of	ADP
inlawrev-25507	567	28	all	all	DET
inlawrev-25507	567	29	patents	patent	NOUN
inlawrev-25507	567	30	.	.	PUNCT
inlawrev-25507	568	1	however	however	ADV
inlawrev-25507	568	2	,	,	PUNCT
inlawrev-25507	568	3	the	the	DET
inlawrev-25507	568	4	uspto	uspto	NOUN
inlawrev-25507	568	5	,	,	PUNCT
inlawrev-25507	568	6	the	the	DET
inlawrev-25507	568	7	ptab	ptab	NOUN
inlawrev-25507	568	8	,	,	PUNCT
inlawrev-25507	568	9	and	and	CCONJ
inlawrev-25507	568	10	the	the	DET
inlawrev-25507	568	11	federal	federal	ADJ
inlawrev-25507	568	12	circuit	circuit	NOUN
inlawrev-25507	568	13	should	should	AUX
inlawrev-25507	568	14	be	be	AUX
inlawrev-25507	568	15	cautious	cautious	ADJ
inlawrev-25507	568	16	in	in	ADP
inlawrev-25507	568	17	implementing	implement	VERB
inlawrev-25507	568	18	this	this	DET
inlawrev-25507	568	19	strategy	strategy	NOUN
inlawrev-25507	568	20	in	in	ADP
inlawrev-25507	568	21	only	only	ADV
inlawrev-25507	568	22	the	the	DET
inlawrev-25507	568	23	cases	case	NOUN
inlawrev-25507	568	24	of	of	ADP
inlawrev-25507	568	25	blatant	blatant	ADJ
inlawrev-25507	568	26	evergreening	evergreening	NOUN
inlawrev-25507	568	27	,	,	PUNCT
inlawrev-25507	568	28	as	as	SCONJ
inlawrev-25507	568	29	over	over	ADP
inlawrev-25507	568	30	-	-	PUNCT
inlawrev-25507	568	31	implementation	implementation	NOUN
inlawrev-25507	568	32	can	can	AUX
inlawrev-25507	568	33	result	result	VERB
inlawrev-25507	568	34	in	in	ADP
inlawrev-25507	568	35	a	a	DET
inlawrev-25507	568	36	decrease	decrease	NOUN
inlawrev-25507	568	37	of	of	ADP
inlawrev-25507	568	38	further	further	ADJ
inlawrev-25507	568	39	research	research	NOUN
inlawrev-25507	568	40	and	and	CCONJ
inlawrev-25507	568	41	development	development	NOUN
inlawrev-25507	568	42	on	on	ADP
inlawrev-25507	568	43	known	know	VERB
inlawrev-25507	568	44	drugs	drug	NOUN
inlawrev-25507	568	45	.	.	PUNCT
inlawrev-25507	569	1	in	in	ADP
inlawrev-25507	569	2	addition	addition	NOUN
inlawrev-25507	569	3	to	to	ADP
inlawrev-25507	569	4	the	the	DET
inlawrev-25507	569	5	increased	increase	VERB
inlawrev-25507	569	6	incentive	incentive	NOUN
inlawrev-25507	569	7	for	for	SCONJ
inlawrev-25507	569	8	generic	generic	ADJ
inlawrev-25507	569	9	companies	company	NOUN
inlawrev-25507	569	10	to	to	PART
inlawrev-25507	569	11	litigate	litigate	VERB
inlawrev-25507	569	12	,	,	PUNCT
inlawrev-25507	569	13	innovator	innovator	NOUN
inlawrev-25507	569	14	companies	company	NOUN
inlawrev-25507	569	15	would	would	AUX
inlawrev-25507	569	16	not	not	PART
inlawrev-25507	569	17	be	be	AUX
inlawrev-25507	569	18	able	able	ADJ
inlawrev-25507	569	19	to	to	PART
inlawrev-25507	569	20	settle	settle	VERB
inlawrev-25507	569	21	with	with	ADP
inlawrev-25507	569	22	generic	generic	ADJ
inlawrev-25507	569	23	companies	company	NOUN
inlawrev-25507	569	24	to	to	PART
inlawrev-25507	569	25	delay	delay	VERB
inlawrev-25507	569	26	them	they	PRON
inlawrev-25507	569	27	from	from	ADP
inlawrev-25507	569	28	entering	enter	VERB
inlawrev-25507	569	29	the	the	DET
inlawrev-25507	569	30	market	market	NOUN
inlawrev-25507	569	31	.	.	PUNCT
inlawrev-25507	570	1	for	for	ADP
inlawrev-25507	570	2	example	example	NOUN
inlawrev-25507	570	3	,	,	PUNCT
inlawrev-25507	570	4	abbvie	abbvie	PROPN
inlawrev-25507	570	5	has	have	AUX
inlawrev-25507	570	6	settled	settle	VERB
inlawrev-25507	570	7	patent	patent	NOUN
inlawrev-25507	570	8	disputes	dispute	NOUN
inlawrev-25507	570	9	with	with	ADP
inlawrev-25507	570	10	multiple	multiple	ADJ
inlawrev-25507	570	11	generic	generic	ADJ
inlawrev-25507	570	12	companies	company	NOUN
inlawrev-25507	570	13	over	over	ADP
inlawrev-25507	570	14	humira	humira	PROPN
inlawrev-25507	570	15	®	®	PROPN
inlawrev-25507	570	16	.195	.195	NUM
inlawrev-25507	570	17	abbvie	abbvie	PROPN
inlawrev-25507	570	18	granted	grant	VERB
inlawrev-25507	570	19	novartis	novartis	PROPN
inlawrev-25507	570	20	a	a	DET
inlawrev-25507	570	21	non	non	ADJ
inlawrev-25507	570	22	-	-	ADJ
inlawrev-25507	570	23	exclusive	exclusive	ADJ
inlawrev-25507	570	24	license	license	NOUN
inlawrev-25507	570	25	to	to	PART
inlawrev-25507	570	26	manufacture	manufacture	VERB
inlawrev-25507	570	27	and	and	CCONJ
inlawrev-25507	570	28	sell	sell	VERB
inlawrev-25507	570	29	a	a	DET
inlawrev-25507	570	30	copycat	copycat	NOUN
inlawrev-25507	570	31	version	version	NOUN
inlawrev-25507	570	32	of	of	ADP
inlawrev-25507	570	33	the	the	DET
inlawrev-25507	570	34	drug	drug	NOUN
inlawrev-25507	570	35	beginning	begin	VERB
inlawrev-25507	570	36	on	on	ADP
inlawrev-25507	570	37	september	september	PROPN
inlawrev-25507	570	38	30	30	NUM
inlawrev-25507	570	39	,	,	PUNCT
inlawrev-25507	570	40	2023.196	2023.196	NUM
inlawrev-25507	570	41	abbvie	abbvie	NOUN
inlawrev-25507	570	42	reached	reach	VERB
inlawrev-25507	570	43	a	a	DET
inlawrev-25507	570	44	similar	similar	ADJ
inlawrev-25507	570	45	agreement	agreement	NOUN
inlawrev-25507	570	46	with	with	ADP
inlawrev-25507	570	47	amgen	amgen	PROPN
inlawrev-25507	570	48	,	,	PUNCT
inlawrev-25507	570	49	allowing	allow	VERB
inlawrev-25507	570	50	the	the	DET
inlawrev-25507	570	51	company	company	NOUN
inlawrev-25507	570	52	to	to	PART
inlawrev-25507	570	53	release	release	VERB
inlawrev-25507	570	54	its	its	PRON
inlawrev-25507	570	55	version	version	NOUN
inlawrev-25507	570	56	of	of	ADP
inlawrev-25507	570	57	the	the	DET
inlawrev-25507	570	58	drug	drug	NOUN
inlawrev-25507	570	59	on	on	ADP
inlawrev-25507	570	60	january	january	PROPN
inlawrev-25507	570	61	31	31	NUM
inlawrev-25507	570	62	,	,	PUNCT
inlawrev-25507	570	63	2023.197	2023.197	NUM
inlawrev-25507	570	64	the	the	DET
inlawrev-25507	570	65	implementation	implementation	NOUN
inlawrev-25507	570	66	of	of	ADP
inlawrev-25507	570	67	this	this	DET
inlawrev-25507	570	68	bill	bill	NOUN
inlawrev-25507	570	69	would	would	AUX
inlawrev-25507	570	70	incentivize	incentivize	VERB
inlawrev-25507	570	71	generic	generic	ADJ
inlawrev-25507	570	72	companies	company	NOUN
inlawrev-25507	570	73	to	to	PART
inlawrev-25507	570	74	litigate	litigate	VERB
inlawrev-25507	570	75	against	against	ADP
inlawrev-25507	570	76	patents	patent	NOUN
inlawrev-25507	570	77	they	they	PRON
inlawrev-25507	570	78	believe	believe	VERB
inlawrev-25507	570	79	are	be	AUX
inlawrev-25507	570	80	attempts	attempt	NOUN
inlawrev-25507	570	81	to	to	PART
inlawrev-25507	570	82	evergreen	evergreen	VERB
inlawrev-25507	570	83	instead	instead	ADV
inlawrev-25507	570	84	of	of	ADP
inlawrev-25507	570	85	settling	settle	VERB
inlawrev-25507	570	86	for	for	ADP
inlawrev-25507	570	87	a	a	DET
inlawrev-25507	570	88	non	non	ADJ
inlawrev-25507	570	89	-	-	ADJ
inlawrev-25507	570	90	exclusive	exclusive	ADJ
inlawrev-25507	570	91	license	license	NOUN
inlawrev-25507	570	92	that	that	PRON
inlawrev-25507	570	93	would	would	AUX
inlawrev-25507	570	94	not	not	PART
inlawrev-25507	570	95	be	be	AUX
inlawrev-25507	570	96	necessary	necessary	ADJ
inlawrev-25507	570	97	in	in	ADP
inlawrev-25507	570	98	the	the	DET
inlawrev-25507	570	99	absence	absence	NOUN
inlawrev-25507	570	100	of	of	ADP
inlawrev-25507	570	101	evergreening	evergreene	VERB
inlawrev-25507	570	102	.	.	PUNCT
inlawrev-25507	571	1	conclusion	conclusion	NOUN
inlawrev-25507	571	2	the	the	DET
inlawrev-25507	571	3	use	use	NOUN
inlawrev-25507	571	4	of	of	ADP
inlawrev-25507	571	5	a	a	DET
inlawrev-25507	571	6	loophole	loophole	NOUN
inlawrev-25507	571	7	in	in	ADP
inlawrev-25507	571	8	the	the	DET
inlawrev-25507	571	9	patent	patent	NOUN
inlawrev-25507	571	10	system	system	NOUN
inlawrev-25507	571	11	that	that	PRON
inlawrev-25507	571	12	allows	allow	VERB
inlawrev-25507	571	13	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	571	14	companies	company	NOUN
inlawrev-25507	571	15	to	to	PART
inlawrev-25507	571	16	evergreen	evergreen	VERB
inlawrev-25507	571	17	is	be	AUX
inlawrev-25507	571	18	a	a	DET
inlawrev-25507	571	19	continuing	continue	VERB
inlawrev-25507	571	20	issue	issue	NOUN
inlawrev-25507	571	21	that	that	PRON
inlawrev-25507	571	22	likely	likely	ADV
inlawrev-25507	571	23	will	will	AUX
inlawrev-25507	571	24	not	not	PART
inlawrev-25507	571	25	be	be	AUX
inlawrev-25507	571	26	resolved	resolve	VERB
inlawrev-25507	571	27	until	until	SCONJ
inlawrev-25507	571	28	there	there	PRON
inlawrev-25507	571	29	is	be	VERB
inlawrev-25507	571	30	an	an	DET
inlawrev-25507	571	31	active	active	ADJ
inlawrev-25507	571	32	push	push	NOUN
inlawrev-25507	571	33	against	against	ADP
inlawrev-25507	571	34	the	the	DET
inlawrev-25507	571	35	practice.198	practice.198	NOUN
inlawrev-25507	571	36	the	the	DET
inlawrev-25507	571	37	continued	continue	VERB
inlawrev-25507	571	38	use	use	NOUN
inlawrev-25507	571	39	of	of	ADP
inlawrev-25507	571	40	evergreening	evergreene	VERB
inlawrev-25507	571	41	194	194	NUM
inlawrev-25507	571	42	.	.	PUNCT
inlawrev-25507	572	1	see	see	VERB
inlawrev-25507	572	2	qiang	qiang	PROPN
inlawrev-25507	572	3	lu	lu	PROPN
inlawrev-25507	572	4	et	et	PROPN
inlawrev-25507	572	5	al	al	PROPN
inlawrev-25507	572	6	.	.	PROPN
inlawrev-25507	572	7	,	,	PUNCT
inlawrev-25507	572	8	uspto	uspto	PROPN
inlawrev-25507	572	9	patent	patent	NOUN
inlawrev-25507	572	10	prosecution	prosecution	NOUN
inlawrev-25507	572	11	research	research	NOUN
inlawrev-25507	572	12	data	datum	NOUN
inlawrev-25507	572	13	:	:	PUNCT
inlawrev-25507	572	14	unlocking	unlock	VERB
inlawrev-25507	572	15	office	office	NOUN
inlawrev-25507	572	16	action	action	NOUN
inlawrev-25507	572	17	traits	trait	NOUN
inlawrev-25507	572	18	,	,	PUNCT
inlawrev-25507	572	19	u.s	u.s	PROPN
inlawrev-25507	572	20	.	.	PROPN
inlawrev-25507	572	21	pat	pat	PROPN
inlawrev-25507	572	22	.	.	PROPN
inlawrev-25507	572	23	&	&	CCONJ
inlawrev-25507	572	24	trademark	trademark	PROPN
inlawrev-25507	572	25	off	off	ADP
inlawrev-25507	572	26	.	.	PUNCT
inlawrev-25507	573	1	(	(	PUNCT
inlawrev-25507	573	2	nov	nov	PROPN
inlawrev-25507	573	3	.	.	PROPN
inlawrev-25507	573	4	2017	2017	NUM
inlawrev-25507	573	5	)	)	PUNCT
inlawrev-25507	573	6	,	,	PUNCT
inlawrev-25507	573	7	https://patentlyo.com/media/2017/11/usptopatent-prosecution-research-data_unlocking-office-action-traits-1.pdf	https://patentlyo.com/media/2017/11/usptopatent-prosecution-research-data_unlocking-office-action-traits-1.pdf	NOUN
inlawrev-25507	573	8	[	[	X
inlawrev-25507	573	9	https://perma.cc/nwh8u33l	https://perma.cc/nwh8u33l	X
inlawrev-25507	573	10	]	]	X
inlawrev-25507	573	11	(	(	PUNCT
inlawrev-25507	573	12	discussing	discuss	VERB
inlawrev-25507	573	13	frequency	frequency	NOUN
inlawrev-25507	573	14	of	of	ADP
inlawrev-25507	573	15	non	non	ADJ
inlawrev-25507	573	16	-	-	ADJ
inlawrev-25507	573	17	statutory	statutory	ADJ
inlawrev-25507	573	18	double	double	ADJ
inlawrev-25507	573	19	patenting	patenting	NOUN
inlawrev-25507	573	20	)	)	PUNCT
inlawrev-25507	573	21	.	.	PUNCT
inlawrev-25507	574	1	195	195	NUM
inlawrev-25507	574	2	.	.	X
inlawrev-25507	574	3	maddipatla	maddipatla	PROPN
inlawrev-25507	574	4	&	&	CCONJ
inlawrev-25507	574	5	joseph	joseph	PROPN
inlawrev-25507	574	6	,	,	PUNCT
inlawrev-25507	574	7	supra	supra	PROPN
inlawrev-25507	574	8	note	note	NOUN
inlawrev-25507	574	9	58	58	NUM
inlawrev-25507	574	10	.	.	PUNCT
inlawrev-25507	574	11	196	196	NUM
inlawrev-25507	574	12	.	.	PUNCT
inlawrev-25507	575	1	i	i	PRON
inlawrev-25507	575	2	d.	d.	PROPN
inlawrev-25507	575	3	197	197	NUM
inlawrev-25507	575	4	.	.	PUNCT
inlawrev-25507	576	1	i	i	PRON
inlawrev-25507	576	2	d.	d.	PROPN
inlawrev-25507	576	3	198	198	NUM
inlawrev-25507	576	4	.	.	PUNCT
inlawrev-25507	577	1	how	how	SCONJ
inlawrev-25507	577	2	big	big	ADJ
inlawrev-25507	577	3	pharma	pharma	NOUN
inlawrev-25507	577	4	plays	play	VERB
inlawrev-25507	577	5	games	game	NOUN
inlawrev-25507	577	6	with	with	ADP
inlawrev-25507	577	7	drug	drug	NOUN
inlawrev-25507	577	8	patents	patent	NOUN
inlawrev-25507	577	9	and	and	CCONJ
inlawrev-25507	577	10	how	how	SCONJ
inlawrev-25507	577	11	to	to	PART
inlawrev-25507	577	12	combat	combat	VERB
inlawrev-25507	577	13	it	it	PRON
inlawrev-25507	577	14	,	,	PUNCT
inlawrev-25507	577	15	usa	usa	PROPN
inlawrev-25507	577	16	today	today	NOUN
inlawrev-25507	577	17	2021	2021	NUM
inlawrev-25507	577	18	]	]	PUNCT
inlawrev-25507	577	19	leaving	leave	VERB
inlawrev-25507	577	20	the	the	DET
inlawrev-25507	577	21	evergreening	evergreene	VERB
inlawrev-25507	577	22	problem	problem	NOUN
inlawrev-25507	577	23	to	to	ADP
inlawrev-25507	577	24	the	the	DET
inlawrev-25507	577	25	patent	patent	NOUN
inlawrev-25507	577	26	experts	expert	NOUN
inlawrev-25507	577	27	219	219	NUM
inlawrev-25507	577	28	will	will	AUX
inlawrev-25507	577	29	prevent	prevent	VERB
inlawrev-25507	577	30	the	the	DET
inlawrev-25507	577	31	reduction	reduction	NOUN
inlawrev-25507	577	32	of	of	ADP
inlawrev-25507	577	33	a	a	DET
inlawrev-25507	577	34	drug	drug	NOUN
inlawrev-25507	577	35	’s	’s	PART
inlawrev-25507	577	36	cost	cost	NOUN
inlawrev-25507	577	37	and	and	CCONJ
inlawrev-25507	577	38	can	can	AUX
inlawrev-25507	577	39	even	even	ADV
inlawrev-25507	577	40	contribute	contribute	VERB
inlawrev-25507	577	41	to	to	ADP
inlawrev-25507	577	42	a	a	DET
inlawrev-25507	577	43	rising	rise	VERB
inlawrev-25507	577	44	price	price	NOUN
inlawrev-25507	577	45	of	of	ADP
inlawrev-25507	577	46	the	the	DET
inlawrev-25507	577	47	drug.199	drug.199	NOUN
inlawrev-25507	577	48	although	although	SCONJ
inlawrev-25507	577	49	many	many	ADJ
inlawrev-25507	577	50	members	member	NOUN
inlawrev-25507	577	51	of	of	ADP
inlawrev-25507	577	52	congress	congress	PROPN
inlawrev-25507	577	53	are	be	AUX
inlawrev-25507	577	54	pushing	push	VERB
inlawrev-25507	577	55	for	for	ADP
inlawrev-25507	577	56	bipartisan	bipartisan	ADJ
inlawrev-25507	577	57	lawmaking	lawmaking	NOUN
inlawrev-25507	577	58	to	to	PART
inlawrev-25507	577	59	solve	solve	VERB
inlawrev-25507	577	60	this	this	DET
inlawrev-25507	577	61	issue,200	issue,200	NOUN
inlawrev-25507	577	62	proposed	propose	VERB
inlawrev-25507	577	63	legislation	legislation	NOUN
inlawrev-25507	577	64	would	would	AUX
inlawrev-25507	577	65	treat	treat	VERB
inlawrev-25507	577	66	the	the	DET
inlawrev-25507	577	67	evergreening	evergreening	NOUN
inlawrev-25507	577	68	problem	problem	NOUN
inlawrev-25507	577	69	as	as	ADP
inlawrev-25507	577	70	a	a	DET
inlawrev-25507	577	71	black	black	ADJ
inlawrev-25507	577	72	-	-	PUNCT
inlawrev-25507	577	73	and	and	CCONJ
inlawrev-25507	577	74	-	-	PUNCT
inlawrev-25507	577	75	white	white	ADJ
inlawrev-25507	577	76	issue	issue	NOUN
inlawrev-25507	577	77	.	.	PUNCT
inlawrev-25507	578	1	legislation	legislation	NOUN
inlawrev-25507	578	2	,	,	PUNCT
inlawrev-25507	578	3	such	such	ADJ
inlawrev-25507	578	4	as	as	ADP
inlawrev-25507	578	5	the	the	DET
inlawrev-25507	578	6	remedy	remedy	NOUN
inlawrev-25507	578	7	act	act	PROPN
inlawrev-25507	578	8	,	,	PUNCT
inlawrev-25507	578	9	the	the	DET
inlawrev-25507	578	10	app	app	PROPN
inlawrev-25507	578	11	act	act	PROPN
inlawrev-25507	578	12	,	,	PUNCT
inlawrev-25507	578	13	or	or	CCONJ
inlawrev-25507	578	14	the	the	DET
inlawrev-25507	578	15	term	term	NOUN
inlawrev-25507	578	16	act	act	NOUN
inlawrev-25507	578	17	,	,	PUNCT
inlawrev-25507	578	18	might	might	AUX
inlawrev-25507	578	19	address	address	VERB
inlawrev-25507	578	20	the	the	DET
inlawrev-25507	578	21	evergreening	evergreening	NOUN
inlawrev-25507	578	22	problem	problem	NOUN
inlawrev-25507	578	23	but	but	CCONJ
inlawrev-25507	578	24	would	would	AUX
inlawrev-25507	578	25	also	also	ADV
inlawrev-25507	578	26	impair	impair	VERB
inlawrev-25507	578	27	innovation	innovation	NOUN
inlawrev-25507	578	28	on	on	ADP
inlawrev-25507	578	29	known	know	VERB
inlawrev-25507	578	30	drugs.201	drugs.201	NOUN
inlawrev-25507	578	31	additionally	additionally	ADV
inlawrev-25507	578	32	,	,	PUNCT
inlawrev-25507	578	33	legislation	legislation	NOUN
inlawrev-25507	578	34	like	like	ADP
inlawrev-25507	578	35	the	the	DET
inlawrev-25507	578	36	remedy	remedy	NOUN
inlawrev-25507	578	37	act	act	NOUN
inlawrev-25507	578	38	provides	provide	VERB
inlawrev-25507	578	39	no	no	DET
inlawrev-25507	578	40	actual	actual	ADJ
inlawrev-25507	578	41	substantive	substantive	ADJ
inlawrev-25507	578	42	answer	answer	NOUN
inlawrev-25507	578	43	to	to	ADP
inlawrev-25507	578	44	a	a	DET
inlawrev-25507	578	45	systematic	systematic	ADJ
inlawrev-25507	578	46	issue	issue	NOUN
inlawrev-25507	578	47	in	in	ADP
inlawrev-25507	578	48	patent	patent	NOUN
inlawrev-25507	578	49	law	law	NOUN
inlawrev-25507	578	50	,	,	PUNCT
inlawrev-25507	578	51	but	but	CCONJ
inlawrev-25507	578	52	only	only	ADV
inlawrev-25507	578	53	acts	act	VERB
inlawrev-25507	578	54	to	to	PART
inlawrev-25507	578	55	give	give	VERB
inlawrev-25507	578	56	the	the	DET
inlawrev-25507	578	57	“	"	PUNCT
inlawrev-25507	578	58	cosmetic	cosmetic	ADJ
inlawrev-25507	578	59	effect	effect	NOUN
inlawrev-25507	578	60	”	"	PUNCT
inlawrev-25507	578	61	of	of	ADP
inlawrev-25507	578	62	a	a	DET
inlawrev-25507	578	63	solution	solution	NOUN
inlawrev-25507	578	64	to	to	ADP
inlawrev-25507	578	65	the	the	DET
inlawrev-25507	578	66	evergreening	evergreene	VERB
inlawrev-25507	578	67	issue.202	issue.202	PROPN
inlawrev-25507	578	68	the	the	DET
inlawrev-25507	578	69	best	good	ADJ
inlawrev-25507	578	70	avenue	avenue	NOUN
inlawrev-25507	578	71	for	for	ADP
inlawrev-25507	578	72	correcting	correct	VERB
inlawrev-25507	578	73	this	this	DET
inlawrev-25507	578	74	issue	issue	NOUN
inlawrev-25507	578	75	is	be	AUX
inlawrev-25507	578	76	to	to	PART
inlawrev-25507	578	77	leave	leave	VERB
inlawrev-25507	578	78	the	the	DET
inlawrev-25507	578	79	dilemma	dilemma	NOUN
inlawrev-25507	578	80	to	to	ADP
inlawrev-25507	578	81	the	the	DET
inlawrev-25507	578	82	branches	branch	NOUN
inlawrev-25507	578	83	of	of	ADP
inlawrev-25507	578	84	government	government	NOUN
inlawrev-25507	578	85	that	that	PRON
inlawrev-25507	578	86	have	have	VERB
inlawrev-25507	578	87	the	the	DET
inlawrev-25507	578	88	most	most	ADJ
inlawrev-25507	578	89	experience	experience	NOUN
inlawrev-25507	578	90	with	with	ADP
inlawrev-25507	578	91	patent	patent	NOUN
inlawrev-25507	578	92	law	law	NOUN
inlawrev-25507	578	93	—	—	PUNCT
inlawrev-25507	578	94	the	the	DET
inlawrev-25507	578	95	judicial	judicial	ADJ
inlawrev-25507	578	96	and	and	CCONJ
inlawrev-25507	578	97	executive	executive	ADJ
inlawrev-25507	578	98	branches	branch	NOUN
inlawrev-25507	578	99	.	.	PUNCT
inlawrev-25507	579	1	specifically	specifically	ADV
inlawrev-25507	579	2	,	,	PUNCT
inlawrev-25507	579	3	the	the	DET
inlawrev-25507	579	4	matter	matter	NOUN
inlawrev-25507	579	5	should	should	AUX
inlawrev-25507	579	6	be	be	AUX
inlawrev-25507	579	7	left	leave	VERB
inlawrev-25507	579	8	to	to	ADP
inlawrev-25507	579	9	the	the	DET
inlawrev-25507	579	10	uspto	uspto	NOUN
inlawrev-25507	579	11	,	,	PUNCT
inlawrev-25507	579	12	the	the	DET
inlawrev-25507	579	13	ptab	ptab	NOUN
inlawrev-25507	579	14	,	,	PUNCT
inlawrev-25507	579	15	and	and	CCONJ
inlawrev-25507	579	16	the	the	DET
inlawrev-25507	579	17	court	court	NOUN
inlawrev-25507	579	18	of	of	ADP
inlawrev-25507	579	19	appeals	appeal	NOUN
inlawrev-25507	579	20	for	for	ADP
inlawrev-25507	579	21	the	the	DET
inlawrev-25507	579	22	federal	federal	ADJ
inlawrev-25507	579	23	circuit	circuit	NOUN
inlawrev-25507	579	24	,	,	PUNCT
inlawrev-25507	579	25	as	as	SCONJ
inlawrev-25507	579	26	not	not	PART
inlawrev-25507	579	27	only	only	ADV
inlawrev-25507	579	28	are	be	AUX
inlawrev-25507	579	29	they	they	PRON
inlawrev-25507	579	30	the	the	DET
inlawrev-25507	579	31	most	most	ADV
inlawrev-25507	579	32	competent	competent	ADJ
inlawrev-25507	579	33	in	in	ADP
inlawrev-25507	579	34	terms	term	NOUN
inlawrev-25507	579	35	of	of	ADP
inlawrev-25507	579	36	patent	patent	NOUN
inlawrev-25507	579	37	law	law	NOUN
inlawrev-25507	579	38	,	,	PUNCT
inlawrev-25507	579	39	but	but	CCONJ
inlawrev-25507	579	40	they	they	PRON
inlawrev-25507	579	41	are	be	AUX
inlawrev-25507	579	42	also	also	ADV
inlawrev-25507	579	43	composed	compose	VERB
inlawrev-25507	579	44	of	of	ADP
inlawrev-25507	579	45	scientists	scientist	NOUN
inlawrev-25507	579	46	and	and	CCONJ
inlawrev-25507	579	47	former	former	ADJ
inlawrev-25507	579	48	patent	patent	NOUN
inlawrev-25507	579	49	attorneys.203	attorneys.203	ADV
inlawrev-25507	579	50	however	however	ADV
inlawrev-25507	579	51	,	,	PUNCT
inlawrev-25507	579	52	this	this	PRON
inlawrev-25507	579	53	does	do	AUX
inlawrev-25507	579	54	not	not	PART
inlawrev-25507	579	55	mean	mean	VERB
inlawrev-25507	579	56	there	there	PRON
inlawrev-25507	579	57	should	should	AUX
inlawrev-25507	579	58	be	be	AUX
inlawrev-25507	579	59	a	a	DET
inlawrev-25507	579	60	straight	straight	ADJ
inlawrev-25507	579	61	-	-	PUNCT
inlawrev-25507	579	62	line	line	NOUN
inlawrev-25507	579	63	rule	rule	NOUN
inlawrev-25507	579	64	,	,	PUNCT
inlawrev-25507	579	65	as	as	SCONJ
inlawrev-25507	579	66	this	this	PRON
inlawrev-25507	579	67	too	too	ADV
inlawrev-25507	579	68	could	could	AUX
inlawrev-25507	579	69	impair	impair	VERB
inlawrev-25507	579	70	innovation	innovation	NOUN
inlawrev-25507	579	71	.	.	PUNCT
inlawrev-25507	580	1	an	an	DET
inlawrev-25507	580	2	observation	observation	NOUN
inlawrev-25507	580	3	of	of	ADP
inlawrev-25507	580	4	a	a	DET
inlawrev-25507	580	5	multitude	multitude	NOUN
inlawrev-25507	580	6	of	of	ADP
inlawrev-25507	580	7	secondary	secondary	ADJ
inlawrev-25507	580	8	patents	patent	NOUN
inlawrev-25507	580	9	does	do	AUX
inlawrev-25507	580	10	not	not	PART
inlawrev-25507	580	11	automatically	automatically	ADV
inlawrev-25507	580	12	mean	mean	VERB
inlawrev-25507	580	13	that	that	SCONJ
inlawrev-25507	580	14	the	the	DET
inlawrev-25507	580	15	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	580	16	company	company	NOUN
inlawrev-25507	580	17	is	be	AUX
inlawrev-25507	580	18	evergreening	evergreene	VERB
inlawrev-25507	580	19	.	.	PUNCT
inlawrev-25507	581	1	therefore	therefore	ADV
inlawrev-25507	581	2	,	,	PUNCT
inlawrev-25507	581	3	a	a	DET
inlawrev-25507	581	4	balancing	balancing	NOUN
inlawrev-25507	581	5	test	test	NOUN
inlawrev-25507	581	6	that	that	PRON
inlawrev-25507	581	7	examines	examine	VERB
inlawrev-25507	581	8	the	the	DET
inlawrev-25507	581	9	most	most	ADV
inlawrev-25507	581	10	likely	likely	ADJ
inlawrev-25507	581	11	factors	factor	NOUN
inlawrev-25507	581	12	that	that	PRON
inlawrev-25507	581	13	would	would	AUX
inlawrev-25507	581	14	convince	convince	VERB
inlawrev-25507	581	15	the	the	DET
inlawrev-25507	581	16	uspto	uspto	NOUN
inlawrev-25507	581	17	or	or	CCONJ
inlawrev-25507	581	18	the	the	DET
inlawrev-25507	581	19	court	court	NOUN
inlawrev-25507	581	20	of	of	ADP
inlawrev-25507	581	21	appeals	appeal	NOUN
inlawrev-25507	581	22	that	that	SCONJ
inlawrev-25507	581	23	the	the	DET
inlawrev-25507	581	24	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	581	25	company	company	NOUN
inlawrev-25507	581	26	is	be	AUX
inlawrev-25507	581	27	evergreening	evergreene	VERB
inlawrev-25507	581	28	would	would	AUX
inlawrev-25507	581	29	be	be	AUX
inlawrev-25507	581	30	beneficial	beneficial	ADJ
inlawrev-25507	581	31	.	.	PUNCT
inlawrev-25507	582	1	additionally	additionally	ADV
inlawrev-25507	582	2	,	,	PUNCT
inlawrev-25507	582	3	a	a	DET
inlawrev-25507	582	4	statute	statute	NOUN
inlawrev-25507	582	5	can	can	AUX
inlawrev-25507	582	6	be	be	AUX
inlawrev-25507	582	7	enacted	enact	VERB
inlawrev-25507	582	8	that	that	PRON
inlawrev-25507	582	9	proposes	propose	VERB
inlawrev-25507	582	10	if	if	SCONJ
inlawrev-25507	582	11	one	one	NUM
inlawrev-25507	582	12	patent	patent	NOUN
inlawrev-25507	582	13	in	in	ADP
inlawrev-25507	582	14	the	the	DET
inlawrev-25507	582	15	family	family	NOUN
inlawrev-25507	582	16	is	be	AUX
inlawrev-25507	582	17	found	find	VERB
inlawrev-25507	582	18	to	to	PART
inlawrev-25507	582	19	be	be	AUX
inlawrev-25507	582	20	double	double	ADJ
inlawrev-25507	582	21	patenting	patenting	NOUN
inlawrev-25507	582	22	and	and	CCONJ
inlawrev-25507	582	23	is	be	AUX
inlawrev-25507	582	24	thought	think	VERB
inlawrev-25507	582	25	to	to	PART
inlawrev-25507	582	26	be	be	AUX
inlawrev-25507	582	27	the	the	DET
inlawrev-25507	582	28	innovator	innovator	NOUN
inlawrev-25507	582	29	’s	’s	PART
inlawrev-25507	582	30	form	form	NOUN
inlawrev-25507	582	31	of	of	ADP
inlawrev-25507	582	32	evergreening	evergreening	NOUN
inlawrev-25507	582	33	,	,	PUNCT
inlawrev-25507	582	34	then	then	ADV
inlawrev-25507	582	35	the	the	DET
inlawrev-25507	582	36	reference	reference	NOUN
inlawrev-25507	582	37	patent	patent	NOUN
inlawrev-25507	582	38	is	be	AUX
inlawrev-25507	582	39	also	also	ADV
inlawrev-25507	582	40	unenforceable	unenforceable	ADJ
inlawrev-25507	582	41	for	for	ADP
inlawrev-25507	582	42	double	double	ADJ
inlawrev-25507	582	43	patenting.204	patenting.204	NOUN
inlawrev-25507	582	44	this	this	PRON
inlawrev-25507	582	45	allows	allow	VERB
inlawrev-25507	582	46	the	the	DET
inlawrev-25507	582	47	risk	risk	NOUN
inlawrev-25507	582	48	of	of	ADP
inlawrev-25507	582	49	a	a	DET
inlawrev-25507	582	50	finding	finding	NOUN
inlawrev-25507	582	51	of	of	ADP
inlawrev-25507	582	52	evergreening	evergreene	VERB
inlawrev-25507	582	53	to	to	PART
inlawrev-25507	582	54	be	be	AUX
inlawrev-25507	582	55	on	on	ADP
inlawrev-25507	582	56	the	the	DET
inlawrev-25507	582	57	pharmaceutical	pharmaceutical	ADJ
inlawrev-25507	582	58	company	company	NOUN
inlawrev-25507	582	59	,	,	PUNCT
inlawrev-25507	582	60	and	and	CCONJ
inlawrev-25507	582	61	it	it	PRON
inlawrev-25507	582	62	would	would	AUX
inlawrev-25507	582	63	likely	likely	ADV
inlawrev-25507	582	64	decrease	decrease	VERB
inlawrev-25507	582	65	efforts	effort	NOUN
inlawrev-25507	582	66	of	of	ADP
inlawrev-25507	582	67	evergreening	evergreene	VERB
inlawrev-25507	582	68	because	because	SCONJ
inlawrev-25507	582	69	of	of	ADP
inlawrev-25507	582	70	the	the	DET
inlawrev-25507	582	71	endangerment	endangerment	NOUN
inlawrev-25507	582	72	of	of	ADP
inlawrev-25507	582	73	the	the	DET
inlawrev-25507	582	74	reference	reference	NOUN
inlawrev-25507	582	75	patent	patent	NOUN
inlawrev-25507	582	76	.	.	PUNCT
inlawrev-25507	583	1	additionally	additionally	ADV
inlawrev-25507	583	2	,	,	PUNCT
inlawrev-25507	583	3	this	this	DET
inlawrev-25507	583	4	statute	statute	NOUN
inlawrev-25507	583	5	would	would	AUX
inlawrev-25507	583	6	prevent	prevent	VERB
inlawrev-25507	583	7	placing	place	VERB
inlawrev-25507	583	8	the	the	DET
inlawrev-25507	583	9	power	power	NOUN
inlawrev-25507	583	10	of	of	ADP
inlawrev-25507	583	11	regulating	regulate	VERB
inlawrev-25507	583	12	a	a	DET
inlawrev-25507	583	13	patent	patent	NOUN
inlawrev-25507	583	14	law	law	NOUN
inlawrev-25507	583	15	issue	issue	NOUN
inlawrev-25507	583	16	on	on	ADP
inlawrev-25507	583	17	the	the	DET
inlawrev-25507	583	18	legislature	legislature	NOUN
inlawrev-25507	583	19	when	when	SCONJ
inlawrev-25507	583	20	it	it	PRON
inlawrev-25507	583	21	should	should	AUX
inlawrev-25507	583	22	remain	remain	VERB
inlawrev-25507	583	23	with	with	ADP
inlawrev-25507	583	24	the	the	DET
inlawrev-25507	583	25	uspto	uspto	NOUN
inlawrev-25507	583	26	,	,	PUNCT
inlawrev-25507	583	27	the	the	DET
inlawrev-25507	583	28	ptab	ptab	NOUN
inlawrev-25507	583	29	,	,	PUNCT
inlawrev-25507	583	30	and	and	CCONJ
inlawrev-25507	583	31	the	the	DET
inlawrev-25507	583	32	federal	federal	ADJ
inlawrev-25507	583	33	circuit	circuit	NOUN
inlawrev-25507	583	34	.	.	PUNCT
inlawrev-25507	584	1	however	however	ADV
inlawrev-25507	584	2	,	,	PUNCT
inlawrev-25507	584	3	it	it	PRON
inlawrev-25507	584	4	would	would	AUX
inlawrev-25507	584	5	allow	allow	VERB
inlawrev-25507	584	6	the	the	DET
inlawrev-25507	584	7	legislature	legislature	NOUN
inlawrev-25507	584	8	to	to	PART
inlawrev-25507	584	9	still	still	ADV
inlawrev-25507	584	10	alleviate	alleviate	VERB
inlawrev-25507	584	11	the	the	DET
inlawrev-25507	584	12	evergreening	evergreene	VERB
inlawrev-25507	584	13	issue	issue	NOUN
inlawrev-25507	584	14	and	and	CCONJ
inlawrev-25507	584	15	help	help	VERB
inlawrev-25507	584	16	decrease	decrease	VERB
inlawrev-25507	584	17	the	the	DET
inlawrev-25507	584	18	costs	cost	NOUN
inlawrev-25507	584	19	of	of	ADP
inlawrev-25507	584	20	drug	drug	NOUN
inlawrev-25507	584	21	prices	price	NOUN
inlawrev-25507	584	22	.	.	PUNCT
inlawrev-25507	585	1	(	(	PUNCT
inlawrev-25507	585	2	jul	jul	PROPN
inlawrev-25507	585	3	.	.	PROPN
inlawrev-25507	585	4	18	18	NUM
inlawrev-25507	585	5	,	,	PUNCT
inlawrev-25507	585	6	2019	2019	NUM
inlawrev-25507	585	7	,	,	PUNCT
inlawrev-25507	585	8	6:29	6:29	NUM
inlawrev-25507	585	9	pm	pm	NOUN
inlawrev-25507	585	10	)	)	PUNCT
inlawrev-25507	585	11	,	,	PUNCT
inlawrev-25507	585	12	https://www.usatoday.com/story/opinion/2019/07/18/big-pharma-playsgames-drug-patents-you-pay-editorials-debates/1769746001/	https://www.usatoday.com/story/opinion/2019/07/18/big-pharma-playsgames-drug-patents-you-pay-editorials-debates/1769746001/	NOUN
inlawrev-25507	586	1	[	[	X
inlawrev-25507	586	2	https://perma.cc/p4zr-qudc	https://perma.cc/p4zr-qudc	NOUN
inlawrev-25507	586	3	]	]	X
inlawrev-25507	586	4	.	.	PUNCT
inlawrev-25507	587	1	199	199	NUM
inlawrev-25507	587	2	.	.	PUNCT
inlawrev-25507	588	1	robert	robert	PROPN
inlawrev-25507	588	2	king	king	PROPN
inlawrev-25507	588	3	,	,	PUNCT
inlawrev-25507	588	4	senators	senator	NOUN
inlawrev-25507	588	5	want	want	VERB
inlawrev-25507	588	6	to	to	PART
inlawrev-25507	588	7	clamp	clamp	VERB
inlawrev-25507	588	8	down	down	ADP
inlawrev-25507	588	9	on	on	ADP
inlawrev-25507	588	10	drugmakers	drugmaker	NOUN
inlawrev-25507	588	11	’	'	PUNCT
inlawrev-25507	588	12	patent	patent	NOUN
inlawrev-25507	588	13	protections	protection	NOUN
inlawrev-25507	588	14	,	,	PUNCT
inlawrev-25507	588	15	wash	wash	NOUN
inlawrev-25507	588	16	.	.	PUNCT
inlawrev-25507	589	1	examiner	examiner	PROPN
inlawrev-25507	589	2	(	(	PUNCT
inlawrev-25507	589	3	dec	dec	PROPN
inlawrev-25507	589	4	.	.	PROPN
inlawrev-25507	589	5	12	12	NUM
inlawrev-25507	589	6	,	,	PUNCT
inlawrev-25507	589	7	2017	2017	NUM
inlawrev-25507	589	8	,	,	PUNCT
inlawrev-25507	589	9	3:33	3:33	NUM
inlawrev-25507	589	10	pm	pm	NOUN
inlawrev-25507	589	11	)	)	PUNCT
inlawrev-25507	589	12	,	,	PUNCT
inlawrev-25507	589	13	https://www.washingtonexaminer.com/senators-want-toclamp-down-on-drugmakers-patent-protections	https://www.washingtonexaminer.com/senators-want-toclamp-down-on-drugmakers-patent-protection	NOUN
inlawrev-25507	590	1	[	[	X
inlawrev-25507	590	2	https://perma.cc/ds96-cfxg	https://perma.cc/ds96-cfxg	X
inlawrev-25507	590	3	]	]	X
inlawrev-25507	590	4	.	.	PUNCT
inlawrev-25507	591	1	200	200	NUM
inlawrev-25507	591	2	.	.	PUNCT
inlawrev-25507	592	1	i	i	PRON
inlawrev-25507	592	2	d.	d.	PROPN
inlawrev-25507	592	3	201	201	NUM
inlawrev-25507	592	4	.	.	PUNCT
inlawrev-25507	593	1	see	see	VERB
inlawrev-25507	593	2	brachmann	brachmann	PROPN
inlawrev-25507	593	3	,	,	PUNCT
inlawrev-25507	593	4	congress	congress	PROPN
inlawrev-25507	593	5	adds	add	VERB
inlawrev-25507	593	6	term	term	PROPN
inlawrev-25507	593	7	act	act	PROPN
inlawrev-25507	593	8	,	,	PUNCT
inlawrev-25507	593	9	supra	supra	PROPN
inlawrev-25507	593	10	note	note	PROPN
inlawrev-25507	593	11	108	108	NUM
inlawrev-25507	593	12	.	.	PUNCT
inlawrev-25507	594	1	202	202	NUM
inlawrev-25507	594	2	.	.	PUNCT
inlawrev-25507	595	1	noonan	noonan	PROPN
inlawrev-25507	595	2	,	,	PUNCT
inlawrev-25507	595	3	supra	supra	PROPN
inlawrev-25507	595	4	note	note	VERB
inlawrev-25507	595	5	73	73	NUM
inlawrev-25507	595	6	.	.	PUNCT
inlawrev-25507	596	1	203	203	NUM
inlawrev-25507	596	2	.	.	PUNCT
inlawrev-25507	596	3	patent	patent	NOUN
inlawrev-25507	596	4	examiner	examiner	NOUN
inlawrev-25507	596	5	:	:	PUNCT
inlawrev-25507	596	6	everything	everything	PRON
inlawrev-25507	596	7	you	you	PRON
inlawrev-25507	596	8	need	need	VERB
inlawrev-25507	596	9	to	to	PART
inlawrev-25507	596	10	know	know	VERB
inlawrev-25507	596	11	,	,	PUNCT
inlawrev-25507	596	12	supra	supra	PROPN
inlawrev-25507	596	13	note	note	PROPN
inlawrev-25507	596	14	117	117	NUM
inlawrev-25507	596	15	;	;	PUNCT
inlawrev-25507	596	16	court	court	NOUN
inlawrev-25507	596	17	jurisdiction	jurisdiction	NOUN
inlawrev-25507	596	18	,	,	PUNCT
inlawrev-25507	596	19	supra	supra	PROPN
inlawrev-25507	596	20	note	note	PROPN
inlawrev-25507	596	21	118	118	NUM
inlawrev-25507	596	22	;	;	PUNCT
inlawrev-25507	596	23	judges	judge	NOUN
inlawrev-25507	596	24	,	,	PUNCT
inlawrev-25507	596	25	supra	supra	PROPN
inlawrev-25507	596	26	note	note	PROPN
inlawrev-25507	596	27	119	119	NUM
inlawrev-25507	596	28	.	.	PUNCT
inlawrev-25507	596	29	204	204	NUM
inlawrev-25507	596	30	.	.	PUNCT
inlawrev-25507	597	1	see	see	VERB
inlawrev-25507	597	2	mpep	mpep	PROPN
inlawrev-25507	597	3	§	§	PROPN
inlawrev-25507	597	4	1504.06	1504.06	NUM
inlawrev-25507	597	5	(	(	PUNCT
inlawrev-25507	597	6	9th	9th	ADJ
inlawrev-25507	597	7	ed	ed	NOUN
inlawrev-25507	597	8	.	.	PUNCT
inlawrev-25507	598	1	rev	rev	PROPN
inlawrev-25507	598	2	.	.	PROPN
inlawrev-25507	598	3	10.2019	10.2019	NUM
inlawrev-25507	598	4	,	,	PUNCT
inlawrev-25507	598	5	june	june	PROPN
inlawrev-25507	598	6	2020	2020	NUM
inlawrev-25507	598	7	)	)	PUNCT
inlawrev-25507	598	8	.	.	PUNCT
inlawrev-25507	599	1	220	220	NUM
inlawrev-25507	599	2	indiana	indiana	PROPN
inlawrev-25507	599	3	law	law	PROPN
inlawrev-25507	599	4	review	review	NOUN
inlawrev-25507	599	5	[	[	X
inlawrev-25507	599	6	vol	vol	NOUN
inlawrev-25507	599	7	.	.	PUNCT
inlawrev-25507	600	1	54:195	54:195	NUM
inlawrev-25507	600	2	the	the	DET
inlawrev-25507	600	3	balancing	balancing	NOUN
inlawrev-25507	600	4	test	test	NOUN
inlawrev-25507	600	5	alone	alone	ADV
inlawrev-25507	600	6	or	or	CCONJ
inlawrev-25507	600	7	both	both	CCONJ
inlawrev-25507	600	8	the	the	DET
inlawrev-25507	600	9	balancing	balancing	NOUN
inlawrev-25507	600	10	test	test	NOUN
inlawrev-25507	600	11	and	and	CCONJ
inlawrev-25507	600	12	the	the	DET
inlawrev-25507	600	13	statute	statute	NOUN
inlawrev-25507	600	14	enacted	enact	VERB
inlawrev-25507	600	15	can	can	AUX
inlawrev-25507	600	16	eliminate	eliminate	VERB
inlawrev-25507	600	17	the	the	DET
inlawrev-25507	600	18	evergreening	evergreene	VERB
inlawrev-25507	600	19	issue	issue	NOUN
inlawrev-25507	600	20	without	without	ADP
inlawrev-25507	600	21	impeding	impede	VERB
inlawrev-25507	600	22	further	further	ADJ
inlawrev-25507	600	23	research	research	NOUN
inlawrev-25507	600	24	and	and	CCONJ
inlawrev-25507	600	25	development	development	NOUN
inlawrev-25507	600	26	.	.	PUNCT
inlawrev-25507	601	1	as	as	ADP
inlawrev-25507	601	2	a	a	DET
inlawrev-25507	601	3	result	result	NOUN
inlawrev-25507	601	4	,	,	PUNCT
inlawrev-25507	601	5	drug	drug	NOUN
inlawrev-25507	601	6	prices	price	NOUN
inlawrev-25507	601	7	will	will	AUX
inlawrev-25507	601	8	not	not	PART
inlawrev-25507	601	9	only	only	ADV
inlawrev-25507	601	10	decrease	decrease	VERB
inlawrev-25507	601	11	due	due	ADP
inlawrev-25507	601	12	to	to	ADP
inlawrev-25507	601	13	the	the	DET
inlawrev-25507	601	14	allowance	allowance	NOUN
inlawrev-25507	601	15	of	of	ADP
inlawrev-25507	601	16	generic	generic	ADJ
inlawrev-25507	601	17	drugs	drug	NOUN
inlawrev-25507	601	18	on	on	ADP
inlawrev-25507	601	19	the	the	DET
inlawrev-25507	601	20	market	market	NOUN
inlawrev-25507	601	21	at	at	ADP
inlawrev-25507	601	22	the	the	DET
inlawrev-25507	601	23	end	end	NOUN
inlawrev-25507	601	24	of	of	ADP
inlawrev-25507	601	25	an	an	DET
inlawrev-25507	601	26	innovator	innovator	NOUN
inlawrev-25507	601	27	’s	’s	PART
inlawrev-25507	601	28	exclusivity	exclusivity	NOUN
inlawrev-25507	601	29	period	period	NOUN
inlawrev-25507	601	30	,	,	PUNCT
inlawrev-25507	601	31	but	but	CCONJ
inlawrev-25507	601	32	it	it	PRON
inlawrev-25507	601	33	would	would	AUX
inlawrev-25507	601	34	also	also	ADV
inlawrev-25507	601	35	work	work	VERB
inlawrev-25507	601	36	to	to	PART
inlawrev-25507	601	37	protect	protect	VERB
inlawrev-25507	601	38	legitimate	legitimate	ADJ
inlawrev-25507	601	39	innovation	innovation	NOUN
inlawrev-25507	601	40	on	on	ADP
inlawrev-25507	601	41	a	a	DET
inlawrev-25507	601	42	known	know	VERB
inlawrev-25507	601	43	drug	drug	NOUN
inlawrev-25507	601	44	.	.	PUNCT